Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Balod,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Balod,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Balod,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Balod,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Balod,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Balod,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Balod,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Balod,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Balod,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Balod,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Balod,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Balod,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Balod,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Balod,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Balod,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Balod,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Balod,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Balod,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Balod,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Balod,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Balod,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Balod,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Balod,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Balod,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balod,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balod,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Balod,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Balod,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Balod,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Balod,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Balod,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Balod,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Balod,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Balod,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Balod,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Balod,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Balod,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Balod,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Balod,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Balod,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Balod,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Balod,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Balod,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Balod,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Balod,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Balod,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Balod,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Balod,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Balod,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Balod,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Balod,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Balod,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Balod,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Balod,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Balod,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Balod,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Balod,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balod,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balod,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Balod,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balod,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balod,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Balod,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balod,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balod,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Balod,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balod,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balod,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Balod,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balod,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Balod,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Balod,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balod,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Balod,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Balod,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Balod,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Balod,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Balod,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Balod,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Balod,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Balod,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Balod,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Balod,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balod,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balod,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Balod,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Balod,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Balod,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Balod,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balod,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balod,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Balod,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Balod,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Balod,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Balod,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balod,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balod,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balod,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Balod,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Balod,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Balod,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Balod,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Balod,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Balod,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Balod,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balod,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Balod,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Balod,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Balod,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Balod,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Balod,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Balod,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Balod,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Balod,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Balod,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Balod,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Balod,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Balod,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Balod,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Balod,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Balod,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Balod,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Balod,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Balod,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Balod,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Balod,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Balod,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Balod,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Balod,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Balod,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Balod,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Balod,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Balod,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Balod,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Balod,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Balod,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Balod,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Balod,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Balod,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Balod,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Balod,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Balod,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Balod,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Balod,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Balod,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Balod,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Balod,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Balod,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Balod,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Balod,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Balod,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Balod,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Balod,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Balod,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Balod,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Balod,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Balod,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Balod,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balod,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Balod,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balod,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balod,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Balod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Balod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Balod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Balod,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balod,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Balod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balod,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Balod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balod,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Balod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balod,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Balod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balod,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Balod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balod,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Balod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balod,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Balod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balod,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Balod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balod,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Balod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Balod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Balod,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Balod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Balod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Balod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Balod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Balod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Balod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Balod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Balod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Balod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Balod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Balod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Balod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Balod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Balod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Balod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Balod,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Balod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Balod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Balod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Balod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Balod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Balod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Balod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Balod,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Baloda Bazar,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Baloda Bazar,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Baloda Bazar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Baloda Bazar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Baloda Bazar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Baloda Bazar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Baloda Bazar,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Baloda Bazar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Baloda Bazar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Baloda Bazar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Baloda Bazar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Baloda Bazar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Baloda Bazar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Baloda Bazar,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Baloda Bazar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Baloda Bazar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Baloda Bazar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Baloda Bazar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Baloda Bazar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Baloda Bazar,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Baloda Bazar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Baloda Bazar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Baloda Bazar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Baloda Bazar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Baloda Bazar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Baloda Bazar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Baloda Bazar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Baloda Bazar,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Baloda Bazar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Baloda Bazar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Baloda Bazar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Baloda Bazar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Baloda Bazar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Baloda Bazar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Baloda Bazar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Baloda Bazar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Baloda Bazar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Baloda Bazar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Baloda Bazar,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Baloda Bazar,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Baloda Bazar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Baloda Bazar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Baloda Bazar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Baloda Bazar,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Baloda Bazar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Baloda Bazar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Baloda Bazar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Baloda Bazar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Baloda Bazar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Baloda Bazar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Baloda Bazar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Baloda Bazar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Baloda Bazar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Baloda Bazar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baloda Bazar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Baloda Bazar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baloda Bazar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Baloda Bazar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baloda Bazar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Baloda Bazar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Baloda Bazar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Baloda Bazar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Baloda Bazar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baloda Bazar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Baloda Bazar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baloda Bazar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Baloda Bazar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baloda Bazar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Baloda Bazar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Baloda Bazar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Baloda Bazar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Baloda Bazar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Baloda Bazar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Baloda Bazar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Baloda Bazar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Baloda Bazar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Balrampur,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Balrampur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Balrampur,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Balrampur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Balrampur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Balrampur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Balrampur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Balrampur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Balrampur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Balrampur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Balrampur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Balrampur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Balrampur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Balrampur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Balrampur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Balrampur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Balrampur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Balrampur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Balrampur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Balrampur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Balrampur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Balrampur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Balrampur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Balrampur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balrampur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Balrampur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Balrampur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Balrampur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Balrampur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Balrampur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Balrampur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Balrampur,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Balrampur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Balrampur,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Balrampur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Balrampur,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Balrampur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Balrampur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Balrampur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Balrampur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Balrampur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Balrampur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Balrampur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Balrampur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Balrampur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Balrampur,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Balrampur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Balrampur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Balrampur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Balrampur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Balrampur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Balrampur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Balrampur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Balrampur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Balrampur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Balrampur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Balrampur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Balrampur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Balrampur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Balrampur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Balrampur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Balrampur,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Balrampur,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Balrampur,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Balrampur,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Balrampur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Balrampur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Balrampur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Balrampur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Balrampur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Balrampur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Balrampur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Balrampur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Balrampur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Balrampur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Balrampur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Balrampur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balrampur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balrampur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Balrampur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Balrampur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Balrampur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Balrampur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Balrampur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Balrampur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Balrampur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Balrampur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Balrampur,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Balrampur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Balrampur,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Balrampur,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Balrampur,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Balrampur,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Balrampur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Balrampur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Balrampur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Balrampur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Balrampur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Balrampur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Balrampur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Balrampur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Balrampur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Balrampur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Balrampur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Balrampur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Balrampur,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Balrampur,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Balrampur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Balrampur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Balrampur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Balrampur,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Balrampur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Balrampur,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Balrampur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Balrampur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Balrampur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Balrampur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Balrampur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Balrampur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Balrampur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Balrampur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Balrampur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Balrampur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Balrampur,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Balrampur,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Balrampur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Balrampur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Balrampur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Balrampur,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Balrampur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Balrampur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Balrampur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Balrampur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Balrampur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Balrampur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Balrampur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Balrampur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Balrampur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balrampur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balrampur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Balrampur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balrampur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balrampur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Balrampur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balrampur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balrampur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Balrampur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Balrampur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Balrampur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Balrampur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balrampur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balrampur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Balrampur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balrampur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balrampur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Balrampur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balrampur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balrampur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Balrampur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Balrampur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Balrampur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Balrampur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Balrampur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Balrampur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Balrampur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Balrampur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Balrampur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Balrampur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Balrampur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Balrampur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Balrampur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Balrampur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Balrampur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Balrampur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Balrampur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Balrampur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Balrampur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Balrampur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Balrampur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Balrampur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Balrampur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Balrampur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Balrampur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Balrampur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,2.0,,,,,,,,,,2.0
Balrampur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,3.0,,,,,,,,,,3.0
Bastar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3258.0,3666.0,3877.0,4131.0,4382.0,3465.0,4192.0,4036.0,4348.0,3771.0,3236.0,3257.0,45619.0
Bastar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,941.0,943.0,1201.0,1108.0,1133.0,1012.0,1239.0,1163.0,1254.0,1140.0,1016.0,1026.0,13176.0
Bastar,1.2,Number of Pregnant women registered under JSY,TOTAL,3172.0,3539.0,3646.0,3894.0,4129.0,3337.0,3986.0,3867.0,4181.0,3719.0,3191.0,3225.0,43886.0
Bastar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1915.0,2165.0,2398.0,2556.0,2613.0,2478.0,2745.0,2478.0,2854.0,2660.0,2639.0,3028.0,30529.0
Bastar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1585.0,1901.0,1926.0,1987.0,2217.0,1960.0,2138.0,2000.0,2123.0,2068.0,1722.0,1765.0,23392.0
Bastar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2142.0,2467.0,2613.0,2759.0,2974.0,2574.0,2846.0,2864.0,3054.0,3011.0,3251.0,2916.0,33471.0
Bastar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1951.0,1942.0,2193.0,2497.0,2314.0,2181.0,2400.0,2132.0,2997.0,2558.0,2411.0,2340.0,27916.0
Bastar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,180.0,229.0,135.0,239.0,215.0,207.0,206.0,228.0,167.0,275.0,168.0,280.0,2529.0
Bastar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,36.0,7.0,6.0,2.0,10.0,8.0,5.0,4.0,3.0,29.0,4.0,28.0,142.0
Bastar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,625.0,793.0,799.0,726.0,797.0,749.0,832.0,852.0,831.0,954.0,1113.0,1042.0,10113.0
Bastar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,158.0,135.0,81.0,115.0,187.0,55.0,130.0,87.0,78.0,147.0,46.0,47.0,1266.0
Bastar,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Bastar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,478.0,718.0,683.0,657.0,838.0,673.0,596.0,630.0,642.0,587.0,597.0,697.0,7796.0
Bastar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,224.0,291.0,349.0,340.0,337.0,355.0,347.0,344.0,387.0,330.0,315.0,376.0,3995.0
Bastar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,702.0,1009.0,1032.0,997.0,1175.0,1028.0,943.0,974.0,1029.0,917.0,912.0,1073.0,11791.0
Bastar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,559.0,803.0,851.0,776.0,964.0,838.0,763.0,809.0,836.0,740.0,733.0,877.0,9549.0
Bastar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,195.0,251.0,284.0,349.0,324.0,259.0,235.0,220.0,280.0,203.0,208.0,192.0,3000.0
Bastar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1406.0,1681.0,1654.0,2053.0,1985.0,1559.0,1530.0,1704.0,1506.0,1508.0,1494.0,2180.0,20260.0
Bastar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,565.0,630.0,788.0,902.0,789.0,545.0,626.0,663.0,594.0,635.0,487.0,726.0,7950.0
Bastar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1312.0,1569.0,1377.0,2135.0,1961.0,1692.0,1790.0,1678.0,1348.0,1299.0,1264.0,2665.0,20090.0
Bastar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1132.0,1243.0,1263.0,1744.0,1665.0,1478.0,1561.0,1404.0,1214.0,1155.0,1084.0,2081.0,17024.0
Bastar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,19.0,12.0,29.0,10.0,31.0,56.0,110.0,45.0,196.0,18.0,11.0,131.0,668.0
Bastar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,101.0,127.0,158.0,139.0,155.0,138.0,116.0,141.0,63.0,69.0,73.0,72.0,1352.0
Bastar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,95.0,117.0,146.0,134.0,139.0,90.0,106.0,99.0,42.0,39.0,37.0,45.0,1089.0
Bastar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,5.0,40.0,13.0,19.0,16.0,23.0,15.0,18.0,18.0,11.0,4.0,19.0,201.0
Bastar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,6.0,6.0,7.0,4.0,7.0,5.0,1.0,6.0,1.0,0.0,2.0,45.0
Bastar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0
Bastar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,7.0
Bastar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,13.0,60.0,22.0,51.0,40.0,14.0,27.0,29.0,14.0,60.0,28.0,52.0,410.0
Bastar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,13.0,60.0,22.0,51.0,40.0,14.0,27.0,29.0,19.0,60.0,28.0,59.0,422.0
Bastar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,57.0,62.0,53.0,42.0,60.0,62.0,54.0,24.0,20.0,26.0,51.0,24.0,535.0
Bastar,4.1.1.a,Number of male live births,TOTAL,1068.0,1438.0,1464.0,1552.0,1657.0,1384.0,1308.0,1429.0,1345.0,1269.0,1233.0,1653.0,16800.0
Bastar,4.1.1.b,Number of female live births,TOTAL,1052.0,1335.0,1358.0,1600.0,1561.0,1284.0,1252.0,1361.0,1239.0,1186.0,1207.0,1580.0,16015.0
Bastar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2120.0,2773.0,2822.0,3152.0,3218.0,2668.0,2560.0,2790.0,2584.0,2455.0,2440.0,3233.0,32815.0
Bastar,4.1.2,Number of still births,TOTAL,71.0,86.0,83.0,118.0,140.0,103.0,82.0,103.0,105.0,94.0,85.0,121.0,1191.0
Bastar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,72.0,78.0,95.0,93.0,99.0,69.0,60.0,99.0,70.0,59.0,51.0,63.0,908.0
Bastar,4.2.1,Number of Newborns weighed at birth,TOTAL,2056.0,2677.0,2603.0,2834.0,2935.0,2562.0,2473.0,2699.0,2424.0,2385.0,2353.0,3135.0,31136.0
Bastar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,336.0,443.0,356.0,617.0,478.0,374.0,399.0,426.0,386.0,255.0,348.0,579.0,4997.0
Bastar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2094.0,2654.0,2764.0,3006.0,3065.0,2516.0,2499.0,2632.0,2465.0,2426.0,2338.0,3000.0,31459.0
Bastar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,13.0
Bastar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,3.0,24.0,15.0,0.0,4.0,9.0,0.0,30.0,35.0,26.0,21.0,168.0
Bastar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,22.0,14.0,20.0,26.0,21.0,16.0,18.0,6.0,20.0,25.0,49.0,250.0
Bastar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,14.0,25.0,38.0,35.0,29.0,25.0,25.0,18.0,36.0,65.0,51.0,70.0,431.0
Bastar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,14.0,39.0,49.0,26.0,27.0,40.0,41.0,27.0,8.0,13.0,24.0,13.0,321.0
Bastar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,52.0,73.0,70.0,177.0,135.0,81.0,113.0,32.0,13.0,342.0,66.0,79.0,1233.0
Bastar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,17.0,18.0,13.0,21.0,12.0,21.0,26.0,8.0,0.0,12.0,11.0,13.0,172.0
Bastar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,53.0,116.0,207.0,235.0,167.0,55.0,95.0,42.0,37.0,74.0,56.0,85.0,1222.0
Bastar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,2.0,1.0,2.0,1.0,2.0,2.0,4.0,0.0,45.0,15.0,17.0,91.0
Bastar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1686.0,2140.0,2332.0,2360.0,2462.0,2052.0,1766.0,2072.0,1849.0,2221.0,1920.0,2597.0,25457.0
Bastar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1422.0,1789.0,1826.0,1873.0,2189.0,1711.0,1496.0,1830.0,1707.0,1443.0,1653.0,2250.0,21189.0
Bastar,6.3,PNC maternal complications attended,TOTAL,37.0,98.0,251.0,45.0,114.0,93.0,39.0,23.0,38.0,36.0,12.0,31.0,817.0
Bastar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,6.0,3.0,5.0,0.0,1.0,3.0,4.0,3.0,13.0,7.0,10.0,56.0
Bastar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,1.0,1.0,3.0,0.0,2.0,1.0,4.0,0.0,7.0,1.0,0.0,22.0
Bastar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,7.0,4.0,8.0,0.0,3.0,4.0,8.0,3.0,20.0,8.0,10.0,78.0
Bastar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,45.0,48.0,42.0,44.0,34.0,37.0,3.0,51.0,2.0,15.0,4.0,3.0,328.0
Bastar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,38.0,39.0,45.0,48.0,32.0,39.0,73.0,38.0,31.0,32.0,28.0,33.0,476.0
Bastar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,54.0,74.0,41.0,51.0,25.0,55.0,76.0,47.0,38.0,45.0,46.0,33.0,585.0
Bastar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,92.0,113.0,86.0,99.0,57.0,94.0,149.0,85.0,69.0,77.0,74.0,66.0,1061.0
Bastar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Bastar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,4.0,0.0,0.0,20.0,13.0,19.0,27.0,9.0,11.0,21.0,6.0,6.0,136.0
Bastar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,15.0,4.0,5.0,72.0,132.0,116.0,104.0,43.0,81.0,96.0,45.0,27.0,740.0
Bastar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,6.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,18.0
Bastar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,19.0,4.0,5.0,98.0,146.0,135.0,131.0,52.0,92.0,117.0,51.0,44.0,894.0
Bastar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,29.0,88.0,78.0,82.0,268.0,42.0,0.0,167.0,0.0,40.0,794.0
Bastar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,20.0,100.0,394.0,202.0,212.0,323.0,131.0,391.0,641.0,253.0,50.0,2717.0
Bastar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,104.0,33.0,0.0,0.0,0.0,70.0,53.0,2.0,112.0,374.0
Bastar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,20.0,129.0,586.0,313.0,294.0,591.0,173.0,461.0,861.0,255.0,202.0,3885.0
Bastar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,13.0,12.0,10.0,14.0,12.0,8.0,0.0,14.0,0.0,1.0,2.0,5.0,91.0
Bastar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,23.0
Bastar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,29.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0,68.0
Bastar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,22.0,29.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,91.0
Bastar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,6.0,4.0,0.0,5.0,3.0,1.0,3.0,0.0,0.0,0.0,0.0,26.0
Bastar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,10.0,0.0,225.0,0.0,0.0,0.0,0.0,0.0,235.0
Bastar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,6.0
Bastar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,3.0,0.0,0.0,10.0,0.0,225.0,0.0,0.0,0.0,3.0,0.0,241.0
Bastar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,1.0,0.0,1.0,5.0,1.0,1.0,0.0,0.0,5.0,0.0,14.0
Bastar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,211.0,363.0,343.0,476.0,382.0,359.0,332.0,261.0,233.0,285.0,276.0,259.0,3780.0
Bastar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,3.0,9.0,13.0,19.0,28.0,11.0,3.0,8.0,9.0,6.0,7.0,6.0,122.0
Bastar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7.0,3.0,4.0,52.0,27.0,12.0,14.0,10.0,13.0,8.0,5.0,13.0,168.0
Bastar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,36.0,24.0,21.0,19.0,103.0,25.0,18.0,21.0,0.0,1.0,25.0,30.0,323.0
Bastar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bastar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,257.0,399.0,381.0,566.0,540.0,407.0,367.0,300.0,255.0,300.0,313.0,308.0,4393.0
Bastar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,38.0,5.0,26.0,26.0,29.0,35.0,18.0,27.0,0.0,1.0,25.0,26.0,256.0
Bastar,9.06,Number of IUCD removals,TOTAL,458.0,326.0,370.0,426.0,544.0,353.0,321.0,544.0,557.0,480.0,402.0,489.0,5270.0
Bastar,9.07,Number of Oral Pills cycles distributed,TOTAL,11367.0,11156.0,9494.0,11533.0,11556.0,11810.0,11968.0,13813.0,12777.0,13479.0,13854.0,12776.0,145583.0
Bastar,9.08,Number of Condom pieces distributed,TOTAL,87322.0,98638.0,84362.0,86840.0,91126.0,97259.0,75579.0,81046.0,73114.0,82024.0,77529.0,75650.0,1010489.0
Bastar,9.09,Number of Centchroman (weekly) pills given,TOTAL,573.0,276.0,432.0,1975.0,305.0,340.0,2535.0,985.0,1841.0,580.0,39.0,858.0,10739.0
Bastar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,201.0,210.0,218.0,898.0,273.0,53.0,154.0,102.0,87.0,259.0,268.0,114.0,2837.0
Bastar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,3.0,0.0,0.0,13.0,26.0,8.0,13.0,16.0,6.0,11.0,5.0,2.0,103.0
Bastar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,3.0,3.0,36.0,108.0,82.0,67.0,108.0,60.0,59.0,146.0,74.0,24.0,770.0
Bastar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,2.0,2.0,2.0,0.0,2.0,13.0,2.0,4.0,5.0,2.0,1.0,35.0
Bastar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,2.0,11.0,6.0,3.0,6.0,12.0,1.0,6.0,3.0,2.0,17.0,69.0
Bastar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,12.0,14.0,10.0,11.0,13.0,14.0,12.0,30.0,38.0,35.0,34.0,-1.0
Bastar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1780.0,2613.0,2632.0,2602.0,3209.0,2441.0,2557.0,2438.0,2470.0,2598.0,2192.0,3635.0,31167.0
Bastar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1770.0,2475.0,2700.0,2582.0,2980.0,2608.0,2741.0,2395.0,2418.0,2687.0,2590.0,2949.0,30895.0
Bastar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2033.0,2364.0,2505.0,2598.0,2885.0,2614.0,2712.0,2677.0,2496.0,2490.0,2646.0,3093.0,31113.0
Bastar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2168.0,2592.0,2514.0,2353.0,2910.0,2588.0,2819.0,2731.0,2680.0,2549.0,2555.0,3167.0,31626.0
Bastar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,919.0,1250.0,1219.0,1359.0,1619.0,1271.0,1224.0,1101.0,1260.0,1249.0,1041.0,1555.0,15067.0
Bastar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1742.0,2437.0,2692.0,2548.0,2923.0,2562.0,2628.0,2374.0,2409.0,2687.0,2525.0,2908.0,30435.0
Bastar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2008.0,2320.0,2471.0,2613.0,2905.0,2601.0,2633.0,2651.0,2510.0,2473.0,2583.0,3030.0,30798.0
Bastar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2127.0,2561.0,2514.0,2332.0,2866.0,2509.0,2745.0,2682.0,2656.0,2539.0,2507.0,3046.0,31084.0
Bastar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,49.0,33.0,38.0,45.0,51.0,37.0,164.0,118.0,186.0,113.0,92.0,154.0,1080.0
Bastar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,73.0,90.0,113.0,107.0,132.0,125.0,2098.0,2431.0,2024.0,2083.0,1996.0,2491.0,13763.0
Bastar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,64.0,56.0,123.0,77.0,88.0,109.0,460.0,1666.0,1593.0,1760.0,1971.0,2292.0,10259.0
Bastar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,89.0,74.0,99.0,99.0,94.0,109.0,506.0,668.0,1424.0,1677.0,1818.0,2291.0,8948.0
Bastar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1461.0,2066.0,2223.0,2064.0,3074.0,2416.0,2483.0,1976.0,3825.0,2775.0,2033.0,3081.0,29477.0
Bastar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,50.0,14.0,77.0,72.0,33.0,53.0,65.0,73.0,183.0,139.0,58.0,108.0,925.0
Bastar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,717.0,998.0,1112.0,991.0,1538.0,1163.0,1156.0,1012.0,1783.0,1512.0,928.0,1444.0,14354.0
Bastar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,678.0,951.0,1060.0,997.0,1546.0,1152.0,1239.0,941.0,1725.0,1526.0,902.0,1442.0,14159.0
Bastar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1395.0,1949.0,2172.0,1988.0,3084.0,2315.0,2395.0,1953.0,3508.0,3038.0,1830.0,2886.0,28513.0
Bastar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1121.0,1714.0,1744.0,1936.0,3334.0,2357.0,2262.0,1922.0,2656.0,2504.0,1939.0,2394.0,25883.0
Bastar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1120.0,1711.0,1765.0,1918.0,3326.0,2327.0,2958.0,1894.0,2649.0,2516.0,1924.0,2377.0,26485.0
Bastar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,59.0,32.0,64.0,45.0,127.0,103.0,60.0,58.0,1066.0,132.0,101.0,82.0,1929.0
Bastar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,321.0,225.0,377.0,335.0,345.0,327.0,361.0,417.0,1234.0,514.0,308.0,344.0,5108.0
Bastar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,273.0,222.0,331.0,332.0,368.0,340.0,363.0,418.0,1346.0,502.0,307.0,351.0,5153.0
Bastar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,594.0,447.0,708.0,667.0,713.0,667.0,724.0,835.0,2580.0,1016.0,615.0,695.0,10261.0
Bastar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,223.0,462.0,573.0,793.0,4132.0,3380.0,2324.0,1486.0,1976.0,2724.0,1910.0,1748.0,21731.0
Bastar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,431.0,871.0,1036.0,1254.0,6332.0,6035.0,6022.0,2646.0,1822.0,2940.0,2077.0,1980.0,33446.0
Bastar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,395.0,820.0,982.0,1089.0,3831.0,3991.0,5468.0,2719.0,2167.0,3351.0,2380.0,2028.0,29221.0
Bastar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14.0,44.0,37.0,32.0,18.0,22.0,36.0,73.0,31.0,33.0,62.0,60.0,462.0
Bastar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14.0,36.0,17.0,27.0,44.0,43.0,48.0,28.0,39.0,30.0,72.0,59.0,457.0
Bastar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1753.0,2069.0,2045.0,2074.0,2161.0,2122.0,2119.0,2102.0,2207.0,2159.0,2149.0,2116.0,25076.0
Bastar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1217.0,1664.0,1670.0,1622.0,1914.0,1685.0,1700.0,1671.0,2023.0,1872.0,1663.0,1826.0,20527.0
Bastar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1033.0,1446.0,1438.0,1430.0,1719.0,1466.0,1528.0,1471.0,1824.0,1623.0,1492.0,1671.0,18141.0
Bastar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0,0.0,0.0,0.0,0.0,23.0
Bastar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1340.0,1887.0,2087.0,1824.0,3438.0,2519.0,2343.0,1875.0,3179.0,2993.0,2060.0,2963.0,28508.0
Bastar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,155.0,342.0,226.0,646.0,11665.0,2048.0,406.0,361.0,4783.0,7245.0,752.0,485.0,29114.0
Bastar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,73.0,217.0,79.0,592.0,11916.0,1965.0,201.0,187.0,4815.0,7836.0,630.0,270.0,28781.0
Bastar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,4.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Bastar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,20.0,12.0,19.0,17.0,14.0,12.0,12.0,17.0,27.0,10.0,12.0,14.0,186.0
Bastar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,50.0,47.0,75.0,48.0,54.0,60.0,89.0,65.0,86.0,45.0,85.0,41.0,745.0
Bastar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,737.0,1089.0,1252.0,1418.0,1328.0,1463.0,1108.0,939.0,1030.0,924.0,1026.0,1247.0,13561.0
Bastar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,399.0,191.0,867.0,525.0,787.0,632.0,544.0,505.0,423.0,469.0,301.0,309.0,5952.0
Bastar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,200.0,326.0,226.0,278.0,300.0,320.0,342.0,270.0,288.0,320.0,347.0,385.0,3602.0
Bastar,13.1,Number of Patients operated for cataract,TOTAL,0.0,4.0,0.0,464.0,1.0,3.0,0.0,0.0,323.0,32.0,10.0,0.0,837.0
Bastar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,4.0,0.0,384.0,1.0,3.0,0.0,0.0,323.0,32.0,9.0,0.0,756.0
Bastar,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,1.0,0.0,0.0,12.0,13.0,0.0,22.0,15.0,58.0,33.0,14.0,170.0
Bastar,13.4,Number of children provided free glasses,TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bastar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,6.0,5.0,5.0,5.0,7.0,9.0,8.0,7.0,8.0,10.0,9.0,-1.0
Bastar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,9.0,4.0,5.0,5.0,9.0,4.0,7.0,19.0,18.0,15.0,16.0,-1.0
Bastar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1516.0,1926.0,2009.0,1925.0,2064.0,1928.0,1919.0,2079.0,2044.0,1981.0,1853.0,2105.0,-1.0
Bastar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,11.0,10.0,10.0,13.0,12.0,12.0,13.0,10.0,14.0,11.0,10.0,-1.0
Bastar,14.05,Number of RKS meetings held during the month,TOTAL,25.0,24.0,20.0,22.0,24.0,22.0,20.0,24.0,19.0,25.0,18.0,18.0,261.0
Bastar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,17.0,16.0,16.0,18.0,19.0,19.0,18.0,31.0,39.0,33.0,32.0,-1.0
Bastar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,217.0,241.0,272.0,260.0,311.0,223.0,329.0,320.0,333.0,322.0,229.0,312.0,3369.0
Bastar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,3.0,5.0,4.0,6.0,5.0,7.0,6.0,5.0,7.0,8.0,9.0,7.0,-1.0
Bastar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,289.0,1.0,0.0,0.0,0.0,0.0,107.0,-1.0
Bastar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,866.0,979.0,1071.0,1018.0,1091.0,1012.0,993.0,899.0,932.0,812.0,1147.0,1034.0,11854.0
Bastar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1634.0,2137.0,2216.0,2133.0,2954.0,2068.0,2044.0,1767.0,1277.0,1339.0,1747.0,1621.0,22937.0
Bastar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,879.0,969.0,1148.0,1001.0,1088.0,1160.0,950.0,926.0,766.0,783.0,1147.0,1019.0,11836.0
Bastar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1787.0,2383.0,2392.0,2557.0,2735.0,3065.0,2324.0,2436.0,1495.0,1959.0,2162.0,2539.0,27834.0
Bastar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1745.0,1948.0,2219.0,2019.0,2179.0,2172.0,1943.0,1825.0,1698.0,1595.0,2294.0,2053.0,23690.0
Bastar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3421.0,4520.0,4608.0,4690.0,5689.0,5133.0,4368.0,4203.0,2772.0,3298.0,3909.0,4160.0,50771.0
Bastar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,56.0,73.0,80.0,111.0,84.0,79.0,78.0,79.0,52.0,56.0,76.0,71.0,895.0
Bastar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,46.0,69.0,68.0,61.0,121.0,83.0,69.0,82.0,56.0,54.0,80.0,68.0,857.0
Bastar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,102.0,142.0,148.0,172.0,205.0,162.0,147.0,161.0,108.0,110.0,156.0,139.0,1752.0
Bastar,14.11,In-Patient Head Count at midnight,TOTAL,2528.0,3122.0,2812.0,3272.0,3275.0,2549.0,4596.0,2699.0,2699.0,2495.0,3095.0,3970.0,37112.0
Bastar,14.12.1,OPD attendance (All),TOTAL,45947.0,52441.0,59756.0,64592.0,77673.0,76783.0,70905.0,61462.0,55585.0,54643.0,65441.0,67549.0,752777.0
Bastar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,228.0,2991.0,108.0,178.0,221.0,108.0,36.0,72.0,76.0,213.0,113.0,64.0,4408.0
Bastar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,296.0,353.0,268.0,389.0,480.0,350.0,268.0,267.0,279.0,310.0,314.0,308.0,3882.0
Bastar,14.14.a,Number of patients given AYUSH treatment,TOTAL,1308.0,1419.0,1299.0,1725.0,2145.0,2075.0,1484.0,1620.0,2299.0,1909.0,2092.0,2184.0,21559.0
Bastar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,97.0,1.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,1.0,104.0
Bastar,14.14.c,Number of Adolescents counselled,TOTAL,0.0,37.0,15.0,2.0,20.0,14.0,32.0,2.0,3.0,7.0,10.0,18.0,160.0
Bastar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1293.0,2106.0,1693.0,1928.0,2416.0,2246.0,2153.0,2036.0,1769.0,2131.0,2110.0,2423.0,24304.0
Bastar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,175.0,244.0,109.0,118.0,127.0,242.0,112.0,129.0,119.0,115.0,191.0,190.0,1871.0
Bastar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,11.0,20.0,0.0,5.0,0.0,32.0,16.0,23.0,6.0,30.0,18.0,34.0,195.0
Bastar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,1.0,5.0,0.0,0.0,3.0,1.0,1.0,0.0,2.0,0.0,1.0,14.0
Bastar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2.0,3.0,0.0,0.0,2.0,3.0,22.0,43.0,108.0,70.0,39.0,52.0,344.0
Bastar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,6.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,9.0
Bastar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,0.0,54.0,0.0,0.0,0.0,15.0,0.0,0.0,0.0,0.0,43.0,48.0,160.0
Bastar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bastar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,13.0,77.0,0.0,5.0,2.0,50.0,38.0,66.0,114.0,100.0,100.0,134.0,699.0
Bastar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,1.0,5.0,0.0,6.0,4.0,3.0,1.0,0.0,2.0,1.0,1.0,24.0
Bastar,15.2,Number of Widal tests conducted,Number tested,141.0,121.0,93.0,155.0,113.0,222.0,171.0,168.0,153.0,152.0,111.0,106.0,1706.0
Bastar,15.3.a,Number of VDRL tests conducted on males,Number tested,54.0,151.0,61.0,71.0,12.0,12.0,9.0,6.0,3.0,20.0,14.0,12.0,425.0
Bastar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,19.0,35.0,14.0,17.0,36.0,6.0,8.0,8.0,5.0,107.0,67.0,34.0,356.0
Bastar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,12.0,4.0,0.0,38.0,42.0,16.0,0.0,0.0,3.0,6.0,3.0,5.0,129.0
Bastar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,85.0,190.0,75.0,126.0,90.0,34.0,17.0,14.0,11.0,133.0,84.0,51.0,910.0
Bastar,15.4.1,Number of blood smears examined for Malaria,TOTAL,6925.0,7001.0,8063.0,9413.0,12366.0,12962.0,11156.0,8732.0,9479.0,8338.0,9686.0,9371.0,113492.0
Bastar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,88.0,78.0,14.0,72.0,199.0,110.0,170.0,214.0,339.0,279.0,84.0,80.0,1727.0
Bastar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,577.0,676.0,596.0,1123.0,1441.0,983.0,682.0,1053.0,892.0,636.0,643.0,638.0,9940.0
Bastar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,29500.0,24500.0,24500.0,31500.0,8000.0,27500.0,38000.0,38000.0,40000.0,,,,261500.0
Bastar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,42000.0,20000.0,0.0,60000.0,50000.0,20000.0,20000.0,0.0,,,,212000.0
Bastar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,19500.0,42000.0,13000.0,23500.0,40500.0,39500.0,19500.0,19500.0,15000.0,,,,232000.0
Bastar,16.1.1,Stock position of DPT vaccines,5. Total Stock,10000.0,24500.0,31500.0,8000.0,27500.0,38000.0,38500.0,38500.0,25000.0,0.0,0.0,0.0,241500.0
Bastar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bastar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bastar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bastar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bastar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8500.0,17500.0,17500.0,19000.0,0.0,16500.0,1500.0,1500.0,56000.0,,,,138000.0
Bastar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,40000.0,20000.0,0.0,60000.0,20000.0,50000.0,50000.0,0.0,,,,265000.0
Bastar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16000.0,40000.0,18500.0,19000.0,43500.0,35000.0,20000.0,20000.0,29000.0,,,,241000.0
Bastar,16.1.2,Stock position of OPV vaccines,5. Total Stock,17500.0,17500.0,19000.0,0.0,16500.0,1500.0,31500.0,31500.0,27000.0,0.0,0.0,0.0,162000.0
Bastar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,55400.0,19800.0,19800.0,28800.0,6500.0,20000.0,27450.0,27450.0,34950.0,,,,240150.0
Bastar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,10000.0,20000.0,0.0,55000.0,50000.0,30000.0,30000.0,0.0,,,,195000.0
Bastar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,19400.0,10000.0,11000.0,22300.0,41500.0,42550.0,21500.0,21500.0,15000.0,,,,204750.0
Bastar,16.1.3,Stock position of TT vaccines,5. Total Stock,36000.0,19800.0,28800.0,6500.0,20000.0,27450.0,35950.0,35950.0,19950.0,0.0,0.0,0.0,230400.0
Bastar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11500.0,20800.0,20800.0,21500.0,6500.0,14000.0,18500.0,18500.0,16000.0,,,,148100.0
Bastar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,25000.0,20000.0,12000.0,0.0,35000.0,30000.0,10000.0,10000.0,0.0,,,,142000.0
Bastar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,13000.0,20000.0,11300.0,15000.0,27500.0,25500.0,10000.0,10000.0,6500.0,,,,138800.0
Bastar,16.1.5,Stock position of BCG vaccines,5. Total Stock,23500.0,20800.0,21500.0,6500.0,14000.0,18500.0,18500.0,18500.0,9500.0,0.0,0.0,0.0,151300.0
Bastar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6250.0,9400.0,9400.0,8750.0,3750.0,13000.0,12000.0,12000.0,126500.0,,,,201050.0
Bastar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,6000.0,0.0,25000.0,15000.0,10000.0,10000.0,100000.0,,,,186000.0
Bastar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7250.0,10000.0,6650.0,5000.0,15750.0,16000.0,6750.0,6750.0,185750.0,,,,259900.0
Bastar,16.1.6,Stock position of Measles vaccines,5. Total Stock,9000.0,9400.0,8750.0,3750.0,13000.0,12000.0,15250.0,15250.0,40750.0,0.0,0.0,0.0,127150.0
Bastar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,0.0,8200.0,,,,8200.0
Bastar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,,,0.0
Bastar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,0.0,5700.0,,,,5700.0
Bastar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2500.0,0.0,0.0,0.0,2500.0
Bastar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,0.0,1200.0,1200.0,1200.0,1200.0,,,4800.0
Bastar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1200.0,1200.0,1200.0,0.0,0.0,4800.0
Bastar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,0.0,0.0,63000.0,63000.0,27720.0,,,153720.0
Bastar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,6000.0,,,,,0.0,1025820.0,0.0,0.0,0.0,,,1031820.0
Bastar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,6000.0,,,,,0.0,962820.0,0.0,35280.0,27720.0,,,1031820.0
Bastar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,63000.0,63000.0,27720.0,0.0,0.0,0.0,153720.0
Bastar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,0.0,0.0,63000.0,1200.0,600.0,,,64800.0
Bastar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,,,5000.0,63000.0,0.0,0.0,0.0,,,68000.0
Bastar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,,,5000.0,0.0,61800.0,0.0,0.0,,,66800.0
Bastar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,63000.0,1200.0,1200.0,600.0,0.0,0.0,66000.0
Bastar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,600.0,,,600.0
Bastar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,600.0
Bastar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,2000.0,,,,,4465.0,0.0,0.0,0.0,0.0,,,6465.0
Bastar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,2000.0,,,,,4465.0,0.0,0.0,0.0,0.0,,,6465.0
Bastar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,,,,0.0,0.0,5000.0,5000.0,1700.0,,,11700.0
Bastar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,,,,0.0,5000.0,0.0,0.0,0.0,,,5000.0
Bastar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,3300.0,1700.0,,,5000.0
Bastar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,5000.0,1700.0,0.0,0.0,0.0,11700.0
Bastar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,14500.0,,,,,0.0,0.0,0.0,0.0,0.0,,,14500.0
Bastar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.02,Stock Position of Gloves,4. Stock Distributed,14500.0,,,,,0.0,0.0,0.0,0.0,0.0,,,14500.0
Bastar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,,,28000.0,0.0,0.0,0.0,0.0,,,28000.0
Bastar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,,,28000.0,0.0,0.0,0.0,0.0,,,28000.0
Bastar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,240000.0,40000.0,,,280000.0
Bastar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,,,,0.0,0.0,24000.0,0.0,330000.0,,,354000.0
Bastar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,200000.0,40000.0,,,240000.0
Bastar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,24000.0,40000.0,330000.0,0.0,0.0,394000.0
Bastar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,5400.0,,,,,0.0,0.0,0.0,0.0,22000.0,,,27400.0
Bastar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,59600.0,,,59600.0
Bastar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,5400.0,,,,,0.0,0.0,0.0,0.0,23800.0,,,29200.0
Bastar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57800.0,0.0,0.0,57800.0
Bastar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bastar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,1465.0,1465.0,0.0,0.0,1465.0,5893.0,0.0,,,10288.0
Bastar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,,0.0,1190.0,0.0,0.0,1465.0,5893.0,0.0,,,8548.0
Bastar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,1465.0,275.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1740.0
Bastar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,,,,,5600.0,750.0,9000.0,200.0,500.0,,,16050.0
Bastar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,5000.0,,,,,0.0,9000.0,0.0,300.0,0.0,,,14300.0
Bastar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0
Bastar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2350.0,,,,,5600.0,750.0,8800.0,0.0,100.0,,,17600.0
Bastar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2650.0,0.0,0.0,0.0,0.0,0.0,9000.0,200.0,500.0,400.0,0.0,0.0,12750.0
Bastar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,,,,43200.0
Bastar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,15000.0,15000.0,15000.0,15000.0,15000.0,15000.0,15000.0,15000.0,,,,120000.0
Bastar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,15000.0,0.0,4800.0,18800.0,18800.0,18800.0,18800.0,18800.0,,,,113800.0
Bastar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4800.0,4800.0,19800.0,15000.0,1000.0,1000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,49400.0
Bastar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,223200.0,223200.0,223200.0,223200.0,223200.0,223200.0,223200.0,489600.0,,,,2052000.0
Bastar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,223200.0,0.0,0.0,215200.0,215200.0,215200.0,215200.0,477600.0,,,,1561600.0
Bastar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,223200.0,223200.0,8000.0,8000.0,8000.0,8000.0,12000.0,0.0,0.0,0.0,490400.0
Bastar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,4000.0,4000.0,4000.0,4000.0,4000.0,4000.0,66000.0,,,,94000.0
Bastar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bastar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,4000.0,0.0,0.0,4000.0,4000.0,0.0,4000.0,66000.0,,,,82000.0
Bastar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,4000.0,4000.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,12000.0
Bastar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,8.0,3.0,11.0,8.0,7.0,4.0,4.0,1.0,1.0,1.0,5.0,3.0,56.0
Bastar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,2.0,,,,,,2.0,3.0,,7.0
Bastar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,1.0,,,1.0,3.0
Bastar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,1.0,2.0,,,,,1.0,2.0,3.0,1.0,10.0
Bastar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,,,,1.0,,,1.0,3.0
Bastar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,2.0,,,,,2.0,4.0
Bastar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,,,,2.0,,1.0,,,3.0,7.0
Bastar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,5.0,4.0,8.0,3.0,5.0,11.0,2.0,9.0,7.0,9.0,9.0,74.0
Bastar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,3.0,1.0,1.0,5.0,3.0,1.0,,1.0,,,2.0,18.0
Bastar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,8.0,5.0,9.0,8.0,8.0,12.0,2.0,10.0,7.0,9.0,11.0,92.0
Bastar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,5.0,3.0,5.0,3.0,5.0,6.0,2.0,3.0,7.0,9.0,5.0,54.0
Bastar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,2.0,1.0,4.0,,,3.0,3.0,1.0,2.0,1.0,2.0,21.0
Bastar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,7.0,4.0,9.0,3.0,5.0,9.0,5.0,4.0,9.0,10.0,7.0,75.0
Bastar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,2.0,4.0,1.0,1.0,9.0,5.0,5.0,2.0,,5.0,5.0,40.0
Bastar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,2.0,2.0,1.0,3.0,3.0,3.0,2.0,2.0,2.0,,4.0,25.0
Bastar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,4.0,6.0,2.0,4.0,12.0,8.0,7.0,4.0,2.0,5.0,9.0,65.0
Bastar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,2.0,,3.0
Bastar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,1.0,1.0,,,1.0,,1.0,4.0
Bastar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,1.0,1.0,,,1.0,2.0,1.0,7.0
Bastar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,1.0,,,1.0,,2.0,1.0,,,1.0,1.0,8.0
Bastar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,2.0,,,2.0,,1.0,,2.0,,1.0,8.0
Bastar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,2.0,,1.0,2.0,2.0,2.0,,2.0,1.0,2.0,16.0
Bastar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Bastar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,1.0,,,,,,1.0,2.0
Bastar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,1.0,,,1.0,,,,,,1.0,3.0
Bastar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,3.0,7.0,9.0,3.0,10.0,8.0,7.0,5.0,,13.0,3.0,71.0
Bastar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,7.0,5.0,2.0,3.0,3.0,5.0,2.0,3.0,8.0,6.0,7.0,5.0,56.0
Bastar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,10.0,8.0,9.0,12.0,6.0,15.0,10.0,10.0,13.0,6.0,20.0,8.0,127.0
Bastar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,2.0,,,1.0,,,,3.0
Bastar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,1.0,1.0,,,,,3.0
Bastar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,3.0,1.0,1.0,1.0,,,,6.0
Bastar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Bastar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,2.0,4.0,5.0,3.0,5.0,1.0,3.0,,4.0,2.0,5.0,38.0
Bastar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,1.0,,,2.0,,3.0,,,,,8.0
Bastar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,3.0,5.0,5.0,3.0,7.0,1.0,6.0,,4.0,3.0,5.0,47.0
Bastar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Bastar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,2.0,1.0,,,2.0,,,,1.0,2.0,1.0,11.0
Bastar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Bastar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,3.0,2.0,,,2.0,,,,1.0,2.0,1.0,13.0
Bastar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,,,2.0,1.0,1.0,,1.0,,1.0,7.0
Bastar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,1.0,,,,,,,,,,1.0
Bastar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,1.0,,,2.0,1.0,1.0,,1.0,,1.0,8.0
Bastar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,2.0,,1.0,1.0,1.0,,1.0,1.0,1.0,,,,8.0
Bastar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,5.0,2.0,3.0,3.0,4.0,1.0,4.0,3.0,3.0,3.0,1.0,2.0,34.0
Bastar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,,1.0,,1.0,,3.0,1.0,,,1.0,,9.0
Bastar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,9.0,2.0,5.0,4.0,6.0,1.0,8.0,5.0,4.0,3.0,2.0,2.0,51.0
Bastar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,1.0,,1.0,,,,,,3.0
Bastar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,1.0,,1.0,,1.0,,,,4.0
Bastar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,1.0,,2.0,,2.0,,1.0,,,,7.0
Bastar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,1.0,,,,2.0
Bastar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,2.0,5.0,1.0,2.0,2.0,1.0,2.0,2.0,2.0,1.0,2.0,22.0
Bastar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,2.0,6.0,4.0,4.0,6.0,5.0,3.0,2.0,1.0,,1.0,37.0
Bastar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,4.0,11.0,5.0,6.0,8.0,7.0,5.0,5.0,3.0,1.0,3.0,61.0
Bastar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Bastar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,2.0,,1.0,1.0,,1.0,2.0,,1.0,1.0,10.0
Bastar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,1.0,,,,,,,,,2.0
Bastar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,2.0,2.0,1.0,2.0,1.0,,1.0,2.0,,1.0,1.0,13.0
Bastar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,1.0,1.0,,,,,,,,1.0,3.0
Bastar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bastar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,1.0,1.0,,,,,,,,1.0,3.0
Bastar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,1.0,,,1.0,,1.0,,,,,4.0
Bastar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,1.0,2.0,,,,,,3.0
Bastar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,1.0,,,2.0,2.0,1.0,,,,,7.0
Bastar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,1.0,,,,1.0,,2.0,1.0,6.0
Bastar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,1.0,,,,1.0,,,,2.0,,4.0
Bastar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,1.0,1.0,,1.0,,1.0,,4.0,1.0,10.0
Bastar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,1.0,1.0,1.0,,,1.0,,,,4.0
Bastar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,1.0,,,,,,,,,,,,1.0
Bastar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,1.0,1.0,1.0,,,1.0,,,,5.0
Bastar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,1.0,,,,2.0
Bastar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,2.0,,,,,,,,,,,2.0
Bastar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,2.0,,,,,,1.0,1.0,,,,4.0
Bastar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,4.0,5.0,4.0,5.0,2.0,5.0,9.0,2.0,8.0,7.0,1.0,56.0
Bastar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,3.0,2.0,3.0,4.0,1.0,6.0,1.0,,,,1.0,,21.0
Bastar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,7.0,6.0,8.0,8.0,6.0,8.0,6.0,9.0,2.0,8.0,8.0,1.0,77.0
Bastar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,1.0,2.0,3.0,2.0,1.0,,,,10.0
Bastar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,9.0,17.0,22.0,15.0,10.0,15.0,15.0,9.0,19.0,17.0,14.0,24.0,186.0
Bastar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,2.0,5.0,3.0,5.0,2.0,1.0,3.0,1.0,,1.0,,25.0
Bastar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,20.0,27.0,18.0,16.0,19.0,19.0,14.0,21.0,17.0,15.0,24.0,221.0
Bastar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bastar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,10.0,11.0,25.0,5.0,12.0,14.0,7.0,6.0,11.0,7.0,11.0,9.0,128.0
Bastar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,1.0,,1.0,1.0,,1.0,2.0,1.0,,,,9.0
Bastar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,12.0,25.0,6.0,13.0,14.0,8.0,8.0,12.0,7.0,11.0,9.0,137.0
Bastar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,2.0,,1.0,1.0,1.0,,1.0,,7.0
Bastar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,4.0,10.0,4.0,3.0,8.0,10.0,5.0,3.0,2.0,1.0,3.0,54.0
Bastar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,7.0,,3.0,1.0,1.0,,,4.0,1.0,,18.0
Bastar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,5.0,18.0,4.0,8.0,9.0,12.0,6.0,4.0,6.0,3.0,3.0,79.0
Bastar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,2.0,2.0,1.0,,1.0,,2.0,,1.0,,,9.0
Bastar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,8.0,12.0,14.0,29.0,13.0,19.0,12.0,14.0,21.0,20.0,16.0,16.0,194.0
Bastar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,8.0,15.0,17.0,15.0,16.0,10.0,13.0,9.0,6.0,6.0,3.0,120.0
Bastar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,10.0,22.0,31.0,47.0,28.0,36.0,22.0,29.0,30.0,27.0,22.0,19.0,323.0
Bastar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,4.0,4.0,,3.0,1.0,1.0,,,,,13.0
Bastar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,18.0,30.0,30.0,33.0,34.0,45.0,20.0,30.0,30.0,20.0,29.0,25.0,344.0
Bastar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,15.0,39.0,22.0,47.0,33.0,33.0,32.0,13.0,18.0,22.0,9.0,295.0
Bastar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,30.0,45.0,73.0,59.0,81.0,81.0,54.0,63.0,43.0,38.0,51.0,34.0,652.0
Bastar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,4.0,1.0,5.0,3.0,7.0,2.0,,,,1.0,25.0
Bastar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,20.0,26.0,27.0,38.0,31.0,34.0,25.0,33.0,32.0,30.0,32.0,26.0,354.0
Bastar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,30.0,46.0,50.0,55.0,57.0,63.0,45.0,66.0,22.0,15.0,22.0,14.0,485.0
Bastar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,50.0,74.0,81.0,94.0,93.0,100.0,77.0,101.0,54.0,45.0,54.0,41.0,864.0
Bemetra,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Bemetra,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Bemetra,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Bemetra,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Bemetra,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Bemetra,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Bemetra,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Bemetra,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Bemetra,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Bemetra,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Bemetra,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Bemetra,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Bemetra,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Bemetra,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Bemetra,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Bemetra,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Bemetra,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Bemetra,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Bemetra,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Bemetra,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Bemetra,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Bemetra,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bemetra,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Bemetra,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bemetra,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bemetra,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bemetra,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Bemetra,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Bemetra,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Bemetra,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Bemetra,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Bemetra,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Bemetra,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Bemetra,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Bemetra,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Bemetra,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Bemetra,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Bemetra,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Bemetra,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Bemetra,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Bemetra,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Bemetra,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Bemetra,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Bemetra,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Bemetra,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Bemetra,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Bemetra,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Bemetra,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Bemetra,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Bemetra,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Bemetra,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Bemetra,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Bemetra,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Bemetra,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Bemetra,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Bemetra,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Bemetra,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Bemetra,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Bemetra,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Bemetra,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Bemetra,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bemetra,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Bemetra,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Bemetra,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Bemetra,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Bemetra,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Bemetra,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Bemetra,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Bemetra,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Bemetra,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Bemetra,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Bemetra,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Bemetra,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Bemetra,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Bemetra,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Bemetra,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Bemetra,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Bemetra,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Bemetra,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Bemetra,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Bemetra,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Bemetra,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Bemetra,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Bemetra,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Bemetra,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Bemetra,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Bemetra,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Bemetra,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Bemetra,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Bemetra,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Bemetra,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Bemetra,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Bemetra,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Bemetra,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Bemetra,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Bemetra,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Bemetra,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Bemetra,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Bemetra,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Bemetra,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Bemetra,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Bemetra,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Bemetra,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Bemetra,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Bemetra,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Bemetra,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Bemetra,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Bemetra,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Bemetra,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Bemetra,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Bemetra,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Bemetra,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Bemetra,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Bemetra,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Bemetra,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Bemetra,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Bemetra,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Bemetra,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Bemetra,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Bemetra,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Bemetra,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Bemetra,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Bemetra,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Bemetra,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Bemetra,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Bemetra,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Bemetra,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Bemetra,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Bemetra,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Bemetra,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Bemetra,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Bemetra,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Bemetra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Bemetra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Bemetra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Bemetra,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bemetra,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bemetra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bemetra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bemetra,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bemetra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bemetra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bemetra,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Bemetra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bemetra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bemetra,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Bemetra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bemetra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bemetra,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Bemetra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bemetra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bemetra,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Bemetra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bemetra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bemetra,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bemetra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bemetra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bemetra,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bemetra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bemetra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bemetra,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bemetra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Bemetra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bemetra,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Bemetra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bemetra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Bemetra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Bemetra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bemetra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Bemetra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bemetra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Bemetra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bemetra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Bemetra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bemetra,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Bemetra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Bemetra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Bemetra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Bemetra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Bemetra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Bemetra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bemetra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Bemetra,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Bijapur,1.1,Total number of pregnant women Registered for ANC,TOTAL,467.0,564.0,487.0,562.0,615.0,571.0,604.0,564.0,734.0,576.0,511.0,592.0,6847.0
Bijapur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,141.0,176.0,143.0,215.0,211.0,201.0,201.0,238.0,250.0,218.0,187.0,271.0,2452.0
Bijapur,1.2,Number of Pregnant women registered under JSY,TOTAL,465.0,564.0,487.0,562.0,615.0,571.0,604.0,564.0,734.0,576.0,511.0,592.0,6845.0
Bijapur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,322.0,311.0,357.0,406.0,432.0,460.0,443.0,429.0,530.0,428.0,390.0,512.0,5020.0
Bijapur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,463.0,564.0,487.0,562.0,615.0,571.0,604.0,564.0,733.0,576.0,511.0,592.0,6842.0
Bijapur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,342.0,389.0,398.0,463.0,472.0,503.0,432.0,459.0,536.0,429.0,428.0,517.0,5368.0
Bijapur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,322.0,311.0,356.0,406.0,434.0,460.0,446.0,429.0,539.0,430.0,402.0,524.0,5059.0
Bijapur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,12.0,28.0,34.0,25.0,4.0,13.0,18.0,26.0,15.0,17.0,19.0,25.0,236.0
Bijapur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bijapur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,46.0,57.0,29.0,64.0,45.0,78.0,73.0,51.0,101.0,93.0,85.0,90.0,812.0
Bijapur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0,2.0,4.0,6.0,22.0
Bijapur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Bijapur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,103.0,157.0,139.0,183.0,198.0,192.0,201.0,199.0,224.0,193.0,103.0,146.0,2038.0
Bijapur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,105.0,113.0,150.0,159.0,138.0,141.0,126.0,132.0,205.0,124.0,186.0,201.0,1780.0
Bijapur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,208.0,270.0,289.0,342.0,336.0,333.0,327.0,331.0,429.0,317.0,289.0,347.0,3818.0
Bijapur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,171.0,213.0,206.0,277.0,283.0,258.0,257.0,262.0,316.0,224.0,221.0,214.0,2902.0
Bijapur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,72.0,76.0,80.0,123.0,136.0,97.0,135.0,117.0,153.0,80.0,74.0,87.0,1230.0
Bijapur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,41.0,48.0,41.0,55.0,75.0,67.0,89.0,98.0,86.0,96.0,77.0,114.0,887.0
Bijapur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1.0,0.0,37.0,2.0,0.0,4.0,2.0,6.0,0.0,0.0,0.0,0.0,52.0
Bijapur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,38.0,48.0,43.0,53.0,74.0,67.0,92.0,98.0,82.0,96.0,76.0,114.0,881.0
Bijapur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,10.0,20.0,37.0,27.0,36.0,47.0,60.0,63.0,47.0,59.0,46.0,65.0,517.0
Bijapur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bijapur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Bijapur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bijapur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Bijapur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Bijapur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,4.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
Bijapur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,4.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
Bijapur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,4.1.1.a,Number of male live births,TOTAL,128.0,176.0,169.0,199.0,205.0,208.0,217.0,218.0,261.0,201.0,184.0,230.0,2396.0
Bijapur,4.1.1.b,Number of female live births,TOTAL,113.0,136.0,135.0,187.0,197.0,187.0,181.0,206.0,241.0,205.0,181.0,227.0,2196.0
Bijapur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,241.0,312.0,304.0,386.0,402.0,395.0,398.0,424.0,502.0,406.0,365.0,457.0,4592.0
Bijapur,4.1.2,Number of still births,TOTAL,7.0,2.0,7.0,7.0,9.0,5.0,14.0,5.0,1.0,6.0,1.0,4.0,68.0
Bijapur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0.0,0.0,3.0,5.0,0.0,4.0,6.0,2.0,7.0,1.0,7.0,9.0,44.0
Bijapur,4.2.1,Number of Newborns weighed at birth,TOTAL,206.0,276.0,256.0,357.0,381.0,332.0,351.0,352.0,409.0,325.0,294.0,382.0,3921.0
Bijapur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,8.0,16.0,13.0,24.0,28.0,12.0,24.0,11.0,49.0,23.0,18.0,43.0,269.0
Bijapur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,236.0,304.0,288.0,371.0,390.0,387.0,400.0,423.0,480.0,372.0,349.0,402.0,4402.0
Bijapur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bijapur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bijapur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,201.0,264.0,246.0,337.0,356.0,305.0,298.0,330.0,370.0,327.0,281.0,308.0,3623.0
Bijapur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,167.0,238.0,226.0,323.0,335.0,282.0,290.0,307.0,408.0,315.0,295.0,336.0,3522.0
Bijapur,6.3,PNC maternal complications attended,TOTAL,1.0,7.0,2.0,11.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,22.0
Bijapur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bijapur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bijapur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0
Bijapur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0.0,5.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,3.0,4.0,3.0,18.0
Bijapur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1.0,7.0,5.0,4.0,3.0,2.0,0.0,2.0,8.0,10.0,6.0,6.0,54.0
Bijapur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1.0,12.0,5.0,5.0,3.0,2.0,1.0,2.0,9.0,13.0,10.0,9.0,72.0
Bijapur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,0.0,0.0,0.0,152.0,177.0
Bijapur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0,44.0
Bijapur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,0.0,0.0,0.0,196.0,221.0
Bijapur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,21.0,51.0,24.0,84.0,133.0,43.0,44.0,44.0,47.0,26.0,29.0,37.0,583.0
Bijapur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,0.0,2.0,14.0,5.0,0.0,2.0,2.0,2.0,0.0,0.0,3.0,35.0
Bijapur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,9.0,1.0,1.0,0.0,1.0,0.0,2.0,0.0,1.0,15.0
Bijapur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,26.0,51.0,26.0,107.0,139.0,44.0,46.0,47.0,49.0,28.0,29.0,41.0,633.0
Bijapur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Bijapur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Bijapur,9.06,Number of IUCD removals,TOTAL,35.0,37.0,49.0,105.0,90.0,72.0,65.0,124.0,73.0,44.0,49.0,73.0,816.0
Bijapur,9.07,Number of Oral Pills cycles distributed,TOTAL,777.0,502.0,360.0,1226.0,1251.0,1231.0,1395.0,1381.0,1449.0,1073.0,864.0,1178.0,12687.0
Bijapur,9.08,Number of Condom pieces distributed,TOTAL,793.0,447.0,3480.0,5090.0,5523.0,5490.0,5684.0,2687.0,3873.0,2438.0,3317.0,4119.0,42941.0
Bijapur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,67.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67.0
Bijapur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bijapur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Bijapur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,2.0,1.0,3.0,1.0,1.0,4.0,4.0,4.0,3.0,4.0,-1.0
Bijapur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,229.0,318.0,332.0,389.0,402.0,429.0,412.0,452.0,574.0,424.0,377.0,463.0,4801.0
Bijapur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,283.0,364.0,339.0,386.0,510.0,449.0,429.0,456.0,624.0,459.0,436.0,495.0,5230.0
Bijapur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,260.0,333.0,347.0,388.0,449.0,459.0,439.0,467.0,560.0,395.0,436.0,495.0,5028.0
Bijapur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,334.0,351.0,339.0,377.0,384.0,410.0,476.0,420.0,537.0,361.0,389.0,580.0,4958.0
Bijapur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Bijapur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Bijapur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Bijapur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,121.0,224.0,208.0,300.0,262.0,250.0,212.0,320.0,428.0,302.0,256.0,376.0,3259.0
Bijapur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,283.0,364.0,339.0,386.0,510.0,449.0,429.0,456.0,624.0,459.0,436.0,495.0,5230.0
Bijapur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,260.0,333.0,347.0,388.0,449.0,459.0,439.0,467.0,560.0,395.0,436.0,495.0,5028.0
Bijapur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,334.0,351.0,339.0,377.0,384.0,410.0,476.0,420.0,537.0,361.0,387.0,580.0,4956.0
Bijapur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,22.0,21.0,31.0,25.0,37.0,136.0
Bijapur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,3.0,0.0,0.0,0.0,,82.0,259.0,575.0,432.0,414.0,491.0,2256.0
Bijapur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,6.0,0.0,0.0,0.0,,8.0,236.0,417.0,346.0,393.0,471.0,1877.0
Bijapur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,8.0,0.0,0.0,0.0,,7.0,216.0,354.0,275.0,316.0,538.0,1714.0
Bijapur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,254.0,282.0,318.0,380.0,739.0,483.0,431.0,340.0,804.0,375.0,393.0,443.0,5242.0
Bijapur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,0.0,,,,,,,0.0,0.0
Bijapur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Bijapur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,128.0,138.0,154.0,187.0,367.0,256.0,221.0,174.0,410.0,197.0,201.0,225.0,2658.0
Bijapur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,126.0,146.0,164.0,193.0,372.0,227.0,210.0,166.0,391.0,178.0,192.0,218.0,2583.0
Bijapur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,254.0,284.0,318.0,380.0,739.0,483.0,431.0,340.0,801.0,375.0,393.0,443.0,5241.0
Bijapur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,196.0,275.0,290.0,328.0,481.0,335.0,322.0,267.0,815.0,362.0,337.0,349.0,4357.0
Bijapur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,196.0,275.0,290.0,328.0,481.0,335.0,322.0,267.0,815.0,362.0,337.0,349.0,4357.0
Bijapur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,101.0,138.0,134.0,191.0,216.0,181.0,230.0,178.0,464.0,137.0,120.0,280.0,2370.0
Bijapur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,93.0,109.0,139.0,184.0,207.0,155.0,193.0,168.0,390.0,117.0,112.0,265.0,2132.0
Bijapur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,194.0,247.0,273.0,375.0,423.0,336.0,423.0,346.0,854.0,254.0,232.0,545.0,4502.0
Bijapur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,93.0,122.0,122.0,144.0,304.0,700.0,270.0,171.0,490.0,304.0,219.0,205.0,3144.0
Bijapur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,218.0,252.0,288.0,366.0,881.0,1184.0,476.0,493.0,1058.0,406.0,347.0,391.0,6360.0
Bijapur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,205.0,188.0,259.0,294.0,533.0,956.0,442.0,432.0,672.0,378.0,322.0,329.0,5010.0
Bijapur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,125.0,116.0,81.0,331.0
Bijapur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48.0,46.0,119.0,213.0
Bijapur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,238.0,316.0,292.0,392.0,366.0,399.0,434.0,416.0,423.0,331.0,328.0,430.0,4365.0
Bijapur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,163.0,256.0,230.0,275.0,269.0,273.0,276.0,292.0,357.0,280.0,244.0,359.0,3274.0
Bijapur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,90.0,134.0,108.0,158.0,182.0,201.0,171.0,144.0,242.0,178.0,167.0,236.0,2011.0
Bijapur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,254.0,284.0,321.0,380.0,739.0,475.0,436.0,345.0,804.0,375.0,393.0,443.0,5249.0
Bijapur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,146.0,175.0,148.0,131.0,1958.0,603.0,394.0,347.0,2758.0,700.0,347.0,330.0,8037.0
Bijapur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,117.0,149.0,142.0,135.0,1862.0,511.0,277.0,191.0,2576.0,750.0,313.0,192.0,7215.0
Bijapur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,8.0,13.0
Bijapur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,9.0,4.0,2.0,14.0,32.0,29.0,0.0,0.0,0.0,0.0,90.0
Bijapur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,192.0,182.0,196.0,239.0,236.0,142.0,163.0,153.0,112.0,185.0,142.0,133.0,2075.0
Bijapur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,167.0,166.0,129.0,405.0,199.0,161.0,267.0,126.0,159.0,108.0,67.0,72.0,2026.0
Bijapur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,11.0,13.0,5.0,0.0,5.0,0.0,10.0,12.0,8.0,0.0,5.0,75.0
Bijapur,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,402.0,17.0,421.0
Bijapur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,115.0,17.0,134.0
Bijapur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,88.0,9.0,8.0,4.0,12.0,104.0,95.0,320.0
Bijapur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,43.0,92.0,204.0,346.0
Bijapur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,-1.0
Bijapur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1.0,1.0,2.0,,1.0,,3.0,1.0,3.0,3.0,2.0,2.0,-1.0
Bijapur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,247.0,336.0,345.0,327.0,346.0,353.0,467.0,414.0,452.0,415.0,440.0,454.0,-1.0
Bijapur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,2.0,3.0,3.0,3.0,3.0,2.0,2.0,2.0,3.0,3.0,3.0,-1.0
Bijapur,14.05,Number of RKS meetings held during the month,TOTAL,0.0,2.0,1.0,2.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,8.0
Bijapur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,4.0,5.0,4.0,4.0,4.0,2.0,4.0,3.0,5.0,4.0,5.0,-1.0
Bijapur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1.0,0.0,21.0,3.0,10.0,5.0,2.0,3.0,3.0,4.0,2.0,3.0,57.0
Bijapur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,1.0,1.0,1.0,1.0,,1.0,1.0,1.0,-1.0
Bijapur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0,36.0,46.0,-1.0
Bijapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,45.0,72.0,29.0,154.0,45.0,61.0,55.0,84.0,112.0,137.0,123.0,158.0,1075.0
Bijapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,125.0,197.0,138.0,354.0,147.0,179.0,174.0,542.0,148.0,205.0,170.0,223.0,2602.0
Bijapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,38.0,62.0,25.0,146.0,38.0,54.0,44.0,69.0,62.0,119.0,90.0,91.0,838.0
Bijapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,127.0,189.0,138.0,355.0,141.0,164.0,120.0,508.0,131.0,207.0,201.0,207.0,2488.0
Bijapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,83.0,134.0,54.0,300.0,83.0,115.0,99.0,153.0,174.0,256.0,213.0,249.0,1913.0
Bijapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,252.0,386.0,276.0,709.0,288.0,343.0,294.0,1050.0,279.0,412.0,371.0,430.0,5090.0
Bijapur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,5.0,5.0,3.0,1.0,2.0,2.0,4.0,3.0,4.0,4.0,6.0,41.0
Bijapur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,1.0,9.0
Bijapur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,6.0,5.0,4.0,2.0,3.0,3.0,5.0,3.0,4.0,4.0,7.0,50.0
Bijapur,14.11,In-Patient Head Count at midnight,TOTAL,0.0,0.0,180.0,211.0,186.0,208.0,126.0,246.0,635.0,1242.0,1122.0,2.0,4158.0
Bijapur,14.12.1,OPD attendance (All),TOTAL,10213.0,10473.0,11138.0,14465.0,16018.0,19323.0,15065.0,17246.0,19971.0,16591.0,14369.0,16837.0,181709.0
Bijapur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,287.0,287.0
Bijapur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Bijapur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,3.0,5.0,0.0,0.0,0.0,3.0,14.0
Bijapur,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,624.0,709.0,539.0,316.0,639.0,765.0,603.0,1367.0,552.0,833.0,438.0,7385.0
Bijapur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,245.0,245.0,219.0,225.0,219.0,125.0,240.0,125.0,120.0,125.0,120.0,2008.0
Bijapur,14.14.c,Number of Adolescents counselled,TOTAL,13.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Bijapur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,107.0,157.0,268.0,323.0,338.0,350.0,237.0,268.0,332.0,240.0,64.0,341.0,3025.0
Bijapur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,11.0,6.0,26.0,15.0,2.0,5.0,5.0,11.0,8.0,24.0,10.0,39.0,162.0
Bijapur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,46.0,22.0,39.0,35.0,44.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,206.0
Bijapur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2.0,0.0,6.0,5.0,7.0,3.0,0.0,1.0,0.0,0.0,3.0,3.0,30.0
Bijapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Bijapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,25.0,48.0,29.0,45.0,44.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,221.0
Bijapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,73.0,70.0,74.0,85.0,95.0,53.0,0.0,1.0,0.0,0.0,3.0,3.0,457.0
Bijapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Bijapur,15.2,Number of Widal tests conducted,Number tested,2.0,7.0,29.0,22.0,45.0,51.0,32.0,53.0,421.0,45.0,0.0,6.0,713.0
Bijapur,15.3.a,Number of VDRL tests conducted on males,Number tested,46.0,22.0,39.0,36.0,44.0,20.0,0.0,0.0,0.0,0.0,0.0,0.0,207.0
Bijapur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,2.0,0.0,8.0,8.0,7.0,8.0,0.0,0.0,0.0,0.0,4.0,4.0,41.0
Bijapur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,25.0,48.0,29.0,45.0,46.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,223.0
Bijapur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,73.0,70.0,76.0,89.0,97.0,58.0,0.0,0.0,0.0,0.0,4.0,4.0,471.0
Bijapur,15.4.1,Number of blood smears examined for Malaria,TOTAL,2546.0,2854.0,3549.0,2830.0,4189.0,3659.0,4927.0,5025.0,6193.0,2493.0,4449.0,4372.0,47086.0
Bijapur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,24.0,14.0,9.0,141.0,135.0,37.0,42.0,99.0,50.0,52.0,28.0,25.0,656.0
Bijapur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,114.0,188.0,95.0,259.0,406.0,313.0,435.0,909.0,572.0,204.0,226.0,249.0,3970.0
Bijapur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,3850.0,2300.0,,,,,,,,,6150.0
Bijapur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,0.0,4000.0,,,,,,,,,4000.0
Bijapur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,1550.0,100.0,,,,,,,,,1650.0
Bijapur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,2300.0,6200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0
Bijapur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bijapur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bijapur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bijapur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bijapur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,1700.0,0.0,,,,,,,,,1700.0
Bijapur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,1700.0,0.0,,,,,,,,,1700.0
Bijapur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,4850.0,2550.0,,,,,,,,,7400.0
Bijapur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,0.0,4000.0,,,,,,,,,4000.0
Bijapur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,2300.0,3550.0,,,,,,,,,5850.0
Bijapur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,2550.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5550.0
Bijapur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,3400.0,2200.0,,,,,,,,,5600.0
Bijapur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,0.0,2000.0,,,,,,,,,2000.0
Bijapur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,1200.0,3000.0,,,,,,,,,4200.0
Bijapur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,2200.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3400.0
Bijapur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,7505.0,7350.0,,,,,,,,,14855.0
Bijapur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,655.0,2675.0,,,,,,,,,3330.0
Bijapur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,6850.0,4675.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11525.0
Bijapur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,0.0,,,,,,,,,,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,6000.0,29850.0,,,,,,,,,35850.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,24000.0,0.0,,,,,,,,,24000.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,150.0,24000.0,,,,,,,,,24150.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,29850.0,5850.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35700.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,5000.0,,,,,,,,,5000.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,5000.0,0.0,,,,,,,,,5000.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,4000.0,,,,,,,,,4000.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,5000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,0.0,2000.0,,,,,,,,,2000.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,2000.0,0.0,,,,,,,,,2000.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,0.0,1500.0,,,,,,,,,1500.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2000.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2500.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,300.0,0.0,,,,,,,,,300.0
Bijapur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,300.0,0.0,,,,,,,,,300.0
Bijapur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,10500.0,10000.0,,,,,,,,,20500.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,500.0,2500.0,,,,,,,,,3000.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,10000.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17500.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,500.0,0.0,,,,,,,,,500.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,368.0,0.0,,,,,,,,,368.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,0.0,229.0,,,,,,,,,229.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,0.0,229.0,,,,,,,,,229.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,368.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,368.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,25530.0,18530.0,,,,,,,,,44060.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,3000.0,0.0,,,,,,,,,3000.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,7000.0,10114.0,,,,,,,,,17114.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,21530.0,8416.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29946.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,3500.0,0.0,,,,,,,,,3500.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,3500.0,0.0,,,,,,,,,3500.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,60200.0,0.0,,,,,,,,,60200.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,0.0,73600.0,,,,,,,,,73600.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,60200.0,73600.0,,,,,,,,,133800.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,6230.0,1030.0,,,,,,,,,7260.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,0.0,20000.0,,,,,,,,,20000.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,0.0,0.0,,,,,,,,,0.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,5200.0,13960.0,,,,,,,,,19160.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,1030.0,7070.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8100.0
Bijapur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Bilaspur,1.1,Total number of pregnant women Registered for ANC,TOTAL,5594.0,6158.0,7337.0,7949.0,7076.0,6207.0,7004.0,6922.0,7768.0,6559.0,5467.0,7328.0,81369.0
Bilaspur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2205.0,2388.0,2569.0,2653.0,2426.0,2179.0,2412.0,2294.0,2814.0,2185.0,2022.0,2479.0,28626.0
Bilaspur,1.2,Number of Pregnant women registered under JSY,TOTAL,5143.0,4325.0,6338.0,6752.0,6253.0,5629.0,6350.0,6243.0,5709.0,5495.0,4627.0,5754.0,68618.0
Bilaspur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3582.0,4209.0,4725.0,5124.0,4922.0,4840.0,4896.0,4699.0,4880.0,4472.0,4117.0,4521.0,54987.0
Bilaspur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3476.0,3442.0,4344.0,4464.0,3875.0,3710.0,4039.0,3788.0,4069.0,3873.0,3117.0,3977.0,46174.0
Bilaspur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4399.0,5312.0,5830.0,6640.0,6306.0,5474.0,5489.0,5909.0,5592.0,5599.0,4295.0,5272.0,66117.0
Bilaspur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3948.0,4104.0,5145.0,5045.0,4970.0,4230.0,4169.0,3854.0,5901.0,5150.0,3369.0,4292.0,54177.0
Bilaspur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,345.0,344.0,424.0,408.0,338.0,403.0,281.0,239.0,363.0,289.0,198.0,306.0,3938.0
Bilaspur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,29.0,18.0,63.0,45.0,9.0,24.0,12.0,15.0,29.0,15.0,15.0,10.0,284.0
Bilaspur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,744.0,849.0,1049.0,954.0,1258.0,1052.0,958.0,958.0,1535.0,1266.0,897.0,1037.0,12557.0
Bilaspur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,22.0,21.0,12.0,24.0,17.0,34.0,14.0,17.0,21.0,22.0,18.0,7.0,229.0
Bilaspur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Bilaspur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1074.0,1178.0,1523.0,1343.0,1679.0,1595.0,1695.0,1612.0,1611.0,1169.0,1001.0,1645.0,17125.0
Bilaspur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,751.0,873.0,996.0,1232.0,1097.0,1099.0,1184.0,1176.0,1282.0,1350.0,1277.0,1274.0,13591.0
Bilaspur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1825.0,2051.0,2519.0,2575.0,2776.0,2694.0,2879.0,2788.0,2893.0,2519.0,2278.0,2919.0,30716.0
Bilaspur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1347.0,1642.0,1859.0,2069.0,2117.0,2070.0,2245.0,2184.0,2282.0,1810.0,1660.0,2396.0,23681.0
Bilaspur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,746.0,756.0,884.0,992.0,753.0,1077.0,859.0,716.0,1014.0,606.0,451.0,977.0,9831.0
Bilaspur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1787.0,1891.0,2062.0,2331.0,2354.0,2469.0,2665.0,2916.0,2478.0,2008.0,1764.0,2343.0,27068.0
Bilaspur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1339.0,1422.0,1590.0,1868.0,1836.0,1900.0,2101.0,1938.0,1895.0,1427.0,1307.0,1716.0,20339.0
Bilaspur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1821.0,1832.0,2034.0,2106.0,2217.0,2437.0,2355.0,2573.0,2184.0,1956.0,1665.0,2311.0,25491.0
Bilaspur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1432.0,1402.0,1653.0,1671.0,1752.0,1943.0,1810.0,2003.0,1763.0,1560.0,1378.0,1821.0,20188.0
Bilaspur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,218.0,64.0,37.0,33.0,37.0,65.0,70.0,52.0,54.0,29.0,22.0,35.0,716.0
Bilaspur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1015.0,1017.0,939.0,1125.0,1075.0,1105.0,840.0,436.0,1205.0,183.0,1273.0,1289.0,11502.0
Bilaspur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,998.0,1006.0,926.0,1074.0,1068.0,975.0,830.0,403.0,1177.0,167.0,1245.0,1289.0,11158.0
Bilaspur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,85.0,103.0,69.0,69.0,79.0,47.0,37.0,31.0,107.0,47.0,84.0,49.0,807.0
Bilaspur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,1.0,3.0,0.0,3.0,2.0,1.0,0.0,0.0,0.0,0.0,10.0
Bilaspur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,45.0,40.0,32.0,37.0,19.0,22.0,24.0,0.0,0.0,0.0,27.0,26.0,272.0
Bilaspur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,45.0,40.0,33.0,40.0,19.0,25.0,26.0,1.0,0.0,0.0,27.0,26.0,282.0
Bilaspur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,243.0,161.0,120.0,134.0,132.0,126.0,111.0,59.0,199.0,161.0,229.0,175.0,1850.0
Bilaspur,4.1.1.a,Number of male live births,TOTAL,2406.0,2578.0,2869.0,3145.0,3196.0,3213.0,3332.0,3152.0,3396.0,2513.0,2751.0,3398.0,35949.0
Bilaspur,4.1.1.b,Number of female live births,TOTAL,2200.0,2379.0,2613.0,2847.0,3009.0,3044.0,3063.0,2975.0,3156.0,2177.0,2553.0,3160.0,33176.0
Bilaspur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4606.0,4957.0,5482.0,5992.0,6205.0,6257.0,6395.0,6127.0,6552.0,4690.0,5304.0,6558.0,69125.0
Bilaspur,4.1.2,Number of still births,TOTAL,42.0,50.0,57.0,66.0,55.0,76.0,51.0,42.0,73.0,48.0,45.0,68.0,673.0
Bilaspur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,51.0,51.0,77.0,74.0,70.0,69.0,66.0,58.0,74.0,60.0,72.0,80.0,802.0
Bilaspur,4.2.1,Number of Newborns weighed at birth,TOTAL,4202.0,4922.0,5120.0,5783.0,5861.0,5677.0,6112.0,5939.0,6345.0,4477.0,5074.0,6369.0,65881.0
Bilaspur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,253.0,225.0,314.0,329.0,235.0,243.0,358.0,292.0,384.0,338.0,258.0,266.0,3495.0
Bilaspur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4017.0,4519.0,4954.0,5532.0,5805.0,5658.0,5960.0,5701.0,6114.0,4545.0,4994.0,6219.0,64018.0
Bilaspur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,4.0,2.0,0.0,10.0,1.0,4.0,0.0,7.0,2.0,0.0,31.0
Bilaspur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,9.0,0.0,0.0,0.0,6.0,10.0,0.0,0.0,6.0,5.0,2.0,5.0,43.0
Bilaspur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,15.0,31.0,4.0,15.0,107.0,52.0,48.0,8.0,4.0,12.0,26.0,348.0
Bilaspur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,36.0,15.0,35.0,6.0,21.0,127.0,53.0,52.0,14.0,16.0,16.0,31.0,422.0
Bilaspur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,62.0,232.0,85.0,75.0,24.0,15.0,0.0,0.0,34.0,102.0,95.0,65.0,789.0
Bilaspur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,222.0,280.0,330.0,245.0,115.0,330.0,185.0,254.0,242.0,157.0,240.0,338.0,2938.0
Bilaspur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,24.0,28.0,27.0,26.0,0.0,16.0,0.0,1.0,2.0,0.0,1.0,2.0,127.0
Bilaspur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,179.0,167.0,77.0,259.0,129.0,207.0,142.0,309.0,185.0,111.0,249.0,221.0,2235.0
Bilaspur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,1.0,0.0,5.0,1.0,0.0,1.0,1.0,1.0,0.0,1.0,1.0,14.0
Bilaspur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2625.0,3109.0,3562.0,3948.0,4062.0,4133.0,4564.0,4642.0,4151.0,3061.0,2800.0,3939.0,44596.0
Bilaspur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1832.0,2027.0,2552.0,2559.0,3032.0,2934.0,3057.0,3216.0,2811.0,2154.0,2041.0,2875.0,31090.0
Bilaspur,6.3,PNC maternal complications attended,TOTAL,41.0,25.0,19.0,16.0,54.0,9.0,11.0,4.0,94.0,103.0,87.0,7.0,470.0
Bilaspur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,1.0,15.0,8.0,12.0,5.0,13.0,11.0,4.0,5.0,12.0,20.0,118.0
Bilaspur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,0.0,5.0,1.0,5.0,2.0,0.0,0.0,0.0,2.0,3.0,0.0,19.0
Bilaspur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,1.0,20.0,9.0,17.0,7.0,13.0,11.0,4.0,7.0,15.0,20.0,137.0
Bilaspur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,52.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52.0
Bilaspur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,49.0,20.0,25.0,38.0,75.0,28.0,25.0,36.0,24.0,34.0,220.0,54.0,628.0
Bilaspur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,61.0,21.0,14.0,71.0,89.0,59.0,52.0,72.0,70.0,81.0,290.0,138.0,1018.0
Bilaspur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,110.0,41.0,39.0,109.0,164.0,87.0,77.0,108.0,94.0,115.0,510.0,192.0,1646.0
Bilaspur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bilaspur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,0.0,3.0,23.0,5.0,3.0,6.0,3.0,7.0,14.0,4.0,0.0,70.0
Bilaspur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,22.0,6.0,5.0,73.0,44.0,69.0,70.0,111.0,179.0,131.0,98.0,26.0,834.0
Bilaspur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,6.0,7.0,10.0,26.0,4.0,4.0,5.0,9.0,3.0,,6.0,2.0,82.0
Bilaspur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,30.0,13.0,18.0,122.0,53.0,76.0,81.0,123.0,189.0,145.0,108.0,28.0,986.0
Bilaspur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,9.0,1.0,4.0,1.0,5.0,10.0,3.0,6.0,0.0,12.0,29.0,3.0,83.0
Bilaspur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,29.0,0.0,31.0,384.0,71.0,403.0,158.0,164.0,514.0,428.0,186.0,91.0,2459.0
Bilaspur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,40.0,54.0,129.0,533.0,125.0,379.0,544.0,1184.0,1487.0,1221.0,864.0,316.0,6876.0
Bilaspur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,10.0,2.0,26.0,1.0,0.0,28.0,4.0,0.0,3.0,,6.0,4.0,84.0
Bilaspur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,79.0,56.0,186.0,918.0,196.0,810.0,706.0,1348.0,2004.0,1649.0,1056.0,411.0,9419.0
Bilaspur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,30.0,47.0,34.0,35.0,38.0,33.0,35.0,26.0,39.0,32.0,201.0,44.0,594.0
Bilaspur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,4.0,7.0
Bilaspur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,64.0,19.0,13.0,81.0,42.0,131.0,196.0,217.0,647.0,984.0,395.0,194.0,2983.0
Bilaspur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,18.0,2.0,42.0,27.0,29.0,0.0,,0.0,,0.0,0.0,118.0
Bilaspur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,64.0,37.0,15.0,123.0,69.0,160.0,197.0,217.0,647.0,986.0,395.0,198.0,3108.0
Bilaspur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,70.0,116.0,123.0,103.0,72.0,84.0,49.0,16.0,168.0,243.0,34.0,62.0,1140.0
Bilaspur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,3.0
Bilaspur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,3.0,0.0,0.0,0.0,130.0,47.0,9.0,4.0,4.0,0.0,0.0,198.0
Bilaspur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,19.0,19.0,16.0,7.0,3.0,31.0,27.0,51.0,,60.0,36.0,269.0
Bilaspur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,22.0,19.0,16.0,7.0,133.0,78.0,36.0,55.0,4.0,61.0,37.0,470.0
Bilaspur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,13.0
Bilaspur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,351.0,587.0,634.0,1116.0,1087.0,922.0,783.0,836.0,663.0,714.0,660.0,456.0,8809.0
Bilaspur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,47.0,22.0,21.0,52.0,18.0,10.0,27.0,39.0,22.0,16.0,16.0,23.0,313.0
Bilaspur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25.0,38.0,21.0,21.0,16.0,92.0,79.0,129.0,149.0,115.0,5.0,144.0,834.0
Bilaspur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,3.0,4.0,0.0,2.0,3.0,5.0,3.0,1.0,5.0,2.0,5.0,37.0
Bilaspur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bilaspur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,427.0,650.0,680.0,1189.0,1123.0,1027.0,894.0,1007.0,835.0,850.0,683.0,628.0,9993.0
Bilaspur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Bilaspur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
Bilaspur,9.06,Number of IUCD removals,TOTAL,604.0,572.0,804.0,852.0,713.0,593.0,763.0,662.0,650.0,633.0,447.0,438.0,7731.0
Bilaspur,9.07,Number of Oral Pills cycles distributed,TOTAL,9151.0,11962.0,11906.0,12258.0,13836.0,16206.0,14626.0,16920.0,12777.0,14416.0,13855.0,11077.0,158990.0
Bilaspur,9.08,Number of Condom pieces distributed,TOTAL,29497.0,37131.0,36961.0,43397.0,43687.0,47215.0,39990.0,48956.0,50765.0,61536.0,52001.0,40199.0,531335.0
Bilaspur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,278.0,1299.0,366.0,593.0,517.0,1572.0,713.0,752.0,233.0,184.0,413.0,737.0,7657.0
Bilaspur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,3.0,14.0,6.0,16.0,15.0,20.0,37.0,20.0,28.0,10.0,16.0,7.0,192.0
Bilaspur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,15.0,47.0,9.0,82.0,56.0,106.0,363.0,174.0,332.0,208.0,165.0,96.0,1653.0
Bilaspur,9.11.2.a,Number of failures following male sterilization,TOTAL,2.0,0.0,1.0,2.0,0.0,0.0,12.0,1.0,1.0,0.0,5.0,3.0,27.0
Bilaspur,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,6.0,6.0,1.0,3.0,0.0,0.0,2.0,0.0,8.0,9.0,5.0,42.0
Bilaspur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,9.12,Number of Institutions having NSV trained doctors,TOTAL,40.0,51.0,53.0,60.0,64.0,51.0,66.0,59.0,57.0,41.0,40.0,40.0,-1.0
Bilaspur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3935.0,4297.0,4717.0,5153.0,5740.0,5608.0,5877.0,6292.0,6544.0,6121.0,4555.0,5047.0,63886.0
Bilaspur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4083.0,4432.0,5278.0,5216.0,5395.0,5533.0,5433.0,6066.0,6527.0,6310.0,5067.0,6107.0,65447.0
Bilaspur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4348.0,4766.0,4909.0,5131.0,5335.0,5322.0,5432.0,5651.0,6023.0,6371.0,5493.0,6414.0,65195.0
Bilaspur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4448.0,5015.0,4987.0,5354.0,5609.0,5414.0,5389.0,5445.0,6046.0,6450.0,5504.0,6887.0,66548.0
Bilaspur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Bilaspur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Bilaspur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Bilaspur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2685.0,3117.0,3496.0,3564.0,4203.0,4247.0,3947.0,4612.0,4441.0,4120.0,3036.0,3580.0,45048.0
Bilaspur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3979.0,4405.0,5205.0,5183.0,5328.0,5540.0,5374.0,5906.0,6553.0,6203.0,5005.0,5946.0,64627.0
Bilaspur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4292.0,4713.0,4871.0,5092.0,5280.0,5236.0,5407.0,5550.0,6000.0,6271.0,5404.0,6310.0,64426.0
Bilaspur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4372.0,4999.0,4885.0,5435.0,5566.0,5304.0,5298.0,5393.0,5978.0,6383.0,5355.0,6709.0,65677.0
Bilaspur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,339.0,204.0,167.0,238.0,230.0,145.0,1328.0
Bilaspur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,50.0,203.0,42.0,65.0,73.0,79.0,3570.0,4958.0,5846.0,5956.0,4559.0,5505.0,30906.0
Bilaspur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,23.0,123.0,43.0,20.0,25.0,29.0,217.0,3264.0,5062.0,5873.0,4979.0,5981.0,25639.0
Bilaspur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,31.0,91.0,37.0,35.0,31.0,28.0,218.0,620.0,3492.0,5097.0,4781.0,6338.0,20799.0
Bilaspur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3876.0,4387.0,5038.0,5528.0,5859.0,5518.0,6213.0,5195.0,6818.0,5391.0,4298.0,6061.0,64182.0
Bilaspur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4.0,0.0,0.0,0.0,0.0,123.0,188.0,166.0,162.0,232.0,268.0,573.0,1716.0
Bilaspur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Bilaspur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1577.0,1881.0,2203.0,2336.0,2539.0,2228.0,2626.0,2286.0,3128.0,2672.0,1840.0,3031.0,28347.0
Bilaspur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1439.0,1652.0,2068.0,2203.0,2450.0,2176.0,2482.0,2163.0,2980.0,2569.0,1787.0,2902.0,26871.0
Bilaspur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3016.0,3533.0,4271.0,4539.0,4989.0,4404.0,5108.0,4449.0,6108.0,5241.0,3627.0,5933.0,55218.0
Bilaspur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2929.0,3224.0,3684.0,3821.0,4503.0,4258.0,4345.0,3835.0,5208.0,4520.0,3432.0,4540.0,48299.0
Bilaspur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2883.0,3185.0,3656.0,3778.0,4502.0,4197.0,3802.0,3763.0,5051.0,4538.0,3343.0,4384.0,47082.0
Bilaspur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1521.0,1816.0,2178.0,2501.0,2620.0,2297.0,2387.0,2513.0,3090.0,2068.0,1425.0,1982.0,26398.0
Bilaspur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1486.0,1759.0,2074.0,2407.0,2428.0,2033.0,2216.0,2156.0,3003.0,1923.0,1446.0,2003.0,24934.0
Bilaspur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3007.0,3575.0,4252.0,4908.0,5048.0,4330.0,4603.0,4669.0,6093.0,3991.0,2871.0,3985.0,51332.0
Bilaspur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,217.0,205.0,318.0,316.0,677.0,798.0,359.0,255.0,797.0,298.0,237.0,223.0,4700.0
Bilaspur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1280.0,1391.0,1826.0,2005.0,3922.0,8369.0,5244.0,3850.0,5555.0,3427.0,2542.0,2468.0,41879.0
Bilaspur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1190.0,1430.0,1677.0,1922.0,2915.0,5174.0,4099.0,3734.0,4987.0,3259.0,2729.0,2435.0,35551.0
Bilaspur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,2.0,4.0,13.0,2.0,9.0,1.0,9.0,12.0,10.0,13.0,20.0,102.0
Bilaspur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,10.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,7.0,20.0
Bilaspur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1566.0,1666.0,1726.0,1628.0,1757.0,1693.0,1713.0,1786.0,1896.0,1856.0,1768.0,1817.0,20872.0
Bilaspur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1444.0,1591.0,1653.0,1608.0,1690.0,1629.0,1639.0,1744.0,1809.0,1896.0,1614.0,1773.0,20090.0
Bilaspur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1199.0,1316.0,1285.0,1269.0,1372.0,1319.0,1397.0,1416.0,1522.0,1692.0,1399.0,1543.0,16729.0
Bilaspur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3047.0,3498.0,4281.0,4465.0,6427.0,4857.0,4696.0,4524.0,8214.0,5304.0,3905.0,5521.0,58739.0
Bilaspur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1683.0,1966.0,1646.0,1768.0,11348.0,3913.0,2211.0,1811.0,19119.0,7666.0,2132.0,1898.0,57161.0
Bilaspur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,882.0,992.0,815.0,679.0,10007.0,3506.0,1284.0,914.0,19043.0,7412.0,1245.0,788.0,47567.0
Bilaspur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,6.0
Bilaspur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Bilaspur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,57.0,42.0,88.0,41.0,96.0,64.0,52.0,55.0,87.0,37.0,17.0,39.0,675.0
Bilaspur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,319.0,362.0,512.0,571.0,622.0,557.0,247.0,253.0,430.0,485.0,341.0,269.0,4968.0
Bilaspur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,301.0,171.0,128.0,184.0,385.0,390.0,657.0,348.0,760.0,292.0,325.0,338.0,4279.0
Bilaspur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,89.0,88.0,121.0,140.0,217.0,137.0,137.0,86.0,178.0,120.0,118.0,90.0,1521.0
Bilaspur,13.1,Number of Patients operated for cataract,TOTAL,160.0,60.0,105.0,124.0,237.0,474.0,410.0,40.0,78.0,259.0,289.0,223.0,2459.0
Bilaspur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,129.0,57.0,111.0,124.0,272.0,536.0,471.0,40.0,82.0,318.0,266.0,317.0,2723.0
Bilaspur,13.3,Number of School children detected with Refractive errors,TOTAL,1.0,0.0,0.0,0.0,132.0,122.0,73.0,42.0,61.0,69.0,110.0,145.0,755.0
Bilaspur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,9.0,0.0,55.0,5.0,72.0
Bilaspur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,3.0,4.0,5.0,4.0,6.0,7.0,8.0,7.0,7.0,8.0,-1.0
Bilaspur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,35.0,41.0,45.0,52.0,57.0,40.0,50.0,48.0,40.0,26.0,31.0,30.0,-1.0
Bilaspur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1424.0,1479.0,1649.0,1390.0,1736.0,1398.0,1628.0,1664.0,1815.0,1798.0,1768.0,1842.0,-1.0
Bilaspur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,9.0,8.0,9.0,9.0,10.0,10.0,11.0,11.0,10.0,12.0,-1.0
Bilaspur,14.05,Number of RKS meetings held during the month,TOTAL,11.0,4.0,5.0,4.0,3.0,9.0,4.0,10.0,15.0,23.0,25.0,16.0,129.0
Bilaspur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,39.0,53.0,57.0,59.0,67.0,51.0,59.0,53.0,40.0,34.0,38.0,44.0,-1.0
Bilaspur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,112.0,111.0,147.0,62.0,99.0,209.0,124.0,229.0,450.0,565.0,539.0,540.0,3187.0
Bilaspur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,7.0,6.0,8.0,6.0,7.0,8.0,9.0,9.0,8.0,9.0,8.0,-1.0
Bilaspur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,2.0,1.0,1.0,2.0,0.0,2.0,1.0,1.0,0.0,0.0,-1.0
Bilaspur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,458.0,205.0,202.0,200.0,231.0,295.0,265.0,308.0,191.0,305.0,139.0,248.0,3047.0
Bilaspur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,741.0,886.0,838.0,867.0,938.0,1156.0,885.0,820.0,822.0,742.0,838.0,1016.0,10549.0
Bilaspur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,564.0,223.0,213.0,171.0,387.0,362.0,365.0,294.0,276.0,272.0,206.0,245.0,3578.0
Bilaspur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1463.0,1300.0,1682.0,1578.0,1646.0,1905.0,2104.0,2324.0,2586.0,2358.0,1886.0,1959.0,22791.0
Bilaspur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1022.0,428.0,415.0,371.0,618.0,657.0,630.0,602.0,467.0,577.0,345.0,493.0,6625.0
Bilaspur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2204.0,2186.0,2520.0,2445.0,2584.0,3061.0,2989.0,3144.0,3408.0,3100.0,2724.0,2975.0,33340.0
Bilaspur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,13.0,7.0,10.0,11.0,4.0,14.0,5.0,15.0,14.0,14.0,8.0,11.0,126.0
Bilaspur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,6.0,3.0,7.0,2.0,4.0,7.0,3.0,8.0,1.0,4.0,3.0,54.0
Bilaspur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,19.0,13.0,13.0,18.0,6.0,18.0,12.0,18.0,22.0,15.0,12.0,14.0,180.0
Bilaspur,14.11,In-Patient Head Count at midnight,TOTAL,681.0,891.0,92.0,176.0,155.0,443.0,90.0,27.0,318.0,1820.0,585.0,841.0,6119.0
Bilaspur,14.12.1,OPD attendance (All),TOTAL,31720.0,33986.0,41479.0,47283.0,49944.0,54975.0,52748.0,45777.0,47392.0,47133.0,51481.0,54059.0,557977.0
Bilaspur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,54.0,52.0,62.0,144.0,57.0,672.0,556.0,460.0,384.0,53.0,139.0,589.0,3222.0
Bilaspur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Bilaspur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,140.0,211.0,233.0,288.0,374.0,313.0,291.0,315.0,786.0,790.0,774.0,403.0,4918.0
Bilaspur,14.14.a,Number of patients given AYUSH treatment,TOTAL,78.0,82.0,2.0,266.0,408.0,744.0,626.0,303.0,726.0,746.0,971.0,923.0,5875.0
Bilaspur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,13.0,8.0,18.0,0.0,32.0,25.0,24.0,38.0,50.0,56.0,35.0,44.0,343.0
Bilaspur,14.14.c,Number of Adolescents counselled,TOTAL,12.0,21.0,22.0,0.0,21.0,11.0,5.0,10.0,26.0,31.0,15.0,3.0,177.0
Bilaspur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2252.0,2620.0,3650.0,3970.0,3454.0,4275.0,4334.0,4624.0,5589.0,5273.0,5037.0,5169.0,50247.0
Bilaspur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,133.0,80.0,169.0,154.0,117.0,107.0,139.0,130.0,136.0,105.0,179.0,130.0,1579.0
Bilaspur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,219.0,332.0,376.0,445.0,413.0,372.0,344.0,557.0,610.0,629.0,351.0,492.0,5140.0
Bilaspur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,35.0,16.0,27.0,4.0,10.0,39.0,6.0,78.0,5.0,5.0,3.0,7.0,235.0
Bilaspur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,376.0,356.0,803.0,967.0,718.0,766.0,911.0,1298.0,1127.0,933.0,888.0,934.0,10077.0
Bilaspur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,110.0,8.0,35.0,2.0,44.0,140.0,83.0,70.0,2.0,3.0,1.0,39.0,537.0
Bilaspur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,245.0,284.0,523.0,406.0,577.0,473.0,520.0,567.0,480.0,645.0,565.0,862.0,6147.0
Bilaspur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,7.0,10.0,0.0,44.0,40.0,38.0,0.0,0.0,34.0,25.0,2.0,200.0
Bilaspur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,840.0,972.0,1702.0,1818.0,1708.0,1611.0,1775.0,2422.0,2217.0,2207.0,1804.0,2288.0,21364.0
Bilaspur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,145.0,31.0,72.0,6.0,98.0,219.0,127.0,148.0,7.0,42.0,29.0,48.0,972.0
Bilaspur,15.2,Number of Widal tests conducted,Number tested,188.0,289.0,417.0,625.0,524.0,973.0,519.0,520.0,348.0,393.0,459.0,1356.0,6611.0
Bilaspur,15.3.a,Number of VDRL tests conducted on males,Number tested,74.0,60.0,104.0,56.0,322.0,380.0,414.0,373.0,454.0,310.0,196.0,151.0,2894.0
Bilaspur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,151.0,174.0,257.0,446.0,355.0,525.0,431.0,351.0,453.0,407.0,224.0,333.0,4107.0
Bilaspur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,182.0,193.0,310.0,434.0,375.0,370.0,387.0,454.0,223.0,309.0,311.0,330.0,3878.0
Bilaspur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,407.0,427.0,671.0,936.0,1052.0,1275.0,1232.0,1178.0,1130.0,1026.0,731.0,814.0,10879.0
Bilaspur,15.4.1,Number of blood smears examined for Malaria,TOTAL,3598.0,4680.0,5186.0,7996.0,10067.0,8931.0,4484.0,9845.0,9399.0,6355.0,4950.0,5645.0,81136.0
Bilaspur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,95.0,18.0,75.0,30.0,76.0,93.0,52.0,75.0,173.0,57.0,73.0,31.0,848.0
Bilaspur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,59.0,82.0,103.0,167.0,296.0,376.0,211.0,296.0,233.0,156.0,121.0,98.0,2198.0
Bilaspur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,29500.0,32500.0,13500.0,22000.0,17000.0,7000.0,12000.0,36000.0,25000.0,12000.0,26000.0,2500.0,235000.0
Bilaspur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,28000.0,20000.0,30000.0,20000.0,20000.0,34000.0,42000.0,0.0,40000.0,40000.0,0.0,30000.0,304000.0
Bilaspur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,25000.0,39000.0,21500.0,25000.0,30000.0,29000.0,18000.0,33500.0,53000.0,26000.0,23500.0,23000.0,346500.0
Bilaspur,16.1.1,Stock position of DPT vaccines,5. Total Stock,32500.0,13500.0,22000.0,17000.0,7000.0,12000.0,36000.0,2500.0,12000.0,26000.0,2500.0,9500.0,192500.0
Bilaspur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Bilaspur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Bilaspur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Bilaspur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Bilaspur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14000.0,28500.0,6000.0,3500.0,500.0,4000.0,1000.0,41000.0,3000.0,3380.0,5380.0,1000.0,111260.0
Bilaspur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,20000.0,20000.0,15000.0,30000.0,30000.0,70000.0,0.0,25380.0,40000.0,468000.0,5000.0,763380.0
Bilaspur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,25500.0,42500.0,22500.0,18000.0,26500.0,33000.0,30000.0,38000.0,25000.0,38000.0,472380.0,4000.0,775380.0
Bilaspur,16.1.2,Stock position of OPV vaccines,5. Total Stock,28500.0,6000.0,3500.0,500.0,4000.0,1000.0,41000.0,3000.0,3380.0,5380.0,1000.0,2000.0,99260.0
Bilaspur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,24500.0,31000.0,19500.0,26500.0,31000.0,13000.0,42000.0,58000.0,18500.0,7500.0,20500.0,8500.0,300500.0
Bilaspur,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,15000.0,30000.0,25000.0,10000.0,65000.0,34000.0,0.0,20000.0,30000.0,0.0,30000.0,289000.0
Bilaspur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,23500.0,26500.0,23000.0,20500.0,28000.0,36000.0,18000.0,39500.0,31000.0,17000.0,12000.0,22000.0,297000.0
Bilaspur,16.1.3,Stock position of TT vaccines,5. Total Stock,31000.0,19500.0,26500.0,31000.0,13000.0,42000.0,58000.0,18500.0,7500.0,20500.0,8500.0,16500.0,292500.0
Bilaspur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12000.0,11000.0,5500.0,3000.0,7500.0,1000.0,1000.0,27000.0,7000.0,4500.0,0.0,0.0,79500.0
Bilaspur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,16000.0,10000.0,10000.0,40000.0,0.0,15000.0,10000.0,0.0,10000.0,141000.0
Bilaspur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,20900.0,15500.0,12500.0,11500.0,16500.0,10000.0,14000.0,20000.0,17500.0,14500.0,0.0,8500.0,161400.0
Bilaspur,16.1.5,Stock position of BCG vaccines,5. Total Stock,1100.0,5500.0,3000.0,7500.0,1000.0,1000.0,27000.0,7000.0,4500.0,0.0,0.0,1500.0,59100.0
Bilaspur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4500.0,10500.0,6500.0,2500.0,5000.0,5000.0,1000.0,23500.0,4500.0,5000.0,9000.0,4000.0,81000.0
Bilaspur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,5000.0,5000.0,10000.0,5000.0,0.0,30000.0,0.0,15000.0,15000.0,0.0,10000.0,105000.0
Bilaspur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4000.0,9000.0,9000.0,7500.0,9000.0,4000.0,7500.0,19000.0,14500.0,11000.0,5000.0,10000.0,109500.0
Bilaspur,16.1.6,Stock position of Measles vaccines,5. Total Stock,10500.0,6500.0,2500.0,5000.0,1000.0,1000.0,23500.0,4500.0,5000.0,9000.0,4000.0,4000.0,76500.0
Bilaspur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,9800.0,59000.0,8600.0,2600.0,19800.0,9000.0,108800.0
Bilaspur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,50000.0,54000.0,0.0,0.0,36700.0,0.0,0.0,140700.0
Bilaspur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,40200.0,4800.0,50400.0,6000.0,19500.0,10800.0,7800.0,139500.0
Bilaspur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,9800.0,59000.0,8600.0,2600.0,19800.0,9000.0,1200.0,110000.0
Bilaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,7600.0,7550.0,5750.0,2700.0,21300.0,19500.0,19500.0,18900.0,17700.0,17100.0,14700.0,14700.0,167000.0
Bilaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,19800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19800.0
Bilaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,50.0,1800.0,3050.0,1200.0,1800.0,600.0,600.0,1200.0,2400.0,2400.0,0.0,600.0,15700.0
Bilaspur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,7550.0,5750.0,2700.0,21300.0,19500.0,18900.0,18900.0,17700.0,15300.0,14700.0,14700.0,14100.0,171100.0
Bilaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,54000.0,24000.0,6000.0,72000.0,54000.0,48000.0,48000.0,30000.0,24000.0,15480.0,0.0,375480.0
Bilaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,60000.0,0.0,0.0,96000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,156000.0
Bilaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15480.0,0.0,15480.0
Bilaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,60000.0,30000.0,18000.0,30000.0,18000.0,6000.0,0.0,18000.0,6000.0,8520.0,0.0,0.0,194520.0
Bilaspur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,24000.0,6000.0,72000.0,54000.0,48000.0,48000.0,30000.0,24000.0,15480.0,0.0,0.0,321480.0
Bilaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,28000.0,28000.0,24000.0,9000.0,19000.0,14000.0,16400.0,14600.0,5600.0,5000.0,4400.0,4400.0,172400.0
Bilaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,15000.0,0.0,8400.0,8400.0,0.0,0.0,0.0,0.0,0.0,31800.0
Bilaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,4000.0,15000.0,5000.0,5000.0,6000.0,10200.0,9000.0,600.0,600.0,0.0,3000.0,58400.0
Bilaspur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,28000.0,24000.0,9000.0,19000.0,14000.0,16400.0,14600.0,5600.0,5000.0,4400.0,4400.0,1400.0,145800.0
Bilaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,10000.0,9000.0,8000.0,8000.0,15100.0,15100.0,14200.0,11800.0,91200.0
Bilaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,9900.0,0.0,0.0,0.0,0.0,19900.0
Bilaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,1000.0,1000.0,0.0,2800.0,0.0,900.0,2400.0,300.0,8400.0
Bilaspur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,10000.0,9000.0,8000.0,8000.0,15100.0,15100.0,14200.0,11800.0,11500.0,102700.0
Bilaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7800.0,7600.0,7600.0,6800.0,5300.0,5300.0,4500.0,3000.0,2000.0,10200.0,8300.0,6300.0,74700.0
Bilaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,10000.0
Bilaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,2000.0
Bilaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,200.0,0.0,800.0,1500.0,0.0,800.0,1500.0,1000.0,1800.0,1900.0,0.0,0.0,9500.0
Bilaspur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7600.0,7600.0,6800.0,5300.0,5300.0,4500.0,3000.0,2000.0,10200.0,8300.0,6300.0,6300.0,73200.0
Bilaspur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,180.0,150.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,405.0
Bilaspur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,30.0,75.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,180.0
Bilaspur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,150.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,225.0
Bilaspur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,3150.0,2250.0,1650.0,1350.0,950.0,650.0,300.0,0.0,0.0,0.0,0.0,0.0,10300.0
Bilaspur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.02,Stock Position of Gloves,4. Stock Distributed,900.0,600.0,300.0,400.0,300.0,350.0,300.0,0.0,0.0,0.0,0.0,0.0,3150.0
Bilaspur,16.3.02,Stock Position of Gloves,5. Total Stock,2250.0,1650.0,1350.0,950.0,650.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,7150.0
Bilaspur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,37400.0,62400.0,58650.0,55450.0,101050.0,84050.0,54050.0,18050.0,13050.0,3050.0,3050.0,3050.0,493300.0
Bilaspur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,41000.0,0.0,0.0,54000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,95000.0
Bilaspur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,16000.0,3750.0,3200.0,8400.0,17000.0,30000.0,36000.0,5000.0,8000.0,0.0,0.0,0.0,127350.0
Bilaspur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,62400.0,58650.0,55450.0,101050.0,84050.0,54050.0,18050.0,13050.0,5050.0,3050.0,3050.0,3050.0,460950.0
Bilaspur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1300.0,1300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2600.0
Bilaspur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,90000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90000.0
Bilaspur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,90000.0,1300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,91300.0
Bilaspur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1300.0
Bilaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,29000.0,16950.0,8850.0,4050.0,2650.0,2250.0,1450.0,450.0,450.0,0.0,57200.0,57200.0,180500.0
Bilaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57200.0,0.0,0.0,57200.0
Bilaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15200.0,15200.0
Bilaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,12050.0,8100.0,4800.0,1400.0,400.0,800.0,1000.0,0.0,450.0,0.0,0.0,0.0,29000.0
Bilaspur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,16950.0,8850.0,4050.0,2650.0,2250.0,1450.0,450.0,450.0,0.0,57200.0,57200.0,42000.0,193500.0
Bilaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,21860.0,18810.0,13610.0,6660.0,3460.0,60.0,0.0,0.0,0.0,0.0,0.0,0.0,64460.0
Bilaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,3050.0,5200.0,6950.0,3200.0,3400.0,60.0,0.0,0.0,0.0,0.0,0.0,0.0,21860.0
Bilaspur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,18810.0,13610.0,6660.0,3460.0,60.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,42600.0
Bilaspur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,3450.0,0.0,3450.0
Bilaspur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,2300.0,0.0,2300.0
Bilaspur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1150.0,0.0,1150.0
Bilaspur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,24330.0,6130.0,230.0,0.0,0.0,0.0,0.0,0.0,20400.0,6450.0,1150.0,1150.0,59840.0
Bilaspur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,20400.0,0.0,0.0,0.0,0.0,26400.0
Bilaspur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13950.0,3000.0,800.0,800.0,18550.0
Bilaspur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,24200.0,5900.0,230.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30330.0
Bilaspur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,6130.0,230.0,0.0,0.0,0.0,0.0,0.0,20400.0,6450.0,3450.0,350.0,350.0,37360.0
Bilaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,40500.0,25900.0,26700.0,14300.0,13700.0,13700.0,13200.0,5800.0,5800.0,3600.0,3600.0,3600.0,170400.0
Bilaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,27000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27000.0
Bilaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,14600.0,26200.0,12400.0,600.0,0.0,500.0,7400.0,0.0,2200.0,0.0,0.0,0.0,63900.0
Bilaspur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,25900.0,26700.0,14300.0,13700.0,13700.0,13200.0,5800.0,5800.0,3600.0,3600.0,3600.0,3600.0,133500.0
Bilaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,472000.0,358000.0,244000.0,28000.0,71200.0,25200.0,21200.0,21200.0,21200.0,20600.0,20600.0,20600.0,1323800.0
Bilaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,330000.0,0.0,43200.0,0.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,403200.0
Bilaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,114000.0,444000.0,216000.0,0.0,46000.0,34000.0,0.0,0.0,600.0,0.0,0.0,0.0,854600.0
Bilaspur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,358000.0,244000.0,28000.0,71200.0,25200.0,21200.0,21200.0,21200.0,20600.0,20600.0,20600.0,20600.0,872400.0
Bilaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5000.0,1600.0,4200.0,1600.0,1600.0,1600.0,800.0,800.0,800.0,200.0,200.0,200.0,18600.0
Bilaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,7600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7600.0
Bilaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bilaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3400.0,5000.0,2600.0,,1600.0,800.0,0.0,0.0,600.0,0.0,0.0,0.0,14000.0
Bilaspur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1600.0,4200.0,1600.0,1600.0,0.0,800.0,800.0,800.0,200.0,200.0,200.0,200.0,12200.0
Bilaspur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,6.0,7.0,3.0,2.0,,11.0,4.0,5.0,3.0,2.0,3.0,47.0
Bilaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,1.0,1.0,3.0
Bilaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bilaspur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,1.0,1.0,3.0
Bilaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,,,1.0
Bilaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,,,,,,,2.0
Bilaspur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,1.0,1.0,,,,,,,,3.0
Bilaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,,,2.0,1.0,,,1.0,2.0,1.0,1.0,11.0
Bilaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,1.0,,,1.0,,,2.0,,,1.0,1.0,8.0
Bilaspur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,2.0,,,3.0,1.0,,2.0,1.0,2.0,2.0,2.0,19.0
Bilaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,,,,,1.0,1.0,2.0,,,,6.0
Bilaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,1.0,,,,,2.0,,1.0,2.0,1.0,1.0,9.0
Bilaspur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,2.0,,,,,3.0,1.0,3.0,2.0,1.0,1.0,15.0
Bilaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,3.0,1.0,,,4.0,1.0,1.0,2.0,1.0,3.0,17.0
Bilaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,4.0,1.0,2.0,3.0,,,10.0
Bilaspur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,3.0,1.0,,,8.0,2.0,3.0,5.0,1.0,3.0,27.0
Bilaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,1.0,,,,,,1.0,,,,2.0
Bilaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,1.0,,,2.0
Bilaspur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,2.0,,,,,,1.0,1.0,,,4.0
Bilaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Bilaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,1.0,,,,2.0
Bilaspur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,2.0,,,,3.0
Bilaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bilaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Bilaspur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,1.0,,,1.0
Bilaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,,3.0,,,3.0,2.0,2.0,1.0,2.0,,17.0
Bilaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,2.0,,,3.0,6.0,3.0,2.0,5.0,1.0,3.0,25.0
Bilaspur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,2.0,3.0,,3.0,9.0,5.0,4.0,6.0,3.0,3.0,42.0
Bilaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,1.0,2.0,,,3.0
Bilaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,1.0,2.0,,,3.0
Bilaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Bilaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,3.0,1.0,,17.0
Bilaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,3.0,,,2.0,,,1.0,7.0
Bilaspur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,3.0,3.0,1.0,1.0,4.0,1.0,1.0,3.0,3.0,1.0,1.0,25.0
Bilaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,1.0,,3.0,3.0,,1.0,,,1.0,1.0,1.0,14.0
Bilaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,2.0,,,,1.0,1.0,,2.0,7.0
Bilaspur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,2.0,,3.0,5.0,,1.0,,1.0,2.0,1.0,3.0,21.0
Bilaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,1.0,,,,,,,1.0,,,,,2.0
Bilaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,,,1.0,,,,,1.0,,3.0
Bilaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Bilaspur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,2.0,,,,,2.0,,1.0,,,1.0,,6.0
Bilaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,1.0,,1.0,,2.0
Bilaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,4.0,,,,,,3.0,3.0,2.0,2.0,,1.0,15.0
Bilaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,2.0,,1.0,,,1.0,1.0,1.0,1.0,,8.0
Bilaspur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,1.0,2.0,,1.0,,3.0,4.0,4.0,3.0,2.0,1.0,25.0
Bilaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Bilaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,1.0,,,,,,,,1.0
Bilaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Bilaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,4.0,2.0,3.0,7.0,4.0,4.0,2.0,6.0,4.0,3.0,4.0,47.0
Bilaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,2.0,2.0,1.0,4.0,1.0,6.0,5.0,3.0,2.0,3.0,6.0,38.0
Bilaspur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,7.0,7.0,4.0,4.0,11.0,5.0,10.0,7.0,9.0,6.0,6.0,10.0,86.0
Bilaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Bilaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,2.0,,1.0,2.0,1.0,,,6.0
Bilaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,1.0,,,,2.0
Bilaspur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,,,,2.0,,1.0,3.0,1.0,,,9.0
Bilaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,1.0,,1.0,,,,,,,,2.0
Bilaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,1.0,,1.0,,,,,,,,2.0
Bilaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Bilaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Bilaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,1.0,1.0,,,1.0,,,1.0,5.0
Bilaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,1.0,,,,,,,1.0,,,,,2.0
Bilaspur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,2.0,,,,1.0,1.0,,1.0,1.0,,,1.0,7.0
Bilaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,2.0,,,,,,,,,3.0
Bilaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,2.0,,,,,,,,,3.0
Bilaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Bilaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bilaspur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,1.0,,,,,1.0
Bilaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bilaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,1.0,1.0,3.0,2.0,1.0,4.0,2.0,1.0,1.0,1.0,19.0
Bilaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,1.0,1.0,,,,1.0,,1.0,,2.0,4.0,10.0
Bilaspur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,2.0,1.0,3.0,2.0,2.0,4.0,3.0,1.0,3.0,5.0,29.0
Bilaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,2.0,4.0,,,,,1.0,,,7.0
Bilaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,3.0,4.0,6.0,3.0,2.0,8.0,1.0,5.0,7.0,4.0,3.0,8.0,54.0
Bilaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,,,1.0,1.0,2.0,,2.0,1.0,,2.0,10.0
Bilaspur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,5.0,6.0,5.0,7.0,9.0,3.0,5.0,9.0,6.0,3.0,10.0,71.0
Bilaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Bilaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,5.0,4.0,5.0,6.0,9.0,1.0,,1.0,8.0,14.0,12.0,66.0
Bilaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Bilaspur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,5.0,4.0,6.0,7.0,10.0,1.0,,1.0,8.0,14.0,12.0,69.0
Bilaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,3.0,1.0,5.0,1.0,3.0,,,,,13.0
Bilaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,3.0,4.0,4.0,3.0,2.0,4.0,5.0,,3.0,6.0,35.0
Bilaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,2.0,,,1.0,,,2.0,2.0,8.0
Bilaspur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,4.0,7.0,7.0,8.0,3.0,8.0,5.0,,5.0,8.0,56.0
Bilaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,1.0,1.0,1.0,,,,,,1.0,5.0
Bilaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,4.0,1.0,7.0,6.0,6.0,11.0,1.0,5.0,13.0,7.0,4.0,66.0
Bilaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,4.0,4.0,4.0,2.0,3.0,4.0,8.0,4.0,4.0,1.0,7.0,47.0
Bilaspur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,9.0,5.0,12.0,9.0,10.0,15.0,9.0,9.0,17.0,8.0,12.0,118.0
Bilaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,1.0,,,1.0,,,,,4.0
Bilaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,3.0,3.0,12.0,7.0,9.0,9.0,10.0,20.0,12.0,10.0,9.0,110.0
Bilaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,5.0,9.0,15.0,8.0,20.0,12.0,6.0,10.0,9.0,1.0,13.0,14.0,122.0
Bilaspur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,11.0,13.0,19.0,20.0,28.0,21.0,15.0,21.0,29.0,13.0,23.0,23.0,236.0
Bilaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,1.0,,1.0,,1.0,1.0,,,1.0,1.0,7.0
Bilaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,12.0,12.0,14.0,11.0,9.0,14.0,14.0,15.0,20.0,18.0,8.0,152.0
Bilaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,12.0,16.0,27.0,42.0,25.0,45.0,48.0,29.0,22.0,8.0,16.0,29.0,319.0
Bilaspur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,17.0,29.0,40.0,56.0,37.0,54.0,63.0,44.0,37.0,28.0,35.0,38.0,478.0
Dantewada,1.1,Total number of pregnant women Registered for ANC,TOTAL,985.0,1094.0,1093.0,1245.0,1170.0,1072.0,994.0,1221.0,1349.0,1358.0,1055.0,1152.0,13788.0
Dantewada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,342.0,461.0,502.0,519.0,517.0,440.0,416.0,516.0,540.0,557.0,552.0,523.0,5885.0
Dantewada,1.2,Number of Pregnant women registered under JSY,TOTAL,912.0,992.0,997.0,1086.0,1017.0,921.0,876.0,1129.0,1303.0,1273.0,996.0,1058.0,12560.0
Dantewada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,584.0,757.0,720.0,837.0,853.0,819.0,786.0,854.0,971.0,1085.0,864.0,1160.0,10290.0
Dantewada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,571.0,696.0,702.0,799.0,762.0,720.0,644.0,862.0,908.0,976.0,758.0,837.0,9235.0
Dantewada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,561.0,708.0,634.0,695.0,845.0,691.0,629.0,890.0,946.0,1029.0,874.0,895.0,9397.0
Dantewada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,834.0,978.0,989.0,1018.0,885.0,808.0,725.0,706.0,1198.0,1046.0,786.0,921.0,10894.0
Dantewada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,50.0,31.0,25.0,83.0,83.0,58.0,72.0,55.0,103.0,119.0,49.0,66.0,794.0
Dantewada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,154.0,130.0,76.0,127.0,156.0,131.0,147.0,165.0,188.0,147.0,116.0,151.0,1688.0
Dantewada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,11.0,1.0,0.0,0.0,0.0,2.0,0.0,5.0,4.0,9.0,17.0,49.0
Dantewada,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Dantewada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,203.0,224.0,250.0,296.0,346.0,246.0,228.0,251.0,241.0,257.0,297.0,303.0,3142.0
Dantewada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,189.0,235.0,238.0,295.0,282.0,267.0,245.0,274.0,278.0,324.0,255.0,318.0,3200.0
Dantewada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,392.0,459.0,488.0,591.0,628.0,513.0,473.0,525.0,519.0,581.0,552.0,621.0,6342.0
Dantewada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,286.0,297.0,296.0,381.0,443.0,326.0,320.0,347.0,374.0,427.0,395.0,491.0,4383.0
Dantewada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,89.0,85.0,109.0,128.0,188.0,139.0,76.0,166.0,227.0,180.0,176.0,156.0,1719.0
Dantewada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,186.0,182.0,227.0,298.0,297.0,222.0,229.0,270.0,289.0,307.0,328.0,344.0,3179.0
Dantewada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,173.0,154.0,184.0,228.0,223.0,160.0,179.0,207.0,237.0,271.0,283.0,301.0,2600.0
Dantewada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,101.0,107.0,139.0,168.0,315.0,507.0,443.0,531.0,394.0,397.0,381.0,323.0,3806.0
Dantewada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,70.0,81.0,98.0,124.0,225.0,296.0,278.0,387.0,252.0,303.0,314.0,249.0,2677.0
Dantewada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,43.0,43.0
Dantewada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,29.0,69.0,111.0,100.0,107.0,125.0,130.0,82.0,97.0,850.0
Dantewada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,29.0,69.0,84.0,62.0,0.0,74.0,60.0,81.0,65.0,524.0
Dantewada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,20.0,64.0,36.0,62.0,0.0,0.0,60.0,81.0,65.0,388.0
Dantewada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,4.1.1.a,Number of male live births,TOTAL,267.0,290.0,346.0,460.0,490.0,418.0,402.0,459.0,453.0,503.0,471.0,544.0,5103.0
Dantewada,4.1.1.b,Number of female live births,TOTAL,293.0,330.0,350.0,430.0,491.0,420.0,398.0,420.0,460.0,499.0,463.0,524.0,5078.0
Dantewada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,560.0,620.0,696.0,890.0,981.0,838.0,800.0,879.0,913.0,1002.0,934.0,1068.0,10181.0
Dantewada,4.1.2,Number of still births,TOTAL,21.0,24.0,25.0,24.0,26.0,21.0,19.0,30.0,54.0,27.0,33.0,46.0,350.0
Dantewada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,19.0,28.0,26.0,24.0,20.0,19.0,17.0,24.0,34.0,31.0,26.0,28.0,296.0
Dantewada,4.2.1,Number of Newborns weighed at birth,TOTAL,529.0,508.0,571.0,820.0,899.0,711.0,745.0,759.0,816.0,938.0,873.0,1037.0,9206.0
Dantewada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,87.0,64.0,89.0,86.0,120.0,104.0,128.0,95.0,177.0,105.0,95.0,93.0,1243.0
Dantewada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,544.0,599.0,676.0,889.0,938.0,812.0,788.0,824.0,878.0,966.0,913.0,1057.0,9884.0
Dantewada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,13.0,0.0,0.0,0.0,15.0
Dantewada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,5.0
Dantewada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3.0,3.0,1.0,4.0,3.0,0.0,2.0,0.0,1.0,2.0,3.0,5.0,27.0
Dantewada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3.0,4.0,2.0,6.0,4.0,1.0,2.0,0.0,14.0,2.0,4.0,5.0,47.0
Dantewada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,0.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,0.0,4.0
Dantewada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,0.0,3.0,0.0,1.0,0.0,0.0,0.0,6.0,0.0,4.0,2.0,17.0
Dantewada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,2.0,0.0,4.0,3.0,0.0,2.0,0.0,1.0,2.0,1.0,3.0,19.0
Dantewada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1.0,2.0,1.0,2.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,10.0
Dantewada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,429.0,434.0,499.0,514.0,653.0,584.0,491.0,584.0,632.0,714.0,683.0,843.0,7060.0
Dantewada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,360.0,397.0,438.0,500.0,621.0,482.0,410.0,545.0,535.0,638.0,580.0,742.0,6248.0
Dantewada,6.3,PNC maternal complications attended,TOTAL,0.0,1.0,5.0,8.0,0.0,3.0,0.0,0.0,0.0,3.0,4.0,0.0,24.0
Dantewada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,6.0,3.0,7.0,1.0,18.0
Dantewada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,6.0,3.0,7.0,1.0,18.0
Dantewada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,6.0,3.0,2.0,0.0,48.0,45.0,99.0,3.0,16.0,7.0,1.0,6.0,236.0
Dantewada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2.0,4.0,4.0,14.0,134.0,163.0,96.0,8.0,14.0,12.0,12.0,11.0,474.0
Dantewada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,8.0,7.0,6.0,14.0,182.0,208.0,195.0,11.0,30.0,19.0,13.0,17.0,710.0
Dantewada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,28.0,20.0,20.0,4.0,4.0,0.0,0.0,15.0,0.0,91.0
Dantewada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,82.0,39.0,6.0,207.0,184.0,108.0,6.0,0.0,0.0,632.0
Dantewada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,17.0,15.0,26.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0
Dantewada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,17.0,125.0,85.0,26.0,211.0,188.0,108.0,6.0,15.0,0.0,781.0
Dantewada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dantewada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,4.0,35.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0
Dantewada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,363.0,9.0,167.0,126.0,47.0,64.0,0.0,0.0,0.0,776.0
Dantewada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,32.0,14.0,90.0,0.0,0.0,0.0,58.0,0.0,0.0,194.0
Dantewada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,395.0,27.0,292.0,126.0,47.0,64.0,58.0,0.0,0.0,1009.0
Dantewada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Dantewada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Dantewada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,0.0,0.0,37.0,0.0,39.0,0.0,0.0,0.0,0.0,76.0
Dantewada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,68.0,123.0,107.0,396.0,237.0,148.0,109.0,108.0,117.0,127.0,85.0,144.0,1769.0
Dantewada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,6.0,8.0,18.0,19.0,12.0,9.0,4.0,12.0,10.0,8.0,3.0,110.0
Dantewada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2.0,0.0,0.0,21.0,0.0,9.0,0.0,0.0,11.0,8.0,4.0,3.0,58.0
Dantewada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4.0,1.0,1.0,4.0,2.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,16.0
Dantewada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dantewada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,75.0,130.0,116.0,439.0,258.0,169.0,119.0,113.0,140.0,147.0,97.0,150.0,1953.0
Dantewada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Dantewada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.06,Number of IUCD removals,TOTAL,166.0,99.0,96.0,205.0,112.0,162.0,136.0,158.0,215.0,109.0,107.0,1947.0,3512.0
Dantewada,9.07,Number of Oral Pills cycles distributed,TOTAL,2828.0,3138.0,2430.0,3352.0,4412.0,4051.0,3890.0,4305.0,5009.0,4687.0,4115.0,4993.0,47210.0
Dantewada,9.08,Number of Condom pieces distributed,TOTAL,28483.0,25230.0,25079.0,25853.0,31933.0,35541.0,32355.0,30646.0,33737.0,24916.0,29748.0,27299.0,350820.0
Dantewada,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dantewada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Dantewada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,3.0,4.0,3.0,4.0,5.0,4.0,3.0,3.0,4.0,4.0,10.0,-1.0
Dantewada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,541.0,627.0,679.0,791.0,903.0,797.0,805.0,936.0,860.0,951.0,902.0,1022.0,9814.0
Dantewada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,583.0,715.0,798.0,752.0,817.0,888.0,880.0,861.0,879.0,1050.0,835.0,1059.0,10117.0
Dantewada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,562.0,693.0,802.0,804.0,789.0,841.0,867.0,880.0,877.0,988.0,896.0,928.0,9927.0
Dantewada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,582.0,710.0,711.0,766.0,826.0,834.0,826.0,881.0,877.0,919.0,800.0,1017.0,9749.0
Dantewada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Dantewada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Dantewada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Dantewada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,437.0,453.0,531.0,532.0,659.0,669.0,618.0,712.0,662.0,781.0,605.0,868.0,7527.0
Dantewada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,583.0,715.0,798.0,752.0,830.0,888.0,878.0,861.0,879.0,1050.0,834.0,1059.0,10127.0
Dantewada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,562.0,693.0,802.0,804.0,789.0,841.0,866.0,880.0,877.0,988.0,890.0,918.0,9910.0
Dantewada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,582.0,710.0,711.0,766.0,826.0,834.0,821.0,881.0,877.0,919.0,795.0,1017.0,9739.0
Dantewada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,0.0,0.0,0.0,3.0,3.0,15.0,93.0,16.0,24.0,154.0
Dantewada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,4.0,2.0,9.0,5.0,8.0,140.0,50.0,140.0,853.0,1606.0,649.0,799.0,4265.0
Dantewada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,5.0,9.0,0.0,11.0,2.0,178.0,428.0,518.0,755.0,1906.0
Dantewada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,64.0,124.0,366.0,753.0,1310.0
Dantewada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,485.0,658.0,681.0,770.0,966.0,866.0,772.0,776.0,1164.0,1119.0,720.0,938.0,9915.0
Dantewada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Dantewada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,250.0,333.0,320.0,368.0,470.0,443.0,387.0,383.0,568.0,538.0,354.0,451.0,4865.0
Dantewada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,235.0,325.0,358.0,402.0,493.0,421.0,392.0,394.0,585.0,551.0,356.0,449.0,4961.0
Dantewada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,485.0,658.0,678.0,770.0,963.0,864.0,779.0,777.0,1153.0,1089.0,710.0,900.0,9826.0
Dantewada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,453.0,538.0,584.0,752.0,845.0,831.0,701.0,709.0,1019.0,1146.0,629.0,871.0,9078.0
Dantewada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,453.0,538.0,584.0,752.0,841.0,831.0,701.0,709.0,1019.0,1146.0,629.0,873.0,9076.0
Dantewada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,317.0,227.0,299.0,323.0,282.0,452.0,318.0,236.0,416.0,429.0,249.0,346.0,3894.0
Dantewada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,262.0,232.0,299.0,312.0,264.0,380.0,322.0,230.0,455.0,413.0,232.0,344.0,3745.0
Dantewada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,579.0,459.0,598.0,635.0,546.0,832.0,640.0,466.0,871.0,842.0,481.0,690.0,7639.0
Dantewada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,187.0,295.0,292.0,566.0,771.0,605.0,869.0,379.0,1094.0,1034.0,419.0,531.0,7042.0
Dantewada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,304.0,423.0,544.0,645.0,988.0,1127.0,1067.0,763.0,1461.0,1465.0,1028.0,931.0,10746.0
Dantewada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,265.0,380.0,478.0,528.0,1002.0,994.0,884.0,686.0,1180.0,1257.0,870.0,1013.0,9537.0
Dantewada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,3.0,7.0,15.0,8.0,6.0,5.0,6.0,24.0,6.0,6.0,4.0,93.0
Dantewada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,161.0,202.0,193.0,234.0,234.0,229.0,217.0,206.0,251.0,168.0,124.0,316.0,2535.0
Dantewada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,630.0,684.0,678.0,619.0,741.0,713.0,648.0,677.0,671.0,718.0,674.0,682.0,8135.0
Dantewada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,455.0,501.0,511.0,511.0,595.0,544.0,510.0,519.0,586.0,608.0,560.0,592.0,6492.0
Dantewada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,259.0,326.0,367.0,369.0,419.0,407.0,371.0,392.0,458.0,479.0,428.0,456.0,4731.0
Dantewada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,484.0,655.0,686.0,731.0,952.0,829.0,816.0,755.0,1142.0,1220.0,682.0,913.0,9865.0
Dantewada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,286.0,378.0,634.0,1536.0,2668.0,1792.0,780.0,492.0,3617.0,3033.0,913.0,616.0,16745.0
Dantewada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,159.0,245.0,521.0,1597.0,3270.0,2066.0,675.0,342.0,4809.0,4129.0,877.0,387.0,19077.0
Dantewada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,511.0,642.0,606.0,677.0,798.0,885.0,713.0,637.0,766.0,739.0,722.0,778.0,8474.0
Dantewada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,399.0,286.0,300.0,708.0,279.0,394.0,272.0,455.0,399.0,256.0,173.0,258.0,4179.0
Dantewada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19.0,22.0,34.0,17.0,12.0,38.0,16.0,10.0,67.0,2.0,8.0,9.0,254.0
Dantewada,13.1,Number of Patients operated for cataract,TOTAL,7.0,0.0,97.0,269.0,217.0,453.0,106.0,156.0,89.0,34.0,42.0,54.0,1524.0
Dantewada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,7.0,0.0,96.0,252.0,213.0,453.0,106.0,154.0,89.0,34.0,42.0,54.0,1500.0
Dantewada,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,62.0,19.0,31.0,19.0,23.0,35.0,25.0,80.0,911.0,1205.0
Dantewada,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,26.0,26.0
Dantewada,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,3.0,3.0,3.0,3.0,4.0,3.0,3.0,3.0,3.0,2.0,4.0,-1.0
Dantewada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,1.0,,4.0,3.0,7.0,-1.0
Dantewada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,534.0,685.0,612.0,594.0,872.0,665.0,596.0,669.0,645.0,875.0,801.0,755.0,-1.0
Dantewada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,6.0,6.0,6.0,6.0,7.0,6.0,6.0,5.0,6.0,6.0,7.0,-1.0
Dantewada,14.05,Number of RKS meetings held during the month,TOTAL,4.0,6.0,4.0,2.0,4.0,4.0,2.0,3.0,2.0,1.0,1.0,2.0,35.0
Dantewada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,10.0,10.0,12.0,12.0,13.0,11.0,10.0,12.0,14.0,11.0,18.0,-1.0
Dantewada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,37.0,42.0,42.0,70.0,78.0,75.0,83.0,65.0,73.0,101.0,78.0,77.0,821.0
Dantewada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,1.0,2.0,2.0,1.0,3.0,-1.0
Dantewada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dantewada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,178.0,159.0,144.0,163.0,165.0,222.0,141.0,218.0,258.0,245.0,279.0,292.0,2464.0
Dantewada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,399.0,510.0,378.0,476.0,437.0,434.0,475.0,308.0,411.0,343.0,465.0,438.0,5074.0
Dantewada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,162.0,161.0,127.0,140.0,148.0,227.0,132.0,275.0,299.0,284.0,249.0,257.0,2461.0
Dantewada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,560.0,710.0,512.0,719.0,536.0,673.0,667.0,586.0,530.0,515.0,583.0,765.0,7356.0
Dantewada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,340.0,320.0,271.0,303.0,313.0,449.0,273.0,493.0,557.0,529.0,528.0,549.0,4925.0
Dantewada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,959.0,1220.0,890.0,1195.0,973.0,1107.0,1142.0,894.0,941.0,858.0,1048.0,1203.0,12430.0
Dantewada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,5.0,3.0,4.0,14.0,8.0,5.0,7.0,4.0,5.0,8.0,12.0,83.0
Dantewada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,3.0,2.0,2.0,20.0,9.0,8.0,5.0,3.0,3.0,3.0,9.0,70.0
Dantewada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11.0,8.0,5.0,6.0,34.0,17.0,13.0,12.0,7.0,8.0,11.0,21.0,153.0
Dantewada,14.11,In-Patient Head Count at midnight,TOTAL,55.0,70.0,86.0,75.0,79.0,75.0,61.0,80.0,154.0,92.0,83.0,69.0,979.0
Dantewada,14.12.1,OPD attendance (All),TOTAL,17580.0,16276.0,18507.0,24981.0,30935.0,29660.0,26559.0,26132.0,28685.0,27228.0,26701.0,27027.0,300271.0
Dantewada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Dantewada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2.0,4.0,94.0,143.0,152.0,319.0,111.0,161.0,91.0,92.0,40.0,1.0,1210.0
Dantewada,14.14.a,Number of patients given AYUSH treatment,TOTAL,604.0,564.0,710.0,1057.0,969.0,1062.0,1328.0,1346.0,1271.0,1241.0,944.0,1467.0,12563.0
Dantewada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,52.0,42.0,18.0,90.0,114.0,113.0,41.0,33.0,96.0,91.0,90.0,98.0,878.0
Dantewada,14.14.c,Number of Adolescents counselled,TOTAL,13.0,26.0,36.0,30.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,1.0,111.0
Dantewada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,641.0,815.0,995.0,997.0,769.0,1194.0,994.0,845.0,817.0,979.0,890.0,939.0,10875.0
Dantewada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,79.0,86.0,73.0,105.0,87.0,89.0,77.0,63.0,97.0,70.0,80.0,152.0,1058.0
Dantewada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,22.0,45.0,38.0,29.0,41.0,49.0,96.0,28.0,66.0,55.0,66.0,68.0,603.0
Dantewada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,4.0
Dantewada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,21.0,38.0,25.0,17.0,9.0,19.0,3.0,10.0,47.0,55.0,69.0,99.0,412.0
Dantewada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,6.0,8.0
Dantewada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,90.0,157.0,86.0,113.0,112.0,88.0,87.0,98.0,97.0,99.0,100.0,92.0,1219.0
Dantewada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Dantewada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,133.0,240.0,149.0,159.0,162.0,156.0,186.0,136.0,210.0,209.0,235.0,259.0,2234.0
Dantewada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,3.0,0.0,2.0,6.0,13.0
Dantewada,15.2,Number of Widal tests conducted,Number tested,250.0,119.0,353.0,408.0,368.0,450.0,480.0,490.0,602.0,563.0,627.0,601.0,5311.0
Dantewada,15.3.a,Number of VDRL tests conducted on males,Number tested,19.0,41.0,36.0,28.0,34.0,41.0,90.0,21.0,11.0,19.0,32.0,59.0,431.0
Dantewada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,20.0,18.0,24.0,16.0,9.0,6.0,5.0,10.0,74.0,74.0,43.0,91.0,390.0
Dantewada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,88.0,156.0,84.0,106.0,96.0,87.0,96.0,112.0,106.0,102.0,88.0,85.0,1206.0
Dantewada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,127.0,215.0,144.0,150.0,139.0,134.0,191.0,143.0,191.0,195.0,163.0,235.0,2027.0
Dantewada,15.4.1,Number of blood smears examined for Malaria,TOTAL,4400.0,3670.0,4815.0,8403.0,7526.0,11765.0,8206.0,7925.0,14439.0,5775.0,7899.0,5917.0,90740.0
Dantewada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,126.0,108.0,106.0,154.0,255.0,330.0,237.0,234.0,342.0,172.0,219.0,149.0,2432.0
Dantewada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,630.0,433.0,520.0,1060.0,1149.0,1357.0,1047.0,1955.0,3149.0,1430.0,1108.0,687.0,14525.0
Dantewada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6500.0,3500.0,11500.0,21000.0,13500.0,15500.0,15000.0,13000.0,18600.0,13100.0,10060.0,15560.0,156820.0
Dantewada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,18000.0,0.0,7000.0,5000.0,0.0,10000.0,0.0,0.0,10000.0,0.0,60000.0
Dantewada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3000.0,2000.0,8500.0,7500.0,5000.0,5500.0,2000.0,4400.0,5500.0,3040.0,4500.0,7000.0,57940.0
Dantewada,16.1.1,Stock position of DPT vaccines,5. Total Stock,3500.0,11500.0,21000.0,13500.0,15500.0,15000.0,13000.0,18600.0,13100.0,10060.0,15560.0,8560.0,158880.0
Dantewada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dantewada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dantewada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dantewada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dantewada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,0.0,10000.0,12500.0,1740.0,1640.0,2540.0,40.0,4140.0,1640.0,640.0,2400.0,40280.0
Dantewada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,10000.0,10000.0,0.0,6000.0,5000.0,0.0,10000.0,5000.0,0.0,93000.0,0.0,139000.0
Dantewada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3000.0,0.0,7500.0,10760.0,6100.0,4100.0,2500.0,5900.0,7500.0,1000.0,91240.0,2060.0,141660.0
Dantewada,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,10000.0,12500.0,1740.0,1640.0,2540.0,40.0,4140.0,1640.0,640.0,2400.0,340.0,37620.0
Dantewada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7150.0,4150.0,9150.0,22900.0,13400.0,15900.0,14900.0,10100.0,13800.0,13300.0,8260.0,18860.0,151870.0
Dantewada,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,8000.0,20000.0,0.0,8000.0,5000.0,0.0,10000.0,5000.0,0.0,15000.0,0.0,71000.0
Dantewada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3000.0,3000.0,6250.0,9500.0,5500.0,6000.0,4800.0,6300.0,5500.0,5040.0,4400.0,5500.0,64790.0
Dantewada,16.1.3,Stock position of TT vaccines,5. Total Stock,4150.0,9150.0,22900.0,13400.0,15900.0,14900.0,10100.0,13800.0,13300.0,8260.0,18860.0,13360.0,158080.0
Dantewada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6450.0,3950.0,6950.0,9450.0,4450.0,4450.0,3000.0,5450.0,7450.0,3950.0,380.0,180.0,56110.0
Dantewada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,5000.0,7000.0,0.0,5000.0,5000.0,5000.0,6000.0,0.0,0.0,1000.0,3000.0,37000.0
Dantewada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2500.0,2000.0,4500.0,5000.0,5000.0,6450.0,2550.0,4000.0,3500.0,3570.0,1200.0,2700.0,42970.0
Dantewada,16.1.5,Stock position of BCG vaccines,5. Total Stock,3950.0,6950.0,9450.0,4450.0,4450.0,3000.0,5450.0,7450.0,3950.0,380.0,180.0,480.0,50140.0
Dantewada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,12885.0,9885.0,10135.0,11385.0,9885.0,10635.0,14195.0,13695.0,16945.0,13695.0,12775.0,10425.0,146540.0
Dantewada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,2000.0,4000.0,0.0,2500.0,4000.0,0.0,5000.0,0.0,0.0,0.0,0.0,17500.0
Dantewada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3000.0,1750.0,2750.0,1500.0,2750.0,440.0,500.0,1750.0,3250.0,920.0,2350.0,1500.0,22460.0
Dantewada,16.1.6,Stock position of Measles vaccines,5. Total Stock,9885.0,10135.0,11385.0,9885.0,9635.0,14195.0,13695.0,16945.0,13695.0,12775.0,10425.0,8925.0,141580.0
Dantewada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,200.0,0.0,0.0,0.0,0.0,4880.0,14380.0,11480.0,9340.0,9340.0,49620.0
Dantewada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,10000.0,10000.0,0.0,0.0,0.0,0.0,30000.0
Dantewada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,200.0,0.0,0.0,0.0,5120.0,500.0,2900.0,2140.0,0.0,2236.0,13096.0
Dantewada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,10000.0,4880.0,14380.0,11480.0,9340.0,9340.0,7104.0,66524.0
Dantewada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1796.0,1796.0,1796.0,4800.0,2300.0,2300.0,0.0,0.0,0.0,0.0,0.0,0.0,14788.0
Dantewada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0
Dantewada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1796.0,2500.0,0.0,2300.0,0.0,0.0,0.0,0.0,0.0,0.0,6596.0
Dantewada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1796.0,1796.0,4800.0,2300.0,2300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12992.0
Dantewada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,12000.0,0.0,0.0,0.0,25200.0,25200.0,25200.0,25200.0,20160.0,132960.0
Dantewada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,24000.0,0.0,0.0,22680.0,25200.0,0.0,0.0,0.0,0.0,0.0,71880.0
Dantewada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,12000.0,12000.0,0.0,22680.0,0.0,0.0,0.0,0.0,5040.0,0.0,51720.0
Dantewada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,12000.0,0.0,0.0,0.0,25200.0,25200.0,25200.0,25200.0,20160.0,20160.0,153120.0
Dantewada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,6000.0,2000.0,2000.0,0.0,2400.0,2400.0,2400.0,2400.0,1200.0,20800.0
Dantewada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,1200.0,2400.0,0.0,0.0,0.0,0.0,0.0,13600.0
Dantewada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,4000.0,4000.0,0.0,3200.0,0.0,0.0,0.0,0.0,1200.0,0.0,12400.0
Dantewada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,6000.0,2000.0,2000.0,0.0,2400.0,2400.0,2400.0,2400.0,1200.0,1200.0,22000.0
Dantewada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2000.0,1000.0,1000.0,0.0,0.0,1800.0,1800.0,1800.0,1200.0,10600.0
Dantewada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,0.0,0.0,4800.0
Dantewada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1000.0,1000.0,0.0,1000.0,0.0,0.0,0.0,0.0,600.0,0.0,3600.0
Dantewada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2000.0,1000.0,1000.0,0.0,0.0,1800.0,1800.0,1800.0,1200.0,1200.0,11800.0
Dantewada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4000.0,4000.0,4000.0,4000.0,1000.0,900.0,700.0,0.0,0.0,0.0,0.0,0.0,18600.0
Dantewada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,0.0,200.0,700.0,0.0,0.0,0.0,0.0,0.0,3900.0
Dantewada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4000.0,4000.0,4000.0,1000.0,1000.0,700.0,0.0,0.0,0.0,0.0,0.0,0.0,14700.0
Dantewada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,360.0,860.0,860.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2080.0
Dantewada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,860.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,860.0
Dantewada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,360.0,860.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1220.0
Dantewada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,10000.0,2000.0,1800.0,1600.0,1600.0,1000.0,1000.0,200.0,0.0,0.0,0.0,0.0,19200.0
Dantewada,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,3000.0
Dantewada,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.02,Stock Position of Gloves,4. Stock Distributed,8000.0,0.0,200.0,0.0,600.0,0.0,800.0,200.0,0.0,0.0,0.0,0.0,9800.0
Dantewada,16.3.02,Stock Position of Gloves,5. Total Stock,2000.0,2000.0,1600.0,1600.0,1000.0,1000.0,200.0,0.0,0.0,0.0,0.0,3000.0,12400.0
Dantewada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,9000.0,3000.0,500.0,20000.0,1000.0,26000.0,13800.0,5800.0,5800.0,5800.0,5800.0,2800.0,99300.0
Dantewada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,20000.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48000.0
Dantewada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,6000.0,2500.0,500.0,19000.0,3000.0,12200.0,8000.0,0.0,0.0,0.0,3000.0,0.0,54200.0
Dantewada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,3000.0,500.0,20000.0,1000.0,26000.0,13800.0,5800.0,5800.0,5800.0,5800.0,2800.0,2800.0,93100.0
Dantewada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Dantewada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,47000.0,7000.0,370000.0,424000.0
Dantewada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,57000.0,0.0,370000.0,0.0,427000.0
Dantewada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,40000.0,7000.0,319873.0,376873.0
Dantewada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,47000.0,7000.0,370000.0,50127.0,474127.0
Dantewada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8875.0,2075.0,1475.0,28425.0
Dantewada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10900.0,0.0,0.0,0.0,10900.0
Dantewada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2025.0,6800.0,600.0,1175.0,26600.0
Dantewada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8875.0,2075.0,1475.0,300.0,12725.0
Dantewada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,2000.0,500.0,0.0,3350.0,1150.0,350.0,0.0,5000.0,5750.0,3950.0,1600.0,800.0,24450.0
Dantewada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,4800.0,0.0,0.0,0.0,5000.0,14800.0
Dantewada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,1500.0,500.0,0.0,2200.0,800.0,350.0,0.0,4050.0,1800.0,2350.0,800.0,400.0,14750.0
Dantewada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,500.0,0.0,0.0,1150.0,350.0,0.0,5000.0,5750.0,3950.0,1600.0,800.0,5400.0,24500.0
Dantewada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,21.0,21.0,21.0,21.0,0.0,0.0,0.0,1443.0,60.0,0.0,60.0,1560.0,3207.0
Dantewada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,481.0,0.0,0.0,1443.0,0.0,0.0,0.0,1500.0,0.0,3424.0
Dantewada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,502.0,0.0,0.0,1094.0,1383.0,0.0,0.0,0.0,1350.0,4329.0
Dantewada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,21.0,21.0,21.0,0.0,0.0,0.0,349.0,60.0,60.0,0.0,1560.0,210.0,2302.0
Dantewada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,17000.0,2000.0,2000.0,1000.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23400.0
Dantewada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,3200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48000.0,51200.0
Dantewada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,15000.0,0.0,1000.0,2800.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,21200.0
Dantewada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2000.0,2000.0,1000.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,47000.0,53400.0
Dantewada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8500.0,7700.0,7700.0,6000.0,5500.0,9400.0,10400.0,9800.0,3000.0,2400.0,2400.0,2400.0,75200.0
Dantewada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,6000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Dantewada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,800.0,0.0,1700.0,500.0,2100.0,0.0,600.0,6800.0,600.0,0.0,0.0,500.0,13600.0
Dantewada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7700.0,7700.0,6000.0,5500.0,9400.0,10400.0,9800.0,3000.0,2400.0,2400.0,2400.0,1900.0,68600.0
Dantewada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,103000.0,100600.0,96600.0,92600.0,92600.0,149400.0,140200.0,131000.0,82200.0,66200.0,66200.0,66200.0,1186800.0
Dantewada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,81600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,81600.0
Dantewada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2400.0,4000.0,4000.0,0.0,24800.0,9200.0,9200.0,48800.0,16000.0,0.0,0.0,600.0,119000.0
Dantewada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,100600.0,96600.0,92600.0,92600.0,149400.0,140200.0,131000.0,82200.0,66200.0,66200.0,66200.0,65600.0,1149400.0
Dantewada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4500.0,4500.0,4500.0,4500.0,3500.0,3100.0,3100.0,3100.0,2100.0,800.0,800.0,800.0,35300.0
Dantewada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,1600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0
Dantewada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dantewada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,1000.0,2000.0,0.0,0.0,1000.0,1300.0,,0.0,500.0,5800.0
Dantewada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4500.0,4500.0,4500.0,3500.0,3100.0,3100.0,3100.0,2100.0,800.0,800.0,800.0,300.0,31100.0
Dantewada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,3.0,,2.0,1.0,1.0,1.0,1.0,,,,1.0,10.0
Dantewada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,,1.0
Dantewada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,,,,,,2.0
Dantewada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,2.0,,,,,,3.0
Dantewada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,1.0,,1.0
Dantewada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dantewada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,1.0,,1.0
Dantewada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,,2.0,,3.0,,2.0,,2.0,2.0,,13.0
Dantewada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,1.0,1.0,4.0,,,2.0,,1.0,1.0,1.0,12.0
Dantewada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,3.0,1.0,3.0,4.0,3.0,,4.0,,3.0,3.0,1.0,25.0
Dantewada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,3.0,2.0,2.0,3.0,1.0,1.0,,,,2.0,15.0
Dantewada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,2.0,1.0,1.0,1.0,2.0,,1.0,,,,1.0,9.0
Dantewada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,4.0,3.0,3.0,5.0,1.0,2.0,,,,3.0,24.0
Dantewada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,2.0,2.0,3.0,2.0,,4.0,1.0,,,1.0,15.0
Dantewada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,1.0,2.0,3.0,4.0,3.0,1.0,2.0,1.0,1.0,19.0
Dantewada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,3.0,3.0,5.0,5.0,4.0,7.0,2.0,2.0,1.0,2.0,34.0
Dantewada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Dantewada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Dantewada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,1.0,,,,,2.0
Dantewada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,2.0,,1.0,1.0,,,,,,3.0,7.0
Dantewada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,4.0,,,1.0,1.0,7.0
Dantewada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,2.0,1.0,,4.0,,,1.0,4.0,14.0
Dantewada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dantewada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dantewada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dantewada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,3.0,5.0,1.0,3.0,,2.0,1.0,2.0,1.0,,1.0,20.0
Dantewada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,3.0,1.0,1.0,1.0,3.0,3.0,2.0,1.0,1.0,4.0,6.0,28.0
Dantewada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,6.0,6.0,2.0,4.0,3.0,5.0,3.0,3.0,2.0,4.0,7.0,48.0
Dantewada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,,,,,,,,,1.0,2.0
Dantewada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Dantewada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,,,,,,,,,,1.0,3.0
Dantewada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Dantewada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,4.0,2.0,1.0,1.0,4.0,2.0,,1.0,,1.0,4.0,20.0
Dantewada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,1.0,,,1.0,2.0,,,,,1.0,7.0
Dantewada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,5.0,3.0,1.0,1.0,6.0,4.0,,1.0,,1.0,5.0,28.0
Dantewada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,1.0,2.0,2.0,2.0,3.0,1.0,,,3.0,2.0,18.0
Dantewada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,1.0,,,1.0,,,,,3.0
Dantewada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,1.0,1.0,3.0,3.0,2.0,3.0,2.0,,,3.0,2.0,21.0
Dantewada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,3.0,,,,,3.0
Dantewada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Dantewada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dantewada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,4.0,,,,,4.0
Dantewada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,1.0,1.0,,,,1.0,4.0
Dantewada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,7.0,5.0,1.0,3.0,4.0,3.0,2.0,2.0,,,2.0,32.0
Dantewada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,2.0,1.0,7.0,1.0,4.0,6.0,1.0,2.0,,2.0,2.0,29.0
Dantewada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,10.0,6.0,8.0,4.0,8.0,10.0,4.0,4.0,,2.0,5.0,65.0
Dantewada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Dantewada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Dantewada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,1.0,,,,,,,,1.0
Dantewada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,,2.0,3.0,1.0,,1.0,1.0,2.0,,1.0,2.0,15.0
Dantewada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,1.0,1.0,3.0,,2.0,1.0,,,,,1.0,9.0
Dantewada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,1.0,3.0,6.0,1.0,2.0,2.0,1.0,2.0,,1.0,3.0,24.0
Dantewada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Dantewada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,1.0,,,1.0,,,,,,1.0,4.0
Dantewada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,1.0,,,,,2.0,3.0
Dantewada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,,1.0,1.0,1.0,,,,,3.0,8.0
Dantewada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dantewada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dantewada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,2.0,,,2.0
Dantewada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dantewada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,2.0,,,2.0
Dantewada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Dantewada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,1.0,,1.0,,,,,,,,2.0
Dantewada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,1.0,1.0,,,,,,,,3.0
Dantewada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,1.0,1.0,,,,,,3.0
Dantewada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dantewada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,1.0,1.0,,,,,,3.0
Dantewada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,1.0,,,,,2.0
Dantewada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dantewada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,1.0,,,,,2.0
Dantewada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,1.0,2.0,1.0,,2.0,1.0,,,,2.0,10.0
Dantewada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,1.0,,,,3.0,1.0,,,,,,5.0
Dantewada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,2.0,1.0,3.0,3.0,1.0,,,,2.0,15.0
Dantewada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,9.0,20.0,1.0,3.0,1.0,2.0,8.0,1.0,4.0,5.0,8.0,67.0
Dantewada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,1.0,,,,2.0,,,,1.0,1.0,5.0
Dantewada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,9.0,21.0,1.0,3.0,1.0,4.0,8.0,1.0,4.0,6.0,9.0,72.0
Dantewada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Dantewada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,4.0,,2.0,4.0,3.0,3.0,1.0,,,,3.0,8.0,28.0
Dantewada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,,,1.0,,,,,,2.0
Dantewada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,1.0,3.0,5.0,3.0,3.0,2.0,,,,3.0,8.0,32.0
Dantewada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,2.0,,,,,,,,1.0,3.0
Dantewada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,2.0,5.0,4.0,,,4.0,,1.0,1.0,18.0
Dantewada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,,1.0,,,3.0,,,1.0,,1.0,1.0,9.0
Dantewada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,1.0,1.0,4.0,5.0,7.0,,,5.0,,2.0,3.0,30.0
Dantewada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Dantewada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,3.0,3.0,1.0,3.0,5.0,3.0,2.0,4.0,2.0,,4.0,33.0
Dantewada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,2.0,1.0,1.0,3.0,3.0,13.0,2.0,3.0,2.0,,,4.0,34.0
Dantewada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,4.0,4.0,4.0,6.0,18.0,5.0,5.0,6.0,2.0,,8.0,67.0
Dantewada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,2.0,,,1.0,,2.0,,1.0,,,,7.0
Dantewada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,6.0,8.0,7.0,5.0,10.0,4.0,8.0,2.0,4.0,,7.0,67.0
Dantewada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,3.0,5.0,11.0,9.0,2.0,15.0,12.0,5.0,,,,3.0,65.0
Dantewada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,10.0,13.0,19.0,16.0,8.0,25.0,18.0,13.0,3.0,4.0,,10.0,139.0
Dantewada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,1.0,2.0,,1.0,,3.0,,,,1.0,10.0
Dantewada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,9.0,11.0,12.0,4.0,10.0,11.0,2.0,3.0,2.0,1.0,15.0,89.0
Dantewada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,8.0,9.0,10.0,10.0,5.0,13.0,9.0,14.0,2.0,,2.0,6.0,88.0
Dantewada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,17.0,20.0,22.0,24.0,9.0,24.0,20.0,19.0,5.0,2.0,3.0,22.0,187.0
Dhamtari,1.1,Total number of pregnant women Registered for ANC,TOTAL,1464.0,1554.0,1689.0,1669.0,1586.0,1698.0,1596.0,1406.0,1571.0,2082.0,1304.0,1428.0,19047.0
Dhamtari,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,950.0,916.0,1106.0,1032.0,983.0,1014.0,1039.0,892.0,1050.0,900.0,855.0,936.0,11673.0
Dhamtari,1.2,Number of Pregnant women registered under JSY,TOTAL,1436.0,1539.0,1684.0,1655.0,1569.0,1681.0,1583.0,1327.0,1557.0,1352.0,1309.0,1411.0,18103.0
Dhamtari,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1060.0,1128.0,1377.0,1345.0,1310.0,1349.0,1334.0,1218.0,1520.0,1517.0,1385.0,1368.0,15911.0
Dhamtari,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,977.0,1005.0,1143.0,1092.0,1018.0,1133.0,1195.0,1019.0,1084.0,892.0,851.0,928.0,12337.0
Dhamtari,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,902.0,1133.0,1187.0,1130.0,1216.0,1127.0,1280.0,1170.0,1113.0,990.0,961.0,923.0,13132.0
Dhamtari,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1007.0,909.0,981.0,1060.0,1808.0,1059.0,1051.0,912.0,1390.0,1290.0,1227.0,1172.0,13866.0
Dhamtari,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55.0,44.0,65.0,52.0,55.0,46.0,59.0,36.0,80.0,54.0,41.0,24.0,611.0
Dhamtari,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Dhamtari,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,284.0,458.0,482.0,543.0,501.0,519.0,422.0,444.0,431.0,507.0,521.0,501.0,5613.0
Dhamtari,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9.0,8.0,17.0,15.0,11.0,17.0,10.0,5.0,3.0,6.0,13.0,11.0,125.0
Dhamtari,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Dhamtari,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,174.0,237.0,205.0,214.0,207.0,207.0,164.0,221.0,302.0,215.0,166.0,138.0,2450.0
Dhamtari,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,126.0,109.0,176.0,172.0,151.0,136.0,138.0,140.0,171.0,169.0,132.0,103.0,1723.0
Dhamtari,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,300.0,346.0,381.0,386.0,358.0,343.0,302.0,361.0,473.0,384.0,298.0,241.0,4173.0
Dhamtari,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,251.0,295.0,327.0,337.0,312.0,321.0,263.0,333.0,385.0,351.0,249.0,222.0,3646.0
Dhamtari,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,93.0,66.0,78.0,64.0,97.0,104.0,74.0,61.0,95.0,126.0,69.0,59.0,986.0
Dhamtari,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,834.0,804.0,696.0,793.0,806.0,930.0,961.0,937.0,928.0,771.0,890.0,837.0,10187.0
Dhamtari,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,833.0,803.0,692.0,788.0,804.0,928.0,957.0,934.0,926.0,749.0,710.0,658.0,9782.0
Dhamtari,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,831.0,802.0,701.0,793.0,809.0,930.0,961.0,937.0,928.0,771.0,890.0,837.0,10190.0
Dhamtari,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,631.0,671.0,610.0,694.0,670.0,746.0,843.0,799.0,765.0,674.0,773.0,753.0,8629.0
Dhamtari,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,7.0,9.0,4.0,5.0,10.0,9.0,7.0,17.0,10.0,16.0,7.0,12.0,113.0
Dhamtari,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,351.0,381.0,364.0,352.0,441.0,315.0,368.0,295.0,321.0,300.0,344.0,289.0,4121.0
Dhamtari,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,351.0,381.0,364.0,352.0,441.0,315.0,368.0,295.0,321.0,300.0,344.0,289.0,4121.0
Dhamtari,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,99.0,130.0,138.0,122.0,141.0,141.0,174.0,133.0,153.0,145.0,158.0,148.0,1682.0
Dhamtari,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,7.0,8.0,1.0,5.0,0.0,4.0,3.0,3.0,1.0,5.0,1.0,2.0,40.0
Dhamtari,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dhamtari,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,1.0,4.0,5.0,1.0,2.0,3.0,1.0,2.0,2.0,2.0,1.0,25.0
Dhamtari,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,1.0,4.0,5.0,1.0,2.0,3.0,1.0,2.0,2.0,2.0,2.0,26.0
Dhamtari,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,163.0,156.0,166.0,155.0,147.0,138.0,137.0,112.0,138.0,139.0,127.0,128.0,1706.0
Dhamtari,4.1.1.a,Number of male live births,TOTAL,805.0,780.0,764.0,817.0,851.0,853.0,853.0,869.0,913.0,744.0,782.0,725.0,9756.0
Dhamtari,4.1.1.b,Number of female live births,TOTAL,673.0,781.0,704.0,745.0,794.0,764.0,814.0,797.0,826.0,715.0,754.0,661.0,9028.0
Dhamtari,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1478.0,1561.0,1468.0,1562.0,1645.0,1617.0,1667.0,1666.0,1739.0,1459.0,1536.0,1386.0,18784.0
Dhamtari,4.1.2,Number of still births,TOTAL,23.0,27.0,24.0,25.0,32.0,45.0,27.0,32.0,33.0,23.0,27.0,26.0,344.0
Dhamtari,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,26.0,46.0,44.0,38.0,45.0,45.0,52.0,38.0,26.0,23.0,34.0,37.0,454.0
Dhamtari,4.2.1,Number of Newborns weighed at birth,TOTAL,1462.0,1549.0,1457.0,1522.0,1625.0,1609.0,1650.0,1612.0,1708.0,1448.0,1508.0,1384.0,18534.0
Dhamtari,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,364.0,340.0,306.0,308.0,386.0,409.0,415.0,372.0,351.0,352.0,407.0,331.0,4341.0
Dhamtari,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1469.0,1553.0,1454.0,1530.0,1643.0,1609.0,1656.0,1632.0,1736.0,1458.0,1516.0,1358.0,18614.0
Dhamtari,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,0.0,1.0,7.0,3.0,11.0,7.0,0.0,2.0,5.0,5.0,9.0,55.0
Dhamtari,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,3.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,13.0,0.0,0.0,44.0,64.0
Dhamtari,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,10.0,22.0,18.0,11.0,27.0,37.0,23.0,27.0,28.0,25.0,33.0,33.0,294.0
Dhamtari,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,18.0,22.0,19.0,18.0,30.0,50.0,32.0,27.0,43.0,30.0,38.0,86.0,413.0
Dhamtari,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Dhamtari,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,10.0,15.0,18.0,8.0,27.0,40.0,25.0,27.0,38.0,30.0,20.0,67.0,325.0
Dhamtari,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,4.0,0.0,10.0,0.0,1.0,3.0,0.0,0.0,0.0,2.0,20.0
Dhamtari,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15.0,14.0,19.0,17.0,30.0,47.0,30.0,15.0,30.0,25.0,38.0,85.0,365.0
Dhamtari,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,1.0,1.0,0.0,1.0,4.0,3.0,1.0,2.0,1.0,1.0,2.0,19.0
Dhamtari,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1006.0,1116.0,1005.0,1066.0,1134.0,1219.0,1182.0,1323.0,1204.0,1099.0,1003.0,1032.0,13389.0
Dhamtari,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,705.0,682.0,637.0,661.0,740.0,820.0,1002.0,1042.0,1164.0,1005.0,1058.0,677.0,10193.0
Dhamtari,6.3,PNC maternal complications attended,TOTAL,3.0,0.0,3.0,0.0,1.0,9.0,2.0,1.0,0.0,0.0,0.0,0.0,19.0
Dhamtari,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,6.0,5.0,6.0,11.0,2.0,5.0,0.0,2.0,7.0,5.0,4.0,57.0
Dhamtari,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,1.0,4.0,0.0,3.0,1.0,0.0,0.0,0.0,0.0,3.0,14.0
Dhamtari,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,8.0,6.0,10.0,11.0,5.0,6.0,0.0,2.0,7.0,5.0,7.0,71.0
Dhamtari,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,9.0,1.0,5.0,0.0,0.0,0.0,0.0,0.0,24.0,1.0,17.0,6.0,63.0
Dhamtari,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,18.0,9.0,7.0,3.0,8.0,29.0,7.0,10.0,25.0,20.0,40.0,25.0,201.0
Dhamtari,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,27.0,10.0,12.0,3.0,8.0,29.0,7.0,10.0,49.0,21.0,57.0,31.0,264.0
Dhamtari,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,11.0
Dhamtari,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,4.0,27.0,90.0,20.0,47.0,13.0,20.0,31.0,38.0,49.0,22.0,365.0
Dhamtari,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,1.0,3.0,12.0,2.0,6.0,0.0,5.0,2.0,2.0,5.0,7.0,50.0
Dhamtari,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,9.0,5.0,30.0,102.0,22.0,53.0,13.0,25.0,33.0,40.0,54.0,29.0,415.0
Dhamtari,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,,,2.0,7.0
Dhamtari,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,16.0,38.0,16.0,29.0,14.0,20.0,20.0,70.0,17.0,0.0,240.0
Dhamtari,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,16.0,38.0,16.0,29.0,14.0,20.0,20.0,70.0,17.0,0.0,240.0
Dhamtari,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Dhamtari,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,25.0,2.0,236.0,601.0,186.0,395.0,207.0,216.0,617.0,479.0,662.0,284.0,3910.0
Dhamtari,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,25.0,12.0,28.0,112.0,36.0,61.0,44.0,33.0,119.0,63.0,72.0,107.0,712.0
Dhamtari,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,50.0,14.0,264.0,713.0,222.0,456.0,251.0,249.0,736.0,542.0,734.0,391.0,4622.0
Dhamtari,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,44.0,22.0,41.0,54.0,51.0,58.0,39.0,42.0,13.0,,,367.0,731.0
Dhamtari,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dhamtari,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Dhamtari,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,104.0,104.0
Dhamtari,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,92.0,93.0,123.0,148.0,175.0,154.0,119.0,90.0,143.0,232.0,231.0,169.0,1769.0
Dhamtari,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,7.0,10.0,18.0,7.0,9.0,8.0,10.0,16.0,9.0,11.0,6.0,116.0
Dhamtari,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6.0,3.0,1.0,3.0,3.0,7.0,5.0,3.0,11.0,5.0,3.0,0.0,50.0
Dhamtari,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,2.0,0.0,2.0,3.0,5.0,2.0,0.0,0.0,1.0,3.0,3.0,2.0,23.0
Dhamtari,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dhamtari,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,105.0,103.0,136.0,172.0,190.0,172.0,132.0,103.0,171.0,249.0,248.0,177.0,1958.0
Dhamtari,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Dhamtari,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Dhamtari,9.06,Number of IUCD removals,TOTAL,190.0,149.0,130.0,239.0,196.0,164.0,130.0,148.0,142.0,202.0,168.0,233.0,2091.0
Dhamtari,9.07,Number of Oral Pills cycles distributed,TOTAL,3502.0,2849.0,1950.0,2954.0,2980.0,2869.0,1685.0,1550.0,1728.0,1852.0,1508.0,1371.0,26798.0
Dhamtari,9.08,Number of Condom pieces distributed,TOTAL,17728.0,13088.0,7473.0,12278.0,9994.0,6371.0,4965.0,4945.0,4192.0,3502.0,3263.0,2925.0,90724.0
Dhamtari,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,50.0,45.0,3.0,11.0,19.0,39.0,53.0,23.0,39.0,22.0,21.0,24.0,349.0
Dhamtari,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,1.0,0.0,0.0,6.0
Dhamtari,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,3.0,2.0,2.0,3.0,3.0,2.0,3.0,1.0,0.0,1.0,21.0
Dhamtari,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,3.0
Dhamtari,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,3.0,3.0,3.0,2.0,2.0,2.0,2.0,2.0,9.0,6.0,5.0,-1.0
Dhamtari,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1225.0,1313.0,1162.0,1433.0,1325.0,1577.0,1306.0,1903.0,1587.0,1372.0,1806.0,2051.0,18060.0
Dhamtari,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1086.0,1278.0,1248.0,1217.0,1285.0,1313.0,1237.0,1319.0,1456.0,1349.0,1278.0,1629.0,15695.0
Dhamtari,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1168.0,1305.0,1219.0,1320.0,1222.0,1172.0,1269.0,1432.0,1227.0,1407.0,1330.0,1590.0,15661.0
Dhamtari,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1170.0,1288.0,1239.0,1281.0,1275.0,1177.0,1130.0,1363.0,1435.0,1251.0,1370.0,1595.0,15574.0
Dhamtari,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Dhamtari,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Dhamtari,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Dhamtari,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1194.0,1323.0,1128.0,1420.0,1357.0,1622.0,1260.0,2093.0,1600.0,1383.0,1829.0,2105.0,18314.0
Dhamtari,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1101.0,1275.0,1179.0,1212.0,1282.0,1295.0,1236.0,1313.0,1454.0,1350.0,1278.0,1628.0,15603.0
Dhamtari,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1166.0,1306.0,1156.0,1319.0,1221.0,1159.0,1265.0,1427.0,1228.0,1409.0,1338.0,1586.0,15580.0
Dhamtari,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1153.0,1281.0,1190.0,1225.0,1274.0,1166.0,1135.0,1364.0,1434.0,1256.0,1369.0,1601.0,15448.0
Dhamtari,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,,0.0,4.0,238.0,173.0,368.0,387.0,458.0,590.0,2218.0
Dhamtari,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,17.0,0.0,9.0,9.0,9.0,11.0,584.0,934.0,1295.0,1081.0,1185.0,1367.0,6501.0
Dhamtari,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,14.0,2.0,21.0,11.0,17.0,19.0,142.0,806.0,1007.0,1159.0,1190.0,1377.0,5765.0
Dhamtari,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,70.0,34.0,49.0,57.0,64.0,87.0,141.0,383.0,1001.0,985.0,1223.0,1410.0,5504.0
Dhamtari,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1022.0,1138.0,1217.0,1352.0,1397.0,1289.0,1280.0,1195.0,1541.0,1242.0,1159.0,1776.0,15608.0
Dhamtari,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,1.0,,2.0,85.0,105.0,68.0,80.0,66.0,149.0,218.0,774.0
Dhamtari,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Dhamtari,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,549.0,620.0,646.0,671.0,743.0,657.0,683.0,581.0,732.0,610.0,577.0,833.0,7902.0
Dhamtari,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,507.0,534.0,590.0,620.0,634.0,643.0,615.0,591.0,704.0,558.0,513.0,731.0,7240.0
Dhamtari,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1056.0,1154.0,1236.0,1291.0,1377.0,1300.0,1298.0,1172.0,1436.0,1168.0,1090.0,1564.0,15142.0
Dhamtari,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,943.0,1022.0,1185.0,1292.0,1230.0,1017.0,1022.0,963.0,1275.0,972.0,1039.0,1568.0,13528.0
Dhamtari,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,941.0,1005.0,1128.0,1302.0,1227.0,1002.0,1015.0,945.0,1288.0,975.0,1033.0,1563.0,13424.0
Dhamtari,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,383.0,423.0,484.0,469.0,491.0,356.0,359.0,284.0,371.0,412.0,316.0,314.0,4662.0
Dhamtari,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,326.0,414.0,403.0,393.0,438.0,330.0,312.0,303.0,388.0,375.0,271.0,271.0,4224.0
Dhamtari,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,709.0,837.0,887.0,862.0,929.0,686.0,671.0,587.0,759.0,787.0,587.0,585.0,8886.0
Dhamtari,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,327.0,406.0,506.0,1264.0,2666.0,3228.0,1354.0,1459.0,1774.0,1661.0,1008.0,1324.0,16977.0
Dhamtari,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,192.0,353.0,343.0,1349.0,5055.0,4562.0,1214.0,1292.0,1105.0,1626.0,1691.0,1687.0,20469.0
Dhamtari,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,207.0,363.0,413.0,727.0,2426.0,4007.0,1315.0,1924.0,1990.0,1727.0,1574.0,809.0,17482.0
Dhamtari,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,15.0,25.0,29.0,43.0,20.0,49.0,13.0,50.0,44.0,23.0,38.0,29.0,378.0
Dhamtari,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,21.0,34.0,31.0,24.0,31.0,24.0,14.0,42.0,46.0,54.0,32.0,365.0
Dhamtari,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,628.0,668.0,671.0,689.0,682.0,680.0,682.0,679.0,822.0,710.0,656.0,693.0,8260.0
Dhamtari,10.4.2,Number of Immunisation sessions held during the month,TOTAL,615.0,658.0,665.0,686.0,660.0,672.0,669.0,677.0,809.0,700.0,643.0,697.0,8151.0
Dhamtari,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,552.0,659.0,612.0,602.0,656.0,652.0,639.0,583.0,803.0,680.0,567.0,612.0,7617.0
Dhamtari,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,909.0,1137.0,1103.0,1315.0,1478.0,1296.0,1235.0,1163.0,1714.0,1323.0,1123.0,1633.0,15429.0
Dhamtari,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,258.0,270.0,215.0,325.0,3530.0,1311.0,489.0,309.0,4575.0,966.0,310.0,505.0,13063.0
Dhamtari,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,135.0,162.0,193.0,316.0,3520.0,1343.0,475.0,308.0,4364.0,1141.0,255.0,370.0,12582.0
Dhamtari,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,203.0,198.0,279.0,361.0,287.0,308.0,232.0,185.0,292.0,281.0,224.0,233.0,3083.0
Dhamtari,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,36.0,15.0,58.0,20.0,6.0,7.0,12.0,44.0,17.0,15.0,27.0,10.0,267.0
Dhamtari,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6.0,1.0,7.0,2.0,8.0,5.0,4.0,1.0,12.0,4.0,4.0,4.0,58.0
Dhamtari,13.1,Number of Patients operated for cataract,TOTAL,91.0,61.0,280.0,358.0,212.0,509.0,554.0,27.0,70.0,99.0,121.0,298.0,2680.0
Dhamtari,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,91.0,45.0,208.0,318.0,183.0,357.0,476.0,29.0,70.0,103.0,121.0,216.0,2217.0
Dhamtari,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,327.0,402.0,121.0,286.0,0.0,1136.0
Dhamtari,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,80.0,300.0,81.0,191.0,0.0,652.0
Dhamtari,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Dhamtari,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,6.0,7.0,7.0,7.0,8.0,7.0,7.0,7.0,8.0,10.0,9.0,11.0,-1.0
Dhamtari,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,641.0,664.0,671.0,694.0,643.0,658.0,721.0,624.0,674.0,692.0,625.0,622.0,-1.0
Dhamtari,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Dhamtari,14.05,Number of RKS meetings held during the month,TOTAL,4.0,5.0,4.0,3.0,7.0,6.0,4.0,3.0,6.0,4.0,1.0,4.0,51.0
Dhamtari,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,5.0,5.0,5.0,5.0,6.0,5.0,5.0,6.0,9.0,8.0,9.0,-1.0
Dhamtari,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,37.0,26.0,18.0,27.0,66.0,100.0,91.0,67.0,84.0,70.0,18.0,179.0,783.0
Dhamtari,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Dhamtari,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Dhamtari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,121.0,89.0,84.0,68.0,75.0,131.0,95.0,44.0,102.0,79.0,96.0,74.0,1058.0
Dhamtari,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,348.0,444.0,429.0,424.0,560.0,741.0,607.0,302.0,400.0,375.0,479.0,616.0,5725.0
Dhamtari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,130.0,118.0,167.0,89.0,118.0,211.0,116.0,52.0,107.0,62.0,83.0,88.0,1341.0
Dhamtari,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,762.0,655.0,813.0,805.0,891.0,1057.0,1117.0,344.0,719.0,856.0,1143.0,988.0,10150.0
Dhamtari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,251.0,207.0,251.0,157.0,193.0,342.0,211.0,96.0,209.0,141.0,179.0,162.0,2399.0
Dhamtari,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1110.0,1099.0,1242.0,1229.0,1451.0,1798.0,1724.0,646.0,1119.0,1231.0,1622.0,1604.0,15875.0
Dhamtari,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,15.0,18.0,10.0,11.0,16.0,7.0,8.0,15.0,12.0,15.0,10.0,144.0
Dhamtari,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,9.0,6.0,2.0,7.0,5.0,5.0,11.0,3.0,10.0,7.0,8.0,78.0
Dhamtari,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,24.0,24.0,12.0,18.0,21.0,12.0,19.0,18.0,22.0,22.0,18.0,222.0
Dhamtari,14.11,In-Patient Head Count at midnight,TOTAL,16.0,3.0,40.0,0.0,0.0,0.0,0.0,10.0,1680.0,27.0,2797.0,3389.0,7962.0
Dhamtari,14.12.1,OPD attendance (All),TOTAL,24161.0,26849.0,27680.0,33652.0,30463.0,37963.0,30282.0,27695.0,30915.0,30192.0,32472.0,38005.0,370329.0
Dhamtari,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,45.0,22.0,38.0,165.0,55.0,78.0,54.0,57.0,186.0,88.0,125.0,137.0,1050.0
Dhamtari,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Dhamtari,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,89.0,82.0,79.0,376.0,254.0,217.0,144.0,185.0,334.0,113.0,123.0,230.0,2226.0
Dhamtari,14.14.a,Number of patients given AYUSH treatment,TOTAL,110.0,123.0,130.0,203.0,223.0,395.0,1459.0,2153.0,552.0,518.0,515.0,624.0,7005.0
Dhamtari,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,14.14.c,Number of Adolescents counselled,TOTAL,20.0,0.0,0.0,5.0,10.0,0.0,0.0,10.0,0.0,0.0,12.0,2.0,59.0
Dhamtari,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3051.0,2551.0,3163.0,4711.0,3570.0,4159.0,4111.0,3321.0,4584.0,3730.0,4575.0,4930.0,46456.0
Dhamtari,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,161.0,131.0,137.0,108.0,64.0,90.0,114.0,53.0,141.0,87.0,89.0,172.0,1347.0
Dhamtari,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,75.0,64.0,83.0,117.0,99.0,90.0,86.0,17.0,254.0,64.0,126.0,92.0,1167.0
Dhamtari,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,1.0,1.0,4.0,0.0,1.0,2.0,0.0,2.0,1.0,1.0,15.0
Dhamtari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,256.0,169.0,353.0,373.0,266.0,136.0,101.0,78.0,185.0,334.0,150.0,262.0,2663.0
Dhamtari,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,4.0
Dhamtari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,102.0,311.0,106.0,327.0,224.0,43.0,198.0,91.0,124.0,195.0,360.0,165.0,2246.0
Dhamtari,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dhamtari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,433.0,544.0,542.0,817.0,589.0,269.0,385.0,186.0,563.0,593.0,636.0,519.0,6076.0
Dhamtari,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4.0,0.0,1.0,1.0,5.0,0.0,1.0,2.0,0.0,3.0,1.0,2.0,20.0
Dhamtari,15.2,Number of Widal tests conducted,Number tested,86.0,99.0,117.0,115.0,101.0,159.0,233.0,153.0,157.0,130.0,133.0,277.0,1760.0
Dhamtari,15.3.a,Number of VDRL tests conducted on males,Number tested,9.0,2.0,5.0,2.0,2.0,28.0,12.0,16.0,42.0,99.0,33.0,63.0,313.0
Dhamtari,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,45.0,3.0,4.0,1.0,7.0,16.0,16.0,36.0,34.0,37.0,32.0,66.0,297.0
Dhamtari,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,108.0,92.0,108.0,81.0,44.0,108.0,68.0,112.0,76.0,193.0,199.0,235.0,1424.0
Dhamtari,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,162.0,97.0,117.0,84.0,53.0,152.0,96.0,164.0,152.0,329.0,264.0,364.0,2034.0
Dhamtari,15.4.1,Number of blood smears examined for Malaria,TOTAL,3150.0,2673.0,3144.0,3201.0,2555.0,5390.0,4070.0,3342.0,3082.0,1923.0,2913.0,5529.0,40972.0
Dhamtari,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,26.0,8.0,6.0,15.0,10.0,7.0,0.0,5.0,2.0,9.0,6.0,98.0
Dhamtari,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,15.0,34.0,21.0,46.0,59.0,68.0,44.0,29.0,26.0,25.0,15.0,33.0,415.0
Dhamtari,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,18000.0,185000.0,18500.0,16000.0,8000.0,8000.0,14500.0,29000.0,16000.0,6000.0,19500.0,18000.0,356500.0
Dhamtari,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,0.0,10000.0,0.0,15000.0,15000.0,20000.0,0.0,0.0,20000.0,0.0,0.0,90000.0
Dhamtari,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9500.0,0.0,12500.0,8000.0,15000.0,8500.0,5500.0,13000.0,10000.0,6500.0,1500.0,8000.0,98000.0
Dhamtari,16.1.1,Stock position of DPT vaccines,5. Total Stock,18500.0,185000.0,16000.0,8000.0,8000.0,14500.0,29000.0,16000.0,6000.0,19500.0,18000.0,10000.0,348500.0
Dhamtari,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Dhamtari,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Dhamtari,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Dhamtari,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Dhamtari,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,17000.0,12000.0,8000.0,1500.0,6500.0,2500.0,23000.0,20000.0,6000.0,11000.0,8500.0,119000.0
Dhamtari,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,0.0,10000.0,0.0,20000.0,10000.0,25000.0,20000.0,0.0,15000.0,135000.0,135000.0,400000.0
Dhamtari,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16000.0,5000.0,14000.0,6500.0,15000.0,14000.0,4500.0,23000.0,14000.0,10000.0,137500.0,125000.0,384500.0
Dhamtari,16.1.2,Stock position of OPV vaccines,5. Total Stock,17000.0,12000.0,8000.0,1500.0,6500.0,2500.0,23000.0,20000.0,6000.0,11000.0,8500.0,18500.0,134500.0
Dhamtari,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16500.0,24000.0,24000.0,30500.0,27000.0,18500.0,10500.0,23500.0,12500.0,2500.0,23000.0,22000.0,234500.0
Dhamtari,16.1.3,Stock position of TT vaccines,2. Stocks Received,25000.0,0.0,10000.0,0.0,5000.0,10000.0,20000.0,0.0,0.0,30000.0,0.0,0.0,100000.0
Dhamtari,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.3,Stock position of TT vaccines,4. Stock Distributed,17500.0,0.0,3500.0,3500.0,13500.0,18000.0,7000.0,11000.0,10000.0,9500.0,1000.0,6000.0,100500.0
Dhamtari,16.1.3,Stock position of TT vaccines,5. Total Stock,24000.0,24000.0,30500.0,27000.0,18500.0,10500.0,23500.0,12500.0,2500.0,23000.0,22000.0,16000.0,234000.0
Dhamtari,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dhamtari,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dhamtari,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dhamtari,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dhamtari,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5000.0,4000.0,2000.0,9000.0,6500.0,3000.0,5000.0,7500.0,9500.0,2500.0,7000.0,4000.0,65000.0
Dhamtari,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,0.0,10000.0,0.0,3000.0,10000.0,5000.0,10000.0,0.0,8000.0,0.0,0.0,51000.0
Dhamtari,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,2000.0,3000.0,2500.0,6500.0,8000.0,2500.0,8000.0,7000.0,3500.0,3000.0,2000.0,54000.0
Dhamtari,16.1.5,Stock position of BCG vaccines,5. Total Stock,4000.0,2000.0,9000.0,6500.0,3000.0,5000.0,7500.0,9500.0,2500.0,7000.0,4000.0,2000.0,62000.0
Dhamtari,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3000.0,4500.0,4500.0,4500.0,3000.0,3000.0,9000.0,6750.0,5750.0,6000.0,4500.0,4500.0,59000.0
Dhamtari,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,3000.0,0.0,3000.0,10000.0,0.0,120000.0,50000.0,0.0,0.0,0.0,191000.0
Dhamtari,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3500.0,0.0,3000.0,1500.0,3000.0,4000.0,2250.0,121000.0,49750.0,1500.0,0.0,750.0,190250.0
Dhamtari,16.1.6,Stock position of Measles vaccines,5. Total Stock,4500.0,4500.0,4500.0,3000.0,3000.0,9000.0,6750.0,5750.0,6000.0,4500.0,4500.0,3750.0,59750.0
Dhamtari,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Dhamtari,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Dhamtari,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Dhamtari,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Dhamtari,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,0.0,6900.0,6900.0,15800.0,8800.0,14500.0,10600.0,63500.0
Dhamtari,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,13000.0,0.0,14000.0,0.0,10000.0,0.0,0.0,37000.0
Dhamtari,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,6100.0,0.0,5100.0,7000.0,4300.0,3900.0,3600.0,30000.0
Dhamtari,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,6900.0,6900.0,15800.0,8800.0,14500.0,10600.0,7000.0,70500.0
Dhamtari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,21600.0
Dhamtari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0
Dhamtari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0
Dhamtari,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,2400.0,24000.0
Dhamtari,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Dhamtari,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0,66000.0
Dhamtari,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5000.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,36000.0
Dhamtari,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30000.0,32000.0
Dhamtari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,1000.0,1000.0,0.0,0.0,4000.0
Dhamtari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,5000.0
Dhamtari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,1000.0,0.0,1000.0,0.0,0.0,5000.0
Dhamtari,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,1000.0,1000.0,0.0,0.0,0.0,4000.0
Dhamtari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2000.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,16400.0
Dhamtari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Dhamtari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0
Dhamtari,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2000.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,1800.0,18200.0
Dhamtari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,1800.0,1800.0,1800.0,1600.0,1600.0,1600.0,1600.0,11800.0
Dhamtari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Dhamtari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,0.0,0.0,0.0,0.0,200.0
Dhamtari,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,1800.0,1800.0,1800.0,1600.0,1600.0,1600.0,1600.0,1600.0,13400.0
Dhamtari,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Dhamtari,16.3.02,Stock Position of Gloves,2. Stocks Received,3500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6500.0,0.0,0.0,10000.0
Dhamtari,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.02,Stock Position of Gloves,4. Stock Distributed,2500.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6500.0,0.0,0.0,10000.0
Dhamtari,16.3.02,Stock Position of Gloves,5. Total Stock,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Dhamtari,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,35000.0,35000.0,54300.0,54300.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,212200.0
Dhamtari,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,50000.0,0.0,36000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,86000.0
Dhamtari,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,15000.0,0.0,16700.0,0.0,49500.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,84200.0
Dhamtari,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,35000.0,35000.0,54300.0,54300.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,4800.0,1800.0,214000.0
Dhamtari,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,17300.0,94800.0,0.0,0.0,0.0,0.0,0.0,80000.0,40000.0,0.0,0.0,232100.0
Dhamtari,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,45000.0,145000.0,0.0,0.0,0.0,0.0,0.0,200000.0,0.0,0.0,0.0,0.0,390000.0
Dhamtari,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,27700.0,67500.0,94800.0,0.0,0.0,0.0,0.0,120000.0,40000.0,40000.0,0.0,0.0,390000.0
Dhamtari,16.3.07,Stock Position of IFA Tablets,5. Total Stock,17300.0,94800.0,0.0,0.0,0.0,0.0,0.0,80000.0,40000.0,0.0,0.0,0.0,232100.0
Dhamtari,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,17900.0,17900.0,17900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,53700.0
Dhamtari,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,17900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17900.0
Dhamtari,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,17900.0,17900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35800.0
Dhamtari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,429.0,429.0,429.0,150.0,150.0,0.0,0.0,0.0,102.0,27.0,27.0,27.0,1770.0
Dhamtari,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,343.0,0.0,0.0,0.0,0.0,1347.0,0.0,0.0,0.0,1500.0,3190.0
Dhamtari,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,622.0,0.0,150.0,0.0,0.0,1245.0,75.0,0.0,0.0,0.0,2092.0
Dhamtari,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,429.0,429.0,150.0,150.0,0.0,0.0,0.0,102.0,27.0,27.0,27.0,1527.0,2868.0
Dhamtari,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,1000.0,1000.0,3250.0,2050.0,2050.0,1000.0,4850.0,3650.0,22850.0
Dhamtari,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,3200.0,0.0,0.0,0.0,8800.0,0.0,2800.0,14800.0
Dhamtari,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,950.0,1200.0,0.0,1050.0,4950.0,1200.0,2050.0,11400.0
Dhamtari,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1000.0,1000.0,1000.0,1000.0,1000.0,3250.0,2050.0,2050.0,1000.0,4850.0,3650.0,4400.0,26250.0
Dhamtari,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,2200.0,2200.0,0.0,0.0,0.0,3000.0,3000.0,1000.0,1000.0,800.0,800.0,14000.0
Dhamtari,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2200.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,6000.0,11200.0
Dhamtari,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,2200.0,0.0,0.0,0.0,0.0,2000.0,0.0,200.0,0.0,800.0,5200.0
Dhamtari,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2200.0,2200.0,0.0,0.0,0.0,3000.0,3000.0,1000.0,1000.0,800.0,800.0,6000.0,20000.0
Dhamtari,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,12000.0,120000.0,120000.0,50400.0,50400.0,50400.0,52000.0,52000.0,82000.0,48000.0,48000.0,48000.0,733200.0
Dhamtari,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,132000.0,0.0,0.0,1600.0,0.0,175200.0,0.0,0.0,0.0,0.0,308800.0
Dhamtari,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,201600.0,0.0,0.0,0.0,0.0,145200.0,34000.0,0.0,0.0,0.0,380800.0
Dhamtari,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,12000.0,120000.0,50400.0,50400.0,50400.0,52000.0,52000.0,82000.0,48000.0,48000.0,48000.0,48000.0,661200.0
Dhamtari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,14527.0,2800.0,2800.0,2800.0,2800.0,0.0,0.0,4627.0,2000.0,0.0,0.0,32354.0
Dhamtari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,28727.0,0.0,0.0,0.0,0.0,0.0,0.0,35200.0,0.0,0.0,0.0,0.0,63927.0
Dhamtari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dhamtari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,14200.0,11727.0,0.0,0.0,0.0,2800.0,0.0,30573.0,2627.0,2000.0,0.0,0.0,63927.0
Dhamtari,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,14527.0,2800.0,2800.0,2800.0,2800.0,0.0,0.0,4627.0,2000.0,0.0,0.0,0.0,32354.0
Dhamtari,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,2.0,1.0,,,1.0,1.0,,3.0,,3.0,,13.0
Dhamtari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,1.0,,1.0,,,,,,,2.0
Dhamtari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Dhamtari,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,1.0,,1.0,,,,,,,2.0
Dhamtari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,,1.0,1.0,,1.0,,,3.0,3.0,11.0
Dhamtari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Dhamtari,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,1.0,,1.0,1.0,,1.0,,,3.0,3.0,12.0
Dhamtari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,,,1.0,4.0,2.0,2.0,2.0,4.0,7.0,3.0,27.0
Dhamtari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,2.0,,,2.0,1.0,,,6.0
Dhamtari,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,2.0,1.0,,1.0,6.0,2.0,2.0,4.0,5.0,7.0,3.0,33.0
Dhamtari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,1.0,2.0,,2.0,,1.0,2.0,1.0,2.0,2.0,15.0
Dhamtari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,3.0,1.0,,,,,,,2.0,8.0
Dhamtari,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,1.0,1.0,5.0,1.0,2.0,,1.0,2.0,1.0,2.0,4.0,23.0
Dhamtari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,2.0,1.0,,,2.0,2.0,1.0,,1.0,2.0,,13.0
Dhamtari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,1.0,,,,2.0,,1.0,,5.0
Dhamtari,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,3.0,2.0,1.0,,1.0,2.0,2.0,1.0,2.0,1.0,3.0,,18.0
Dhamtari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Dhamtari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhamtari,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,1.0,,,1.0
Dhamtari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Dhamtari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Dhamtari,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,1.0,,,,2.0
Dhamtari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dhamtari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dhamtari,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dhamtari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,6.0,3.0,2.0,1.0,4.0,1.0,1.0,1.0,1.0,1.0,23.0
Dhamtari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,2.0,1.0,3.0,5.0,,,1.0,2.0,,2.0,17.0
Dhamtari,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,8.0,4.0,5.0,6.0,4.0,1.0,2.0,3.0,1.0,3.0,40.0
Dhamtari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Dhamtari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,1.0,1.0,,,,,,,,3.0
Dhamtari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,2.0,1.0,1.0,,,,,,,5.0
Dhamtari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,3.0,1.0,2.0,1.0,2.0,1.0,1.0,1.0,2.0,5.0,21.0
Dhamtari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,4.0,4.0,2.0,,2.0,,,,,1.0,,13.0
Dhamtari,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,5.0,7.0,3.0,2.0,3.0,2.0,1.0,1.0,1.0,3.0,5.0,34.0
Dhamtari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,2.0,2.0,4.0,2.0,3.0,1.0,1.0,2.0,3.0,21.0
Dhamtari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,1.0,3.0,1.0,,3.0,1.0,2.0,2.0,3.0,1.0,,20.0
Dhamtari,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,2.0,3.0,3.0,2.0,7.0,3.0,5.0,3.0,4.0,3.0,3.0,41.0
Dhamtari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Dhamtari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,,,,,,1.0
Dhamtari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,1.0,,1.0,,,,,,,,,3.0
Dhamtari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,3.0,2.0,2.0,3.0,2.0,2.0,1.0,3.0,,,21.0
Dhamtari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,,3.0,,,1.0,,,2.0,,1.0,,9.0
Dhamtari,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,3.0,6.0,3.0,2.0,4.0,2.0,2.0,3.0,3.0,1.0,,33.0
Dhamtari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Dhamtari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,2.0,,,,,,,,,,,2.0
Dhamtari,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,2.0,,,,,,1.0,,,,,3.0
Dhamtari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Dhamtari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,6.0,6.0,5.0,5.0,7.0,3.0,14.0,7.0,6.0,8.0,10.0,77.0
Dhamtari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,5.0,7.0,6.0,6.0,4.0,9.0,7.0,5.0,3.0,11.0,7.0,72.0
Dhamtari,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,11.0,13.0,11.0,11.0,11.0,12.0,22.0,12.0,9.0,19.0,17.0,150.0
Dhamtari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Dhamtari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,1.0,2.0,1.0,1.0,2.0,3.0,,1.0,1.0,13.0
Dhamtari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,1.0,2.0,1.0,1.0,2.0,3.0,,1.0,2.0,14.0
Dhamtari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dhamtari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,1.0,,,,,,,,,,,,1.0
Dhamtari,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,,,,,,,1.0
Dhamtari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Dhamtari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,1.0,,,,,,1.0
Dhamtari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dhamtari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,1.0,,,,1.0,,,,,,,,2.0
Dhamtari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dhamtari,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,1.0,,,,1.0,,,,,,,,2.0
Dhamtari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dhamtari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,3.0,1.0,,2.0,3.0,,1.0,3.0,4.0,,19.0
Dhamtari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,5.0,2.0,,1.0,,,3.0,,,1.0,12.0
Dhamtari,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,8.0,3.0,,3.0,3.0,,4.0,3.0,4.0,1.0,31.0
Dhamtari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,2.0,,,,,,,,2.0,5.0
Dhamtari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,17.0,7.0,3.0,9.0,4.0,2.0,10.0,9.0,13.0,10.0,10.0,100.0
Dhamtari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,3.0,1.0,3.0,1.0,,,,2.0,1.0,1.0,1.0,14.0
Dhamtari,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,8.0,20.0,8.0,8.0,10.0,4.0,2.0,10.0,11.0,14.0,11.0,13.0,119.0
Dhamtari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Dhamtari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,11.0,7.0,6.0,9.0,12.0,8.0,6.0,12.0,3.0,13.0,17.0,110.0
Dhamtari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,2.0,2.0,,1.0,,3.0,,,,,,8.0
Dhamtari,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,13.0,9.0,6.0,10.0,12.0,11.0,6.0,13.0,3.0,13.0,17.0,119.0
Dhamtari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,,,,,,1.0,,,2.0
Dhamtari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,1.0,3.0,6.0,7.0,1.0,2.0,4.0,1.0,3.0,3.0,5.0,38.0
Dhamtari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,3.0,4.0,,,2.0,1.0,,,1.0,2.0,14.0
Dhamtari,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,2.0,6.0,11.0,7.0,1.0,4.0,5.0,1.0,4.0,4.0,7.0,54.0
Dhamtari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Dhamtari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,6.0,2.0,15.0,5.0,7.0,6.0,7.0,14.0,7.0,8.0,8.0,90.0
Dhamtari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,7.0,8.0,2.0,13.0,7.0,12.0,5.0,13.0,6.0,10.0,9.0,10.0,102.0
Dhamtari,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,14.0,4.0,28.0,12.0,20.0,11.0,20.0,20.0,17.0,17.0,18.0,193.0
Dhamtari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,,1.0,,,1.0,,1.0,,,,5.0
Dhamtari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,4.0,11.0,10.0,15.0,17.0,22.0,16.0,16.0,21.0,18.0,15.0,167.0
Dhamtari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,10.0,18.0,19.0,21.0,11.0,28.0,20.0,25.0,22.0,18.0,11.0,15.0,218.0
Dhamtari,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,23.0,30.0,32.0,26.0,45.0,43.0,41.0,39.0,39.0,29.0,30.0,390.0
Dhamtari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,2.0,1.0,3.0,,3.0,3.0,,,,,14.0
Dhamtari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,10.0,15.0,7.0,24.0,18.0,25.0,18.0,24.0,19.0,15.0,26.0,28.0,229.0
Dhamtari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,36.0,37.0,49.0,55.0,28.0,62.0,78.0,68.0,42.0,18.0,23.0,23.0,519.0
Dhamtari,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,46.0,54.0,58.0,80.0,49.0,87.0,99.0,95.0,61.0,33.0,49.0,51.0,762.0
Durg,1.1,Total number of pregnant women Registered for ANC,TOTAL,5525.0,6940.0,7985.0,7518.0,7006.0,6991.0,7431.0,6338.0,7289.0,5882.0,13801.0,6705.0,89411.0
Durg,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2703.0,3376.0,3380.0,3637.0,3232.0,3216.0,3062.0,2716.0,3047.0,2706.0,2619.0,3672.0,37366.0
Durg,1.2,Number of Pregnant women registered under JSY,TOTAL,4847.0,5705.0,6464.0,6583.0,6357.0,6317.0,6793.0,6068.0,6964.0,5639.0,13238.0,6279.0,81254.0
Durg,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3849.0,5032.0,4976.0,5143.0,5380.0,4294.0,5275.0,5184.0,4981.0,4717.0,5143.0,4989.0,58963.0
Durg,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4377.0,5595.0,6005.0,5924.0,5661.0,5419.0,5919.0,4912.0,5657.0,4559.0,6707.0,5116.0,65851.0
Durg,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4351.0,5436.0,6112.0,5923.0,8123.0,5452.0,5719.0,5502.0,5580.0,5217.0,7783.0,5075.0,70273.0
Durg,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2893.0,3676.0,3751.0,4238.0,3662.0,3091.0,4043.0,3405.0,5440.0,3248.0,3775.0,3740.0,44962.0
Durg,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,243.0,217.0,340.0,321.0,195.0,235.0,294.0,226.0,271.0,157.0,258.0,309.0,3066.0
Durg,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,29.0,5.0,8.0,4.0,5.0,8.0,25.0,8.0,13.0,10.0,7.0,27.0,149.0
Durg,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,908.0,1134.0,1416.0,1449.0,1616.0,1235.0,1461.0,1301.0,1458.0,1420.0,1691.0,2280.0,17369.0
Durg,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14.0,12.0,4.0,13.0,15.0,20.0,21.0,7.0,30.0,15.0,15.0,13.0,179.0
Durg,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Durg,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,772.0,1159.0,1064.0,1347.0,1289.0,1209.0,1407.0,1356.0,1283.0,1030.0,1005.0,1088.0,14009.0
Durg,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,451.0,610.0,641.0,830.0,715.0,876.0,911.0,1200.0,1145.0,980.0,839.0,980.0,10178.0
Durg,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1223.0,1769.0,1705.0,2177.0,2004.0,2085.0,2318.0,2556.0,2428.0,2010.0,1844.0,2068.0,24187.0
Durg,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,889.0,1344.0,1348.0,1682.0,1595.0,1769.0,1786.0,2040.0,1925.0,1571.0,1335.0,1685.0,18969.0
Durg,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,153.0,246.0,200.0,283.0,273.0,300.0,330.0,298.0,240.0,224.0,204.0,256.0,3007.0
Durg,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1922.0,2281.0,2333.0,2479.0,2480.0,2466.0,2575.0,2633.0,2444.0,2454.0,2726.0,2951.0,29744.0
Durg,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1195.0,1540.0,1519.0,1607.0,1575.0,1491.0,1685.0,1705.0,1397.0,1528.0,1872.0,2752.0,19866.0
Durg,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1185.0,1278.0,1595.0,1573.0,1720.0,1688.0,1708.0,2030.0,1624.0,1599.0,1898.0,2119.0,20017.0
Durg,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,654.0,685.0,892.0,980.0,1021.0,1026.0,1144.0,1335.0,957.0,936.0,1116.0,1424.0,12170.0
Durg,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,68.0,57.0,71.0,64.0,36.0,62.0,60.0,46.0,36.0,23.0,28.0,5.0,556.0
Durg,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,167.0,304.0,320.0,,638.0,0.0,662.0,0.0,0.0,0.0,3780.0,,5871.0
Durg,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,120.0,,120.0
Durg,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,3.0,7.0,0.0,0.0,6.0,0.0,4.0,0.0,0.0,0.0,0.0,21.0
Durg,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,66.0,78.0,80.0,90.0,192.0,104.0,108.0,104.0,99.0,110.0,103.0,116.0,1250.0
Durg,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,67.0,81.0,87.0,90.0,192.0,110.0,108.0,108.0,99.0,110.0,103.0,116.0,1271.0
Durg,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,65.0,45.0,109.0,,236.0,0.0,244.0,0.0,0.0,0.0,1713.0,,2412.0
Durg,4.1.1.a,Number of male live births,TOTAL,1981.0,2488.0,2645.0,2640.0,2757.0,2551.0,2984.0,2895.0,2596.0,2485.0,4360.0,2650.0,33032.0
Durg,4.1.1.b,Number of female live births,TOTAL,1831.0,2314.0,2349.0,2422.0,2673.0,2465.0,2804.0,2775.0,2587.0,2378.0,4173.0,2402.0,31173.0
Durg,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3812.0,4802.0,4994.0,5062.0,5430.0,5016.0,5788.0,5670.0,5183.0,4863.0,8533.0,5052.0,64205.0
Durg,4.1.2,Number of still births,TOTAL,63.0,94.0,104.0,177.0,103.0,101.0,168.0,88.0,82.0,74.0,124.0,65.0,1243.0
Durg,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,92.0,99.0,117.0,141.0,114.0,119.0,93.0,67.0,82.0,111.0,93.0,83.0,1211.0
Durg,4.2.1,Number of Newborns weighed at birth,TOTAL,3541.0,4479.0,4520.0,4621.0,5097.0,4649.0,5504.0,5359.0,4925.0,4731.0,8445.0,4780.0,60651.0
Durg,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,293.0,488.0,416.0,901.0,1302.0,901.0,1220.0,1026.0,908.0,783.0,1059.0,348.0,9645.0
Durg,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3517.0,4499.0,4580.0,4634.0,5160.0,4752.0,5596.0,5333.0,4968.0,4774.0,8427.0,4718.0,60958.0
Durg,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,22.0,1.0,10.0,13.0,23.0,19.0,7.0,20.0,13.0,11.0,71.0,2.0,212.0
Durg,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,1.0,7.0,2.0,0.0,2.0,76.0,4.0,10.0,24.0,126.0
Durg,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,88.0,45.0,46.0,190.0,210.0,210.0,83.0,80.0,180.0,101.0,83.0,90.0,1406.0
Durg,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,110.0,46.0,56.0,204.0,240.0,231.0,90.0,102.0,269.0,116.0,164.0,116.0,1744.0
Durg,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Durg,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,103.0,45.0,51.0,191.0,211.0,204.0,83.0,80.0,180.0,112.0,92.0,109.0,1461.0
Durg,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,14.0,25.0,14.0,16.0,14.0,12.0,22.0,45.0,11.0,8.0,6.0,14.0,201.0
Durg,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,29.0,46.0,52.0,191.0,221.0,204.0,79.0,80.0,186.0,110.0,111.0,113.0,1422.0
Durg,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,70.0,32.0,30.0,125.0,150.0,194.0,65.0,65.0,65.0,67.0,63.0,15.0,941.0
Durg,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2246.0,2679.0,2989.0,3283.0,3262.0,3254.0,3533.0,3707.0,3282.0,3139.0,3332.0,4290.0,38996.0
Durg,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1794.0,2343.0,2682.0,2663.0,2601.0,2606.0,2751.0,2874.0,2713.0,2488.0,2279.0,3059.0,30853.0
Durg,6.3,PNC maternal complications attended,TOTAL,227.0,234.0,151.0,231.0,270.0,269.0,223.0,188.0,313.0,339.0,330.0,404.0,3179.0
Durg,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,18.0,18.0,14.0,15.0,19.0,17.0,23.0,22.0,14.0,10.0,19.0,28.0,217.0
Durg,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,12.0,11.0,16.0,18.0,12.0,8.0,9.0,7.0,11.0,11.0,5.0,14.0,134.0
Durg,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,30.0,29.0,30.0,33.0,31.0,25.0,32.0,29.0,25.0,21.0,24.0,42.0,351.0
Durg,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,4.0
Durg,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,169.0,67.0,121.0,115.0,104.0,208.0,231.0,177.0,118.0,147.0,56.0,229.0,1742.0
Durg,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,319.0,98.0,187.0,188.0,167.0,186.0,431.0,511.0,195.0,339.0,189.0,296.0,3106.0
Durg,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,488.0,165.0,308.0,303.0,271.0,394.0,662.0,688.0,313.0,486.0,245.0,525.0,4848.0
Durg,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Durg,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,11.0,0.0,4.0,0.0,0.0,4.0,2.0,5.0,7.0,34.0
Durg,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,5.0,1.0,1.0,56.0,12.0,13.0,1.0,7.0,9.0,8.0,17.0,10.0,140.0
Durg,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,8.0,1.0,9.0,10.0,7.0,2.0,10.0,10.0,12.0,4.0,8.0,3.0,84.0
Durg,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,13.0,2.0,11.0,77.0,19.0,19.0,11.0,17.0,25.0,14.0,30.0,20.0,258.0
Durg,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,3.0,5.0,5.0,2.0,8.0,5.0,3.0,15.0,5.0,28.0,36.0,0.0,115.0
Durg,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,15.0,1.0,11.0,135.0,116.0,92.0,134.0,124.0,132.0,425.0,440.0,234.0,1859.0
Durg,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,172.0,26.0,35.0,577.0,135.0,248.0,152.0,323.0,660.0,1200.0,777.0,531.0,4836.0
Durg,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,73.0,36.0,19.0,117.0,110.0,94.0,133.0,105.0,156.0,201.0,305.0,465.0,1814.0
Durg,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,260.0,63.0,65.0,829.0,361.0,434.0,419.0,552.0,948.0,1826.0,1522.0,1230.0,8509.0
Durg,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,3.0,19.0,39.0,0.0,68.0,30.0,44.0,117.0,64.0,352.0,442.0,224.0,1402.0
Durg,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,17.0,3.0,41.0,119.0,66.0,89.0,51.0,59.0,127.0,262.0,310.0,59.0,1203.0
Durg,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,94.0,13.0,64.0,641.0,156.0,313.0,164.0,499.0,1130.0,1928.0,1389.0,736.0,7127.0
Durg,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,126.0,124.0,183.0,233.0,244.0,217.0,189.0,198.0,313.0,351.0,526.0,443.0,3147.0
Durg,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,237.0,140.0,288.0,993.0,466.0,619.0,404.0,756.0,1570.0,2541.0,2225.0,1238.0,11477.0
Durg,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,12.0,34.0,23.0,44.0,55.0,43.0,45.0,41.0,39.0,36.0,3524.0,636.0,4532.0
Durg,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,3.0,0.0,2.0,3.0,0.0,0.0,2.0,2.0,0.0,13.0
Durg,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,59.0,63.0
Durg,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,389.0,90.0,125.0,125.0,160.0,65.0,12.0,160.0,156.0,132.0,48.0,26.0,1488.0
Durg,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,390.0,90.0,125.0,128.0,160.0,67.0,19.0,160.0,156.0,134.0,50.0,85.0,1564.0
Durg,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,141.0,213.0,416.0,474.0,432.0,381.0,279.0,225.0,181.0,211.0,322.0,235.0,3510.0
Durg,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,47.0,35.0,88.0,76.0,78.0,49.0,145.0,131.0,35.0,138.0,26.0,97.0,945.0
Durg,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,187.0,79.0,194.0,297.0,140.0,90.0,166.0,182.0,19.0,88.0,18.0,90.0,1550.0
Durg,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,84.0,114.0,131.0,125.0,186.0,157.0,136.0,120.0,89.0,37.0,77.0,100.0,1356.0
Durg,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Durg,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,459.0,441.0,829.0,972.0,836.0,677.0,726.0,658.0,324.0,474.0,443.0,522.0,7361.0
Durg,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Durg,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,4.0,5.0,6.0,5.0,10.0,58.0,7.0,6.0,13.0,0.0,10.0,0.0,124.0
Durg,9.06,Number of IUCD removals,TOTAL,721.0,1634.0,689.0,759.0,829.0,510.0,844.0,514.0,590.0,668.0,599.0,731.0,9088.0
Durg,9.07,Number of Oral Pills cycles distributed,TOTAL,6337.0,6224.0,6399.0,4167.0,6604.0,6167.0,5114.0,4578.0,4346.0,3367.0,3040.0,2533.0,58876.0
Durg,9.08,Number of Condom pieces distributed,TOTAL,15578.0,12438.0,10237.0,8780.0,21018.0,16399.0,12499.0,13137.0,7518.0,6692.0,6032.0,4407.0,134735.0
Durg,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,2.0,2.0,8.0,28.0,8.0,3.0,0.0,0.0,9.0,5.0,3.0,2.0,70.0
Durg,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,18.0,16.0,24.0,180.0,48.0,35.0,31.0,4.0,48.0,126.0,37.0,53.0,620.0
Durg,9.11.2.a,Number of failures following male sterilization,TOTAL,1.0,6.0,0.0,4.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Durg,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,4.0,5.0,7.0,0.0,4.0,3.0,0.0,0.0,7.0,5.0,1.0,36.0
Durg,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,3.0,3.0,3.0,3.0,5.0,5.0,6.0,6.0,7.0,18.0,13.0,-1.0
Durg,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3787.0,4766.0,4984.0,5015.0,5410.0,4946.0,5749.0,5655.0,5170.0,4792.0,8397.0,5050.0,63721.0
Durg,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3766.0,4749.0,5239.0,4635.0,4803.0,4984.0,5617.0,5679.0,5753.0,5644.0,5756.0,6088.0,62713.0
Durg,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4030.0,4995.0,5071.0,5070.0,4845.0,4373.0,5174.0,5801.0,5073.0,5573.0,5832.0,6404.0,62241.0
Durg,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3995.0,5182.0,5252.0,4874.0,5321.0,4362.0,4539.0,5218.0,5007.0,5389.0,6844.0,6585.0,62568.0
Durg,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Durg,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Durg,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Durg,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3143.0,3765.0,4252.0,3833.0,4167.0,3559.0,4179.0,4217.0,3785.0,3701.0,5489.0,4002.0,48092.0
Durg,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3713.0,4689.0,5192.0,4565.0,4493.0,4390.0,4916.0,5188.0,5659.0,5566.0,5534.0,6295.0,60200.0
Durg,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3965.0,4920.0,5032.0,5002.0,4523.0,3961.0,4584.0,5260.0,5024.0,5515.0,6836.0,6586.0,61208.0
Durg,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3922.0,5085.0,5179.0,4769.0,4902.0,3906.0,4074.0,4762.0,4952.0,5251.0,5429.0,6754.0,58985.0
Durg,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,553.0,1091.0,1428.0,1099.0,1335.0,1417.0,2075.0,8998.0
Durg,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,224.0,222.0,240.0,208.0,226.0,257.0,2456.0,3372.0,3740.0,3709.0,3820.0,5298.0,23772.0
Durg,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,184.0,160.0,170.0,171.0,170.0,189.0,478.0,2718.0,3154.0,3751.0,3944.0,5594.0,20683.0
Durg,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,176.0,163.0,196.0,198.0,182.0,214.0,312.0,613.0,2742.0,3339.0,3699.0,4759.0,16593.0
Durg,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3213.0,4588.0,5312.0,4991.0,5474.0,4942.0,5387.0,4976.0,5152.0,5254.0,5583.0,4440.0,59312.0
Durg,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,11.0,0.0,0.0,0.0,0.0,358.0,277.0,135.0,1128.0,1228.0,50.0,45.0,3232.0
Durg,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Durg,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1622.0,2316.0,2819.0,2623.0,2744.0,2359.0,2841.0,2497.0,2553.0,2657.0,2883.0,2276.0,30190.0
Durg,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1495.0,2190.0,2485.0,2342.0,2640.0,2178.0,2539.0,2419.0,2518.0,2523.0,2666.0,2154.0,28149.0
Durg,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3117.0,4506.0,5304.0,4965.0,5384.0,4537.0,5380.0,4916.0,5071.0,5180.0,5549.0,4430.0,58339.0
Durg,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3420.0,4484.0,5078.0,4709.0,4656.0,4188.0,4341.0,4751.0,5075.0,4606.0,5428.0,5674.0,56410.0
Durg,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3351.0,4386.0,4985.0,4555.0,4328.0,3713.0,3793.0,4302.0,5047.0,4507.0,5189.0,5663.0,53819.0
Durg,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1590.0,2650.0,2523.0,2486.0,2227.0,1987.0,2179.0,2568.0,2288.0,2254.0,2465.0,1292.0,26509.0
Durg,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1522.0,2425.0,2334.0,2249.0,2248.0,1879.0,2040.0,2344.0,2243.0,2180.0,2218.0,1284.0,24966.0
Durg,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3112.0,5075.0,4857.0,4735.0,4475.0,3866.0,4219.0,4912.0,4531.0,4434.0,4683.0,2576.0,51475.0
Durg,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1226.0,1645.0,1930.0,2621.0,4826.0,4590.0,4128.0,3037.0,4676.0,3582.0,2707.0,2497.0,37465.0
Durg,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1014.0,1313.0,1560.0,2360.0,10165.0,11122.0,8320.0,4792.0,5194.0,2816.0,3267.0,1797.0,53720.0
Durg,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,978.0,1292.0,1585.0,1874.0,5408.0,6907.0,4089.0,5301.0,4824.0,2856.0,5010.0,2021.0,42145.0
Durg,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,1.0,0.0,2.0,0.0,0.0,3.0,0.0,0.0,0.0,1.0,8.0
Durg,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Durg,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1874.0,2060.0,2140.0,1842.0,2195.0,2037.0,2278.0,2253.0,2230.0,2261.0,2388.0,2236.0,25794.0
Durg,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1747.0,2071.0,2050.0,1832.0,2173.0,1987.0,2243.0,2228.0,2214.0,2251.0,2306.0,2212.0,25314.0
Durg,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1510.0,1805.0,1823.0,1568.0,2029.0,1818.0,1991.0,2034.0,1901.0,1831.0,1799.0,1871.0,21980.0
Durg,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3330.0,4637.0,4907.0,4930.0,5505.0,4724.0,5471.0,4930.0,6247.0,5158.0,5054.0,5064.0,59957.0
Durg,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2855.0,2012.0,2349.0,2651.0,5254.0,3140.0,2394.0,2383.0,16601.0,12516.0,2736.0,2768.0,57659.0
Durg,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,622.0,1354.0,1261.0,2443.0,4741.0,2252.0,1805.0,1728.0,18237.0,13019.0,2187.0,1882.0,51531.0
Durg,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,41.0,54.0,44.0,29.0,31.0,7.0,5.0,12.0,8.0,19.0,2.0,3.0,255.0
Durg,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1134.0,1331.0,1186.0,1425.0,1209.0,1083.0,854.0,716.0,854.0,915.0,817.0,966.0,12490.0
Durg,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,449.0,460.0,528.0,425.0,836.0,671.0,328.0,272.0,419.0,323.0,298.0,399.0,5408.0
Durg,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,2.0,5.0,0.0,4.0,3.0,0.0,3.0,0.0,5.0,19.0,16.0,57.0
Durg,13.1,Number of Patients operated for cataract,TOTAL,271.0,56.0,116.0,217.0,388.0,984.0,139.0,91.0,72.0,76.0,201.0,222.0,2833.0
Durg,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,152.0,32.0,79.0,73.0,131.0,797.0,29.0,20.0,36.0,22.0,87.0,127.0,1585.0
Durg,13.3,Number of School children detected with Refractive errors,TOTAL,4.0,2.0,12.0,24.0,47.0,53.0,10.0,37.0,11.0,33.0,49.0,122.0,404.0
Durg,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,10.0,19.0,0.0,0.0,0.0,0.0,31.0
Durg,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,6.0
Durg,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,6.0
Durg,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,4.0,6.0,6.0,6.0,6.0,8.0,5.0,4.0,4.0,6.0,-1.0
Durg,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,9.0,7.0,6.0,7.0,4.0,5.0,5.0,5.0,3.0,5.0,5.0,8.0,-1.0
Durg,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1301.0,1540.0,1534.0,1475.0,1685.0,1636.0,1444.0,1602.0,1700.0,1891.0,1928.0,1860.0,-1.0
Durg,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,9.0,9.0,11.0,12.0,13.0,13.0,13.0,13.0,14.0,12.0,14.0,-1.0
Durg,14.05,Number of RKS meetings held during the month,TOTAL,13.0,4.0,9.0,4.0,11.0,9.0,10.0,5.0,6.0,3.0,5.0,13.0,92.0
Durg,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,17.0,16.0,11.0,15.0,17.0,17.0,17.0,16.0,16.0,18.0,20.0,18.0,-1.0
Durg,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,114.0,66.0,40.0,77.0,107.0,114.0,122.0,80.0,71.0,115.0,289.0,339.0,1534.0
Durg,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,2.0,3.0,2.0,1.0,2.0,2.0,4.0,4.0,3.0,3.0,-1.0
Durg,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,0.0,1.0,29.0,0.0,0.0,49.0,41.0,219.0,82.0,62.0,-1.0
Durg,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,265.0,216.0,219.0,312.0,420.0,457.0,512.0,232.0,190.0,234.0,1029.0,1008.0,5094.0
Durg,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3173.0,4350.0,3714.0,3869.0,3747.0,3967.0,1730.0,1364.0,3817.0,2650.0,2629.0,2543.0,37553.0
Durg,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,237.0,163.0,287.0,625.0,450.0,321.0,281.0,282.0,118.0,283.0,774.0,997.0,4818.0
Durg,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3340.0,2921.0,3689.0,5057.0,4810.0,3953.0,3110.0,2395.0,4808.0,4699.0,4501.0,4308.0,47591.0
Durg,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,502.0,379.0,506.0,937.0,870.0,778.0,793.0,514.0,308.0,517.0,1803.0,2005.0,9912.0
Durg,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6513.0,7271.0,7403.0,8926.0,8557.0,7920.0,4840.0,3759.0,8625.0,7349.0,7130.0,6851.0,85144.0
Durg,14.10.2.a,Number of death cases of Inpatient males,TOTAL,17.0,16.0,26.0,33.0,32.0,28.0,29.0,29.0,21.0,31.0,45.0,26.0,333.0
Durg,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,24.0,23.0,23.0,24.0,43.0,27.0,12.0,63.0,21.0,28.0,33.0,331.0
Durg,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,27.0,40.0,49.0,56.0,56.0,71.0,56.0,41.0,84.0,52.0,73.0,59.0,664.0
Durg,14.11,In-Patient Head Count at midnight,TOTAL,1825.0,1966.0,2859.0,2378.0,2304.0,2211.0,2193.0,2074.0,2324.0,2253.0,2552.0,2619.0,27558.0
Durg,14.12.1,OPD attendance (All),TOTAL,59023.0,53564.0,55957.0,72303.0,70761.0,74820.0,63558.0,57352.0,64479.0,67940.0,73990.0,71818.0,785565.0
Durg,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,168.0,524.0,226.0,358.0,178.0,170.0,145.0,183.0,172.0,664.0,451.0,194.0,3433.0
Durg,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Durg,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,592.0,643.0,724.0,928.0,1013.0,598.0,524.0,669.0,1057.0,1042.0,872.0,710.0,9372.0
Durg,14.14.a,Number of patients given AYUSH treatment,TOTAL,1076.0,1055.0,1043.0,1091.0,837.0,769.0,697.0,1045.0,1299.0,1076.0,1271.0,1157.0,12416.0
Durg,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,760.0,420.0,621.0,554.0,625.0,810.0,625.0,710.0,825.0,603.0,685.0,619.0,7857.0
Durg,14.14.c,Number of Adolescents counselled,TOTAL,106.0,213.0,91.0,96.0,121.0,106.0,156.0,111.0,190.0,166.0,137.0,158.0,1651.0
Durg,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4051.0,4145.0,4551.0,4952.0,4814.0,5419.0,5451.0,5238.0,5317.0,5819.0,6497.0,6053.0,62307.0
Durg,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,128.0,173.0,201.0,185.0,157.0,255.0,181.0,195.0,142.0,141.0,130.0,101.0,1989.0
Durg,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,290.0,330.0,364.0,724.0,395.0,418.0,474.0,630.0,410.0,561.0,458.0,535.0,5589.0
Durg,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,20.0,12.0,15.0,19.0,24.0,56.0,10.0,23.0,24.0,26.0,30.0,24.0,283.0
Durg,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,374.0,433.0,447.0,676.0,302.0,455.0,477.0,816.0,754.0,1056.0,1501.0,1094.0,8385.0
Durg,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,19.0,29.0,12.0,11.0,78.0,78.0,126.0,30.0,32.0,25.0,7.0,83.0,530.0
Durg,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,213.0,423.0,414.0,323.0,521.0,489.0,539.0,372.0,586.0,588.0,626.0,729.0,5823.0
Durg,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,2.0,20.0,28.0,24.0,1.0,0.0,0.0,0.0,75.0
Durg,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,877.0,1186.0,1225.0,1723.0,1218.0,1362.0,1490.0,1818.0,1750.0,2205.0,2585.0,2358.0,19797.0
Durg,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,39.0,41.0,27.0,30.0,104.0,154.0,164.0,77.0,57.0,51.0,37.0,107.0,888.0
Durg,15.2,Number of Widal tests conducted,Number tested,135.0,140.0,107.0,139.0,306.0,204.0,235.0,269.0,172.0,151.0,327.0,167.0,2352.0
Durg,15.3.a,Number of VDRL tests conducted on males,Number tested,54.0,30.0,26.0,87.0,116.0,116.0,127.0,147.0,120.0,53.0,64.0,33.0,973.0
Durg,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,299.0,296.0,211.0,216.0,189.0,175.0,237.0,178.0,268.0,284.0,381.0,96.0,2830.0
Durg,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,119.0,210.0,20.0,8.0,86.0,56.0,65.0,74.0,137.0,64.0,140.0,100.0,1079.0
Durg,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,472.0,536.0,257.0,311.0,391.0,347.0,429.0,399.0,525.0,401.0,585.0,229.0,4882.0
Durg,15.4.1,Number of blood smears examined for Malaria,TOTAL,10805.0,10142.0,11311.0,17312.0,15426.0,16830.0,17718.0,17120.0,12683.0,7720.0,11841.0,10213.0,159121.0
Durg,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,67.0,38.0,38.0,64.0,107.0,139.0,57.0,62.0,59.0,43.0,20.0,64.0,758.0
Durg,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,10.0,9.0,13.0,46.0,14.0,14.0,13.0,23.0,11.0,31.0,14.0,10.0,208.0
Durg,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,43480.0,20060.0,20060.0,19170.0,13210.0,23630.0,23140.0,31870.0,0.0,15430.0,35740.0,48260.0,294050.0
Durg,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,25000.0,75000.0,40000.0,30000.0,30000.0,8000.0,30000.0,50000.0,30000.0,,348000.0
Durg,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,21720.0,31700.0,25890.0,61790.0,29580.0,25930.0,21270.0,39870.0,14570.0,29690.0,17480.0,48260.0,367750.0
Durg,16.1.1,Stock position of DPT vaccines,5. Total Stock,21760.0,18360.0,19170.0,32380.0,23630.0,27700.0,31870.0,0.0,15430.0,35740.0,48260.0,0.0,274300.0
Durg,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Durg,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Durg,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Durg,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Durg,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20500.0,29260.0,12560.0,80.0,1200.0,6900.0,680.0,42840.0,1840.0,3360.0,10180.0,14140.0,143540.0
Durg,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,20000.0,10000.0,65000.0,30000.0,25000.0,70000.0,15000.0,25000.0,35000.0,577000.0,572000.0,1469000.0
Durg,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16240.0,36700.0,22480.0,63800.0,24300.0,31220.0,27840.0,56000.0,23480.0,28180.0,573040.0,488760.0,1392040.0
Durg,16.1.2,Stock position of OPV vaccines,5. Total Stock,29260.0,12560.0,80.0,1280.0,6900.0,680.0,42840.0,1840.0,3360.0,10180.0,14140.0,97380.0,220500.0
Durg,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,44950.0,32130.0,32130.0,27400.0,14830.0,15000.0,2110.0,26840.0,8020.0,24450.0,29290.0,17040.0,274190.0
Durg,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,30000.0,25000.0,65000.0,30000.0,30000.0,40000.0,20000.0,40000.0,30000.0,16000.0,40000.0,366000.0
Durg,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.1.3,Stock position of TT vaccines,4. Stock Distributed,23020.0,19800.0,29730.0,50170.0,29830.0,42890.0,15270.0,38820.0,23570.0,25160.0,28250.0,36290.0,362800.0
Durg,16.1.3,Stock position of TT vaccines,5. Total Stock,21930.0,42330.0,27400.0,42230.0,15000.0,2110.0,26840.0,8020.0,24450.0,29290.0,17040.0,20750.0,277390.0
Durg,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10000.0,14220.0,14220.0,8770.0,6560.0,12860.0,15130.0,19200.0,4270.0,5980.0,7130.0,8400.0,126740.0
Durg,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,20000.0,10000.0,50000.0,20000.0,20000.0,13000.0,10000.0,17000.0,15000.0,7000.0,15000.0,207000.0
Durg,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10710.0,16070.0,15450.0,43440.0,13700.0,17730.0,8930.0,24930.0,15290.0,13850.0,5730.0,23400.0,209230.0
Durg,16.1.5,Stock position of BCG vaccines,5. Total Stock,9290.0,18150.0,8770.0,15330.0,12860.0,15130.0,19200.0,4270.0,5980.0,7130.0,8400.0,0.0,124510.0
Durg,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8470.0,6430.0,6430.0,3160.0,500.0,14095.0,10850.0,19070.0,15410.0,14450.0,3095.0,1980.0,103940.0
Durg,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,10000.0,5000.0,30000.0,20000.0,10000.0,15000.0,475000.0,240000.0,5445.0,0.0,,815445.0
Durg,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8140.0,8900.0,8270.0,26195.0,6405.0,13245.0,6780.0,478660.0,240960.0,16800.0,1115.0,1140.0,816610.0
Durg,16.1.6,Stock position of Measles vaccines,5. Total Stock,5330.0,7530.0,3160.0,6965.0,14095.0,10850.0,19070.0,15410.0,14450.0,3095.0,1980.0,840.0,102775.0
Durg,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,28070.0,87870.0,42270.0,26570.0,28720.0,34970.0,248470.0
Durg,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,60000.0,64000.0,0.0,0.0,15000.0,15000.0,,154000.0
Durg,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,31930.0,4200.0,45600.0,15700.0,12850.0,8750.0,33910.0,152940.0
Durg,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,28070.0,87870.0,42270.0,26570.0,28720.0,34970.0,1060.0,249530.0
Durg,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3000.0,0.0,1800.0,1300.0,9500.0,4500.0,3100.0,2700.0,2300.0,2300.0,1700.0,1700.0,33900.0
Durg,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10200.0,,,,0.0,0.0,0.0,0.0,,10200.0
Durg,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,0.0,500.0,700.0,5000.0,1400.0,400.0,400.0,0.0,600.0,0.0,200.0,9800.0
Durg,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2400.0,0.0,1300.0,10800.0,4500.0,3100.0,2700.0,2300.0,2300.0,1700.0,1700.0,1500.0,34300.0
Durg,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,114000.0,12000.0,6000.0,6000.0,6000.0,6000.0,0.0,,150000.0
Durg,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,132000.0,,,,0.0,0.0,0.0,0.0,,132000.0
Durg,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,18000.0,102000.0,6000.0,,0.0,0.0,6000.0,0.0,,132000.0
Durg,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,114000.0,12000.0,6000.0,6000.0,6000.0,6000.0,0.0,0.0,0.0,150000.0
Durg,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,7000.0,7000.0,2000.0,1000.0,1000.0,1000.0,0.0,,19000.0
Durg,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,10000.0,,,0.0,0.0,0.0,0.0,,20000.0
Durg,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,15000.0,5000.0,1000.0,0.0,0.0,1000.0,0.0,,25000.0
Durg,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,7000.0,2000.0,2000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,14000.0
Durg,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,7000.0,,0.0,0.0,0.0,0.0,0.0,,7000.0
Durg,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,,,0.0,0.0,0.0,0.0,0.0,,10000.0
Durg,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,7000.0,,0.0,0.0,0.0,0.0,0.0,,10000.0
Durg,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0
Durg,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5800.0,0.0,5600.0,5100.0,3300.0,3300.0,12556.0,12556.0,10365.0,8365.0,13165.0,16165.0,96272.0
Durg,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,9465.0,,0.0,0.0,5000.0,5000.0,,19465.0
Durg,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,200.0,0.0,500.0,1800.0,,200.0,,2191.0,2000.0,200.0,2000.0,1500.0,10591.0
Durg,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,5600.0,0.0,5100.0,3300.0,3300.0,12565.0,12556.0,10365.0,8365.0,13165.0,16165.0,14665.0,105146.0
Durg,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,1100.0,1750.0,0.0,0.0,,2850.0
Durg,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,,,3000.0,3000.0,0.0,0.0,0.0,,6000.0
Durg,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,,,1900.0,2350.0,1750.0,0.0,0.0,,6000.0
Durg,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1100.0,1750.0,0.0,0.0,0.0,0.0,2850.0
Durg,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Durg,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,32500.0,6500.0,6500.0,6500.0,,,0.0,0.0,0.0,0.0,0.0,,52000.0
Durg,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,47500.0,67500.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,115000.0
Durg,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,6500.0,,,0.0,0.0,0.0,0.0,0.0,,6500.0
Durg,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,73500.0,67500.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,141000.0
Durg,16.3.07,Stock Position of IFA Tablets,5. Total Stock,6500.0,6500.0,6500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19500.0
Durg,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,44250.0,31750.0,31750.0,22250.0,19250.0,5650.0,5650.0,1650.0,1650.0,47000.0,11350.0,5850.0,228050.0
Durg,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,,,,0.0,66800.0,0.0,0.0,,66800.0
Durg,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,12500.0,0.0,9500.0,1000.0,13600.0,,4000.0,0.0,21450.0,35650.0,5500.0,5850.0,109050.0
Durg,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,31750.0,31750.0,22250.0,21250.0,5650.0,5650.0,1650.0,1650.0,47000.0,11350.0,5850.0,0.0,185800.0
Durg,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,2200.0,0.0,0.0,0.0,3820.0,2036.0,0.0,0.0,0.0,0.0,1100.0,3600.0,12756.0
Durg,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,12000.0,6000.0,,18000.0
Durg,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,,,0.0
Durg,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,1700.0,0.0,0.0,0.0,1784.0,2036.0,0.0,0.0,0.0,10900.0,3500.0,3600.0,23520.0
Durg,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,500.0,0.0,0.0,0.0,2036.0,0.0,0.0,0.0,0.0,1100.0,3600.0,0.0,7236.0
Durg,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,139.0,0.0,0.0,936.0,701.0,249.0,190.0,2980.0,285.0,130.0,120.0,110.0,5840.0
Durg,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,936.0,,,2808.0,2837.0,0.0,0.0,0.0,,6581.0
Durg,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,235.0,452.0,59.0,18.0,5532.0,155.0,10.0,10.0,2.0,6473.0
Durg,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,139.0,0.0,0.0,1637.0,249.0,190.0,2980.0,285.0,130.0,120.0,110.0,108.0,5948.0
Durg,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5300.0,2700.0,1200.0,0.0,,,,900.0,200.0,0.0,0.0,,10300.0
Durg,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,9000.0,2000.0,0.0,0.0,,,3200.0,0.0,0.0,0.0,0.0,4800.0,19000.0
Durg,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,11600.0,3500.0,1200.0,0.0,,,2300.0,700.0,200.0,0.0,0.0,4700.0,24200.0
Durg,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2700.0,1200.0,0.0,0.0,0.0,0.0,900.0,200.0,0.0,0.0,0.0,100.0,5100.0
Durg,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6000.0,434400.0,0.0,36200.0,600.0,31000.0,23200.0,19200.0,17700.0,2800.0,400.0,,571500.0
Durg,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,36200.0,67200.0,,,0.0,0.0,0.0,0.0,,103400.0
Durg,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Durg,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,350000.0,0.0,1600.0,36800.0,7800.0,4000.0,1500.0,14900.0,2400.0,400.0,,419400.0
Durg,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6000.0,84400.0,0.0,70800.0,31000.0,23200.0,19200.0,17700.0,2800.0,400.0,0.0,0.0,255500.0
Durg,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,274400.0,,166800.0,84800.0,74400.0,225200.0,101800.0,417200.0,0.0,0.0,0.0,,1344600.0
Durg,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,160000.0,,0.0,0.0,174000.0,,360000.0,374400.0,0.0,0.0,0.0,,1068400.0
Durg,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,,82000.0,10000.0,23200.0,123400.0,44600.0,791600.0,0.0,0.0,0.0,,1074800.0
Durg,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,434400.0,0.0,84800.0,74800.0,225200.0,101800.0,417200.0,0.0,0.0,0.0,0.0,0.0,1338200.0
Durg,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,800.0,,0.0,0.0,,6000.0,3900.0,3000.0,1000.0,1000.0,0.0,,15700.0
Durg,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,0.0,0.0,16600.0,,,147000.0,0.0,0.0,0.0,,163600.0
Durg,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Durg,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,,0.0,0.0,14400.0,2100.0,900.0,149000.0,0.0,1000.0,0.0,,167400.0
Durg,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,800.0,0.0,0.0,0.0,2200.0,3900.0,3000.0,1000.0,1000.0,0.0,0.0,0.0,11900.0
Durg,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,3.0,,7.0,,7.0,,4.0,4.0,,1.0,1.0,29.0
Durg,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,1.0,1.0,,1.0,1.0,,1.0,1.0,1.0,1.0,10.0
Durg,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Durg,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,,1.0,1.0,,1.0,1.0,,1.0,1.0,1.0,1.0,11.0
Durg,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,,2.0,7.0,,1.0,4.0,2.0,2.0,1.0,1.0,1.0,24.0
Durg,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,1.0,,1.0,,3.0
Durg,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,,2.0,7.0,,1.0,5.0,2.0,3.0,1.0,2.0,1.0,27.0
Durg,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,2.0,4.0,3.0,7.0,8.0,8.0,4.0,6.0,4.0,10.0,59.0
Durg,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,2.0,1.0,,1.0,,,1.0,2.0,2.0,,1.0,12.0
Durg,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,4.0,3.0,4.0,4.0,7.0,8.0,9.0,6.0,8.0,4.0,11.0,71.0
Durg,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,3.0,2.0,6.0,,1.0,3.0,4.0,,2.0,4.0,,25.0
Durg,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,3.0,,1.0,2.0,,,1.0,1.0,1.0,,,10.0
Durg,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,6.0,2.0,7.0,2.0,1.0,3.0,5.0,1.0,3.0,4.0,,35.0
Durg,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,3.0,1.0,2.0,1.0,,2.0,4.0,4.0,2.0,1.0,6.0,28.0
Durg,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,3.0,,,1.0,1.0,,,,6.0
Durg,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,3.0,2.0,2.0,4.0,,2.0,5.0,5.0,2.0,1.0,6.0,34.0
Durg,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Durg,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Durg,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,2.0,,,,2.0
Durg,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,2.0,2.0,,1.0,,,,,,5.0
Durg,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,1.0,,,2.0,4.0
Durg,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,2.0,3.0,,1.0,,1.0,,,2.0,9.0
Durg,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Durg,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Durg,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Durg,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,2.0,4.0,3.0,3.0,1.0,1.0,5.0,7.0,8.0,4.0,4.0,42.0
Durg,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,2.0,5.0,2.0,2.0,3.0,4.0,2.0,8.0,3.0,2.0,35.0
Durg,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,3.0,6.0,8.0,5.0,3.0,4.0,9.0,9.0,16.0,7.0,6.0,77.0
Durg,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,2.0,,2.0,,,,,4.0
Durg,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,2.0,,,,,,3.0,6.0
Durg,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,4.0,,2.0,,,,3.0,10.0
Durg,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,1.0,,,,,2.0
Durg,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,3.0,1.0,2.0,4.0,1.0,4.0,4.0,4.0,1.0,3.0,2.0,29.0
Durg,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,2.0,1.0,2.0,1.0,,1.0,1.0,1.0,3.0,2.0,15.0
Durg,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,4.0,3.0,3.0,6.0,2.0,4.0,6.0,5.0,2.0,6.0,4.0,46.0
Durg,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,1.0,,,,1.0,,,,,3.0
Durg,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,2.0,3.0,,1.0,2.0,2.0,2.0,,,,2.0,14.0
Durg,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,2.0,1.0,,1.0,,3.0,1.0,,,1.0,1.0,10.0
Durg,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,5.0,4.0,1.0,2.0,2.0,5.0,4.0,,,1.0,3.0,27.0
Durg,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,5.0,1.0,,2.0,,,,1.0,9.0
Durg,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,1.0,,,2.0
Durg,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,6.0,1.0,,2.0,,1.0,,1.0,11.0
Durg,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,3.0,,1.0,,1.0,,,,1.0,,,1.0,7.0
Durg,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,,1.0,2.0,5.0,2.0,1.0,,1.0,,14.0
Durg,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,4.0,4.0,,9.0,3.0,3.0,3.0,1.0,,,2.0,29.0
Durg,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,5.0,6.0,,11.0,5.0,8.0,5.0,3.0,,1.0,3.0,50.0
Durg,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,2.0,,,,,,,,1.0,,4.0
Durg,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Durg,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,2.0,,,,1.0,,,,1.0,,5.0
Durg,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,1.0,,1.0,,,,,1.0,4.0
Durg,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,5.0,17.0,5.0,14.0,15.0,20.0,14.0,12.0,8.0,17.0,10.0,141.0
Durg,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,14.0,11.0,10.0,8.0,8.0,16.0,15.0,11.0,5.0,11.0,6.0,120.0
Durg,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,9.0,19.0,29.0,15.0,23.0,23.0,37.0,29.0,23.0,13.0,28.0,17.0,265.0
Durg,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,,1.0,,,,,,,,,2.0
Durg,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,2.0,1.0,3.0,,1.0,3.0,7.0,1.0,2.0,1.0,23.0
Durg,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,,1.0,2.0,1.0,1.0,2.0,1.0,,,1.0,11.0
Durg,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,3.0,2.0,2.0,3.0,5.0,1.0,2.0,5.0,8.0,1.0,2.0,2.0,36.0
Durg,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Durg,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Durg,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,1.0,,,,,,1.0
Durg,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Durg,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,1.0,,1.0
Durg,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,1.0,,1.0
Durg,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,1.0,2.0,1.0,3.0,,,1.0,,9.0
Durg,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,3.0,,1.0,1.0,,3.0,,1.0,,1.0,,10.0
Durg,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,3.0,1.0,1.0,2.0,2.0,4.0,3.0,1.0,,2.0,,19.0
Durg,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,1.0,,,,2.0,,,,4.0
Durg,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,1.0,1.0,,,,,2.0
Durg,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,1.0,,1.0,1.0,2.0,,,,6.0
Durg,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,2.0,,1.0,2.0,1.0,,,,,,6.0
Durg,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,1.0,,,,,,1.0
Durg,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,2.0,,1.0,2.0,2.0,,,,,,7.0
Durg,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Durg,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,5.0,5.0,4.0,2.0,4.0,5.0,4.0,5.0,4.0,4.0,4.0,48.0
Durg,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,2.0,9.0,7.0,5.0,4.0,10.0,9.0,2.0,4.0,10.0,5.0,1.0,68.0
Durg,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,14.0,12.0,9.0,6.0,14.0,14.0,6.0,9.0,14.0,9.0,5.0,116.0
Durg,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,1.0,2.0,2.0,1.0,,,1.0,,,10.0
Durg,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,12.0,22.0,18.0,19.0,8.0,11.0,20.0,22.0,15.0,19.0,10.0,182.0
Durg,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,2.0,5.0,1.0,2.0,1.0,6.0,3.0,1.0,4.0,1.0,4.0,30.0
Durg,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,16.0,28.0,20.0,23.0,11.0,18.0,23.0,23.0,20.0,20.0,14.0,222.0
Durg,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Durg,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,10.0,11.0,16.0,11.0,11.0,7.0,13.0,10.0,16.0,13.0,21.0,145.0
Durg,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,2.0,2.0,1.0,,1.0,1.0,1.0,1.0,1.0,12.0
Durg,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,11.0,13.0,18.0,13.0,12.0,7.0,14.0,11.0,17.0,14.0,22.0,158.0
Durg,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,1.0,1.0,,1.0,1.0,,,,5.0
Durg,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,3.0,3.0,4.0,3.0,3.0,4.0,4.0,5.0,4.0,3.0,38.0
Durg,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,2.0,1.0,4.0,1.0,11.0,3.0,17.0,3.0,,6.0,1.0,50.0
Durg,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,3.0,4.0,8.0,6.0,15.0,6.0,22.0,8.0,5.0,10.0,4.0,93.0
Durg,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,3.0,1.0,,,,,5.0
Durg,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,10.0,6.0,5.0,10.0,7.0,12.0,15.0,10.0,15.0,16.0,15.0,125.0
Durg,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,8.0,11.0,13.0,10.0,13.0,17.0,23.0,21.0,15.0,25.0,15.0,175.0
Durg,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,18.0,17.0,19.0,20.0,20.0,32.0,39.0,31.0,30.0,41.0,30.0,305.0
Durg,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,2.0,,2.0,1.0,,1.0,1.0,,2.0,10.0
Durg,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,5.0,17.0,14.0,11.0,9.0,12.0,9.0,33.0,23.0,16.0,16.0,22.0,187.0
Durg,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,30.0,45.0,23.0,39.0,56.0,38.0,44.0,38.0,54.0,51.0,48.0,474.0
Durg,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,13.0,48.0,59.0,36.0,48.0,70.0,48.0,77.0,62.0,71.0,67.0,72.0,671.0
Durg,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,3.0,2.0,3.0,1.0,4.0,2.0,2.0,,,1.0,,18.0
Durg,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,9.0,29.0,30.0,30.0,31.0,17.0,29.0,28.0,16.0,21.0,17.0,41.0,298.0
Durg,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,23.0,65.0,72.0,59.0,108.0,103.0,136.0,99.0,91.0,86.0,71.0,130.0,1043.0
Durg,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,32.0,97.0,104.0,92.0,140.0,124.0,167.0,129.0,107.0,107.0,89.0,171.0,1359.0
Gariyaband,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Gariyaband,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Gariyaband,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Gariyaband,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Gariyaband,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Gariyaband,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Gariyaband,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Gariyaband,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Gariyaband,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Gariyaband,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,4.1.1.a,Number of male live births,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.1.1.b,Number of female live births,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.1.2,Number of still births,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Gariyaband,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Gariyaband,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Gariyaband,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Gariyaband,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Gariyaband,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Gariyaband,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Gariyaband,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Gariyaband,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Gariyaband,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Gariyaband,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Gariyaband,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Gariyaband,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Gariyaband,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Gariyaband,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Gariyaband,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Gariyaband,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Gariyaband,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Gariyaband,9.06,Number of IUCD removals,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.08,Number of Condom pieces distributed,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Gariyaband,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Gariyaband,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Gariyaband,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Gariyaband,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Gariyaband,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Gariyaband,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Gariyaband,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Gariyaband,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Gariyaband,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Gariyaband,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Gariyaband,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Gariyaband,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Gariyaband,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Gariyaband,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Gariyaband,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Gariyaband,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,0.0,,,,,,,,-1.0
Gariyaband,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Gariyaband,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Gariyaband,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Gariyaband,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Gariyaband,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Gariyaband,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Gariyaband,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Gariyaband,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Gariyaband,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Gariyaband,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Gariyaband,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Gariyaband,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Gariyaband,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Gariyaband,14.12.1,OPD attendance (All),TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Gariyaband,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Gariyaband,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Gariyaband,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Gariyaband,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Gariyaband,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Gariyaband,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,0.0,,,,,,,,0.0
Gariyaband,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Gariyaband,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Gariyaband,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Gariyaband,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Gariyaband,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Gariyaband,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Gariyaband,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Gariyaband,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Gariyaband,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Gariyaband,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Gariyaband,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Gariyaband,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Gariyaband,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Gariyaband,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Gariyaband,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Gariyaband,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Gariyaband,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Gariyaband,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Gariyaband,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Gariyaband,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Gariyaband,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gariyaband,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Gariyaband,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gariyaband,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gariyaband,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Gariyaband,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gariyaband,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gariyaband,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Gariyaband,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gariyaband,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gariyaband,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Gariyaband,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gariyaband,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gariyaband,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Gariyaband,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gariyaband,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gariyaband,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Gariyaband,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gariyaband,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gariyaband,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Gariyaband,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gariyaband,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gariyaband,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Gariyaband,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gariyaband,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gariyaband,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gariyaband,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Gariyaband,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Gariyaband,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Gariyaband,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Gariyaband,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Gariyaband,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Gariyaband,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Gariyaband,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Janjgir Champa,1.1,Total number of pregnant women Registered for ANC,TOTAL,3305.0,3953.0,4673.0,5467.0,4511.0,4779.0,4683.0,4506.0,4690.0,4161.0,3700.0,4271.0,52699.0
Janjgir Champa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1182.0,1296.0,1583.0,1887.0,1522.0,1590.0,1528.0,1581.0,1664.0,1359.0,1370.0,1520.0,18082.0
Janjgir Champa,1.2,Number of Pregnant women registered under JSY,TOTAL,1917.0,2309.0,2981.0,3543.0,2814.0,2921.0,2967.0,2917.0,2983.0,2706.0,2461.0,2872.0,33391.0
Janjgir Champa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2427.0,3117.0,3050.0,3379.0,3369.0,3708.0,3278.0,3606.0,3454.0,3349.0,3340.0,3115.0,39192.0
Janjgir Champa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1955.0,2350.0,2734.0,3126.0,2596.0,2739.0,2622.0,2533.0,2682.0,2226.0,2003.0,2236.0,29802.0
Janjgir Champa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2344.0,2736.0,3273.0,3744.0,3345.0,3490.0,3227.0,3178.0,4821.0,2953.0,2716.0,3029.0,38856.0
Janjgir Champa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2449.0,2692.0,2879.0,3180.0,2635.0,2846.0,2745.0,2605.0,3405.0,2940.0,2565.0,3247.0,34188.0
Janjgir Champa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,142.0,141.0,154.0,152.0,111.0,181.0,122.0,113.0,97.0,116.0,114.0,93.0,1536.0
Janjgir Champa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,3.0,9.0,6.0,2.0,7.0,9.0,5.0,3.0,4.0,5.0,18.0,75.0
Janjgir Champa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,573.0,696.0,765.0,739.0,686.0,746.0,687.0,674.0,753.0,687.0,597.0,945.0,8548.0
Janjgir Champa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3.0,17.0,27.0,23.0,27.0,21.0,94.0,35.0,28.0,22.0,23.0,14.0,334.0
Janjgir Champa,1.8,Number of pregnancy test kits used at SC level,TOTAL,6.0,,,,,,0.0,,,,,,6.0
Janjgir Champa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,620.0,860.0,907.0,983.0,947.0,957.0,757.0,669.0,777.0,785.0,714.0,645.0,9621.0
Janjgir Champa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,766.0,936.0,865.0,1028.0,897.0,933.0,857.0,1024.0,1073.0,863.0,761.0,851.0,10854.0
Janjgir Champa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1386.0,1796.0,1772.0,2011.0,1844.0,1890.0,1614.0,1693.0,1850.0,1648.0,1475.0,1496.0,20475.0
Janjgir Champa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1209.0,1445.0,1389.0,1628.0,1504.0,1411.0,1300.0,1447.0,1463.0,1294.0,1156.0,1300.0,16546.0
Janjgir Champa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,539.0,515.0,447.0,460.0,463.0,448.0,452.0,474.0,631.0,446.0,278.0,367.0,5520.0
Janjgir Champa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,724.0,1183.0,1291.0,1504.0,1500.0,1558.0,1550.0,1600.0,1518.0,1283.0,1157.0,1645.0,16513.0
Janjgir Champa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,588.0,1004.0,1082.0,1281.0,1159.0,1345.0,1323.0,1432.0,1420.0,1212.0,1122.0,1184.0,14152.0
Janjgir Champa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,673.0,901.0,925.0,1008.0,981.0,1025.0,1109.0,1074.0,1144.0,1044.0,1008.0,1114.0,12006.0
Janjgir Champa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,407.0,550.0,542.0,660.0,563.0,591.0,588.0,581.0,585.0,604.0,573.0,614.0,6858.0
Janjgir Champa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,30.0,30.0,52.0,59.0,44.0,31.0,31.0,68.0,27.0,16.0,8.0,9.0,405.0
Janjgir Champa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,166.0,209.0,214.0,190.0,178.0,183.0,231.0,194.0,186.0,157.0,165.0,192.0,2265.0
Janjgir Champa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,166.0,209.0,214.0,190.0,178.0,183.0,231.0,194.0,186.0,157.0,165.0,192.0,2265.0
Janjgir Champa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,12.0,13.0,0.0,0.0,0.0,0.0,30.0
Janjgir Champa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,1.0,9.0,3.0,6.0,8.0,10.0,2.0,6.0,6.0,7.0,4.0,64.0
Janjgir Champa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,16.0,16.0,7.0,10.0,16.0,8.0,4.0,0.0,0.0,4.0,3.0,3.0,87.0
Janjgir Champa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,18.0,17.0,16.0,13.0,22.0,21.0,26.0,15.0,6.0,10.0,10.0,7.0,181.0
Janjgir Champa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,56.0,97.0,82.0,84.0,71.0,69.0,103.0,66.0,30.0,31.0,81.0,107.0,877.0
Janjgir Champa,4.1.1.a,Number of male live births,TOTAL,1232.0,1706.0,1755.0,1901.0,1800.0,1951.0,1829.0,1812.0,1983.0,1673.0,1657.0,1865.0,21164.0
Janjgir Champa,4.1.1.b,Number of female live births,TOTAL,1054.0,1542.0,1609.0,1769.0,1723.0,1801.0,1682.0,1698.0,1848.0,1552.0,1410.0,1794.0,19482.0
Janjgir Champa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2286.0,3248.0,3364.0,3670.0,3523.0,3752.0,3511.0,3510.0,3831.0,3225.0,3067.0,3659.0,40646.0
Janjgir Champa,4.1.2,Number of still births,TOTAL,62.0,88.0,119.0,119.0,95.0,80.0,106.0,69.0,75.0,116.0,72.0,93.0,1094.0
Janjgir Champa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,40.0,60.0,50.0,56.0,85.0,66.0,48.0,45.0,48.0,57.0,64.0,49.0,668.0
Janjgir Champa,4.2.1,Number of Newborns weighed at birth,TOTAL,2103.0,3007.0,3019.0,3426.0,3034.0,3488.0,3274.0,3241.0,3582.0,3006.0,2796.0,3448.0,37424.0
Janjgir Champa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,112.0,199.0,167.0,169.0,137.0,252.0,233.0,181.0,175.0,212.0,178.0,207.0,2222.0
Janjgir Champa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2112.0,3105.0,3017.0,3411.0,3102.0,3364.0,3326.0,3402.0,3641.0,3098.0,2845.0,3568.0,37991.0
Janjgir Champa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Janjgir Champa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,4.0,5.0,3.0,2.0,7.0,10.0,3.0,3.0,5.0,6.0,0.0,48.0
Janjgir Champa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3.0,4.0,2.0,10.0,8.0,9.0,8.0,8.0,7.0,3.0,5.0,2.0,69.0
Janjgir Champa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3.0,8.0,7.0,13.0,10.0,17.0,18.0,11.0,10.0,8.0,12.0,2.0,119.0
Janjgir Champa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,46.0,46.0,91.0,72.0,,79.0,90.0,57.0,55.0,38.0,61.0,54.0,689.0
Janjgir Champa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,46.0,52.0,92.0,50.0,6.0,89.0,124.0,31.0,49.0,33.0,70.0,63.0,705.0
Janjgir Champa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,2.0,10.0,5.0,3.0,4.0,6.0,3.0,1.0,2.0,0.0,0.0,38.0
Janjgir Champa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,49.0,41.0,52.0,42.0,8.0,54.0,69.0,74.0,60.0,40.0,52.0,34.0,575.0
Janjgir Champa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,2.0,7.0,5.0,3.0,2.0,6.0,8.0,1.0,0.0,40.0,0.0,0.0,74.0
Janjgir Champa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1542.0,2138.0,2183.0,2393.0,2331.0,2395.0,2265.0,2347.0,2476.0,2115.0,1939.0,2664.0,26788.0
Janjgir Champa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1259.0,1691.0,1802.0,1889.0,1655.0,1905.0,1597.0,1709.0,1973.0,979.0,1108.0,1077.0,18644.0
Janjgir Champa,6.3,PNC maternal complications attended,TOTAL,6.0,2.0,4.0,87.0,10.0,14.0,12.0,12.0,16.0,26.0,8.0,49.0,246.0
Janjgir Champa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,7.0,7.0,7.0,10.0,20.0,10.0,9.0,6.0,3.0,10.0,5.0,99.0
Janjgir Champa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,29.0,0.0,33.0
Janjgir Champa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,6.0,8.0,7.0,7.0,10.0,21.0,10.0,9.0,7.0,3.0,39.0,5.0,132.0
Janjgir Champa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,16.0,15.0,7.0,8.0,69.0,11.0,11.0,32.0,5.0,30.0,11.0,8.0,223.0
Janjgir Champa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,6.0,15.0,48.0,25.0,51.0,56.0,25.0,52.0,34.0,23.0,6.0,24.0,365.0
Janjgir Champa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,22.0,30.0,55.0,33.0,120.0,67.0,36.0,84.0,39.0,53.0,17.0,32.0,588.0
Janjgir Champa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,1.0,1.0,3.0,3.0,2.0,0.0,0.0,0.0,12.0
Janjgir Champa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,2.0,2.0,1.0,13.0,3.0,3.0,8.0,3.0,2.0,0.0,11.0,2.0,50.0
Janjgir Champa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Janjgir Champa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,1.0,15.0,4.0,4.0,12.0,6.0,4.0,0.0,11.0,2.0,63.0
Janjgir Champa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Janjgir Champa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,3.0,40.0,305.0,27.0,289.0,223.0,96.0,271.0,395.0,262.0,50.0,1961.0
Janjgir Champa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,12.0,15.0,55.0,826.0,93.0,553.0,652.0,382.0,477.0,646.0,893.0,314.0,4918.0
Janjgir Champa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,7.0,42.0,8.0,7.0,28.0,26.0,44.0,40.0,0.0,3.0,205.0
Janjgir Champa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,12.0,18.0,102.0,1173.0,128.0,849.0,903.0,504.0,792.0,1081.0,1155.0,367.0,7084.0
Janjgir Champa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Janjgir Champa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,2.0,3.0,44.0,2.0,28.0,30.0,3.0,20.0,14.0,30.0,6.0,182.0
Janjgir Champa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,4.0
Janjgir Champa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,2.0,3.0,45.0,2.0,28.0,30.0,3.0,20.0,15.0,32.0,6.0,186.0
Janjgir Champa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,8.0,9.0,12.0,9.0,15.0,13.0,12.0,21.0,14.0,18.0,15.0,18.0,164.0
Janjgir Champa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,3.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,7.0,2.0,13.0
Janjgir Champa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2.0,4.0,2.0,1.0,4.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Janjgir Champa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,4.0,5.0,1.0,5.0,1.0,0.0,0.0,0.0,0.0,7.0,2.0,27.0
Janjgir Champa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,10.0,7.0,2.0,14.0,10.0,9.0,12.0,13.0,20.0,11.0,20.0,10.0,138.0
Janjgir Champa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,344.0,348.0,532.0,837.0,516.0,388.0,344.0,451.0,382.0,392.0,372.0,360.0,5266.0
Janjgir Champa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,11.0,10.0,7.0,7.0,15.0,18.0,20.0,22.0,19.0,5.0,5.0,2.0,141.0
Janjgir Champa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,27.0,8.0,18.0,12.0,13.0,22.0,10.0,23.0,13.0,11.0,40.0,208.0
Janjgir Champa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3.0,5.0,5.0,4.0,6.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0
Janjgir Champa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Janjgir Champa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,369.0,390.0,552.0,866.0,549.0,424.0,386.0,483.0,424.0,410.0,388.0,402.0,5643.0
Janjgir Champa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,0.0,,,,,,,,0.0
Janjgir Champa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,1.0,,1.0,,,,,,2.0
Janjgir Champa,9.06,Number of IUCD removals,TOTAL,535.0,553.0,732.0,647.0,472.0,518.0,452.0,413.0,434.0,487.0,381.0,433.0,6057.0
Janjgir Champa,9.07,Number of Oral Pills cycles distributed,TOTAL,10018.0,9322.0,11336.0,9760.0,9745.0,9382.0,9834.0,8778.0,9940.0,8123.0,7998.0,8852.0,113088.0
Janjgir Champa,9.08,Number of Condom pieces distributed,TOTAL,55063.0,39140.0,56876.0,51876.0,42458.0,42210.0,43835.0,47272.0,50738.0,35888.0,40855.0,37765.0,543976.0
Janjgir Champa,9.09,Number of Centchroman (weekly) pills given,TOTAL,900.0,233.0,501.0,503.0,263.0,1607.0,1858.0,245.0,1688.0,166.0,308.0,305.0,8577.0
Janjgir Champa,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,151.0,256.0,196.0,165.0,676.0,382.0,279.0,116.0,159.0,137.0,27.0,63.0,2607.0
Janjgir Champa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,11.0,10.0,10.0,52.0,18.0,12.0,13.0,10.0,14.0,17.0,0.0,1.0,168.0
Janjgir Champa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,13.0,19.0,30.0,156.0,42.0,180.0,89.0,55.0,65.0,175.0,98.0,21.0,943.0
Janjgir Champa,9.11.2.a,Number of failures following male sterilization,TOTAL,1.0,0.0,1.0,22.0,3.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,31.0
Janjgir Champa,9.11.2.b,Number of failures following female sterilization,TOTAL,5.0,4.0,7.0,19.0,2.0,8.0,3.0,6.0,10.0,5.0,6.0,1.0,76.0
Janjgir Champa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,18.0,10.0,10.0,15.0,16.0,13.0,13.0,24.0,15.0,21.0,15.0,-1.0
Janjgir Champa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2058.0,3133.0,3298.0,3662.0,3567.0,3606.0,3189.0,3233.0,3790.0,3222.0,3027.0,3673.0,39458.0
Janjgir Champa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2178.0,3022.0,3330.0,3707.0,3554.0,3646.0,3443.0,3330.0,3750.0,3464.0,3188.0,3806.0,40418.0
Janjgir Champa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2340.0,2966.0,3113.0,3487.0,3607.0,3649.0,3419.0,3328.0,3604.0,3416.0,3193.0,3692.0,39814.0
Janjgir Champa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2372.0,3189.0,3025.0,3445.0,3589.0,3807.0,3385.0,3290.0,3561.0,3272.0,3383.0,3874.0,40192.0
Janjgir Champa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Janjgir Champa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Janjgir Champa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Janjgir Champa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1411.0,1998.0,2139.0,2390.0,2484.0,2514.0,2286.0,2205.0,2580.0,2191.0,1999.0,2172.0,26369.0
Janjgir Champa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2157.0,2970.0,3278.0,3703.0,3471.0,3627.0,3437.0,3305.0,3757.0,3440.0,3171.0,3735.0,40051.0
Janjgir Champa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2359.0,2933.0,3100.0,3516.0,3568.0,3587.0,3414.0,3235.0,3530.0,3404.0,3182.0,3658.0,39486.0
Janjgir Champa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2370.0,3126.0,2998.0,3435.0,3431.0,3752.0,3370.0,3282.0,3560.0,3275.0,4597.0,3826.0,41022.0
Janjgir Champa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,40.0,37.0,38.0,38.0,32.0,119.0,424.0,310.0,580.0,471.0,573.0,667.0,3329.0
Janjgir Champa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,62.0,128.0,79.0,106.0,105.0,91.0,1871.0,2314.0,3123.0,2744.0,2841.0,3216.0,16680.0
Janjgir Champa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,43.0,75.0,44.0,84.0,42.0,66.0,314.0,1928.0,2779.0,3185.0,3063.0,3661.0,15284.0
Janjgir Champa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,37.0,120.0,56.0,44.0,32.0,69.0,283.0,372.0,2151.0,2802.0,3213.0,3728.0,12907.0
Janjgir Champa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1956.0,2934.0,3270.0,3426.0,3555.0,3590.0,3203.0,2955.0,3858.0,3074.0,3175.0,4102.0,39098.0
Janjgir Champa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,23.0,31.0,39.0,10.0,26.0,42.0,121.0,69.0,148.0,125.0,222.0,130.0,986.0
Janjgir Champa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Janjgir Champa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1064.0,1568.0,1790.0,1819.0,1804.0,1845.0,1678.0,1563.0,1948.0,1537.0,1651.0,2020.0,20287.0
Janjgir Champa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,936.0,1421.0,1636.0,1764.0,1772.0,1767.0,1677.0,1456.0,1784.0,1417.0,1442.0,1880.0,18952.0
Janjgir Champa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2000.0,2989.0,3426.0,3583.0,3576.0,3612.0,3355.0,3019.0,3732.0,2954.0,3093.0,3900.0,39239.0
Janjgir Champa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1627.0,2242.0,2565.0,2967.0,2867.0,2993.0,2767.0,2524.0,4178.0,3051.0,2456.0,3126.0,33363.0
Janjgir Champa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1582.0,2218.0,2574.0,2890.0,2840.0,2976.0,2725.0,2503.0,4177.0,3029.0,2461.0,3061.0,33036.0
Janjgir Champa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,68.0,101.0,68.0,77.0,21.0,59.0,53.0,48.0,344.0,96.0,53.0,35.0,1023.0
Janjgir Champa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,808.0,1064.0,1314.0,1293.0,1244.0,1285.0,1237.0,1050.0,1521.0,877.0,953.0,1011.0,13657.0
Janjgir Champa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,707.0,918.0,1257.0,1087.0,1170.0,1223.0,1181.0,990.0,1389.0,909.0,938.0,917.0,12686.0
Janjgir Champa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1515.0,1982.0,2571.0,2380.0,2414.0,2508.0,2418.0,2040.0,2910.0,1786.0,1891.0,1928.0,26343.0
Janjgir Champa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,528.0,1027.0,1645.0,3053.0,7419.0,6183.0,4216.0,3631.0,4135.0,2177.0,1392.0,1782.0,37188.0
Janjgir Champa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,692.0,1196.0,1573.0,2871.0,8907.0,7448.0,3673.0,3515.0,3959.0,2129.0,1852.0,1588.0,39403.0
Janjgir Champa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,741.0,1173.0,1602.0,2746.0,5810.0,6328.0,4021.0,4161.0,4127.0,2251.0,1861.0,1673.0,36494.0
Janjgir Champa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,0.0,8.0,20.0,36.0,82.0,35.0,49.0,44.0,30.0,36.0,26.0,372.0
Janjgir Champa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,5.0
Janjgir Champa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,965.0,1086.0,1078.0,1106.0,1097.0,1144.0,1017.0,981.0,1282.0,1125.0,1021.0,1133.0,13035.0
Janjgir Champa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,862.0,1076.0,1057.0,1101.0,1082.0,1121.0,1006.0,983.0,1261.0,1120.0,982.0,1122.0,12773.0
Janjgir Champa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,720.0,914.0,1100.0,1111.0,1100.0,1316.0,1062.0,889.0,1183.0,956.0,897.0,979.0,12227.0
Janjgir Champa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,4.0
Janjgir Champa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1885.0,2671.0,2963.0,3781.0,3550.0,3496.0,3015.0,2770.0,4113.0,3182.0,2640.0,3653.0,37719.0
Janjgir Champa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,677.0,977.0,853.0,835.0,1276.0,2235.0,1581.0,1079.0,12385.0,6148.0,837.0,1518.0,30401.0
Janjgir Champa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,266.0,349.0,316.0,281.0,758.0,1150.0,1271.0,476.0,12632.0,6411.0,449.0,962.0,25321.0
Janjgir Champa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16.0,10.0,14.0,25.0,73.0,21.0,7.0,10.0,0.0,6.0,0.0,25.0,207.0
Janjgir Champa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,224.0,300.0,380.0,574.0,528.0,536.0,336.0,272.0,274.0,264.0,246.0,381.0,4315.0
Janjgir Champa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,215.0,431.0,313.0,492.0,383.0,560.0,245.0,251.0,240.0,173.0,58.0,205.0,3566.0
Janjgir Champa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,4.0,4.0,16.0,25.0,69.0,0.0,79.0,0.0,19.0,0.0,0.0,0.0,216.0
Janjgir Champa,13.1,Number of Patients operated for cataract,TOTAL,35.0,17.0,55.0,228.0,110.0,100.0,294.0,95.0,80.0,91.0,49.0,155.0,1309.0
Janjgir Champa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,34.0,17.0,55.0,226.0,110.0,99.0,217.0,73.0,72.0,56.0,32.0,222.0,1213.0
Janjgir Champa,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,0.0,17.0,71.0,113.0,666.0,34.0,90.0,62.0,52.0,306.0,171.0,1587.0
Janjgir Champa,13.4,Number of children provided free glasses,TOTAL,5.0,0.0,0.0,1.0,0.0,15.0,15.0,41.0,1.0,10.0,0.0,68.0,156.0
Janjgir Champa,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,311.0,311.0
Janjgir Champa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,99.0,99.0
Janjgir Champa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,4.0,4.0,2.0,3.0,2.0,2.0,2.0,-1.0
Janjgir Champa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,23.0,13.0,10.0,13.0,9.0,9.0,11.0,15.0,7.0,11.0,8.0,-1.0
Janjgir Champa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1073.0,1210.0,1288.0,1198.0,1123.0,1269.0,1159.0,1087.0,1247.0,1204.0,1157.0,1261.0,-1.0
Janjgir Champa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,7.0,8.0,6.0,6.0,7.0,7.0,4.0,6.0,5.0,-1.0
Janjgir Champa,14.05,Number of RKS meetings held during the month,TOTAL,8.0,12.0,8.0,14.0,12.0,10.0,11.0,11.0,8.0,3.0,2.0,4.0,103.0
Janjgir Champa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,28.0,16.0,15.0,19.0,14.0,16.0,19.0,24.0,12.0,18.0,12.0,-1.0
Janjgir Champa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,57.0,61.0,46.0,48.0,52.0,53.0,42.0,51.0,47.0,154.0,249.0,366.0,1226.0
Janjgir Champa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,2.0,1.0,1.0,1.0,,,1.0,3.0,1.0,1.0,1.0,-1.0
Janjgir Champa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,64.0,12.0,14.0,8.0,2.0,3.0,13.0,11.0,2.0,2.0,2.0,-1.0
Janjgir Champa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,133.0,123.0,141.0,126.0,160.0,142.0,197.0,90.0,60.0,95.0,117.0,134.0,1518.0
Janjgir Champa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,390.0,473.0,433.0,524.0,449.0,685.0,481.0,439.0,457.0,388.0,435.0,473.0,5627.0
Janjgir Champa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,142.0,124.0,158.0,133.0,230.0,165.0,151.0,150.0,50.0,96.0,104.0,145.0,1648.0
Janjgir Champa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,792.0,921.0,1013.0,915.0,816.0,772.0,839.0,634.0,590.0,905.0,857.0,1088.0,10142.0
Janjgir Champa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,275.0,247.0,299.0,259.0,390.0,307.0,348.0,240.0,110.0,191.0,221.0,279.0,3166.0
Janjgir Champa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1182.0,1394.0,1446.0,1439.0,1265.0,1457.0,1320.0,1073.0,1047.0,1293.0,1292.0,1561.0,15769.0
Janjgir Champa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,30.0,22.0,16.0,14.0,29.0,17.0,6.0,16.0,17.0,11.0,13.0,207.0
Janjgir Champa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,21.0,14.0,23.0,15.0,14.0,13.0,12.0,7.0,6.0,16.0,11.0,166.0
Janjgir Champa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,30.0,51.0,36.0,39.0,29.0,43.0,30.0,18.0,23.0,23.0,27.0,24.0,373.0
Janjgir Champa,14.11,In-Patient Head Count at midnight,TOTAL,165.0,141.0,154.0,118.0,64.0,82.0,86.0,94.0,82.0,234.0,89.0,159.0,1468.0
Janjgir Champa,14.12.1,OPD attendance (All),TOTAL,22536.0,23949.0,28416.0,29669.0,31606.0,31302.0,33225.0,30085.0,27083.0,25360.0,30187.0,30948.0,344366.0
Janjgir Champa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,129.0,126.0,111.0,208.0,284.0,211.0,475.0,141.0,530.0,212.0,214.0,253.0,2894.0
Janjgir Champa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Janjgir Champa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,257.0,245.0,258.0,482.0,251.0,316.0,348.0,247.0,326.0,434.0,276.0,343.0,3783.0
Janjgir Champa,14.14.a,Number of patients given AYUSH treatment,TOTAL,0.0,211.0,678.0,689.0,587.0,714.0,466.0,593.0,791.0,717.0,758.0,1058.0,7262.0
Janjgir Champa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,134.0,106.0,182.0,235.0,160.0,144.0,8.0,183.0,130.0,171.0,160.0,231.0,1844.0
Janjgir Champa,14.14.c,Number of Adolescents counselled,TOTAL,5.0,16.0,20.0,72.0,101.0,142.0,108.0,0.0,0.0,0.0,0.0,0.0,464.0
Janjgir Champa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2421.0,4192.0,3465.0,4299.0,4051.0,3317.0,4610.0,3000.0,4303.0,3129.0,3876.0,3633.0,44296.0
Janjgir Champa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,113.0,142.0,151.0,144.0,124.0,99.0,253.0,136.0,116.0,120.0,97.0,125.0,1620.0
Janjgir Champa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,204.0,259.0,363.0,301.0,391.0,429.0,549.0,396.0,345.0,319.0,417.0,391.0,4364.0
Janjgir Champa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1.0,0.0,2.0,3.0,1.0,2.0,2.0,1.0,124.0,3.0,3.0,1.0,143.0
Janjgir Champa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,264.0,211.0,426.0,346.0,379.0,458.0,403.0,430.0,240.0,132.0,273.0,233.0,3795.0
Janjgir Champa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,0.0,1.0,2.0,7.0,25.0,11.0,1.0,134.0,11.0,1.0,0.0,194.0
Janjgir Champa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,319.0,375.0,423.0,273.0,192.0,133.0,166.0,270.0,247.0,210.0,286.0,163.0,3057.0
Janjgir Champa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,11.0,10.0,0.0,0.0,22.0
Janjgir Champa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,787.0,845.0,1212.0,920.0,962.0,1020.0,1118.0,1096.0,832.0,661.0,976.0,787.0,11216.0
Janjgir Champa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,3.0,6.0,8.0,27.0,13.0,2.0,269.0,24.0,4.0,1.0,359.0
Janjgir Champa,15.2,Number of Widal tests conducted,Number tested,203.0,256.0,205.0,222.0,410.0,286.0,398.0,208.0,152.0,140.0,239.0,310.0,3029.0
Janjgir Champa,15.3.a,Number of VDRL tests conducted on males,Number tested,125.0,229.0,247.0,189.0,245.0,332.0,198.0,198.0,377.0,98.0,196.0,129.0,2563.0
Janjgir Champa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,79.0,161.0,167.0,140.0,105.0,234.0,487.0,217.0,268.0,66.0,152.0,67.0,2143.0
Janjgir Champa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,285.0,269.0,423.0,115.0,147.0,137.0,100.0,280.0,257.0,191.0,284.0,145.0,2633.0
Janjgir Champa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,489.0,659.0,837.0,444.0,497.0,703.0,785.0,695.0,902.0,355.0,632.0,341.0,7339.0
Janjgir Champa,15.4.1,Number of blood smears examined for Malaria,TOTAL,6328.0,6731.0,5674.0,10912.0,5386.0,4582.0,6097.0,5160.0,6675.0,2808.0,2057.0,3999.0,66409.0
Janjgir Champa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,15.0,5.0,2.0,105.0,2.0,3.0,2.0,2.0,29.0,28.0,9.0,203.0
Janjgir Champa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4.0,3.0,30.0,57.0,30.0,9.0,17.0,19.0,32.0,5.0,5.0,5.0,216.0
Janjgir Champa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,31140.0,12540.0,30040.0,31390.0,10490.0,12990.0,20990.0,16890.0,8890.0,12390.0,12190.0,4690.0,204630.0
Janjgir Champa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,20000.0,0.0,30000.0,26000.0,10000.0,12000.0,20000.0,20000.0,,20000.0,188000.0
Janjgir Champa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18600.0,12500.0,18650.0,20900.0,27500.0,18000.0,14100.0,20000.0,16500.0,20200.0,7500.0,18000.0,212450.0
Janjgir Champa,16.1.1,Stock position of DPT vaccines,5. Total Stock,12540.0,30040.0,31390.0,10490.0,12990.0,20990.0,16890.0,8890.0,12390.0,12190.0,4690.0,6690.0,180180.0
Janjgir Champa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Janjgir Champa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Janjgir Champa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Janjgir Champa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Janjgir Champa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6500.0,16900.0,26000.0,20900.0,2000.0,11000.0,4500.0,30100.0,7700.0,13800.0,2000.0,1500.0,142900.0
Janjgir Champa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,30000.0,20000.0,15000.0,0.0,40000.0,5000.0,50000.0,0.0,25000.0,10000.0,289000.0,291000.0,775000.0
Janjgir Champa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,19600.0,10900.0,20100.0,18900.0,31000.0,11500.0,24400.0,22400.0,18900.0,21800.0,289500.0,289000.0,778000.0
Janjgir Champa,16.1.2,Stock position of OPV vaccines,5. Total Stock,16900.0,26000.0,20900.0,2000.0,11000.0,4500.0,30100.0,7700.0,13800.0,2000.0,1500.0,3500.0,139900.0
Janjgir Champa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,55500.0,30050.0,39550.0,57950.0,39150.0,32650.0,42750.0,26650.0,6150.0,22150.0,30950.0,25450.0,408950.0
Janjgir Champa,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,30000.0,0.0,25000.0,30000.0,0.0,0.0,30000.0,30000.0,,10000.0,175000.0
Janjgir Champa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,25450.0,10500.0,11600.0,18800.0,31500.0,19900.0,16100.0,20500.0,14000.0,21200.0,5500.0,14500.0,209550.0
Janjgir Champa,16.1.3,Stock position of TT vaccines,5. Total Stock,30050.0,39550.0,57950.0,39150.0,32650.0,42750.0,26650.0,6150.0,22150.0,30950.0,25450.0,20950.0,374400.0
Janjgir Champa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Janjgir Champa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Janjgir Champa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,,0.0
Janjgir Champa,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11050.0,700.0,4200.0,20450.0,8550.0,17050.0,16450.0,21350.0,13750.0,15250.0,5050.0,1050.0,134900.0
Janjgir Champa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10000.0,25000.0,0.0,20000.0,10000.0,10000.0,5000.0,10000.0,2000.0,,20000.0,112000.0
Janjgir Champa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,10350.0,6500.0,8750.0,11900.0,11500.0,10600.0,5100.0,12600.0,8500.0,12200.0,4000.0,11000.0,113000.0
Janjgir Champa,16.1.5,Stock position of BCG vaccines,5. Total Stock,700.0,4200.0,20450.0,8550.0,17050.0,16450.0,21350.0,13750.0,15250.0,5050.0,1050.0,10050.0,133900.0
Janjgir Champa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,7725.0,675.0,2175.0,5550.0,500.0,7750.0,17250.0,23200.0,16450.0,23900.0,21400.0,18650.0,145225.0
Janjgir Champa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,8000.0,0.0,15000.0,15000.0,10000.0,0.0,10000.0,5000.0,,5000.0,73000.0
Janjgir Champa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7050.0,3500.0,4625.0,5050.0,7750.0,5500.0,4050.0,6750.0,2550.0,7500.0,2750.0,6000.0,63075.0
Janjgir Champa,16.1.6,Stock position of Measles vaccines,5. Total Stock,675.0,2175.0,5550.0,500.0,7750.0,17250.0,23200.0,16450.0,23900.0,21400.0,18650.0,17650.0,155150.0
Janjgir Champa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Janjgir Champa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Janjgir Champa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Janjgir Champa,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,25700.0,45750.0,33980.0,27180.0,39380.0,36680.0,208670.0
Janjgir Champa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,30000.0,27000.0,0.0,,20000.0,,20000.0,97000.0
Janjgir Champa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,4300.0,6960.0,11770.0,6800.0,7800.0,2700.0,12080.0,52410.0
Janjgir Champa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,25700.0,45740.0,33980.0,27180.0,39380.0,36680.0,44600.0,253260.0
Janjgir Champa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,9000.0,4200.0,4200.0,1400.0,800.0,0.0,0.0,0.0,0.0,19600.0
Janjgir Champa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,9600.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,9600.0
Janjgir Champa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,600.0,4800.0,0.0,2800.0,600.0,800.0,,0.0,,0.0,9600.0
Janjgir Champa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,9000.0,4200.0,4200.0,1400.0,800.0,0.0,0.0,0.0,0.0,0.0,19600.0
Janjgir Champa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,18000.0,12000.0,12000.0,16520.0,560.0,500.0,0.0,18000.0,0.0,77580.0
Janjgir Champa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,24000.0,0.0,0.0,106020.0,75600.0,0.0,,30000.0,,,235620.0
Janjgir Champa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,6000.0,6000.0,0.0,101500.0,91560.0,60.0,500.0,12000.0,18000.0,0.0,235620.0
Janjgir Champa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,18000.0,12000.0,12000.0,16520.0,560.0,500.0,0.0,18000.0,0.0,0.0,77580.0
Janjgir Champa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,13000.0,4000.0,4000.0,5400.0,200.0,200.0,0.0,0.0,0.0,26800.0
Janjgir Champa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,15000.0,0.0,0.0,17400.0,7200.0,0.0,,0.0,0.0,,39600.0
Janjgir Champa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,2000.0,9000.0,0.0,16000.0,12400.0,0.0,200.0,0.0,,0.0,39600.0
Janjgir Champa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,13000.0,4000.0,4000.0,5400.0,200.0,200.0,0.0,0.0,0.0,0.0,26800.0
Janjgir Champa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,5000.0,1000.0,1000.0,1000.0,1000.0,1000.0,2200.0,1600.0,1600.0,15400.0
Janjgir Champa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,,,11000.0
Janjgir Champa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,4800.0,600.0,,250.0,9650.0
Janjgir Champa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,5000.0,1000.0,1000.0,1000.0,1000.0,1000.0,2200.0,1600.0,1600.0,1350.0,16750.0
Janjgir Champa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4430.0,3930.0,3930.0,3630.0,1830.0,1830.0,5460.0,4860.0,3560.0,6485.0,8335.0,5535.0,53815.0
Janjgir Champa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,4630.0,0.0,0.0,3225.0,4550.0,,,12405.0
Janjgir Champa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,500.0,0.0,300.0,1800.0,0.0,1000.0,600.0,1300.0,300.0,2700.0,2800.0,300.0,11600.0
Janjgir Champa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3930.0,3930.0,3630.0,1830.0,1830.0,5460.0,4860.0,3560.0,6485.0,8335.0,5535.0,5235.0,54620.0
Janjgir Champa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,975.0,725.0,725.0,4600.0,1250.0,1050.0,500.0,0.0,0.0,4000.0,900.0,800.0,15525.0
Janjgir Champa,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,4000.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,2000.0,6000.0,17000.0
Janjgir Champa,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.02,Stock Position of Gloves,4. Stock Distributed,250.0,0.0,125.0,3350.0,200.0,550.0,500.0,0.0,1000.0,0.0,2100.0,2400.0,10475.0
Janjgir Champa,16.3.02,Stock Position of Gloves,5. Total Stock,725.0,725.0,4600.0,1250.0,1050.0,500.0,0.0,0.0,4000.0,4000.0,800.0,4400.0,22050.0
Janjgir Champa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Janjgir Champa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0
Janjgir Champa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,27670.0,19670.0,7670.0,0.0,0.0,28000.0,8000.0,6000.0,6000.0,6000.0,5000.0,5000.0,119010.0
Janjgir Champa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,,,28000.0
Janjgir Champa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,20000.0,12000.0,7670.0,0.0,0.0,20000.0,2000.0,0.0,0.0,1000.0,,5000.0,67670.0
Janjgir Champa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,7670.0,7670.0,0.0,0.0,28000.0,8000.0,6000.0,6000.0,6000.0,5000.0,5000.0,0.0,79340.0
Janjgir Champa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Janjgir Champa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Janjgir Champa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Janjgir Champa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Janjgir Champa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,8.0,8.0,7.0,7.0,4.0,3.0,3.0,1.0,0.0,,0.0,1.0,42.0
Janjgir Champa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2.0,,2.0
Janjgir Champa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,1.0,1.0,0.0,3.0,1.0,0.0,2.0,1.0,0.0,,1.0,1.0,11.0
Janjgir Champa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,7.0,7.0,7.0,4.0,3.0,3.0,1.0,0.0,0.0,0.0,1.0,0.0,33.0
Janjgir Champa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,100000.0,16000.0,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,110000.0,105000.0,7000.0,354000.0
Janjgir Champa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,164000.0,200000.0,,999000.0,1363000.0
Janjgir Champa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,84000.0,0.0,16000.0,0.0,0.0,0.0,0.0,0.0,54000.0,205000.0,98000.0,111500.0,568500.0
Janjgir Champa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,16000.0,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,110000.0,105000.0,7000.0,894500.0,1148500.0
Janjgir Champa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,7000.0,8200.0,5000.0,3000.0,1400.0,1100.0,0.0,0.0,0.0,0.0,32100.0,0.0,57800.0
Janjgir Champa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23000.0,39600.0,0.0,,62600.0
Janjgir Champa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,2000.0,3200.0,2000.0,1600.0,300.0,1100.0,0.0,0.0,23000.0,7500.0,32100.0,,72800.0
Janjgir Champa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,5000.0,5000.0,3000.0,1400.0,1100.0,0.0,0.0,0.0,0.0,32100.0,0.0,0.0,47600.0
Janjgir Champa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1950.0,900.0,200.0,200.0,0.0,0.0,0.0,2500.0,5600.0,1700.0,3700.0,600.0,17350.0
Janjgir Champa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,5600.0,0.0,5000.0,0.0,5000.0,19600.0
Janjgir Champa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0
Janjgir Champa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,1050.0,700.0,0.0,200.0,0.0,0.0,1500.0,2500.0,3900.0,3000.0,3100.0,600.0,16550.0
Janjgir Champa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,900.0,200.0,200.0,0.0,0.0,0.0,2500.0,5600.0,1700.0,3700.0,600.0,5000.0,20400.0
Janjgir Champa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,42.0,22.0,22.0,7.0,533.0,433.0,433.0,4877.0,1977.0,1727.0,1627.0,6327.0,18027.0
Janjgir Champa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,1540.0,0.0,0.0,4644.0,0.0,,0.0,4700.0,4700.0,15584.0
Janjgir Champa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,20.0,0.0,15.0,1014.0,100.0,0.0,200.0,2900.0,250.0,100.0,,3250.0,7849.0
Janjgir Champa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,22.0,22.0,7.0,533.0,433.0,433.0,4877.0,1977.0,1727.0,1627.0,6327.0,7777.0,25762.0
Janjgir Champa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,7400.0,2100.0,900.0,41460.0,18460.0,16460.0,2800.0,600.0,510.0,4000.0,2000.0,0.0,96690.0
Janjgir Champa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,50000.0,0.0,0.0,3200.0,0.0,0.0,5000.0,0.0,0.0,15600.0,73800.0
Janjgir Champa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,6500.0,1200.0,9440.0,23000.0,2000.0,16860.0,2200.0,90.0,1510.0,2000.0,2000.0,5600.0,72400.0
Janjgir Champa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,900.0,900.0,41460.0,18460.0,16460.0,2800.0,600.0,510.0,4000.0,2000.0,0.0,10000.0,98090.0
Janjgir Champa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,14800.0,23800.0,23000.0,17000.0,5700.0,8700.0,2300.0,2300.0,0.0,0.0,0.0,0.0,97600.0
Janjgir Champa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000.0,0.0,0.0,0.0,3000.0,6000.0,0.0,0.0,0.0,0.0,0.0,,21000.0
Janjgir Champa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Janjgir Champa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,800.0,6000.0,11300.0,0.0,12400.0,0.0,2300.0,0.0,0.0,0.0,,35800.0
Janjgir Champa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,23800.0,23000.0,17000.0,5700.0,8700.0,2300.0,2300.0,0.0,0.0,0.0,0.0,0.0,82800.0
Janjgir Champa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,166000.0,166000.0,62000.0,35500.0,117100.0,30500.0,4100.0,0.0,0.0,0.0,0.0,581200.0
Janjgir Champa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,16600.0,0.0,0.0,0.0,81600.0,3000.0,0.0,0.0,0.0,0.0,,,101200.0
Janjgir Champa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Janjgir Champa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,104000.0,26500.0,0.0,89600.0,26400.0,4100.0,0.0,0.0,,,250600.0
Janjgir Champa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,16600.0,166000.0,62000.0,35500.0,117100.0,30500.0,4100.0,0.0,0.0,0.0,0.0,0.0,431800.0
Janjgir Champa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200.0,200.0,200.0,200.0,2200.0,6200.0,4500.0,4000.0,3500.0,3500.0,3400.0,3400.0,31500.0
Janjgir Champa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,2000.0,4000.0,800.0,0.0,0.0,,,,,6800.0
Janjgir Champa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Janjgir Champa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,2500.0,500.0,500.0,0.0,100.0,,3300.0,6900.0
Janjgir Champa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200.0,200.0,200.0,2200.0,6200.0,4500.0,4000.0,3500.0,3500.0,3400.0,3400.0,100.0,31400.0
Janjgir Champa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,,6.0,1.0,,,,,,,3.0,12.0
Janjgir Champa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,1.0,1.0,,,,,,,2.0,,5.0
Janjgir Champa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Janjgir Champa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,1.0,1.0,,,,,,,2.0,,6.0
Janjgir Champa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Janjgir Champa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Janjgir Champa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,,,,,1.0
Janjgir Champa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,1.0,,,2.0,2.0,1.0,2.0,,9.0
Janjgir Champa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,1.0,1.0,,,,,,4.0
Janjgir Champa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,2.0,,13.0
Janjgir Champa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,3.0,,,,2.0,3.0,,2.0,2.0,,13.0
Janjgir Champa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,1.0,,,,,,1.0,,4.0
Janjgir Champa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,,3.0,1.0,1.0,,2.0,3.0,,2.0,3.0,,17.0
Janjgir Champa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,2.0,,1.0,,,1.0,,1.0,1.0,,6.0
Janjgir Champa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,1.0,,,1.0,1.0,,,4.0
Janjgir Champa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,2.0,1.0,1.0,1.0,,1.0,1.0,2.0,1.0,,10.0
Janjgir Champa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Janjgir Champa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,1.0,,,,1.0,,3.0
Janjgir Champa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,1.0,,,,1.0,,3.0
Janjgir Champa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,1.0,,,,,,1.0
Janjgir Champa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Janjgir Champa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,1.0,,,1.0,,,2.0
Janjgir Champa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Janjgir Champa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Janjgir Champa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,1.0,1.0
Janjgir Champa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,1.0,2.0,3.0,4.0,3.0,,1.0,,1.0,2.0,18.0
Janjgir Champa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,,1.0,1.0,1.0,,1.0,5.0,1.0,5.0,2.0,19.0
Janjgir Champa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,2.0,1.0,3.0,4.0,5.0,3.0,1.0,6.0,1.0,6.0,4.0,37.0
Janjgir Champa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Janjgir Champa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Janjgir Champa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,,,,,,,,,,2.0
Janjgir Champa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,2.0,,3.0,1.0,,2.0,2.0,1.0,1.0,,14.0
Janjgir Champa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,1.0,1.0,,1.0,,,,,,,4.0
Janjgir Champa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,3.0,1.0,3.0,2.0,,2.0,2.0,1.0,1.0,,18.0
Janjgir Champa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,2.0,1.0,1.0,4.0,1.0,,3.0,2.0,1.0,,16.0
Janjgir Champa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,2.0,,,2.0,2.0,,2.0,2.0,,,,1.0,11.0
Janjgir Champa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,3.0,,2.0,3.0,3.0,4.0,3.0,2.0,3.0,2.0,1.0,1.0,27.0
Janjgir Champa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,2.0,1.0,,2.0,3.0,,3.0,4.0,,1.0,,17.0
Janjgir Champa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Janjgir Champa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,2.0,1.0,,2.0,3.0,,3.0,4.0,,1.0,,17.0
Janjgir Champa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Janjgir Champa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,3.0,2.0,1.0,3.0,5.0,3.0,1.0,1.0,,1.0,,20.0
Janjgir Champa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,1.0,1.0,1.0,1.0,,,,1.0,,1.0,7.0
Janjgir Champa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,4.0,4.0,3.0,4.0,6.0,3.0,1.0,1.0,1.0,1.0,1.0,29.0
Janjgir Champa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Janjgir Champa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Janjgir Champa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,1.0,,,1.0,,,,,,,2.0
Janjgir Champa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Janjgir Champa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,8.0,7.0,4.0,7.0,10.0,15.0,4.0,5.0,7.0,7.0,10.0,85.0
Janjgir Champa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,11.0,4.0,7.0,6.0,5.0,3.0,3.0,3.0,1.0,9.0,2.0,56.0
Janjgir Champa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,3.0,19.0,11.0,11.0,13.0,15.0,19.0,7.0,8.0,8.0,16.0,12.0,142.0
Janjgir Champa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,1.0,,3.0,1.0,,,,,,,7.0
Janjgir Champa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,1.0,,3.0,2.0,,1.0,,,,,8.0
Janjgir Champa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,3.0,2.0,,6.0,3.0,,1.0,,,,,15.0
Janjgir Champa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Janjgir Champa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Janjgir Champa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,1.0,,,,,1.0,,2.0,5.0
Janjgir Champa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Janjgir Champa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,1.0,,,,,1.0,,2.0,5.0
Janjgir Champa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,1.0,,1.0,,1.0,,,1.0,,5.0
Janjgir Champa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,1.0,,,,,,,,,,,,1.0
Janjgir Champa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,1.0,1.0,,1.0,,1.0,,,1.0,,6.0
Janjgir Champa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,2.0,,1.0,1.0,,,1.0,,,,5.0
Janjgir Champa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,1.0,,,,,,,,,,1.0
Janjgir Champa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,3.0,,1.0,1.0,,,1.0,,,,6.0
Janjgir Champa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,1.0,,2.0
Janjgir Champa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Janjgir Champa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,1.0,,2.0
Janjgir Champa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Janjgir Champa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,2.0,,3.0,3.0,1.0,1.0,1.0,,1.0,,14.0
Janjgir Champa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,3.0,2.0,,2.0,1.0,4.0,,,,1.0,,14.0
Janjgir Champa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,4.0,4.0,,5.0,4.0,5.0,1.0,1.0,,2.0,,28.0
Janjgir Champa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,1.0,,2.0,1.0,,,,,1.0,,7.0
Janjgir Champa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,4.0,12.0,3.0,10.0,13.0,15.0,15.0,6.0,4.0,5.0,9.0,4.0,100.0
Janjgir Champa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,2.0,5.0,2.0,8.0,,,,3.0,,23.0
Janjgir Champa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,13.0,6.0,12.0,20.0,18.0,23.0,6.0,4.0,5.0,13.0,4.0,130.0
Janjgir Champa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Janjgir Champa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,9.0,11.0,10.0,6.0,5.0,6.0,2.0,2.0,5.0,4.0,7.0,75.0
Janjgir Champa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,1.0,,1.0,1.0,,,,,4.0
Janjgir Champa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,9.0,12.0,10.0,7.0,6.0,7.0,3.0,2.0,5.0,4.0,7.0,80.0
Janjgir Champa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,3.0,,1.0,1.0,,,,,,6.0
Janjgir Champa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,4.0,2.0,4.0,4.0,5.0,8.0,3.0,1.0,,1.0,,33.0
Janjgir Champa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,3.0,6.0,2.0,4.0,8.0,2.0,,,,,26.0
Janjgir Champa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,6.0,5.0,13.0,6.0,10.0,17.0,5.0,1.0,,1.0,,65.0
Janjgir Champa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Janjgir Champa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,9.0,7.0,8.0,9.0,10.0,8.0,6.0,7.0,6.0,5.0,4.0,83.0
Janjgir Champa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,5.0,10.0,10.0,10.0,8.0,10.0,7.0,3.0,2.0,2.0,1.0,71.0
Janjgir Champa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,15.0,17.0,19.0,19.0,18.0,18.0,13.0,10.0,8.0,7.0,5.0,156.0
Janjgir Champa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,1.0,1.0,,1.0,,,,,,4.0
Janjgir Champa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,8.0,8.0,7.0,14.0,14.0,8.0,12.0,7.0,4.0,5.0,2.0,95.0
Janjgir Champa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,7.0,25.0,10.0,28.0,12.0,19.0,16.0,5.0,1.0,2.0,,134.0
Janjgir Champa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,15.0,16.0,33.0,18.0,43.0,26.0,28.0,28.0,12.0,5.0,7.0,2.0,233.0
Janjgir Champa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,3.0,2.0,3.0,3.0,,2.0,1.0,1.0,3.0,,18.0
Janjgir Champa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,6.0,27.0,16.0,12.0,22.0,17.0,11.0,14.0,29.0,31.0,13.0,30.0,228.0
Janjgir Champa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,20.0,54.0,43.0,45.0,42.0,40.0,60.0,39.0,22.0,27.0,16.0,8.0,416.0
Janjgir Champa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,26.0,81.0,62.0,59.0,67.0,60.0,71.0,55.0,52.0,59.0,32.0,38.0,662.0
Jashpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,2061.0,1888.0,2004.0,2185.0,2572.0,2593.0,2282.0,1928.0,2133.0,2151.0,1886.0,1898.0,25581.0
Jashpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,903.0,791.0,832.0,897.0,1109.0,1118.0,997.0,805.0,926.0,857.0,775.0,736.0,10746.0
Jashpur,1.2,Number of Pregnant women registered under JSY,TOTAL,1914.0,1767.0,1842.0,1952.0,2351.0,2416.0,2084.0,1829.0,1955.0,2012.0,1774.0,1768.0,23664.0
Jashpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1653.0,1486.0,1503.0,1742.0,1782.0,1755.0,1673.0,1674.0,1643.0,1577.0,1559.0,1514.0,19561.0
Jashpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1254.0,1071.0,1199.0,1332.0,1515.0,1650.0,1427.0,1270.0,1339.0,1354.0,1142.0,1200.0,15753.0
Jashpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1510.0,1427.0,1429.0,1706.0,1868.0,1823.0,1788.0,1501.0,1565.0,1552.0,1476.0,1462.0,19107.0
Jashpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1705.0,1606.0,2480.0,1475.0,1726.0,1611.0,1479.0,1244.0,2191.0,1720.0,1413.0,1405.0,20055.0
Jashpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,156.0,65.0,87.0,95.0,71.0,87.0,123.0,45.0,79.0,76.0,64.0,59.0,1007.0
Jashpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,1.0,2.0,0.0,13.0,3.0,0.0,1.0,0.0,1.0,2.0,25.0
Jashpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,279.0,196.0,164.0,365.0,259.0,338.0,378.0,344.0,289.0,201.0,268.0,356.0,3437.0
Jashpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,65.0,26.0,31.0,19.0,24.0,16.0,14.0,58.0,0.0,5.0,30.0,26.0,314.0
Jashpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Jashpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,287.0,301.0,317.0,365.0,375.0,361.0,338.0,246.0,255.0,273.0,234.0,309.0,3661.0
Jashpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,383.0,324.0,330.0,347.0,417.0,390.0,367.0,332.0,367.0,386.0,344.0,345.0,4332.0
Jashpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,670.0,625.0,647.0,712.0,792.0,751.0,705.0,578.0,622.0,659.0,578.0,654.0,7993.0
Jashpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,459.0,460.0,479.0,508.0,604.0,521.0,511.0,484.0,461.0,530.0,416.0,476.0,5909.0
Jashpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,101.0,91.0,104.0,76.0,117.0,90.0,66.0,86.0,57.0,54.0,73.0,67.0,982.0
Jashpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,656.0,641.0,681.0,767.0,731.0,691.0,682.0,767.0,765.0,780.0,752.0,964.0,8877.0
Jashpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,487.0,428.0,473.0,539.0,494.0,465.0,442.0,514.0,635.0,594.0,563.0,495.0,6129.0
Jashpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,659.0,631.0,656.0,736.0,758.0,726.0,671.0,775.0,785.0,787.0,748.0,971.0,8903.0
Jashpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,576.0,510.0,557.0,571.0,539.0,497.0,507.0,584.0,615.0,630.0,580.0,733.0,6899.0
Jashpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,5.0,5.0,22.0,11.0,4.0,20.0,15.0,18.0,136.0,3.0,7.0,49.0,295.0
Jashpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,201.0,193.0,188.0,196.0,188.0,184.0,193.0,154.0,191.0,188.0,148.0,206.0,2230.0
Jashpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,176.0,190.0,168.0,196.0,176.0,180.0,173.0,161.0,171.0,170.0,148.0,206.0,2115.0
Jashpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,167.0,161.0,167.0,194.0,175.0,180.0,173.0,161.0,171.0,169.0,147.0,198.0,2063.0
Jashpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Jashpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Jashpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Jashpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,55.0,45.0,44.0,45.0,32.0,51.0,42.0,48.0,59.0,49.0,36.0,49.0,555.0
Jashpur,4.1.1.a,Number of male live births,TOTAL,796.0,744.0,772.0,835.0,903.0,807.0,783.0,802.0,795.0,865.0,774.0,938.0,9814.0
Jashpur,4.1.1.b,Number of female live births,TOTAL,744.0,713.0,730.0,851.0,859.0,831.0,785.0,710.0,786.0,774.0,697.0,884.0,9364.0
Jashpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1540.0,1457.0,1502.0,1686.0,1762.0,1638.0,1568.0,1512.0,1581.0,1639.0,1471.0,1822.0,19178.0
Jashpur,4.1.2,Number of still births,TOTAL,47.0,28.0,41.0,32.0,28.0,49.0,36.0,44.0,34.0,32.0,45.0,37.0,453.0
Jashpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,89.0,76.0,76.0,105.0,167.0,160.0,174.0,148.0,126.0,103.0,94.0,123.0,1441.0
Jashpur,4.2.1,Number of Newborns weighed at birth,TOTAL,1358.0,1294.0,1344.0,1476.0,1547.0,1427.0,1398.0,1404.0,1419.0,1584.0,1396.0,1719.0,17366.0
Jashpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,130.0,179.0,142.0,180.0,164.0,167.0,154.0,130.0,151.0,178.0,161.0,191.0,1927.0
Jashpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1443.0,1392.0,1381.0,1599.0,1665.0,1574.0,1519.0,1466.0,1560.0,1621.0,1444.0,1765.0,18429.0
Jashpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,8.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,0.0,11.0
Jashpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,0.0,7.0,15.0,18.0,31.0,29.0,7.0,16.0,12.0,23.0,9.0,175.0
Jashpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5.0,8.0,7.0,3.0,8.0,2.0,1.0,4.0,0.0,2.0,2.0,1.0,43.0
Jashpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,13.0,8.0,14.0,26.0,26.0,34.0,31.0,11.0,16.0,14.0,26.0,10.0,229.0
Jashpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,38.0,25.0,29.0,3.0,0.0,14.0,,,,,,,109.0
Jashpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,51.0,33.0,43.0,21.0,26.0,47.0,31.0,11.0,16.0,14.0,25.0,10.0,328.0
Jashpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,0.0,1.0,3.0,0.0,2.0,1.0,3.0,0.0,2.0,1.0,0.0,15.0
Jashpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,21.0,23.0,19.0,7.0,8.0,3.0,3.0,0.0,0.0,2.0,2.0,3.0,91.0
Jashpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,19.0,18.0,6.0,4.0,2.0,1.0,0.0,0.0,2.0,2.0,1.0,69.0
Jashpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1061.0,1016.0,1004.0,1321.0,1229.0,1193.0,1190.0,930.0,1136.0,871.0,899.0,1262.0,13112.0
Jashpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,947.0,795.0,727.0,1073.0,995.0,976.0,851.0,743.0,502.0,559.0,570.0,661.0,9399.0
Jashpur,6.3,PNC maternal complications attended,TOTAL,88.0,4.0,22.0,7.0,5.0,5.0,6.0,22.0,0.0,76.0,114.0,107.0,456.0
Jashpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,11.0,10.0,12.0,10.0,12.0,14.0,10.0,5.0,0.0,5.0,11.0,109.0
Jashpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,5.0,6.0,5.0,9.0,2.0,0.0,3.0,2.0,1.0,3.0,2.0,42.0
Jashpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,16.0,16.0,17.0,19.0,14.0,14.0,13.0,7.0,1.0,8.0,13.0,151.0
Jashpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,14.0,16.0,10.0,22.0,13.0,8.0,15.0,11.0,32.0,13.0,10.0,15.0,179.0
Jashpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,11.0,10.0,17.0,22.0,24.0,18.0,29.0,14.0,57.0,21.0,26.0,18.0,267.0
Jashpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,25.0,26.0,27.0,44.0,37.0,26.0,44.0,25.0,89.0,34.0,36.0,33.0,446.0
Jashpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,10.0
Jashpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,2.0,2.0,28.0,0.0,4.0,10.0,0.0,3.0,51.0
Jashpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,14.0,0.0,22.0
Jashpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,9.0,2.0,2.0,35.0,0.0,7.0,10.0,14.0,3.0,83.0
Jashpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Jashpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,1.0,0.0,0.0,38.0,11.0,0.0,3.0,25.0,50.0,2.0,27.0,21.0,178.0
Jashpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,28.0,0.0,5.0,81.0,110.0,197.0,235.0,446.0,678.0,472.0,400.0,261.0,2913.0
Jashpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,31.0,0.0,0.0,0.0,0.0,47.0,0.0,0.0,0.0,78.0
Jashpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,29.0,0.0,5.0,150.0,121.0,197.0,238.0,471.0,775.0,474.0,427.0,282.0,3169.0
Jashpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Jashpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Jashpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,7.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,12.0,21.0
Jashpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,7.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,12.0,21.0
Jashpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,8.0,4.0,8.0,5.0,,6.0,13.0,10.0,8.0,62.0
Jashpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,138.0,97.0,143.0,287.0,200.0,140.0,193.0,93.0,97.0,107.0,88.0,141.0,1724.0
Jashpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,4.0,4.0,43.0,2.0,2.0,6.0,6.0,5.0,4.0,8.0,153.0,238.0
Jashpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,36.0,4.0,35.0,76.0,37.0,16.0,18.0,14.0,13.0,15.0,18.0,22.0,304.0
Jashpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,6.0,6.0,7.0,8.0,4.0,3.0,3.0,8.0,12.0,12.0,3.0,80.0
Jashpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Jashpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,183.0,111.0,188.0,413.0,247.0,162.0,220.0,116.0,123.0,138.0,126.0,319.0,2346.0
Jashpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Jashpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,,,,,,,,,,,,0.0
Jashpur,9.06,Number of IUCD removals,TOTAL,210.0,108.0,105.0,221.0,178.0,144.0,120.0,114.0,139.0,96.0,167.0,176.0,1778.0
Jashpur,9.07,Number of Oral Pills cycles distributed,TOTAL,2362.0,2308.0,3221.0,3382.0,2562.0,2764.0,2306.0,2358.0,2252.0,2284.0,2263.0,1640.0,29702.0
Jashpur,9.08,Number of Condom pieces distributed,TOTAL,19798.0,19725.0,18886.0,22957.0,16112.0,15723.0,13764.0,13260.0,16241.0,10973.0,12092.0,9725.0,189256.0
Jashpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,233.0,217.0,202.0,477.0,320.0,164.0,27.0,167.0,121.0,41.0,160.0,56.0,2185.0
Jashpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,4.0,7.0,4.0,10.0,4.0,4.0,4.0,10.0,0.0,0.0,0.0,0.0,47.0
Jashpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,7.0,4.0,2.0,26.0,3.0,11.0,14.0,21.0,9.0,0.0,29.0,0.0,126.0
Jashpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,0.0,6.0
Jashpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,2.0,1.0,2.0,2.0,2.0,3.0,4.0,6.0,7.0,8.0,7.0,-1.0
Jashpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1480.0,1412.0,1387.0,1662.0,1744.0,1774.0,1449.0,1347.0,1691.0,1720.0,1399.0,1619.0,18684.0
Jashpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1413.0,1291.0,1579.0,1736.0,1635.0,1727.0,1596.0,1532.0,1651.0,1803.0,1378.0,1549.0,18890.0
Jashpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1374.0,1365.0,1416.0,1661.0,1705.0,1692.0,1800.0,1604.0,1634.0,1721.0,1614.0,1525.0,19111.0
Jashpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1423.0,1339.0,1586.0,1627.0,1746.0,1836.0,1706.0,1777.0,1640.0,1871.0,1546.0,1751.0,19848.0
Jashpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Jashpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Jashpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Jashpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,797.0,822.0,823.0,912.0,1163.0,1063.0,955.0,845.0,1086.0,1004.0,929.0,1127.0,11526.0
Jashpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1391.0,1284.0,1578.0,1735.0,1583.0,1712.0,1597.0,1540.0,1655.0,1803.0,1411.0,1550.0,18839.0
Jashpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1364.0,1362.0,1414.0,1664.0,1643.0,1684.0,1795.0,1578.0,1645.0,1717.0,1620.0,1501.0,18987.0
Jashpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1423.0,1332.0,1472.0,1533.0,1686.0,1818.0,1703.0,1752.0,1644.0,1864.0,1535.0,1749.0,19511.0
Jashpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,8.0,303.0,188.0,141.0,510.0,406.0,394.0,1950.0
Jashpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,27.0,8.0,6.0,15.0,16.0,14.0,1372.0,1375.0,1382.0,1618.0,1233.0,1521.0,8587.0
Jashpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,38.0,9.0,8.0,14.0,7.0,2.0,308.0,1410.0,1524.0,1567.0,1454.0,1375.0,7716.0
Jashpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,49.0,21.0,2.0,11.0,17.0,9.0,251.0,336.0,1361.0,1622.0,1401.0,1587.0,6667.0
Jashpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1209.0,1257.0,1450.0,1691.0,1747.0,1684.0,1460.0,1395.0,1845.0,1807.0,1235.0,1575.0,18355.0
Jashpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,26.0,3.0,125.0,139.0,42.0,97.0,49.0,108.0,66.0,655.0
Jashpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Jashpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,618.0,654.0,698.0,860.0,856.0,833.0,783.0,681.0,951.0,910.0,600.0,798.0,9242.0
Jashpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,619.0,644.0,677.0,873.0,923.0,818.0,726.0,655.0,899.0,894.0,604.0,810.0,9142.0
Jashpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1237.0,1298.0,1375.0,1733.0,1779.0,1651.0,1509.0,1336.0,1850.0,1804.0,1204.0,1608.0,18384.0
Jashpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,864.0,900.0,1048.0,1205.0,1465.0,1595.0,1336.0,1170.0,2705.0,2410.0,1164.0,1312.0,17174.0
Jashpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,869.0,887.0,1055.0,1190.0,1395.0,1571.0,1311.0,1158.0,2655.0,2397.0,1163.0,1317.0,16968.0
Jashpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,776.0,828.0,699.0,863.0,970.0,786.0,744.0,759.0,876.0,726.0,579.0,627.0,9233.0
Jashpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,747.0,834.0,703.0,830.0,1022.0,756.0,718.0,749.0,841.0,732.0,562.0,626.0,9120.0
Jashpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1523.0,1662.0,1402.0,1693.0,1992.0,1542.0,1462.0,1508.0,1717.0,1458.0,1141.0,1253.0,18353.0
Jashpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,375.0,415.0,355.0,427.0,871.0,1441.0,724.0,605.0,2263.0,2318.0,412.0,498.0,10704.0
Jashpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,818.0,862.0,971.0,1166.0,2522.0,3765.0,1701.0,1510.0,3136.0,4431.0,1010.0,1037.0,22929.0
Jashpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,799.0,763.0,985.0,1111.0,2061.0,2835.0,1529.0,1375.0,2662.0,2842.0,1133.0,1112.0,19207.0
Jashpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,5.0,1.0,4.0,0.0,4.0,2.0,2.0,0.0,19.0
Jashpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,1.0,0.0,2.0,0.0,4.0,3.0,3.0,0.0,14.0
Jashpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1133.0,1167.0,1203.0,1268.0,1329.0,1370.0,1364.0,1320.0,1544.0,1525.0,1292.0,1296.0,15811.0
Jashpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1012.0,1036.0,1084.0,1176.0,1179.0,1214.0,1189.0,1120.0,1331.0,1374.0,1052.0,1127.0,13894.0
Jashpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,846.0,859.0,931.0,976.0,996.0,997.0,965.0,944.0,1152.0,1185.0,913.0,948.0,11712.0
Jashpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1225.0,1192.0,1386.0,1344.0,1737.0,1883.0,1440.0,1313.0,2035.0,1883.0,1168.0,1603.0,18209.0
Jashpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,380.0,326.0,361.0,240.0,1287.0,2735.0,763.0,380.0,5346.0,3927.0,430.0,587.0,16762.0
Jashpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,277.0,205.0,294.0,121.0,1432.0,2353.0,689.0,249.0,5932.0,4945.0,367.0,644.0,17508.0
Jashpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,15.0,42.0,18.0,36.0,38.0,17.0,8.0,39.0,36.0,9.0,13.0,18.0,289.0
Jashpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,308.0,391.0,463.0,333.0,271.0,357.0,220.0,188.0,195.0,263.0,296.0,462.0,3747.0
Jashpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,157.0,85.0,938.0,216.0,241.0,185.0,143.0,115.0,486.0,322.0,77.0,555.0,3520.0
Jashpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,32.0,36.0,51.0,66.0,25.0,126.0,32.0,36.0,61.0,80.0,137.0,135.0,817.0
Jashpur,13.1,Number of Patients operated for cataract,TOTAL,2.0,72.0,105.0,101.0,32.0,37.0,1066.0,213.0,84.0,61.0,78.0,110.0,1961.0
Jashpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2.0,71.0,105.0,99.0,74.0,33.0,36.0,178.0,83.0,58.0,80.0,105.0,924.0
Jashpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,13.0,201.0,62.0,0.0,40.0,0.0,0.0,0.0,7.0,323.0
Jashpur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,2.0,4.0,2.0,2.0,5.0,3.0,3.0,3.0,3.0,2.0,3.0,-1.0
Jashpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,2.0,2.0,2.0,5.0,3.0,4.0,5.0,6.0,7.0,4.0,5.0,-1.0
Jashpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1206.0,1222.0,1316.0,1292.0,1219.0,1158.0,1276.0,1366.0,1203.0,1376.0,1510.0,1217.0,-1.0
Jashpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,4.0,4.0,3.0,3.0,2.0,2.0,3.0,6.0,6.0,5.0,6.0,-1.0
Jashpur,14.05,Number of RKS meetings held during the month,TOTAL,3.0,1.0,2.0,2.0,3.0,2.0,2.0,2.0,3.0,5.0,4.0,4.0,33.0
Jashpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,10.0,7.0,6.0,8.0,9.0,10.0,7.0,8.0,10.0,13.0,12.0,15.0,-1.0
Jashpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,6.0,7.0,15.0,13.0,34.0,20.0,16.0,15.0,19.0,85.0,13.0,27.0,270.0
Jashpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,3.0,1.0,2.0,3.0,2.0,2.0,2.0,3.0,5.0,6.0,-1.0
Jashpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Jashpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,371.0,109.0,269.0,327.0,299.0,290.0,321.0,553.0,118.0,75.0,153.0,145.0,3030.0
Jashpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,448.0,690.0,539.0,565.0,823.0,730.0,825.0,827.0,226.0,315.0,384.0,343.0,6715.0
Jashpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,360.0,99.0,301.0,278.0,349.0,381.0,348.0,205.0,204.0,63.0,148.0,210.0,2946.0
Jashpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,786.0,656.0,902.0,1053.0,1118.0,1232.0,1294.0,1271.0,468.0,473.0,687.0,706.0,10646.0
Jashpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,731.0,208.0,570.0,605.0,648.0,671.0,669.0,758.0,322.0,138.0,301.0,355.0,5976.0
Jashpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1234.0,1346.0,1441.0,1618.0,1941.0,1962.0,2119.0,2098.0,694.0,788.0,1071.0,1049.0,17361.0
Jashpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14.0,15.0,12.0,14.0,16.0,19.0,46.0,3.0,5.0,5.0,7.0,6.0,162.0
Jashpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,14.0,15.0,7.0,11.0,10.0,9.0,69.0,5.0,4.0,0.0,5.0,5.0,154.0
Jashpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,28.0,30.0,19.0,25.0,26.0,28.0,115.0,8.0,9.0,5.0,12.0,11.0,316.0
Jashpur,14.11,In-Patient Head Count at midnight,TOTAL,456.0,4127.0,689.0,773.0,5578.0,743.0,763.0,672.0,511.0,547.0,869.0,1608.0,17336.0
Jashpur,14.12.1,OPD attendance (All),TOTAL,32306.0,29823.0,31798.0,37313.0,38989.0,43017.0,39483.0,31624.0,30981.0,55155.0,39976.0,42247.0,452712.0
Jashpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,81.0,60.0,68.0,65.0,51.0,80.0,80.0,74.0,80.0,69.0,90.0,76.0,874.0
Jashpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Jashpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,198.0,225.0,328.0,288.0,260.0,214.0,224.0,233.0,242.0,329.0,302.0,206.0,3049.0
Jashpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1101.0,1346.0,1605.0,2280.0,1833.0,1583.0,2137.0,1914.0,1692.0,2291.0,2545.0,2883.0,23210.0
Jashpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,22.0,17.0,20.0,15.0,19.0,18.0,24.0,19.0,16.0,15.0,25.0,35.0,245.0
Jashpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,6.0,0.0,0.0,0.0,9.0
Jashpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1858.0,1584.0,2277.0,1732.0,2358.0,2248.0,2259.0,1909.0,2098.0,1954.0,2024.0,2095.0,24396.0
Jashpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,199.0,133.0,74.0,73.0,147.0,159.0,148.0,103.0,134.0,113.0,154.0,180.0,1617.0
Jashpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,60.0,51.0,80.0,57.0,57.0,78.0,204.0,148.0,198.0,86.0,51.0,183.0,1253.0
Jashpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,2.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,1.0,0.0,1.0,8.0
Jashpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,274.0,148.0,425.0,251.0,308.0,285.0,216.0,137.0,421.0,210.0,488.0,320.0,3483.0
Jashpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,2.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,6.0
Jashpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,115.0,93.0,64.0,57.0,28.0,67.0,30.0,54.0,43.0,225.0,112.0,109.0,997.0
Jashpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,18.0,2.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,23.0
Jashpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,449.0,292.0,569.0,365.0,393.0,430.0,450.0,339.0,662.0,521.0,651.0,612.0,5733.0
Jashpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,4.0,0.0,18.0,4.0,2.0,2.0,0.0,1.0,2.0,1.0,3.0,37.0
Jashpur,15.2,Number of Widal tests conducted,Number tested,626.0,564.0,664.0,763.0,1119.0,766.0,1012.0,838.0,856.0,733.0,757.0,467.0,9165.0
Jashpur,15.3.a,Number of VDRL tests conducted on males,Number tested,40.0,17.0,30.0,17.0,20.0,23.0,44.0,20.0,56.0,26.0,38.0,92.0,423.0
Jashpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,285.0,314.0,424.0,220.0,324.0,265.0,257.0,190.0,616.0,193.0,514.0,303.0,3905.0
Jashpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0.0,5.0,20.0,18.0,3.0,26.0,38.0,15.0,52.0,216.0,175.0,144.0,712.0
Jashpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,325.0,336.0,474.0,255.0,347.0,314.0,339.0,225.0,724.0,435.0,727.0,539.0,5040.0
Jashpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,5402.0,6032.0,6607.0,8867.0,10671.0,17188.0,8795.0,7240.0,9521.0,5746.0,9126.0,9545.0,104740.0
Jashpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,157.0,51.0,85.0,116.0,189.0,314.0,407.0,353.0,294.0,142.0,89.0,268.0,2465.0
Jashpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,536.0,532.0,609.0,791.0,979.0,1412.0,1090.0,1029.0,926.0,523.0,720.0,779.0,9926.0
Jashpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6950.0,0.0,20700.0,24700.0,17960.0,13960.0,21710.0,27710.0,19060.0,15260.0,23260.0,18760.0,210030.0
Jashpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,20000.0,0.0,10000.0,20000.0,15000.0,0.0,10000.0,20000.0,,10000.0,135000.0
Jashpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6950.0,9300.0,16000.0,6740.0,14000.0,12250.0,9000.0,8650.0,13800.0,12000.0,4500.0,9000.0,122190.0
Jashpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,20700.0,24700.0,17960.0,13960.0,21710.0,27710.0,19060.0,15260.0,23260.0,18760.0,19760.0,222840.0
Jashpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Jashpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Jashpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Jashpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Jashpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,14080.0,1580.0,8580.0,20580.0,2640.0,7140.0,15640.0,43140.0,21140.0,8640.0,15240.0,4860.0,163260.0
Jashpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,20000.0,0.0,20000.0,20000.0,50000.0,0.0,10000.0,25000.0,,,165000.0
Jashpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,12500.0,13000.0,8000.0,17940.0,15500.0,11500.0,22500.0,2200.0,22500.0,18400.0,10380.0,4860.0,159280.0
Jashpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,1580.0,8580.0,20580.0,2640.0,7140.0,15640.0,43140.0,40940.0,8640.0,15240.0,4860.0,0.0,168980.0
Jashpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5050.0,0.0,19700.0,24200.0,12480.0,6980.0,17500.0,40200.0,24000.0,24100.0,40200.0,36200.0,250610.0
Jashpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,30000.0,20000.0,0.0,10000.0,20000.0,40000.0,0.0,20000.0,30000.0,,8000.0,178000.0
Jashpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5050.0,10300.0,15500.0,11720.0,15500.0,9480.0,17300.0,16200.0,19900.0,13900.0,4000.0,10000.0,148850.0
Jashpur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,19700.0,24200.0,12480.0,6980.0,17500.0,40200.0,24000.0,24100.0,40200.0,36200.0,34200.0,279760.0
Jashpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10650.0,2180.0,8430.0,12930.0,4120.0,4690.0,3690.0,13790.0,3640.0,12140.0,6540.0,1540.0,84340.0
Jashpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,10000.0,10000.0,0.0,10000.0,5000.0,15000.0,0.0,20000.0,5000.0,,5000.0,80000.0
Jashpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,8470.0,3750.0,5500.0,8810.0,9430.0,6000.0,4900.0,10150.0,11500.0,10600.0,5000.0,2000.0,86110.0
Jashpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,2180.0,8430.0,12930.0,4120.0,4690.0,3690.0,13790.0,3640.0,12140.0,6540.0,1540.0,4540.0,78230.0
Jashpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10045.0,3045.0,5725.0,3725.0,1240.0,1740.0,8740.0,14490.0,10890.0,12510.0,14160.0,13160.0,99470.0
Jashpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,3000.0,0.0,5000.0,10000.0,10000.0,0.0,10000.0,5000.0,,,48000.0
Jashpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7000.0,2320.0,5000.0,2485.0,4500.0,3000.0,4250.0,3600.0,8380.0,3350.0,1000.0,3750.0,48635.0
Jashpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,3045.0,5725.0,3725.0,1240.0,1740.0,8740.0,14490.0,10890.0,12510.0,14160.0,13160.0,9410.0,98835.0
Jashpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5700.0,1600.0,9700.0,18900.0,15900.0,51800.0
Jashpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20000.0,20000.0,,,40000.0
Jashpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4100.0,11900.0,10800.0,3000.0,9600.0,39400.0
Jashpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0,9700.0,18900.0,15900.0,6300.0,52400.0
Jashpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,4450.0,2850.0,1700.0,1700.0,1700.0,1100.0,850.0,0.0,,14350.0
Jashpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,4950.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,4950.0
Jashpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,500.0,1600.0,1150.0,0.0,0.0,600.0,250.0,550.0,,,4650.0
Jashpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,4450.0,2850.0,1700.0,1700.0,1700.0,1100.0,850.0,300.0,0.0,0.0,14650.0
Jashpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,6000.0,6000.0,24000.0,18000.0,0.0,20160.0,35280.0,35280.0,0.0,0.0,,144720.0
Jashpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,6000.0,0.0,24000.0,0.0,0.0,37800.0,37800.0,0.0,0.0,0.0,,,105600.0
Jashpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,6000.0,6000.0,18000.0,17640.0,22680.0,0.0,35280.0,0.0,,,105600.0
Jashpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,6000.0,6000.0,24000.0,18000.0,0.0,20160.0,35280.0,35280.0,0.0,0.0,0.0,0.0,144720.0
Jashpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,9000.0,5000.0,10000.0,15400.0,10600.0,0.0,0.0,0.0,,50000.0
Jashpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,0.0,10000.0,5400.0,0.0,0.0,0.0,0.0,,,25400.0
Jashpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1000.0,4000.0,5000.0,0.0,4800.0,10600.0,0.0,0.0,,,25400.0
Jashpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,9000.0,5000.0,10000.0,15400.0,10600.0,0.0,0.0,0.0,0.0,0.0,50000.0
Jashpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,0.0,,4500.0
Jashpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,,,10000.0
Jashpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,500.0,3500.0,0.0,0.0,0.0,0.0,0.0,,,4000.0
Jashpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,5000.0,4500.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0
Jashpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,4300.0,4300.0,3800.0,2700.0,2600.0,0.0,4400.0,3200.0,2600.0,2500.0,30400.0
Jashpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,3000.0,,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,,,8000.0
Jashpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,,0.0,500.0,1100.0,100.0,2600.0,600.0,1200.0,100.0,100.0,,6300.0
Jashpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3000.0,0.0,4300.0,3800.0,2700.0,2600.0,0.0,4400.0,3200.0,3100.0,2500.0,2500.0,32100.0
Jashpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,3000.0
Jashpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,1300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,1300.0
Jashpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,4300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4300.0
Jashpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,240000.0,240000.0,480000.0
Jashpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,160000.0,0.0,0.0,24000.0,,184000.0
Jashpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,160000.0,0.0,0.0,,140000.0,300000.0
Jashpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,264000.0,100000.0,364000.0
Jashpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,4000.0,2100.0,2100.0,2100.0,2100.0,0.0,0.0,0.0,0.0,0.0,0.0,,12400.0
Jashpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2590.0,20500.0,0.0,,,23090.0
Jashpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,1900.0,0.0,0.0,0.0,0.0,0.0,0.0,2590.0,20500.0,0.0,,,24990.0
Jashpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,2100.0,2100.0,2100.0,2100.0,2100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10500.0
Jashpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Jashpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Jashpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,81.0,81.0,0.0,2300.0,2462.0
Jashpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,757.0,0.0,0.0,0.0,2271.0,0.0,0.0,,2300.0,5328.0
Jashpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,757.0,0.0,0.0,0.0,2190.0,0.0,0.0,,1700.0,4647.0
Jashpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,81.0,81.0,81.0,0.0,2900.0,3143.0
Jashpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,4000.0,8000.0
Jashpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,,4000.0
Jashpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,2000.0,2000.0
Jashpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8000.0,2000.0,10000.0
Jashpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2700.0,10800.0,10800.0,10800.0,10800.0,10200.0,10200.0,6200.0,4700.0,2700.0,2700.0,,82600.0
Jashpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9800.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,,,12800.0
Jashpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1700.0,0.0,0.0,0.0,600.0,3000.0,4000.0,1500.0,2000.0,0.0,2700.0,,15500.0
Jashpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10800.0,10800.0,10800.0,10800.0,10200.0,10200.0,6200.0,4700.0,2700.0,2700.0,0.0,0.0,79900.0
Jashpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,140000.0,232000.0,232000.0,212000.0,212000.0,229600.0,228400.0,215200.0,89200.0,77200.0,57200.0,,1924800.0
Jashpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,140000.0,0.0,0.0,0.0,36000.0,1800.0,0.0,0.0,0.0,0.0,,,177800.0
Jashpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,48000.0,0.0,20000.0,0.0,16000.0,3000.0,13200.0,126000.0,12000.0,20000.0,57200.0,,315400.0
Jashpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,232000.0,232000.0,212000.0,212000.0,232000.0,228400.0,215200.0,89200.0,77200.0,57200.0,0.0,0.0,1787200.0
Jashpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1500.0,3100.0,3100.0,3100.0,3100.0,5700.0,7000.0,6800.0,3300.0,2300.0,0.0,,39000.0
Jashpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2800.0,0.0,0.0,0.0,2600.0,2000.0,0.0,0.0,0.0,0.0,,,7400.0
Jashpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Jashpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,0.0,0.0,0.0,0.0,700.0,200.0,3500.0,1000.0,0.0,,,6600.0
Jashpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3100.0,3100.0,3100.0,3100.0,5700.0,7000.0,6800.0,3300.0,2300.0,2300.0,0.0,0.0,39800.0
Jashpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,3.0,2.0,,2.0,4.0,4.0,2.0,,2.0,4.0,1.0,24.0
Jashpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,,,2.0,,,1.0,4.0
Jashpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Jashpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,,,,2.0,,,1.0,4.0
Jashpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,,,,1.0
Jashpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,2.0,,2.0
Jashpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,1.0,,2.0,,3.0
Jashpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,4.0,1.0,3.0,6.0,5.0,5.0,5.0,7.0,9.0,10.0,8.0,64.0
Jashpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,1.0,2.0,,1.0,,,6.0
Jashpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,5.0,2.0,3.0,6.0,5.0,6.0,7.0,7.0,10.0,10.0,8.0,70.0
Jashpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,3.0,2.0,4.0,6.0,5.0,2.0,8.0,6.0,5.0,11.0,54.0
Jashpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,1.0,1.0,5.0,4.0,3.0,2.0,1.0,3.0,1.0,,22.0
Jashpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,1.0,4.0,3.0,9.0,10.0,8.0,4.0,9.0,9.0,6.0,11.0,76.0
Jashpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,1.0,2.0,,1.0,3.0,,,,8.0
Jashpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,,,1.0,1.0,1.0,1.0,,,1.0,6.0
Jashpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,1.0,1.0,3.0,1.0,2.0,4.0,,,1.0,14.0
Jashpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,1.0,,,,,,,,,,2.0
Jashpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,1.0,,3.0
Jashpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,1.0,1.0,,,,1.0,,,,1.0,,5.0
Jashpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,2.0,1.0,,,1.0,,,,,1.0,7.0
Jashpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,1.0,,,,,,,,,,2.0
Jashpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,1.0,3.0,1.0,,,1.0,,,,,1.0,9.0
Jashpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Jashpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Jashpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,1.0,,,1.0,,,,,,,,2.0
Jashpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,2.0,2.0,,1.0,2.0,6.0,4.0,,3.0,8.0,2.0,36.0
Jashpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,4.0,2.0,2.0,5.0,3.0,3.0,4.0,2.0,1.0,1.0,31.0
Jashpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,4.0,6.0,2.0,3.0,7.0,9.0,7.0,4.0,5.0,9.0,3.0,67.0
Jashpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,2.0,,,,,2.0
Jashpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,1.0,,2.0,2.0,1.0,,1.0,1.0,,9.0
Jashpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,2.0,,,,,,,2.0
Jashpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,,4.0,2.0,3.0,,1.0,1.0,,13.0
Jashpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Jashpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,,,1.0,3.0,3.0,1.0,1.0,2.0,1.0,3.0,1.0,18.0
Jashpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,1.0,1.0,1.0,,,,,,,4.0
Jashpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,2.0,,2.0,4.0,4.0,1.0,1.0,2.0,1.0,3.0,1.0,23.0
Jashpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,,1.0,1.0,1.0,,,,,4.0
Jashpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Jashpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,,,,1.0,1.0,1.0,,,,,4.0
Jashpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,1.0,1.0,1.0,,,,,,4.0
Jashpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,2.0,,,,1.0,,,1.0,,,4.0
Jashpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Jashpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,2.0,1.0,1.0,1.0,2.0,,,1.0,,,8.0
Jashpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,2.0,1.0,4.0,2.0,1.0,2.0,1.0,,1.0,,,,14.0
Jashpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,4.0,3.0,2.0,6.0,2.0,3.0,3.0,3.0,4.0,4.0,,37.0
Jashpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,4.0,2.0,2.0,3.0,3.0,2.0,1.0,,,,19.0
Jashpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,7.0,11.0,6.0,9.0,7.0,7.0,5.0,5.0,4.0,4.0,,70.0
Jashpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,1.0,,,,,1.0
Jashpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Jashpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,1.0,,,,,1.0
Jashpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,1.0,2.0,,1.0,3.0,,1.0,4.0,1.0,2.0,18.0
Jashpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,3.0,3.0,1.0,,3.0,2.0,,,,,13.0
Jashpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,2.0,4.0,5.0,1.0,1.0,6.0,2.0,1.0,4.0,1.0,2.0,31.0
Jashpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,3.0,1.0,1.0,,,2.0,,1.0,1.0,10.0
Jashpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,1.0,,,,,,,,,,2.0
Jashpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,1.0,3.0,1.0,1.0,,,2.0,,1.0,1.0,12.0
Jashpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Jashpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Jashpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,1.0,,,1.0
Jashpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,1.0,,1.0,,,,1.0,,,,4.0
Jashpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,1.0,,,,,,,,,,,1.0
Jashpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,2.0,1.0,,1.0,,,,1.0,,,,5.0
Jashpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Jashpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Jashpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,,1.0
Jashpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,2.0,1.0,,,,,,,,,3.0
Jashpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Jashpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,2.0,1.0,,,,,,,,,3.0
Jashpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,2.0,,,,,1.0,,3.0
Jashpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Jashpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,2.0,,,,,1.0,,3.0
Jashpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,,1.0,2.0,3.0,2.0,3.0,2.0,,2.0,1.0,19.0
Jashpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,2.0,,1.0,,2.0,,,,,,,6.0
Jashpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,4.0,,2.0,2.0,5.0,2.0,3.0,2.0,,2.0,1.0,25.0
Jashpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,1.0,,1.0,3.0,2.0,,,,,,9.0
Jashpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,10.0,12.0,8.0,13.0,14.0,5.0,12.0,13.0,12.0,8.0,7.0,121.0
Jashpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,1.0,6.0,4.0,3.0,3.0,3.0,,3.0,,1.0,,27.0
Jashpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,12.0,19.0,12.0,17.0,20.0,10.0,12.0,16.0,12.0,9.0,7.0,157.0
Jashpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Jashpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,3.0,6.0,3.0,18.0,6.0,5.0,2.0,7.0,11.0,7.0,3.0,6.0,77.0
Jashpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,,,,2.0,,1.0,,,,,,6.0
Jashpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,6.0,3.0,18.0,8.0,5.0,3.0,7.0,11.0,7.0,3.0,6.0,83.0
Jashpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,1.0,,1.0,2.0,,,,,,,5.0
Jashpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,5.0,5.0,4.0,3.0,2.0,2.0,2.0,,1.0,1.0,27.0
Jashpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,,1.0,,1.0,1.0,,,,,4.0
Jashpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,3.0,1.0,6.0,5.0,6.0,5.0,3.0,3.0,2.0,,1.0,1.0,36.0
Jashpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,1.0,1.0,1.0,,1.0,,,,,,6.0
Jashpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,8.0,6.0,10.0,6.0,10.0,6.0,8.0,10.0,12.0,13.0,9.0,8.0,106.0
Jashpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,5.0,5.0,6.0,9.0,5.0,4.0,7.0,3.0,1.0,2.0,,51.0
Jashpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,13.0,12.0,16.0,13.0,20.0,11.0,13.0,17.0,15.0,14.0,11.0,8.0,163.0
Jashpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,3.0,1.0,,3.0,4.0,,,,,11.0
Jashpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,18.0,11.0,24.0,16.0,19.0,16.0,16.0,10.0,22.0,15.0,13.0,14.0,194.0
Jashpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,26.0,15.0,23.0,19.0,36.0,43.0,16.0,28.0,13.0,14.0,4.0,4.0,241.0
Jashpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,44.0,26.0,47.0,38.0,56.0,59.0,35.0,42.0,35.0,29.0,17.0,18.0,446.0
Jashpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,2.0,1.0,5.0,3.0,2.0,1.0,3.0,,,,,21.0
Jashpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,22.0,13.0,22.0,27.0,33.0,35.0,31.0,27.0,21.0,25.0,24.0,27.0,307.0
Jashpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,27.0,25.0,40.0,44.0,70.0,46.0,56.0,62.0,27.0,26.0,16.0,19.0,458.0
Jashpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,53.0,40.0,63.0,76.0,106.0,83.0,88.0,92.0,48.0,51.0,40.0,46.0,786.0
Kanker,1.1,Total number of pregnant women Registered for ANC,TOTAL,1279.0,1319.0,1393.0,1559.0,1432.0,1514.0,1636.0,1394.0,1693.0,1248.0,1261.0,1371.0,17099.0
Kanker,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,689.0,728.0,802.0,915.0,841.0,910.0,980.0,844.0,1048.0,791.0,718.0,829.0,10095.0
Kanker,1.2,Number of Pregnant women registered under JSY,TOTAL,1242.0,1318.0,1364.0,1559.0,1382.0,1464.0,1553.0,1320.0,1693.0,1183.0,1201.0,1325.0,16604.0
Kanker,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,949.0,985.0,1166.0,1120.0,1157.0,1177.0,1248.0,1131.0,1305.0,1152.0,1162.0,1239.0,13791.0
Kanker,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,944.0,910.0,1019.0,1118.0,1002.0,1122.0,1163.0,1019.0,1243.0,913.0,917.0,998.0,12368.0
Kanker,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,954.0,1087.0,1149.0,1224.0,1269.0,1195.0,1360.0,1325.0,1357.0,1302.0,1069.0,1220.0,14511.0
Kanker,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1233.0,1136.0,1317.0,1399.0,1344.0,1427.0,1525.0,1251.0,1676.0,1188.0,1177.0,1273.0,15946.0
Kanker,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,31.0,27.0,26.0,40.0,38.0,31.0,12.0,14.0,24.0,21.0,17.0,10.0,291.0
Kanker,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,2.0,2.0,2.0,2.0,2.0,2.0,3.0,0.0,0.0,0.0,18.0
Kanker,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,686.0,718.0,792.0,800.0,707.0,764.0,747.0,707.0,849.0,639.0,637.0,515.0,8561.0
Kanker,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2.0,1.0,0.0,2.0,3.0,2.0,0.0,4.0,5.0,6.0,9.0,2.0,36.0
Kanker,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Kanker,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,155.0,165.0,187.0,177.0,192.0,204.0,172.0,217.0,195.0,173.0,151.0,177.0,2165.0
Kanker,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,209.0,246.0,275.0,282.0,256.0,258.0,263.0,202.0,229.0,199.0,180.0,270.0,2869.0
Kanker,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,364.0,411.0,462.0,459.0,448.0,462.0,435.0,419.0,424.0,372.0,331.0,447.0,5034.0
Kanker,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,290.0,303.0,430.0,374.0,345.0,338.0,326.0,308.0,334.0,274.0,261.0,320.0,3903.0
Kanker,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,19.0,22.0,30.0,43.0,21.0,27.0,30.0,38.0,51.0,50.0,48.0,57.0,436.0
Kanker,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,669.0,547.0,592.0,776.0,730.0,555.0,561.0,696.0,650.0,650.0,767.0,884.0,8077.0
Kanker,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,395.0,385.0,387.0,635.0,491.0,403.0,404.0,446.0,432.0,387.0,423.0,302.0,5090.0
Kanker,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,642.0,534.0,605.0,779.0,731.0,550.0,573.0,696.0,665.0,650.0,781.0,903.0,8109.0
Kanker,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,574.0,477.0,514.0,697.0,635.0,470.0,492.0,616.0,587.0,542.0,675.0,808.0,7087.0
Kanker,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,2.0,1.0,0.0,1.0,3.0,3.0,2.0,3.0,7.0,0.0,0.0,0.0,22.0
Kanker,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,27.0,55.0,50.0,39.0,46.0,43.0,43.0,26.0,46.0,29.0,48.0,39.0,491.0
Kanker,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,27.0,55.0,50.0,39.0,46.0,43.0,43.0,26.0,46.0,29.0,48.0,39.0,491.0
Kanker,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,7.0
Kanker,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,7.0
Kanker,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,19.0,19.0,31.0,8.0,24.0,25.0,25.0,0.0,21.0,15.0,24.0,19.0,230.0
Kanker,4.1.1.a,Number of male live births,TOTAL,527.0,541.0,587.0,663.0,629.0,520.0,523.0,595.0,556.0,503.0,607.0,720.0,6971.0
Kanker,4.1.1.b,Number of female live births,TOTAL,523.0,471.0,508.0,593.0,569.0,520.0,490.0,529.0,561.0,524.0,519.0,635.0,6442.0
Kanker,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1050.0,1012.0,1095.0,1256.0,1198.0,1040.0,1013.0,1124.0,1117.0,1027.0,1126.0,1355.0,13413.0
Kanker,4.1.2,Number of still births,TOTAL,18.0,29.0,17.0,23.0,34.0,23.0,28.0,28.0,42.0,32.0,32.0,32.0,338.0
Kanker,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,15.0,11.0,29.0,29.0,30.0,34.0,26.0,15.0,38.0,31.0,46.0,35.0,339.0
Kanker,4.2.1,Number of Newborns weighed at birth,TOTAL,1025.0,983.0,1041.0,1214.0,1135.0,965.0,969.0,1067.0,1076.0,1000.0,1062.0,1329.0,12866.0
Kanker,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,72.0,64.0,81.0,113.0,111.0,101.0,119.0,130.0,98.0,86.0,142.0,106.0,1223.0
Kanker,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1038.0,921.0,1029.0,1107.0,1088.0,1008.0,972.0,1070.0,1071.0,1010.0,1090.0,1329.0,12733.0
Kanker,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,4.0,0.0,6.0,12.0,5.0,0.0,0.0,0.0,0.0,0.0,27.0
Kanker,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1.0,0.0,2.0,2.0,9.0,6.0,0.0,58.0,14.0,5.0,9.0,6.0,112.0
Kanker,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1.0,0.0,6.0,2.0,15.0,18.0,5.0,58.0,14.0,5.0,9.0,6.0,139.0
Kanker,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1.0,58.0,43.0,72.0,93.0,82.0,75.0,63.0,91.0,1.0,0.0,0.0,579.0
Kanker,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,61.0,38.0,67.0,86.0,74.0,71.0,70.0,67.0,5.0,6.0,0.0,545.0
Kanker,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,2.0,9.0,6.0,0.0,0.0,1.0,0.0,9.0,6.0,33.0
Kanker,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,773.0,663.0,874.0,873.0,784.0,705.0,737.0,852.0,765.0,715.0,673.0,914.0,9328.0
Kanker,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,535.0,533.0,534.0,615.0,579.0,552.0,554.0,628.0,621.0,518.0,487.0,789.0,6945.0
Kanker,6.3,PNC maternal complications attended,TOTAL,14.0,6.0,12.0,6.0,22.0,28.0,10.0,15.0,11.0,3.0,6.0,93.0,226.0
Kanker,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,4.0,4.0,4.0,19.0,8.0,10.0,14.0,13.0,16.0,23.0,115.0
Kanker,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,2.0,0.0,0.0,3.0,1.0,3.0,1.0,2.0,2.0,15.0
Kanker,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,5.0,6.0,4.0,19.0,11.0,11.0,17.0,14.0,18.0,25.0,130.0
Kanker,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,26.0,20.0,18.0,29.0,14.0,29.0,20.0,25.0,21.0,15.0,7.0,27.0,251.0
Kanker,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,67.0,42.0,55.0,47.0,34.0,54.0,29.0,47.0,37.0,25.0,20.0,45.0,502.0
Kanker,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,93.0,62.0,73.0,76.0,48.0,83.0,49.0,72.0,58.0,40.0,27.0,72.0,753.0
Kanker,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,13.0,11.0,5.0,4.0,11.0,0.0,5.0,0.0,4.0,5.0,0.0,58.0
Kanker,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,12.0,4.0,37.0,0.0,1.0,7.0,0.0,1.0,6.0,2.0,70.0
Kanker,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,6.0,18.0,37.0,266.0,66.0,87.0,66.0,14.0,16.0,54.0,72.0,63.0,765.0
Kanker,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,5.0,1.0,1.0,0.0,2.0,1.0,1.0,1.0,1.0,0.0,15.0
Kanker,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,8.0,18.0,54.0,271.0,104.0,87.0,69.0,22.0,17.0,56.0,79.0,65.0,850.0
Kanker,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,73.0,114.0,61.0,0.0,0.0,0.0,419.0,22.0,689.0
Kanker,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,137.0,646.0,125.0,139.0,231.0,133.0,168.0,454.0,302.0,222.0,2557.0
Kanker,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,3.0,15.0,3.0,35.0,1.0,5.0,1.0,3.0,3.0,5.0,26.0,101.0
Kanker,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1.0,3.0,152.0,649.0,233.0,254.0,297.0,134.0,171.0,457.0,726.0,270.0,3347.0
Kanker,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kanker,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,3.0,1.0,2.0,3.0,0.0,1.0,0.0,2.0,5.0,0.0,17.0
Kanker,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,3.0,4.0,2.0,3.0,0.0,1.0,0.0,2.0,5.0,0.0,20.0
Kanker,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,7.0
Kanker,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,7.0
Kanker,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,160.0,205.0,276.0,854.0,315.0,231.0,211.0,169.0,158.0,171.0,158.0,166.0,3074.0
Kanker,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,1.0,3.0,6.0,5.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,18.0
Kanker,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11.0,13.0,13.0,39.0,15.0,15.0,12.0,11.0,6.0,22.0,12.0,12.0,181.0
Kanker,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kanker,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,171.0,219.0,292.0,899.0,335.0,248.0,223.0,181.0,164.0,193.0,170.0,178.0,3273.0
Kanker,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Kanker,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kanker,9.06,Number of IUCD removals,TOTAL,505.0,289.0,282.0,442.0,300.0,289.0,253.0,182.0,213.0,161.0,173.0,228.0,3317.0
Kanker,9.07,Number of Oral Pills cycles distributed,TOTAL,3844.0,3388.0,4247.0,5008.0,5085.0,4798.0,5057.0,2272.0,1985.0,1374.0,1989.0,1637.0,40684.0
Kanker,9.08,Number of Condom pieces distributed,TOTAL,50883.0,54607.0,63837.0,67865.0,64207.0,65251.0,68406.0,33132.0,25816.0,19527.0,17504.0,23903.0,554938.0
Kanker,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Kanker,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,3.0,2.0,0.0,0.0,0.0,1.0,7.0
Kanker,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,7.0,6.0,6.0,5.0,5.0,6.0,7.0,8.0,8.0,4.0,5.0,-1.0
Kanker,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,958.0,1007.0,1115.0,1241.0,1124.0,1092.0,999.0,1111.0,1118.0,1026.0,1039.0,1450.0,13280.0
Kanker,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,880.0,1005.0,1158.0,1111.0,1153.0,1280.0,1212.0,1034.0,1112.0,1090.0,1049.0,1257.0,13341.0
Kanker,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1032.0,1036.0,1073.0,1185.0,1171.0,1162.0,1270.0,1185.0,1104.0,1132.0,1090.0,1259.0,13699.0
Kanker,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1015.0,1060.0,1098.0,1112.0,1204.0,1174.0,1201.0,1240.0,1204.0,1112.0,1095.0,1299.0,13814.0
Kanker,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Kanker,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Kanker,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Kanker,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,940.0,999.0,1102.0,1237.0,1105.0,1050.0,989.0,1044.0,1081.0,1016.0,1035.0,1436.0,13034.0
Kanker,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,892.0,1012.0,1158.0,1111.0,1153.0,1273.0,1212.0,1032.0,1112.0,1090.0,1049.0,1257.0,13351.0
Kanker,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1031.0,1036.0,1073.0,1181.0,1171.0,1156.0,1273.0,1172.0,1107.0,1132.0,1090.0,1259.0,13681.0
Kanker,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1016.0,1043.0,1098.0,1114.0,1204.0,1168.0,1201.0,1236.0,1204.0,1111.0,1095.0,1299.0,13789.0
Kanker,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,60.0,443.0,554.0,606.0,489.0,822.0,2974.0
Kanker,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,230.0,642.0,1060.0,1025.0,1030.0,1237.0,5229.0
Kanker,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,36.0,468.0,909.0,1041.0,1070.0,1210.0,4739.0
Kanker,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,40.0,345.0,829.0,905.0,1084.0,1269.0,4475.0
Kanker,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,801.0,992.0,1053.0,1157.0,1132.0,1205.0,1098.0,960.0,1285.0,927.0,1003.0,1394.0,13007.0
Kanker,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Kanker,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,412.0,506.0,568.0,577.0,591.0,625.0,546.0,461.0,621.0,468.0,490.0,713.0,6578.0
Kanker,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,389.0,486.0,485.0,547.0,532.0,580.0,506.0,436.0,552.0,457.0,513.0,681.0,6164.0
Kanker,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,801.0,992.0,1053.0,1124.0,1123.0,1205.0,1052.0,897.0,1173.0,925.0,1003.0,1394.0,12742.0
Kanker,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,609.0,672.0,844.0,908.0,1487.0,1003.0,967.0,851.0,1852.0,922.0,908.0,1178.0,12201.0
Kanker,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,609.0,670.0,846.0,908.0,1490.0,1001.0,968.0,823.0,1823.0,923.0,904.0,1176.0,12141.0
Kanker,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,127.0,200.0,226.0,159.0,458.0,251.0,122.0,112.0,644.0,158.0,184.0,207.0,2848.0
Kanker,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,146.0,174.0,206.0,171.0,368.0,210.0,113.0,107.0,619.0,147.0,168.0,216.0,2645.0
Kanker,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,273.0,374.0,432.0,330.0,826.0,461.0,235.0,219.0,1263.0,305.0,352.0,423.0,5493.0
Kanker,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,96.0,150.0,325.0,673.0,3397.0,2320.0,1235.0,863.0,1560.0,916.0,803.0,897.0,13235.0
Kanker,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,212.0,332.0,456.0,932.0,6294.0,4490.0,2246.0,1460.0,1301.0,1023.0,1215.0,893.0,20854.0
Kanker,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,265.0,375.0,466.0,819.0,3650.0,4243.0,2080.0,1592.0,1720.0,1424.0,1580.0,1098.0,19312.0
Kanker,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,3.0,0.0,3.0,0.0,1.0,14.0,12.0,1.0,0.0,1.0,38.0
Kanker,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,2.0,3.0,4.0,2.0,5.0,13.0,6.0,5.0,1.0,0.0,43.0
Kanker,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1047.0,1080.0,1122.0,1087.0,1105.0,1083.0,1084.0,1085.0,1401.0,1249.0,1127.0,1149.0,13619.0
Kanker,10.4.2,Number of Immunisation sessions held during the month,TOTAL,934.0,1022.0,1037.0,1041.0,1063.0,1032.0,1040.0,1043.0,1356.0,1201.0,1079.0,1119.0,12967.0
Kanker,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,844.0,907.0,932.0,917.0,949.0,928.0,929.0,916.0,1231.0,1092.0,996.0,1040.0,11681.0
Kanker,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,793.0,991.0,1044.0,1142.0,1125.0,1198.0,1109.0,951.0,1303.0,919.0,1002.0,1399.0,12976.0
Kanker,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,99.0,81.0,53.0,394.0,4180.0,800.0,143.0,96.0,4047.0,2062.0,124.0,128.0,12207.0
Kanker,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,9.0,14.0,23.0,271.0,4552.0,1017.0,79.0,61.0,3849.0,2173.0,48.0,20.0,12116.0
Kanker,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,8.0,0.0,0.0,7.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,25.0
Kanker,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,89.0,109.0,197.0,248.0,239.0,164.0,125.0,117.0,79.0,88.0,108.0,86.0,1649.0
Kanker,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,48.0,33.0,58.0,84.0,66.0,111.0,103.0,72.0,91.0,28.0,115.0,32.0,841.0
Kanker,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,22.0,39.0,9.0,62.0,40.0,25.0,6.0,67.0,20.0,15.0,20.0,32.0,357.0
Kanker,13.1,Number of Patients operated for cataract,TOTAL,21.0,19.0,4.0,283.0,316.0,349.0,273.0,119.0,144.0,141.0,183.0,134.0,1986.0
Kanker,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,21.0,19.0,3.0,258.0,287.0,349.0,272.0,119.0,144.0,141.0,183.0,134.0,1930.0
Kanker,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,4.0,2.0,22.0,25.0,0.0,141.0,30.0,0.0,32.0,51.0,307.0
Kanker,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,4.0,0.0,2.0,0.0,0.0,0.0,20.0,0.0,25.0,15.0,66.0
Kanker,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,3.0,4.0,1.0,1.0,-1.0
Kanker,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,3.0,1.0,1.0,1.0,1.0,2.0,2.0,3.0,1.0,2.0,3.0,-1.0
Kanker,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,932.0,1095.0,1136.0,1088.0,1381.0,1084.0,1091.0,1071.0,1124.0,1201.0,1227.0,1127.0,-1.0
Kanker,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,8.0,6.0,8.0,8.0,9.0,9.0,8.0,6.0,6.0,-1.0
Kanker,14.05,Number of RKS meetings held during the month,TOTAL,15.0,15.0,14.0,17.0,14.0,13.0,14.0,13.0,14.0,14.0,13.0,8.0,164.0
Kanker,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,12.0,13.0,14.0,15.0,16.0,15.0,15.0,18.0,17.0,16.0,19.0,20.0,-1.0
Kanker,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,86.0,116.0,95.0,111.0,189.0,249.0,208.0,223.0,303.0,311.0,406.0,493.0,2790.0
Kanker,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,3.0,2.0,2.0,2.0,2.0,2.0,3.0,3.0,2.0,1.0,1.0,-1.0
Kanker,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,1.0,1.0,3.0,1.0,1.0,8.0,3.0,1.0,1.0,1.0,-1.0
Kanker,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,231.0,250.0,290.0,352.0,298.0,252.0,229.0,291.0,240.0,271.0,277.0,538.0,3519.0
Kanker,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,899.0,1083.0,1058.0,1143.0,1206.0,1106.0,1114.0,650.0,630.0,848.0,1053.0,1291.0,12081.0
Kanker,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,243.0,289.0,280.0,313.0,308.0,295.0,265.0,282.0,252.0,317.0,355.0,515.0,3714.0
Kanker,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1251.0,1411.0,1586.0,1763.0,1754.0,1957.0,1790.0,1080.0,1192.0,1186.0,1757.0,1886.0,18613.0
Kanker,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,474.0,539.0,570.0,665.0,606.0,547.0,494.0,573.0,492.0,588.0,632.0,1053.0,7233.0
Kanker,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2150.0,2494.0,2644.0,2906.0,2960.0,3063.0,2904.0,1730.0,1822.0,2034.0,2810.0,3177.0,30694.0
Kanker,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,19.0,9.0,20.0,19.0,15.0,12.0,14.0,18.0,12.0,22.0,7.0,175.0
Kanker,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,8.0,7.0,10.0,17.0,11.0,15.0,8.0,7.0,7.0,7.0,11.0,113.0
Kanker,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13.0,27.0,16.0,30.0,36.0,26.0,27.0,22.0,25.0,19.0,29.0,18.0,288.0
Kanker,14.11,In-Patient Head Count at midnight,TOTAL,1000.0,922.0,1031.0,1400.0,1464.0,1686.0,1172.0,1064.0,1277.0,2622.0,1454.0,3162.0,18254.0
Kanker,14.12.1,OPD attendance (All),TOTAL,29946.0,34574.0,37969.0,44735.0,48300.0,55997.0,47109.0,39078.0,41758.0,40583.0,46156.0,54298.0,520503.0
Kanker,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,3.0,2.0,3.0,8.0,6.0,2.0,1.0,4.0,2.0,5.0,5.0,2.0,43.0
Kanker,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Kanker,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,221.0,313.0,287.0,481.0,436.0,235.0,248.0,231.0,285.0,307.0,165.0,247.0,3456.0
Kanker,14.14.a,Number of patients given AYUSH treatment,TOTAL,1566.0,1792.0,2442.0,3332.0,3180.0,3731.0,3207.0,2531.0,3161.0,3726.0,4018.0,3300.0,35986.0
Kanker,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,1.0,73.0,0.0,0.0,90.0,0.0,87.0,99.0,93.0,109.0,0.0,552.0
Kanker,14.14.c,Number of Adolescents counselled,TOTAL,1.0,10.0,75.0,1.0,7.0,13.0,8.0,0.0,0.0,3.0,2.0,11.0,131.0
Kanker,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2130.0,2657.0,3329.0,3238.0,2866.0,3211.0,3240.0,2696.0,3059.0,3113.0,2987.0,3531.0,36057.0
Kanker,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,96.0,141.0,127.0,129.0,176.0,158.0,125.0,124.0,118.0,113.0,151.0,131.0,1589.0
Kanker,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,115.0,71.0,229.0,96.0,70.0,225.0,95.0,248.0,164.0,153.0,155.0,137.0,1758.0
Kanker,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4.0,1.0,3.0,2.0,2.0,0.0,2.0,2.0,2.0,1.0,5.0,1.0,25.0
Kanker,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,125.0,125.0,127.0,385.0,62.0,384.0,182.0,305.0,208.0,318.0,224.0,402.0,2847.0
Kanker,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1.0,1.0,1.0,25.0,10.0,0.0,1.0,3.0,1.0,2.0,1.0,2.0,48.0
Kanker,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,310.0,310.0,273.0,213.0,278.0,298.0,332.0,295.0,355.0,385.0,349.0,316.0,3714.0
Kanker,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0
Kanker,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,550.0,506.0,629.0,694.0,410.0,907.0,609.0,848.0,727.0,856.0,728.0,855.0,8319.0
Kanker,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6.0,2.0,5.0,27.0,12.0,0.0,3.0,5.0,3.0,3.0,7.0,4.0,77.0
Kanker,15.2,Number of Widal tests conducted,Number tested,311.0,462.0,575.0,735.0,800.0,865.0,934.0,778.0,649.0,648.0,725.0,853.0,8335.0
Kanker,15.3.a,Number of VDRL tests conducted on males,Number tested,51.0,28.0,67.0,88.0,124.0,59.0,101.0,142.0,35.0,88.0,128.0,186.0,1097.0
Kanker,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,146.0,56.0,177.0,157.0,100.0,178.0,163.0,273.0,137.0,133.0,211.0,231.0,1962.0
Kanker,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,191.0,203.0,167.0,262.0,201.0,95.0,124.0,182.0,301.0,227.0,182.0,285.0,2420.0
Kanker,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,388.0,287.0,411.0,507.0,425.0,332.0,388.0,597.0,473.0,448.0,521.0,702.0,5479.0
Kanker,15.4.1,Number of blood smears examined for Malaria,TOTAL,8291.0,6273.0,7081.0,10183.0,14993.0,16604.0,13780.0,10587.0,11066.0,6373.0,10349.0,11249.0,126829.0
Kanker,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,57.0,8.0,23.0,19.0,27.0,33.0,20.0,24.0,30.0,12.0,29.0,18.0,300.0
Kanker,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,256.0,256.0,249.0,567.0,904.0,826.0,670.0,782.0,828.0,276.0,523.0,433.0,6570.0
Kanker,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,12500.0,22500.0,21000.0,31500.0,20000.0,23500.0,11000.0,,26000.0,14500.0,27500.0,22000.0,232000.0
Kanker,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,10000.0,20000.0,0.0,15000.0,0.0,31000.0,,0.0,20000.0,0.0,10000.0,126000.0
Kanker,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10000.0,11500.0,9500.0,11500.0,11500.0,12500.0,8000.0,,11500.0,7000.0,5500.0,11000.0,109500.0
Kanker,16.1.1,Stock position of DPT vaccines,5. Total Stock,22500.0,21000.0,31500.0,20000.0,23500.0,11000.0,34000.0,0.0,14500.0,27500.0,22000.0,21000.0,248500.0
Kanker,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kanker,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kanker,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kanker,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kanker,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3500.0,12800.0,7300.0,6300.0,600.0,1100.0,600.0,,17100.0,600.0,1100.0,5100.0,56100.0
Kanker,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,10000.0,10000.0,7000.0,10000.0,13000.0,20000.0,,0.0,10000.0,127000.0,128000.0,355000.0
Kanker,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,10700.0,15500.0,11000.0,12700.0,9500.0,13500.0,12500.0,,16500.0,9500.0,123000.0,6100.0,240500.0
Kanker,16.1.2,Stock position of OPV vaccines,5. Total Stock,12800.0,7300.0,6300.0,600.0,1100.0,600.0,8100.0,0.0,600.0,1100.0,5100.0,127000.0,170600.0
Kanker,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16500.0,6000.0,18000.0,28000.0,14500.0,13000.0,7000.0,,22500.0,8500.0,17000.0,10500.0,161500.0
Kanker,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,20000.0,0.0,15000.0,10000.0,35000.0,,0.0,20000.0,0.0,20000.0,140000.0
Kanker,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10500.0,8000.0,10000.0,13500.0,16500.0,16000.0,12000.0,,14000.0,11500.0,6500.0,12500.0,131000.0
Kanker,16.1.3,Stock position of TT vaccines,5. Total Stock,6000.0,18000.0,28000.0,14500.0,13000.0,7000.0,30000.0,0.0,8500.0,17000.0,10500.0,18000.0,170500.0
Kanker,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3500.0,7500.0,8000.0,10000.0,5000.0,6000.0,5500.0,,8000.0,0.0,500.0,0.0,54000.0
Kanker,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,8000.0,3000.0,5000.0,6000.0,10000.0,,0.0,5000.0,0.0,8000.0,65000.0
Kanker,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,9500.0,6000.0,8000.0,4000.0,6500.0,5500.0,,8000.0,4500.0,500.0,5500.0,64000.0
Kanker,16.1.5,Stock position of BCG vaccines,5. Total Stock,7500.0,8000.0,10000.0,5000.0,6000.0,5500.0,10000.0,0.0,0.0,500.0,0.0,2500.0,55000.0
Kanker,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4750.0,6750.0,5000.0,5000.0,6000.0,6500.0,2500.0,,72000.0,4000.0,7750.0,6250.0,126500.0
Kanker,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,3000.0,3000.0,5000.0,3000.0,0.0,5000.0,,0.0,5000.0,0.0,5000.0,34000.0
Kanker,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,3250.0,3250.0
Kanker,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3000.0,4750.0,3000.0,4000.0,2500.0,4000.0,2750.0,,68000.0,1250.0,1500.0,,94750.0
Kanker,16.1.6,Stock position of Measles vaccines,5. Total Stock,6750.0,5000.0,5000.0,6000.0,6500.0,2500.0,4750.0,0.0,4000.0,7750.0,6250.0,8000.0,62500.0
Kanker,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,13000.0,13000.0,,4500.0,900.0,8800.0,6400.0,46600.0
Kanker,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,10000.0,0.0,0.0,10000.0
Kanker,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,6100.0,6100.0
Kanker,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,11000.0,11100.0,,3600.0,2100.0,2400.0,,30200.0
Kanker,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,2000.0,1900.0,0.0,900.0,8800.0,6400.0,300.0,20300.0
Kanker,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2600.0,2000.0,2000.0,1400.0,150.0,4750.0,4150.0,,3500.0,0.0,0.0,0.0,20550.0
Kanker,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,5200.0,0.0,0.0,,0.0,0.0,0.0,0.0,5200.0
Kanker,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,0.0,600.0,1250.0,600.0,600.0,600.0,,3500.0,0.0,0.0,0.0,7750.0
Kanker,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2000.0,2000.0,1400.0,150.0,4750.0,4150.0,3550.0,0.0,0.0,0.0,0.0,0.0,18000.0
Kanker,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,6000.0,18000.0,12000.0,0.0,32760.0,,30240.0,0.0,0.0,0.0,99000.0
Kanker,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,6000.0,0.0,18000.0,0.0,0.0,0.0,32760.0,,0.0,0.0,0.0,0.0,56760.0
Kanker,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,6000.0,6000.0,12000.0,0.0,0.0,,30240.0,0.0,0.0,0.0,54240.0
Kanker,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,6000.0,0.0,18000.0,12000.0,0.0,0.0,65520.0,0.0,0.0,0.0,0.0,0.0,101520.0
Kanker,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,1000.0,10000.0,9000.0,,13800.0,0.0,0.0,0.0,34800.0
Kanker,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,4000.0,0.0,9000.0,0.0,4800.0,,0.0,0.0,0.0,0.0,17800.0
Kanker,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3000.0,0.0,0.0,1000.0,0.0,,13800.0,0.0,0.0,0.0,17800.0
Kanker,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,1000.0,1000.0,10000.0,9000.0,13800.0,0.0,0.0,0.0,0.0,0.0,34800.0
Kanker,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500.0,0.0,500.0,500.0,4150.0,5500.0,4000.0,,4700.0,0.0,0.0,0.0,19850.0
Kanker,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,5000.0,1350.0,0.0,1500.0,,0.0,0.0,0.0,0.0,7850.0
Kanker,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1350.0,,1500.0,0.0,,4700.0,0.0,0.0,0.0,7550.0
Kanker,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,500.0,0.0,500.0,4150.0,5500.0,4000.0,5500.0,0.0,0.0,0.0,0.0,0.0,20150.0
Kanker,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2815.0,3715.0,3715.0,3315.0,3315.0,1915.0,1815.0,,1715.0,1715.0,5915.0,4815.0,34765.0
Kanker,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,5000.0,0.0,200.0,6200.0
Kanker,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,100.0,0.0,400.0,0.0,1400.0,100.0,0.0,,0.0,800.0,1100.0,400.0,4300.0
Kanker,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3715.0,3715.0,3315.0,3315.0,1915.0,1815.0,1815.0,0.0,1715.0,5915.0,4815.0,4615.0,36665.0
Kanker,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,2970.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,2970.0
Kanker,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,2970.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,2970.0
Kanker,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,5983.0,6975.0,400.0,200.0,1100.0,3550.0,650.0,,1650.0,1150.0,950.0,500.0,23108.0
Kanker,16.3.02,Stock Position of Gloves,2. Stocks Received,3392.0,0.0,0.0,2700.0,3900.0,0.0,2300.0,,0.0,0.0,0.0,8265.0,20557.0
Kanker,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.02,Stock Position of Gloves,4. Stock Distributed,2400.0,6575.0,200.0,1800.0,1450.0,2900.0,750.0,,500.0,200.0,450.0,700.0,17925.0
Kanker,16.3.02,Stock Position of Gloves,5. Total Stock,6975.0,400.0,200.0,1100.0,3550.0,650.0,2200.0,0.0,1150.0,950.0,500.0,8065.0,25740.0
Kanker,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,1000.0,0.0,0.0,0.0,41600.0,0.0,0.0,,0.0,0.0,0.0,0.0,42600.0
Kanker,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,41600.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,41600.0
Kanker,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1000.0,0.0,0.0,41600.0,41600.0,0.0,0.0,,0.0,0.0,0.0,0.0,84200.0
Kanker,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,70700.0,1500.0,0.0,0.0,30000.0,10000.0,0.0,,0.0,0.0,120000.0,6000.0,238200.0
Kanker,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,120000.0,0.0,0.0,0.0,,0.0,200000.0,0.0,370000.0,690000.0
Kanker,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,69200.0,1500.0,0.0,90000.0,20000.0,10000.0,0.0,,0.0,80000.0,114000.0,111000.0,495700.0
Kanker,16.3.07,Stock Position of IFA Tablets,5. Total Stock,1500.0,0.0,0.0,30000.0,10000.0,0.0,0.0,0.0,0.0,120000.0,6000.0,265000.0,432500.0
Kanker,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,2820.0,7220.0,0.0,0.0,0.0,0.0,0.0,,0.0,5400.0,100.0,600.0,16140.0
Kanker,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,8000.0,0.0,0.0,0.0,0.0,0.0,0.0,,6400.0,0.0,1000.0,0.0,15400.0
Kanker,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,3600.0,7220.0,0.0,0.0,0.0,0.0,0.0,,1000.0,5300.0,500.0,500.0,18120.0
Kanker,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,7220.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0,100.0,600.0,100.0,13420.0
Kanker,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,424.0,124.0,0.0,,374.0,0.0,0.0,0.0,922.0
Kanker,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,1700.0,1700.0
Kanker,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,300.0,124.0,0.0,,374.0,0.0,0.0,500.0,1298.0
Kanker,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,124.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1324.0
Kanker,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,56080.0,55250.0,52450.0,50000.0,42200.0,52300.0,45950.0,,42800.0,35000.0,19570.0,17144.0,468744.0
Kanker,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,1800.0,0.0,0.0,0.0,11700.0,3200.0,31600.0,,0.0,0.0,0.0,30501.0,78801.0
Kanker,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Kanker,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2630.0,2800.0,2450.0,7800.0,1600.0,9550.0,10550.0,,7800.0,15430.0,2426.0,5500.0,68536.0
Kanker,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,55250.0,52450.0,50000.0,42200.0,52300.0,45950.0,67000.0,0.0,35000.0,19570.0,17144.0,42145.0,479009.0
Kanker,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6700.0,6300.0,14300.0,10800.0,9800.0,9800.0,8200.0,,9400.0,0.0,0.0,0.0,75300.0
Kanker,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,10000.0
Kanker,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,400.0,2000.0,3500.0,1000.0,0.0,1600.0,800.0,,9400.0,0.0,0.0,0.0,18700.0
Kanker,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6300.0,14300.0,10800.0,9800.0,9800.0,8200.0,7400.0,0.0,0.0,0.0,0.0,0.0,66600.0
Kanker,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,94600.0,86600.0,194600.0,181000.0,102200.0,222200.0,51200.0,,92500.0,0.0,0.0,0.0,1024900.0
Kanker,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,120000.0,0.0,0.0,120000.0,0.0,0.0,,0.0,0.0,0.0,0.0,240000.0
Kanker,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8000.0,12000.0,13600.0,78800.0,,6000.0,40000.0,,92500.0,0.0,0.0,0.0,250900.0
Kanker,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,86600.0,194600.0,181000.0,102200.0,222200.0,216200.0,11200.0,0.0,0.0,0.0,0.0,0.0,1014000.0
Kanker,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,300.0,0.0,2500.0,1200.0,1000.0,0.0,200.0,,9919.0,0.0,0.0,0.0,15119.0
Kanker,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2500.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,2500.0
Kanker,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kanker,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,400.0,1300.0,200.0,1000.0,0.0,200.0,,9919.0,0.0,0.0,0.0,13019.0
Kanker,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,300.0,2100.0,1200.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4600.0
Kanker,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,4.0,3.0,2.0,,3.0,4.0,,3.0,,2.0,1.0,22.0
Kanker,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,1.0,,,2.0
Kanker,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kanker,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,1.0,,,2.0
Kanker,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,1.0,,1.0,,1.0,1.0,2.0,,1.0,1.0,9.0
Kanker,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,1.0,,,,,,2.0
Kanker,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,1.0,,1.0,,2.0,1.0,2.0,,1.0,1.0,11.0
Kanker,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,4.0,,2.0,2.0,3.0,2.0,5.0,4.0,2.0,5.0,6.0,39.0
Kanker,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,4.0,,1.0,,,,,,,,1.0,7.0
Kanker,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,5.0,8.0,,3.0,2.0,3.0,2.0,5.0,4.0,2.0,5.0,7.0,46.0
Kanker,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,6.0,3.0,1.0,1.0,1.0,1.0,4.0,1.0,5.0,3.0,1.0,30.0
Kanker,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,2.0,,2.0,2.0,,,,2.0,,,1.0,11.0
Kanker,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,8.0,3.0,3.0,3.0,1.0,1.0,4.0,3.0,5.0,3.0,2.0,41.0
Kanker,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,2.0,,1.0,1.0,2.0,4.0,2.0,3.0,16.0
Kanker,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,1.0,,1.0,,,2.0,5.0
Kanker,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,2.0,1.0,2.0,1.0,3.0,4.0,2.0,5.0,21.0
Kanker,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Kanker,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kanker,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,,1.0
Kanker,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,1.0,,1.0,,,,,,,3.0
Kanker,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kanker,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,1.0,,1.0,,,,,,,3.0
Kanker,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kanker,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kanker,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kanker,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,6.0,1.0,1.0,4.0,3.0,4.0,3.0,3.0,1.0,6.0,1.0,36.0
Kanker,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,3.0,,1.0,1.0,2.0,1.0,1.0,2.0,3.0,3.0,4.0,22.0
Kanker,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,9.0,1.0,2.0,5.0,5.0,5.0,4.0,5.0,4.0,9.0,5.0,58.0
Kanker,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,2.0,,,,,,,,,,,2.0
Kanker,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Kanker,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,,,1.0,,,,,,,3.0
Kanker,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,3.0,1.0,1.0,2.0,1.0,3.0,5.0,1.0,,3.0,23.0
Kanker,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,1.0,1.0,,2.0,,1.0,1.0,1.0,1.0,,9.0
Kanker,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,2.0,4.0,2.0,1.0,4.0,1.0,4.0,6.0,2.0,1.0,3.0,32.0
Kanker,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Kanker,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,1.0,,,,,,1.0,,4.0,1.0,9.0
Kanker,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,1.0,,1.0,,,,1.0,,,4.0
Kanker,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,1.0,1.0,1.0,,2.0,,,1.0,1.0,4.0,1.0,14.0
Kanker,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Kanker,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Kanker,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Kanker,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,2.0,,,,,,1.0,,4.0
Kanker,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,1.0,1.0,1.0,2.0,2.0,2.0,,,,1.0,,11.0
Kanker,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,1.0,3.0,1.0,,1.0,,,,6.0
Kanker,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,1.0,3.0,5.0,3.0,,1.0,,1.0,,17.0
Kanker,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Kanker,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Kanker,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kanker,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,,,,,,1.0,,,2.0
Kanker,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,1.0,,,,,,2.0
Kanker,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,7.0,3.0,3.0,,2.0,2.0,,1.0,3.0,4.0,28.0
Kanker,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,5.0,7.0,3.0,7.0,7.0,2.0,5.0,2.0,6.0,3.0,7.0,57.0
Kanker,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,4.0,7.0,14.0,6.0,11.0,7.0,5.0,7.0,2.0,7.0,6.0,11.0,87.0
Kanker,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Kanker,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,,,,,,,,,,1.0,,2.0
Kanker,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,1.0,,1.0,,,3.0
Kanker,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,1.0,1.0,,,,,,1.0,,2.0,1.0,,6.0
Kanker,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kanker,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kanker,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kanker,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,1.0,1.0,,,,,1.0,,4.0
Kanker,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kanker,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,1.0,1.0,,,,,1.0,,4.0
Kanker,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Kanker,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kanker,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,1.0,,1.0
Kanker,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,1.0,1.0,1.0,,,,,3.0
Kanker,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kanker,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,1.0,1.0,1.0,,,,,3.0
Kanker,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Kanker,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kanker,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Kanker,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kanker,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,3.0,,2.0,2.0,,2.0,1.0,2.0,1.0,15.0
Kanker,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,2.0,,,,,,,,,,,,2.0
Kanker,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,2.0,3.0,,2.0,2.0,,2.0,1.0,2.0,1.0,17.0
Kanker,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,2.0,,1.0,,,,,1.0,6.0
Kanker,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,6.0,13.0,6.0,9.0,4.0,10.0,5.0,8.0,7.0,12.0,16.0,101.0
Kanker,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,4.0,3.0,4.0,1.0,3.0,1.0,,1.0,1.0,1.0,2.0,1.0,22.0
Kanker,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,10.0,18.0,7.0,14.0,5.0,11.0,6.0,9.0,8.0,14.0,18.0,129.0
Kanker,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,2.0,1.0,3.0
Kanker,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,14.0,12.0,7.0,9.0,4.0,5.0,4.0,6.0,2.0,3.0,13.0,88.0
Kanker,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,2.0,4.0,2.0,,3.0,1.0,,,,1.0,3.0,16.0
Kanker,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,9.0,16.0,16.0,9.0,9.0,7.0,6.0,4.0,6.0,2.0,6.0,17.0,107.0
Kanker,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Kanker,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,3.0,3.0,3.0,6.0,1.0,1.0,,2.0,3.0,1.0,1.0,26.0
Kanker,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,,,4.0,1.0,1.0,5.0,1.0,1.0,,2.0,,17.0
Kanker,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,4.0,3.0,7.0,8.0,2.0,6.0,1.0,3.0,3.0,3.0,1.0,45.0
Kanker,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,3.0,1.0,,2.0,1.0,,,,,7.0
Kanker,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,3.0,10.0,11.0,9.0,11.0,13.0,12.0,10.0,6.0,4.0,13.0,106.0
Kanker,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,7.0,10.0,4.0,12.0,9.0,13.0,10.0,11.0,7.0,7.0,11.0,107.0
Kanker,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,10.0,10.0,20.0,18.0,22.0,20.0,28.0,23.0,21.0,13.0,11.0,24.0,220.0
Kanker,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,,1.0,1.0,,3.0,1.0,,,1.0,,3.0,12.0
Kanker,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,8.0,14.0,16.0,15.0,29.0,20.0,18.0,20.0,16.0,12.0,23.0,199.0
Kanker,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,19.0,30.0,23.0,26.0,30.0,53.0,30.0,19.0,11.0,12.0,37.0,30.0,320.0
Kanker,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,29.0,38.0,38.0,43.0,45.0,85.0,51.0,37.0,31.0,29.0,49.0,56.0,531.0
Kanker,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,3.0,3.0,1.0,1.0,4.0,1.0,2.0,1.0,4.0,22.0
Kanker,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,18.0,28.0,16.0,16.0,29.0,28.0,22.0,20.0,20.0,30.0,14.0,24.0,265.0
Kanker,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,30.0,50.0,77.0,42.0,56.0,76.0,59.0,70.0,42.0,21.0,40.0,41.0,604.0
Kanker,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,48.0,78.0,95.0,61.0,88.0,105.0,82.0,94.0,63.0,53.0,55.0,69.0,891.0
Kawardha,1.1,Total number of pregnant women Registered for ANC,TOTAL,1814.0,2087.0,2126.0,2109.0,1916.0,1842.0,1857.0,1877.0,1997.0,2060.0,1947.0,2368.0,24000.0
Kawardha,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,630.0,671.0,697.0,719.0,606.0,521.0,544.0,556.0,613.0,542.0,573.0,706.0,7378.0
Kawardha,1.2,Number of Pregnant women registered under JSY,TOTAL,1423.0,1716.0,1639.0,1739.0,1504.0,1441.0,1434.0,1557.0,1379.0,1554.0,1457.0,1853.0,18696.0
Kawardha,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1357.0,1561.0,1597.0,1715.0,1738.0,1621.0,1663.0,1592.0,1554.0,1499.0,1488.0,1657.0,19042.0
Kawardha,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1520.0,1944.0,1896.0,1866.0,1654.0,1569.0,1559.0,1552.0,1522.0,1552.0,1506.0,1801.0,19941.0
Kawardha,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1529.0,1589.0,1850.0,1923.0,1752.0,1698.0,1586.0,1643.0,1538.0,1569.0,1511.0,1591.0,19779.0
Kawardha,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1210.0,1717.0,1202.0,1163.0,1178.0,960.0,964.0,767.0,1372.0,1389.0,990.0,1168.0,14080.0
Kawardha,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,145.0,266.0,185.0,246.0,183.0,196.0,225.0,344.0,200.0,180.0,185.0,187.0,2542.0
Kawardha,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,0.0,0.0,0.0,2.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Kawardha,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,542.0,647.0,613.0,726.0,514.0,527.0,475.0,599.0,422.0,459.0,555.0,543.0,6622.0
Kawardha,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0.0,2.0,0.0,0.0,1.0,3.0,0.0,6.0,3.0,3.0,0.0,2.0,20.0
Kawardha,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Kawardha,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,326.0,372.0,330.0,382.0,421.0,318.0,412.0,366.0,387.0,216.0,129.0,145.0,3804.0
Kawardha,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,411.0,520.0,575.0,704.0,636.0,780.0,710.0,914.0,719.0,765.0,530.0,721.0,7985.0
Kawardha,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,737.0,892.0,905.0,1086.0,1057.0,1098.0,1122.0,1280.0,1106.0,981.0,659.0,866.0,11789.0
Kawardha,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,441.0,529.0,544.0,769.0,776.0,710.0,728.0,675.0,640.0,588.0,418.0,487.0,7305.0
Kawardha,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,145.0,258.0,220.0,250.0,190.0,176.0,166.0,242.0,143.0,109.0,110.0,103.0,2112.0
Kawardha,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,477.0,524.0,551.0,690.0,633.0,698.0,763.0,809.0,733.0,705.0,722.0,870.0,8175.0
Kawardha,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,359.0,471.0,459.0,597.0,534.0,601.0,598.0,567.0,569.0,701.0,747.0,494.0,6697.0
Kawardha,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,496.0,525.0,579.0,728.0,652.0,675.0,770.0,808.0,737.0,771.0,859.0,878.0,8478.0
Kawardha,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,405.0,398.0,493.0,608.0,569.0,586.0,692.0,671.0,629.0,668.0,775.0,779.0,7273.0
Kawardha,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,17.0,13.0,19.0,13.0,18.0,4.0,27.0,6.0,14.0,12.0,16.0,2.0,161.0
Kawardha,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,68.0,120.0,48.0,80.0,64.0,80.0,57.0,89.0,66.0,82.0,78.0,97.0,929.0
Kawardha,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,68.0,120.0,48.0,80.0,64.0,80.0,57.0,89.0,66.0,82.0,78.0,97.0,929.0
Kawardha,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,25.0,28.0,12.0,28.0,14.0,33.0,24.0,32.0,24.0,34.0,23.0,24.0,301.0
Kawardha,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,3.0,0.0,1.0,2.0,3.0,2.0,1.0,2.0,3.0,2.0,4.0,0.0,23.0
Kawardha,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,16.0
Kawardha,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,18.0,25.0,15.0,23.0,25.0,19.0,18.0,32.0,25.0,28.0,37.0,49.0,314.0
Kawardha,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Kawardha,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,18.0,25.0,15.0,23.0,26.0,19.0,18.0,32.0,25.0,28.0,53.0,50.0,332.0
Kawardha,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,18.0,50.0,15.0,23.0,25.0,19.0,18.0,32.0,25.0,28.0,37.0,49.0,339.0
Kawardha,4.1.1.a,Number of male live births,TOTAL,693.0,812.0,881.0,966.0,957.0,1023.0,1059.0,1201.0,975.0,923.0,846.0,940.0,11276.0
Kawardha,4.1.1.b,Number of female live births,TOTAL,655.0,801.0,743.0,918.0,841.0,889.0,936.0,1063.0,913.0,967.0,752.0,907.0,10385.0
Kawardha,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1348.0,1613.0,1624.0,1884.0,1798.0,1912.0,1995.0,2264.0,1888.0,1890.0,1598.0,1847.0,21661.0
Kawardha,4.1.2,Number of still births,TOTAL,29.0,31.0,39.0,36.0,48.0,52.0,57.0,33.0,43.0,34.0,41.0,39.0,482.0
Kawardha,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,14.0,18.0,37.0,42.0,27.0,16.0,41.0,28.0,29.0,50.0,29.0,24.0,355.0
Kawardha,4.2.1,Number of Newborns weighed at birth,TOTAL,1193.0,1431.0,1458.0,1731.0,1704.0,1809.0,1862.0,2057.0,1766.0,1788.0,1464.0,1798.0,20061.0
Kawardha,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,73.0,100.0,80.0,101.0,106.0,147.0,126.0,127.0,100.0,106.0,75.0,107.0,1248.0
Kawardha,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1246.0,1517.0,1528.0,1816.0,1751.0,1801.0,1930.0,2078.0,1806.0,1829.0,1521.0,1824.0,20647.0
Kawardha,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,3.0,3.0,0.0,2.0,11.0
Kawardha,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,6.0,7.0,5.0,7.0,3.0,5.0,8.0,5.0,8.0,19.0,36.0,113.0
Kawardha,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Kawardha,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,5.0,6.0,7.0,5.0,7.0,4.0,5.0,9.0,8.0,11.0,19.0,39.0,125.0
Kawardha,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,5.0,18.0,14.0,12.0,18.0,6.0,17.0,24.0,13.0,18.0,22.0,25.0,192.0
Kawardha,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,0.0,0.0,4.0
Kawardha,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15.0,17.0,12.0,12.0,12.0,9.0,17.0,20.0,10.0,11.0,26.0,42.0,203.0
Kawardha,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Kawardha,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,666.0,1043.0,746.0,1021.0,881.0,885.0,978.0,1136.0,1041.0,1099.0,990.0,979.0,11465.0
Kawardha,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,704.0,875.0,848.0,974.0,893.0,1019.0,1030.0,1097.0,873.0,907.0,727.0,893.0,10840.0
Kawardha,6.3,PNC maternal complications attended,TOTAL,4.0,10.0,9.0,16.0,7.0,6.0,5.0,8.0,5.0,16.0,4.0,14.0,104.0
Kawardha,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,24.0,16.0,7.0,10.0,8.0,8.0,14.0,8.0,8.0,2.0,11.0,9.0,125.0
Kawardha,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,35.0,24.0,14.0,23.0,13.0,18.0,30.0,11.0,8.0,9.0,28.0,31.0,244.0
Kawardha,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,59.0,40.0,21.0,33.0,21.0,26.0,44.0,19.0,16.0,11.0,39.0,40.0,369.0
Kawardha,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Kawardha,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1.0,1.0,0.0,8.0,4.0,2.0,2.0,2.0,6.0,8.0,6.0,3.0,43.0
Kawardha,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,6.0
Kawardha,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,2.0,0.0,10.0,5.0,2.0,2.0,2.0,8.0,9.0,6.0,3.0,50.0
Kawardha,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,0.0,,,,0.0,,,0.0,0.0,,,0.0
Kawardha,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Kawardha,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,20.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0
Kawardha,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,0.0,,,,0.0,,,0.0,0.0,,,0.0
Kawardha,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,111.0,73.0,145.0,132.0,49.0,49.0,561.0
Kawardha,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,28.0,1.0,11.0,190.0,44.0,40.0,161.0,250.0,1223.0,1448.0,796.0,757.0,4949.0
Kawardha,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,5.0,62.0,23.0,11.0,19.0,46.0,178.0,21.0,11.0,4.0,380.0
Kawardha,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,28.0,1.0,16.0,252.0,67.0,53.0,291.0,369.0,1546.0,1601.0,856.0,810.0,5890.0
Kawardha,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,0.0,,,,19.0,,,24.0,0.0,,,43.0
Kawardha,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kawardha,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Kawardha,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Kawardha,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,0.0,,,,0.0,,,0.0,0.0,,,0.0
Kawardha,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,79.0,43.0,71.0,169.0,123.0,81.0,61.0,51.0,111.0,79.0,77.0,99.0,1044.0
Kawardha,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,1.0,2.0,1.0,22.0,6.0,6.0,4.0,6.0,3.0,8.0,6.0,6.0,71.0
Kawardha,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,2.0,2.0,12.0,4.0,5.0,6.0,2.0,4.0,5.0,4.0,2.0,49.0
Kawardha,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Kawardha,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kawardha,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,81.0,47.0,75.0,206.0,133.0,92.0,71.0,59.0,118.0,92.0,87.0,107.0,1168.0
Kawardha,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Kawardha,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,0.0,,,,0.0,,,0.0,0.0,,,0.0
Kawardha,9.06,Number of IUCD removals,TOTAL,116.0,171.0,125.0,172.0,133.0,98.0,175.0,123.0,83.0,124.0,127.0,146.0,1593.0
Kawardha,9.07,Number of Oral Pills cycles distributed,TOTAL,1669.0,1566.0,2015.0,1608.0,2144.0,2020.0,2438.0,1918.0,1693.0,2118.0,1978.0,2027.0,23194.0
Kawardha,9.08,Number of Condom pieces distributed,TOTAL,4755.0,2856.0,3364.0,4286.0,8222.0,8731.0,5473.0,6413.0,6317.0,7439.0,5662.0,5174.0,68692.0
Kawardha,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,4.0,0.0,0.0,0.0,21.0,26.0,31.0,55.0,27.0,10.0,296.0,63.0,533.0
Kawardha,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,5.0,0.0,0.0,88.0,8.0,5.0,109.0
Kawardha,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,43.0,0.0,0.0,6.0,32.0,33.0,62.0,20.0,22.0,219.0
Kawardha,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,13.0,0.0,0.0,0.0,23.0
Kawardha,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,10.0
Kawardha,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,4.0,4.0,6.0,5.0,4.0,8.0,6.0,8.0,6.0,7.0,6.0,-1.0
Kawardha,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1172.0,1316.0,1435.0,1637.0,1660.0,1676.0,1809.0,1612.0,2066.0,1971.0,1425.0,1773.0,19552.0
Kawardha,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1210.0,1319.0,1560.0,1577.0,1551.0,1638.0,1777.0,1792.0,1937.0,1995.0,1754.0,1854.0,19964.0
Kawardha,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1444.0,1420.0,1418.0,1585.0,1557.0,1511.0,1683.0,1789.0,1626.0,2003.0,1846.0,2023.0,19905.0
Kawardha,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1537.0,1603.0,1467.0,1481.0,1456.0,1479.0,1523.0,1643.0,1697.0,1690.0,1959.0,2130.0,19665.0
Kawardha,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Kawardha,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Kawardha,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Kawardha,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,958.0,1080.0,1109.0,1226.0,1201.0,1241.0,1387.0,1327.0,1455.0,1502.0,1171.0,1271.0,14928.0
Kawardha,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1182.0,1297.0,1545.0,1637.0,1546.0,1621.0,1797.0,1799.0,1938.0,1981.0,1739.0,1849.0,19931.0
Kawardha,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1431.0,1446.0,1434.0,1588.0,1550.0,1511.0,1682.0,1811.0,1632.0,2013.0,1842.0,2019.0,19959.0
Kawardha,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1521.0,1566.0,1450.0,1491.0,1469.0,1490.0,1486.0,1660.0,1689.0,1678.0,1846.0,2114.0,19460.0
Kawardha,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,21.0,7.0,14.0,20.0,0.0,74.0,559.0,703.0,701.0,713.0,276.0,235.0,3323.0
Kawardha,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,209.0,203.0,291.0,194.0,173.0,150.0,1295.0,1658.0,1750.0,1874.0,1562.0,1711.0,11070.0
Kawardha,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,163.0,161.0,217.0,175.0,168.0,124.0,282.0,1432.0,1427.0,1797.0,1667.0,1947.0,9560.0
Kawardha,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,198.0,181.0,206.0,162.0,152.0,145.0,280.0,430.0,1177.0,1402.0,1671.0,1973.0,7977.0
Kawardha,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1181.0,1269.0,1613.0,1888.0,1891.0,1864.0,1855.0,1560.0,1761.0,1586.0,1385.0,1762.0,19615.0
Kawardha,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,7.0,15.0,30.0,5.0,0.0,48.0,376.0,478.0,574.0,540.0,161.0,240.0,2474.0
Kawardha,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Kawardha,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,627.0,670.0,846.0,1061.0,949.0,968.0,949.0,845.0,914.0,865.0,729.0,877.0,10300.0
Kawardha,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,563.0,645.0,766.0,939.0,943.0,884.0,914.0,765.0,948.0,861.0,628.0,832.0,9688.0
Kawardha,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1190.0,1315.0,1612.0,2000.0,1892.0,1852.0,1863.0,1610.0,1862.0,1726.0,1357.0,1709.0,19988.0
Kawardha,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1106.0,1227.0,1367.0,1380.0,1549.0,1271.0,1235.0,1256.0,1724.0,1515.0,1314.0,1602.0,16546.0
Kawardha,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1082.0,1225.0,1361.0,1376.0,1520.0,1256.0,1237.0,1218.0,1704.0,1511.0,1297.0,1613.0,16400.0
Kawardha,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,597.0,603.0,611.0,602.0,989.0,683.0,1123.0,875.0,868.0,929.0,513.0,741.0,9134.0
Kawardha,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,532.0,623.0,536.0,631.0,917.0,653.0,969.0,808.0,806.0,830.0,453.0,688.0,8446.0
Kawardha,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1129.0,1226.0,1147.0,1233.0,1906.0,1336.0,2092.0,1683.0,1674.0,1759.0,966.0,1429.0,17580.0
Kawardha,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,196.0,257.0,364.0,476.0,1664.0,1395.0,561.0,573.0,960.0,948.0,517.0,416.0,8327.0
Kawardha,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,389.0,455.0,526.0,984.0,6424.0,3502.0,1125.0,1122.0,1414.0,1411.0,1078.0,1031.0,19461.0
Kawardha,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,396.0,485.0,567.0,648.0,3614.0,3377.0,1382.0,1083.0,1960.0,1641.0,771.0,1091.0,17015.0
Kawardha,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,1.0,0.0,1.0,0.0,3.0,2.0,0.0,5.0,3.0,3.0,2.0,21.0
Kawardha,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Kawardha,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,759.0,762.0,802.0,775.0,814.0,764.0,778.0,835.0,826.0,807.0,791.0,839.0,9552.0
Kawardha,10.4.2,Number of Immunisation sessions held during the month,TOTAL,703.0,749.0,776.0,770.0,794.0,745.0,759.0,814.0,798.0,798.0,742.0,826.0,9274.0
Kawardha,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,680.0,719.0,750.0,746.0,770.0,734.0,731.0,777.0,784.0,751.0,715.0,791.0,8948.0
Kawardha,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1105.0,1175.0,1543.0,1675.0,1950.0,1717.0,1733.0,1379.0,1925.0,1585.0,1323.0,1716.0,18826.0
Kawardha,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,301.0,331.0,520.0,660.0,6501.0,884.0,577.0,364.0,4575.0,5258.0,533.0,637.0,21141.0
Kawardha,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,115.0,118.0,115.0,395.0,7342.0,452.0,216.0,184.0,5662.0,6013.0,207.0,289.0,21108.0
Kawardha,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14.0,0.0,0.0,13.0,0.0,0.0,21.0,0.0,5.0,33.0,0.0,0.0,86.0
Kawardha,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,266.0,301.0,331.0,314.0,350.0,250.0,230.0,209.0,202.0,243.0,234.0,259.0,3189.0
Kawardha,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,178.0,155.0,190.0,187.0,214.0,121.0,189.0,116.0,112.0,206.0,157.0,44.0,1869.0
Kawardha,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,52.0,51.0,73.0,34.0,45.0,45.0,48.0,49.0,50.0,350.0,83.0,102.0,982.0
Kawardha,13.1,Number of Patients operated for cataract,TOTAL,1.0,0.0,58.0,46.0,35.0,1101.0,408.0,121.0,2.0,103.0,40.0,512.0,2427.0
Kawardha,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,354.0,119.0,0.0,103.0,40.0,512.0,1129.0
Kawardha,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,1.0,0.0,23.0,1.0,0.0,150.0,0.0,0.0,31.0,220.0,0.0,426.0
Kawardha,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,13.5,Number of eyes collected through eye donation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kawardha,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kawardha,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,3.0,4.0,5.0,5.0,4.0,4.0,-1.0
Kawardha,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2.0,2.0,3.0,3.0,1.0,3.0,3.0,1.0,,,2.0,,-1.0
Kawardha,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,895.0,950.0,1000.0,1101.0,1127.0,1079.0,1098.0,1052.0,1048.0,1134.0,1024.0,1054.0,-1.0
Kawardha,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,4.0,5.0,6.0,6.0,5.0,5.0,-1.0
Kawardha,14.05,Number of RKS meetings held during the month,TOTAL,5.0,5.0,4.0,5.0,2.0,4.0,3.0,3.0,3.0,5.0,5.0,1.0,45.0
Kawardha,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,7.0,9.0,9.0,9.0,9.0,10.0,8.0,11.0,14.0,14.0,12.0,-1.0
Kawardha,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,48.0,58.0,57.0,50.0,28.0,39.0,29.0,80.0,105.0,76.0,40.0,49.0,659.0
Kawardha,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,2.0,2.0,2.0,2.0,2.0,1.0,2.0,2.0,3.0,2.0,3.0,-1.0
Kawardha,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Kawardha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,45.0,92.0,74.0,68.0,68.0,76.0,95.0,104.0,89.0,87.0,94.0,100.0,992.0
Kawardha,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,335.0,454.0,488.0,387.0,380.0,864.0,435.0,431.0,487.0,357.0,378.0,597.0,5593.0
Kawardha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,78.0,83.0,83.0,78.0,60.0,71.0,82.0,85.0,98.0,87.0,90.0,92.0,987.0
Kawardha,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,433.0,613.0,518.0,484.0,566.0,1220.0,610.0,737.0,1060.0,1446.0,1079.0,1560.0,10326.0
Kawardha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,123.0,175.0,157.0,146.0,128.0,147.0,177.0,189.0,187.0,174.0,184.0,192.0,1979.0
Kawardha,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,768.0,1067.0,1006.0,871.0,946.0,2084.0,1045.0,1168.0,1547.0,1803.0,1457.0,2157.0,15919.0
Kawardha,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4.0,6.0,4.0,10.0,5.0,4.0,2.0,10.0,6.0,9.0,7.0,5.0,72.0
Kawardha,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,2.0,0.0,4.0,8.0,2.0,4.0,7.0,4.0,2.0,4.0,4.0,42.0
Kawardha,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5.0,8.0,4.0,14.0,13.0,6.0,6.0,17.0,10.0,11.0,11.0,9.0,114.0
Kawardha,14.11,In-Patient Head Count at midnight,TOTAL,755.0,613.0,724.0,839.0,737.0,1910.0,784.0,1109.0,1302.0,899.0,865.0,988.0,11525.0
Kawardha,14.12.1,OPD attendance (All),TOTAL,14475.0,14952.0,15847.0,20063.0,20844.0,25366.0,19004.0,17472.0,19736.0,19416.0,20829.0,22810.0,230814.0
Kawardha,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1.0,552.0,13.0,284.0,27.0,9.0,57.0,90.0,397.0,595.0,2.0,594.0,2621.0
Kawardha,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Kawardha,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,7.0,17.0,5.0,66.0,40.0,42.0,92.0,193.0,326.0,204.0,585.0,14.0,1591.0
Kawardha,14.14.a,Number of patients given AYUSH treatment,TOTAL,89.0,0.0,65.0,111.0,98.0,92.0,87.0,412.0,416.0,418.0,469.0,416.0,2673.0
Kawardha,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,40.0,44.0,77.0,57.0,40.0,47.0,305.0
Kawardha,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1101.0,1156.0,1436.0,1836.0,1497.0,1630.0,1399.0,1077.0,1706.0,1810.0,1502.0,1406.0,17556.0
Kawardha,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,30.0,34.0,72.0,154.0,199.0,86.0,58.0,29.0,52.0,47.0,49.0,64.0,874.0
Kawardha,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,70.0,73.0,49.0,109.0,86.0,108.0,87.0,96.0,64.0,66.0,72.0,110.0,990.0
Kawardha,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3.0,1.0,3.0,3.0,5.0,3.0,4.0,6.0,7.0,7.0,1.0,6.0,49.0
Kawardha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,118.0,195.0,141.0,252.0,176.0,186.0,214.0,465.0,585.0,820.0,325.0,232.0,3709.0
Kawardha,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,1.0,1.0,3.0,5.0,2.0,4.0,4.0,4.0,2.0,23.0,5.0,62.0
Kawardha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,66.0,63.0,98.0,149.0,141.0,158.0,137.0,124.0,153.0,121.0,297.0,269.0,1776.0
Kawardha,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0,0.0,0.0,0.0,5.0
Kawardha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,254.0,331.0,288.0,510.0,403.0,452.0,438.0,685.0,802.0,1007.0,694.0,611.0,6475.0
Kawardha,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,2.0,4.0,6.0,10.0,5.0,8.0,12.0,14.0,9.0,24.0,11.0,116.0
Kawardha,15.2,Number of Widal tests conducted,Number tested,101.0,138.0,91.0,114.0,151.0,294.0,279.0,89.0,83.0,98.0,109.0,137.0,1684.0
Kawardha,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,0.0,1.0,7.0,2.0,2.0,2.0,3.0,3.0,2.0,4.0,15.0,45.0
Kawardha,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,25.0,19.0,21.0,75.0,101.0,92.0,69.0,50.0,68.0,83.0,67.0,32.0,702.0
Kawardha,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,20.0,13.0,12.0,24.0,18.0,20.0,15.0,5.0,52.0,61.0,28.0,119.0,387.0
Kawardha,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,49.0,32.0,34.0,106.0,121.0,114.0,86.0,58.0,123.0,146.0,99.0,166.0,1134.0
Kawardha,15.4.1,Number of blood smears examined for Malaria,TOTAL,590.0,471.0,492.0,803.0,1348.0,1647.0,1487.0,811.0,671.0,512.0,560.0,841.0,10233.0
Kawardha,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,70.0,68.0,58.0,110.0,145.0,208.0,161.0,159.0,84.0,53.0,55.0,82.0,1253.0
Kawardha,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,2.0,6.0,17.0,19.0,42.0,48.0,98.0,28.0,22.0,14.0,8.0,311.0
Kawardha,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,6000.0,11500.0,19000.0,9000.0,9500.0,7500.0,,9500.0,16000.0,5000.0,,14500.0,107500.0
Kawardha,16.1.1,Stock position of DPT vaccines,2. Stocks Received,15000.0,15000.0,0.0,10000.0,10000.0,20000.0,,16000.0,0.0,20000.0,,0.0,106000.0
Kawardha,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9500.0,7500.0,10000.0,9500.0,12000.0,9500.0,,9500.0,11000.0,5000.0,,9500.0,93000.0
Kawardha,16.1.1,Stock position of DPT vaccines,5. Total Stock,11500.0,19000.0,9000.0,9500.0,7500.0,18000.0,0.0,16000.0,5000.0,20000.0,0.0,5000.0,120500.0
Kawardha,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kawardha,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kawardha,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kawardha,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kawardha,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3000.0,11500.0,21500.0,7000.0,500.0,2000.0,,500.0,17000.0,2000.0,,3000.0,68000.0
Kawardha,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,20000.0,0.0,5000.0,20000.0,10000.0,,35000.0,0.0,10000.0,,1000.0,121000.0
Kawardha,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11500.0,10000.0,14500.0,11500.0,18500.0,10000.0,,18500.0,15000.0,,,4000.0,113500.0
Kawardha,16.1.2,Stock position of OPV vaccines,5. Total Stock,11500.0,21500.0,7000.0,500.0,2000.0,2000.0,0.0,17000.0,2000.0,12000.0,0.0,0.0,75500.0
Kawardha,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12000.0,15500.0,18000.0,9000.0,19000.0,21500.0,,5000.0,11500.0,1000.0,,14500.0,127000.0
Kawardha,16.1.3,Stock position of TT vaccines,2. Stocks Received,12000.0,10000.0,0.0,20000.0,19000.0,20000.0,,20000.0,0.0,10000.0,,0.0,111000.0
Kawardha,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.3,Stock position of TT vaccines,4. Stock Distributed,8500.0,7500.0,9000.0,10000.0,16500.0,28500.0,,13500.0,10500.0,9000.0,,6000.0,119000.0
Kawardha,16.1.3,Stock position of TT vaccines,5. Total Stock,15500.0,18000.0,9000.0,19000.0,21500.0,13000.0,0.0,11500.0,1000.0,2000.0,0.0,8500.0,119000.0
Kawardha,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8000.0,12000.0,15000.0,8000.0,6500.0,3500.0,,2000.0,11000.0,5000.0,,1500.0,72500.0
Kawardha,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,0.0,5000.0,5000.0,5000.0,,20000.0,0.0,5000.0,,10000.0,70000.0
Kawardha,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,7000.0,7000.0,6500.0,8000.0,5500.0,,11000.0,6000.0,4500.0,,6000.0,67500.0
Kawardha,16.1.5,Stock position of BCG vaccines,5. Total Stock,12000.0,15000.0,8000.0,6500.0,3500.0,3000.0,0.0,11000.0,5000.0,5500.0,0.0,5500.0,75000.0
Kawardha,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1700.0,4000.0,6500.0,3250.0,4000.0,250.0,,8250.0,4000.0,250.0,,3750.0,35950.0
Kawardha,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,0.0,5000.0,0.0,5000.0,,0.0,0.0,5000.0,,5000.0,30000.0
Kawardha,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2700.0,2500.0,3250.0,4250.0,3750.0,3000.0,,4250.0,3750.0,2000.0,,3000.0,32450.0
Kawardha,16.1.6,Stock position of Measles vaccines,5. Total Stock,4000.0,6500.0,3250.0,4000.0,250.0,2250.0,0.0,4000.0,250.0,3250.0,0.0,5750.0,33500.0
Kawardha,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0,0.0
Kawardha,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0,0.0
Kawardha,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,4800.0,19400.0,13700.0,,8800.0,46700.0
Kawardha,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,20000.0,0.0,0.0,,0.0,20000.0
Kawardha,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,5400.0,5700.0,5700.0,,4800.0,21600.0
Kawardha,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19400.0,13700.0,8000.0,0.0,4000.0,45100.0
Kawardha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2300.0,2300.0,2300.0,2000.0,5600.0,2400.0,,2400.0,2400.0,2400.0,,2400.0,26500.0
Kawardha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,7800.0,0.0,0.0,,0.0,0.0,0.0,,0.0,7800.0
Kawardha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,300.0,4200.0,3200.0,0.0,,0.0,0.0,400.0,,0.0,8100.0
Kawardha,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2300.0,2300.0,2000.0,5600.0,2400.0,2400.0,0.0,2400.0,2400.0,2000.0,0.0,2400.0,26200.0
Kawardha,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,6000.0,0.0,,0.0,0.0,0.0,,0.0,6000.0
Kawardha,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,30000.0,0.0,0.0,,0.0,0.0,0.0,,0.0,30000.0
Kawardha,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,24000.0,6000.0,0.0,,0.0,0.0,0.0,,0.0,30000.0
Kawardha,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Kawardha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,2000.0,0.0,,0.0,0.0,0.0,,0.0,2000.0
Kawardha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,,0.0,0.0,0.0,,0.0,10000.0
Kawardha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,8000.0,2000.0,0.0,,0.0,0.0,0.0,,0.0,10000.0
Kawardha,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Kawardha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1000.0,500.0,,500.0,0.0,0.0,,500.0,2500.0
Kawardha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,4000.0,0.0,0.0,,2700.0,0.0,0.0,,2700.0,9400.0
Kawardha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,3000.0,500.0,0.0,,3200.0,0.0,0.0,,3200.0,9900.0
Kawardha,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1000.0,500.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Kawardha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,3000.0,2100.0,1700.0,1500.0,1500.0,1400.0,,800.0,6210.0,3570.0,,800.0,22580.0
Kawardha,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,7210.0,0.0,0.0,,0.0,7210.0
Kawardha,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.02,Stock Position of Gloves,4. Stock Distributed,900.0,400.0,200.0,0.0,100.0,0.0,,1800.0,2640.0,780.0,,500.0,7320.0
Kawardha,16.3.02,Stock Position of Gloves,5. Total Stock,2100.0,1700.0,1500.0,1500.0,1400.0,1400.0,0.0,6210.0,3570.0,2790.0,0.0,300.0,22470.0
Kawardha,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,7500.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,7500.0
Kawardha,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,25000.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,25000.0
Kawardha,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,17500.0,7500.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,25000.0
Kawardha,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7500.0
Kawardha,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kawardha,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,164000.0,106000.0,0.0,,370000.0,640000.0
Kawardha,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,164000.0,0.0,0.0,,296000.0,460000.0
Kawardha,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,106000.0,0.0,0.0,74000.0,180000.0
Kawardha,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,4000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,6000.0,,0.0,10000.0
Kawardha,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,0.0,21300.0,22400.0,,0.0,43700.0
Kawardha,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,4000.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,28400.0,,0.0,32400.0
Kawardha,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21300.0,0.0,0.0,0.0,21300.0
Kawardha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,1500.0,,3000.0,11000.0,8600.0,,2000.0,26100.0
Kawardha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,,,12000.0,0.0,0.0,,0.0,15000.0
Kawardha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,1500.0,0.0,,4000.0,2400.0,0.0,,2000.0,9900.0
Kawardha,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,1500.0,1500.0,0.0,11000.0,8600.0,8600.0,0.0,0.0,31200.0
Kawardha,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,100.0,,0.0,100.0
Kawardha,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,999.0,0.0,0.0,,0.0,0.0,0.0,,0.0,999.0
Kawardha,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,999.0,0.0,0.0,,0.0,0.0,0.0,,0.0,999.0
Kawardha,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,100.0
Kawardha,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2000.0,1500.0,1500.0,1500.0,1500.0,1500.0,,400.0,18310.0,6000.0,,2000.0,36210.0
Kawardha,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,1500.0,0.0,0.0,0.0,0.0,,,18310.0,0.0,0.0,,0.0,19810.0
Kawardha,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2000.0,0.0,1500.0,0.0,0.0,,,400.0,12310.0,0.0,,0.0,16210.0
Kawardha,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,1500.0,1500.0,0.0,1500.0,1500.0,1500.0,0.0,18310.0,6000.0,6000.0,0.0,2000.0,39810.0
Kawardha,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8000.0,7000.0,5000.0,2600.0,13000.0,14400.0,,10600.0,7200.0,4200.0,,11800.0,83800.0
Kawardha,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,12000.0,3000.0,0.0,,0.0,0.0,9000.0,,0.0,24000.0
Kawardha,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,2000.0,2400.0,1600.0,1600.0,2200.0,,3400.0,3000.0,800.0,,2600.0,20600.0
Kawardha,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7000.0,5000.0,2600.0,13000.0,14400.0,12200.0,0.0,7200.0,4200.0,12400.0,0.0,9200.0,87200.0
Kawardha,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,159200.0,153200.0,147200.0,130400.0,206800.0,188200.0,,177800.0,161600.0,151600.0,,139600.0,1615600.0
Kawardha,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,110400.0,1400.0,0.0,,0.0,0.0,0.0,,0.0,111800.0
Kawardha,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,6000.0,6000.0,16800.0,34000.0,20000.0,,,16200.0,10000.0,8000.0,,12000.0,129000.0
Kawardha,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,153200.0,147200.0,130400.0,206800.0,188200.0,188200.0,0.0,161600.0,151600.0,143600.0,0.0,127600.0,1598400.0
Kawardha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,500.0,500.0,0.0,0.0,1000.0,1900.0,,200.0,1200.0,300.0,,1800.0,7400.0
Kawardha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,2000.0,1400.0,0.0,,2500.0,0.0,2000.0,,0.0,7900.0
Kawardha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Kawardha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,500.0,0.0,1000.0,500.0,1200.0,,1500.0,900.0,300.0,,500.0,6400.0
Kawardha,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,500.0,0.0,0.0,1000.0,1900.0,700.0,0.0,1200.0,300.0,2000.0,0.0,1300.0,8900.0
Kawardha,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,3.0,6.0,5.0,5.0,6.0,1.0,3.0,2.0,4.0,7.0,45.0
Kawardha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kawardha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,1.0,,,,2.0
Kawardha,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,,,1.0,,,,2.0
Kawardha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,1.0,,,,,1.0,2.0
Kawardha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kawardha,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,1.0,,,,,1.0,2.0
Kawardha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,,1.0,2.0,3.0,1.0,1.0,2.0,3.0,5.0,1.0,21.0
Kawardha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,3.0,,2.0,2.0,1.0,,3.0,1.0,2.0,,1.0,15.0
Kawardha,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,5.0,,3.0,4.0,4.0,1.0,4.0,3.0,5.0,5.0,2.0,36.0
Kawardha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,2.0,2.0,1.0,1.0,3.0,9.0
Kawardha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,9.0
Kawardha,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,1.0,,1.0,1.0,3.0,3.0,2.0,2.0,4.0,18.0
Kawardha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,3.0,,2.0,1.0,6.0,3.0,4.0,2.0,4.0,2.0,,27.0
Kawardha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,1.0,1.0,1.0,2.0,1.0,,,2.0,,9.0
Kawardha,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,4.0,,3.0,2.0,7.0,5.0,5.0,2.0,4.0,4.0,,36.0
Kawardha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kawardha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,,,,1.0,2.0
Kawardha,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,,,,1.0,2.0
Kawardha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,1.0,,1.0,,,,,,3.0
Kawardha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,1.0,,3.0,,,,5.0
Kawardha,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,1.0,2.0,,3.0,,,,8.0
Kawardha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kawardha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kawardha,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kawardha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,2.0,2.0,1.0,2.0,3.0,5.0,5.0,2.0,2.0,1.0,27.0
Kawardha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,2.0,,2.0,3.0,,4.0,1.0,3.0,3.0,19.0
Kawardha,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,3.0,4.0,1.0,4.0,6.0,5.0,9.0,3.0,5.0,4.0,46.0
Kawardha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,1.0,,,,1.0,1.0,3.0
Kawardha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Kawardha,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,,,,1.0,,,,1.0,1.0,4.0
Kawardha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,2.0,,2.0,,,,,,1.0,,6.0
Kawardha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,,1.0,,1.0,1.0,1.0,1.0,,1.0,,8.0
Kawardha,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,2.0,1.0,2.0,1.0,1.0,1.0,1.0,,2.0,,14.0
Kawardha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,1.0,,1.0,2.0,1.0,1.0,,2.0,9.0
Kawardha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,1.0,,,,1.0,,1.0,,,4.0
Kawardha,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,1.0,1.0,1.0,,1.0,3.0,1.0,2.0,,2.0,13.0
Kawardha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Kawardha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,1.0,1.0,,,,,3.0
Kawardha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Kawardha,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,1.0,2.0,1.0,1.0,,,,,6.0
Kawardha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,1.0,1.0,,,,,,3.0
Kawardha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,3.0,,1.0,1.0,1.0,1.0,2.0,,,1.0,,10.0
Kawardha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,3.0,,,,1.0,1.0,,5.0
Kawardha,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,3.0,,1.0,2.0,5.0,2.0,2.0,,1.0,2.0,,18.0
Kawardha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,1.0,2.0,,1.0,,,,,5.0
Kawardha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kawardha,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,1.0,2.0,,1.0,,,,,5.0
Kawardha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,2.0,3.0,4.0,5.0,1.0,2.0,3.0,2.0,5.0,2.0,4.0,36.0
Kawardha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,1.0,2.0,3.0,1.0,2.0,1.0,2.0,,4.0,1.0,2.0,22.0
Kawardha,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,3.0,5.0,7.0,6.0,3.0,3.0,5.0,2.0,9.0,3.0,6.0,58.0
Kawardha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,,,,,,,,,,1.0,4.0
Kawardha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Kawardha,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,2.0,,,,,,,,,,1.0,5.0
Kawardha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kawardha,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kawardha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Kawardha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kawardha,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,1.0,,,,,1.0
Kawardha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,1.0,1.0,,,2.0
Kawardha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kawardha,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,1.0,1.0,,,2.0
Kawardha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,1.0,1.0,,,,,3.0
Kawardha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kawardha,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,1.0,1.0,,,,,3.0
Kawardha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,2.0,2.0,,,,1.0,,5.0
Kawardha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kawardha,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,2.0,2.0,,,,1.0,,5.0
Kawardha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kawardha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,1.0,2.0,,,,1.0,2.0,,,8.0
Kawardha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,1.0,1.0,2.0,,,4.0
Kawardha,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,1.0,2.0,,,1.0,2.0,4.0,,,12.0
Kawardha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,,,,,1.0,,,,1.0,3.0
Kawardha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,7.0,5.0,5.0,10.0,4.0,6.0,5.0,1.0,8.0,2.0,2.0,60.0
Kawardha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,2.0,1.0,1.0,1.0,1.0,,,1.0,,,7.0
Kawardha,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,5.0,8.0,7.0,6.0,11.0,5.0,7.0,6.0,1.0,9.0,2.0,3.0,70.0
Kawardha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,2.0,,,,,1.0,,,,,3.0
Kawardha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,5.0,4.0,5.0,7.0,3.0,5.0,4.0,2.0,5.0,6.0,1.0,52.0
Kawardha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,,2.0,,,,,,,,3.0
Kawardha,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,5.0,5.0,7.0,5.0,9.0,3.0,5.0,5.0,2.0,5.0,6.0,1.0,58.0
Kawardha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,1.0,1.0,,,,3.0
Kawardha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,6.0,4.0,1.0,1.0,2.0,,1.0,1.0,,,18.0
Kawardha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,1.0,,1.0,3.0,1.0,2.0,,1.0,10.0
Kawardha,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,1.0,7.0,4.0,2.0,1.0,3.0,4.0,3.0,3.0,,1.0,31.0
Kawardha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,,1.0,,,2.0,1.0,,,5.0
Kawardha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,,4.0,,5.0,6.0,2.0,6.0,2.0,5.0,9.0,9.0,49.0
Kawardha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,3.0,6.0,4.0,6.0,7.0,12.0,12.0,8.0,8.0,5.0,7.0,82.0
Kawardha,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,5.0,4.0,10.0,4.0,11.0,14.0,14.0,18.0,12.0,14.0,14.0,16.0,136.0
Kawardha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,3.0,1.0,1.0,,4.0,2.0,1.0,,1.0,,,,13.0
Kawardha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,6.0,10.0,5.0,16.0,14.0,17.0,10.0,13.0,7.0,5.0,13.0,124.0
Kawardha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,9.0,7.0,3.0,16.0,17.0,32.0,20.0,30.0,18.0,10.0,21.0,184.0
Kawardha,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,12.0,16.0,18.0,8.0,36.0,33.0,50.0,30.0,44.0,25.0,15.0,34.0,321.0
Kawardha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,,2.0,1.0,5.0,2.0,2.0,4.0,1.0,,1.0,21.0
Kawardha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,7.0,9.0,10.0,8.0,24.0,24.0,11.0,13.0,13.0,14.0,14.0,9.0,156.0
Kawardha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,17.0,43.0,37.0,33.0,68.0,50.0,47.0,46.0,45.0,54.0,20.0,41.0,501.0
Kawardha,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,25.0,54.0,47.0,43.0,93.0,79.0,60.0,61.0,62.0,69.0,34.0,51.0,678.0
Kondagaon,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Kondagaon,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Kondagaon,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Kondagaon,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Kondagaon,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Kondagaon,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Kondagaon,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Kondagaon,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,3.0,,,,,,,,,3.0
Kondagaon,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Kondagaon,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Kondagaon,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Kondagaon,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Kondagaon,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,4.1.1.a,Number of male live births,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,4.1.1.b,Number of female live births,TOTAL,,,,3.0,,,,,,,,,3.0
Kondagaon,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,3.0,,,,,,,,,3.0
Kondagaon,4.1.2,Number of still births,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Kondagaon,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,6.3,PNC maternal complications attended,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,4.0,,4.0
Kondagaon,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Kondagaon,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kondagaon,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,0.0,,,,,,,4.0,,4.0
Kondagaon,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Kondagaon,9.06,Number of IUCD removals,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,1.0,,,,,,,,,1.0
Kondagaon,9.08,Number of Condom pieces distributed,TOTAL,,,,2.0,,,,,,,,,2.0
Kondagaon,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Kondagaon,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,1.0,,,,,,,,,1.0
Kondagaon,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,1.0,,,,,,,,,1.0
Kondagaon,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,1.0,,,,,,,,,1.0
Kondagaon,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Kondagaon,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Kondagaon,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,10.0,,,,,,,,,10.0
Kondagaon,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,10.0,,,,,,,,,10.0
Kondagaon,13.1,Number of Patients operated for cataract,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,13.3,Number of School children detected with Refractive errors,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,13.4,Number of children provided free glasses,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Kondagaon,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Kondagaon,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Kondagaon,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Kondagaon,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Kondagaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,3.0,,,,,,,,,3.0
Kondagaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,0.0,,,,,,,,,0.0
Kondagaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,2.0,,,,,,,,,2.0
Kondagaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,9.0,,,,,,,,,9.0
Kondagaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,5.0,,,,,,,,,5.0
Kondagaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,9.0,,,,,,,,,9.0
Kondagaon,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.11,In-Patient Head Count at midnight,TOTAL,,,,6.0,,,,,,,,,6.0
Kondagaon,14.12.1,OPD attendance (All),TOTAL,,,,229.0,,,,,,,,,229.0
Kondagaon,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,7.0,,,,,,,,,7.0
Kondagaon,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,14.14.c,Number of Adolescents counselled,TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,16.0,,,,,,,,,16.0
Kondagaon,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,0.0,,,,,,,,,0.0
Kondagaon,15.2,Number of Widal tests conducted,Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,0.0,,,,,,,,,0.0
Kondagaon,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,20.0,,,,,,,,,20.0
Kondagaon,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,0.0,,,,,,,,,0.0
Kondagaon,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Kondagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Kondagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Kondagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Kondagaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kondagaon,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Kondagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kondagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kondagaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Kondagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kondagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kondagaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Kondagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kondagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kondagaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Kondagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Kondagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kondagaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Kondagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kondagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kondagaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Kondagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kondagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kondagaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kondagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kondagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kondagaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Kondagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kondagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kondagaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kondagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Kondagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Kondagaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Kondagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Kondagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Kondagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Kondagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Kondagaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Korba,1.1,Total number of pregnant women Registered for ANC,TOTAL,2057.0,1746.0,1942.0,2083.0,1779.0,2064.0,2236.0,1976.0,2308.0,2109.0,1839.0,2039.0,24178.0
Korba,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,868.0,777.0,730.0,801.0,724.0,843.0,1014.0,892.0,990.0,928.0,789.0,857.0,10213.0
Korba,1.2,Number of Pregnant women registered under JSY,TOTAL,1879.0,1726.0,1860.0,2023.0,1760.0,2032.0,1998.0,1805.0,2234.0,2030.0,1829.0,2033.0,23209.0
Korba,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1935.0,1908.0,2015.0,2150.0,1867.0,1935.0,2048.0,2077.0,2185.0,2022.0,2165.0,2160.0,24467.0
Korba,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1669.0,1419.0,1662.0,1664.0,1382.0,1600.0,1678.0,1526.0,1817.0,1503.0,1399.0,1523.0,18842.0
Korba,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1913.0,1907.0,1790.0,1865.0,1636.0,1702.0,2126.0,1960.0,1807.0,1772.0,1613.0,1640.0,21731.0
Korba,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1838.0,1948.0,1865.0,1880.0,1647.0,1730.0,1909.0,1728.0,1967.0,1629.0,1625.0,1655.0,21421.0
Korba,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,114.0,157.0,171.0,160.0,168.0,191.0,141.0,131.0,141.0,152.0,93.0,89.0,1708.0
Korba,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,21.0,13.0,9.0,12.0,19.0,12.0,13.0,12.0,13.0,8.0,11.0,8.0,151.0
Korba,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,446.0,536.0,625.0,637.0,632.0,696.0,766.0,697.0,665.0,662.0,664.0,671.0,7697.0
Korba,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,42.0,32.0,57.0,26.0,25.0,34.0,23.0,27.0,27.0,30.0,27.0,32.0,382.0
Korba,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Korba,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,255.0,240.0,271.0,235.0,225.0,284.0,223.0,258.0,226.0,162.0,130.0,35.0,2544.0
Korba,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,506.0,483.0,625.0,611.0,617.0,580.0,501.0,484.0,496.0,487.0,447.0,610.0,6447.0
Korba,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,761.0,723.0,896.0,846.0,842.0,864.0,724.0,742.0,722.0,649.0,577.0,645.0,8991.0
Korba,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,623.0,632.0,686.0,650.0,706.0,688.0,608.0,596.0,569.0,536.0,508.0,563.0,7365.0
Korba,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,183.0,150.0,172.0,192.0,179.0,155.0,158.0,174.0,125.0,101.0,134.0,125.0,1848.0
Korba,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,760.0,710.0,839.0,836.0,930.0,817.0,806.0,871.0,880.0,810.0,852.0,1081.0,10192.0
Korba,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,657.0,617.0,746.0,686.0,777.0,686.0,712.0,756.0,765.0,663.0,693.0,861.0,8619.0
Korba,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,760.0,710.0,839.0,836.0,929.0,818.0,806.0,868.0,880.0,810.0,854.0,1092.0,10202.0
Korba,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,512.0,497.0,570.0,565.0,573.0,558.0,533.0,539.0,588.0,541.0,519.0,678.0,6673.0
Korba,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,24.0,21.0,29.0,47.0,40.0,36.0,35.0,69.0,56.0,42.0,34.0,49.0,482.0
Korba,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,338.0,419.0,368.0,455.0,496.0,404.0,438.0,399.0,384.0,361.0,364.0,402.0,4828.0
Korba,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,338.0,419.0,368.0,455.0,496.0,404.0,438.0,399.0,384.0,361.0,364.0,402.0,4828.0
Korba,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,20.0,48.0,34.0,53.0,46.0,25.0,41.0,51.0,36.0,13.0,36.0,39.0,442.0
Korba,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,0.0,2.0,0.0,0.0,7.0
Korba,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,10.0,13.0,0.0,0.0,0.0,0.0,4.0,27.0
Korba,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,24.0,16.0,14.0,24.0,18.0,25.0,16.0,12.0,15.0,12.0,16.0,21.0,213.0
Korba,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,24.0,16.0,14.0,24.0,18.0,35.0,29.0,12.0,15.0,12.0,16.0,25.0,240.0
Korba,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,112.0,146.0,127.0,164.0,187.0,139.0,157.0,134.0,138.0,120.0,130.0,135.0,1689.0
Korba,4.1.1.a,Number of male live births,TOTAL,979.0,940.0,1079.0,1105.0,1098.0,1043.0,1041.0,1041.0,1012.0,874.0,920.0,1081.0,12213.0
Korba,4.1.1.b,Number of female live births,TOTAL,846.0,888.0,969.0,983.0,1118.0,1001.0,890.0,940.0,936.0,909.0,848.0,1025.0,11353.0
Korba,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1825.0,1828.0,2048.0,2088.0,2216.0,2044.0,1931.0,1981.0,1948.0,1783.0,1768.0,2106.0,23566.0
Korba,4.1.2,Number of still births,TOTAL,39.0,34.0,60.0,64.0,59.0,53.0,48.0,34.0,46.0,41.0,36.0,43.0,557.0
Korba,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11.0,16.0,37.0,33.0,25.0,39.0,28.0,23.0,47.0,29.0,26.0,24.0,338.0
Korba,4.2.1,Number of Newborns weighed at birth,TOTAL,1750.0,1745.0,1914.0,1988.0,2116.0,1967.0,1838.0,1908.0,1793.0,1749.0,1388.0,2076.0,22232.0
Korba,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,171.0,126.0,171.0,167.0,120.0,163.0,171.0,162.0,217.0,172.0,146.0,218.0,2004.0
Korba,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1646.0,1598.0,1825.0,1825.0,1943.0,1818.0,1705.0,1758.0,1624.0,1545.0,1373.0,1909.0,20569.0
Korba,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3.0,1.0,7.0,2.0,2.0,4.0,6.0,1.0,0.0,1.0,15.0,13.0,55.0
Korba,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,14.0,4.0,0.0,10.0,20.0,11.0,4.0,7.0,6.0,1.0,17.0,2.0,96.0
Korba,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,111.0,98.0,84.0,84.0,95.0,94.0,90.0,89.0,92.0,108.0,102.0,122.0,1169.0
Korba,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,128.0,103.0,91.0,96.0,117.0,109.0,100.0,97.0,98.0,110.0,134.0,137.0,1320.0
Korba,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,112.0,146.0,127.0,164.0,187.0,139.0,157.0,134.0,134.0,123.0,130.0,135.0,1688.0
Korba,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,233.0,247.0,206.0,250.0,298.0,244.0,251.0,230.0,232.0,233.0,253.0,249.0,2926.0
Korba,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,124.0,153.0,135.0,151.0,174.0,151.0,172.0,149.0,149.0,129.0,141.0,139.0,1767.0
Korba,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,231.0,247.0,211.0,254.0,298.0,239.0,256.0,230.0,216.0,233.0,256.0,250.0,2921.0
Korba,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13.0,11.0,11.0,11.0,18.0,13.0,14.0,12.0,13.0,8.0,12.0,12.0,148.0
Korba,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1467.0,1232.0,1473.0,1366.0,1560.0,1458.0,1277.0,1329.0,1120.0,1102.0,956.0,1083.0,15423.0
Korba,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,787.0,772.0,937.0,897.0,928.0,742.0,859.0,781.0,814.0,534.0,513.0,818.0,9382.0
Korba,6.3,PNC maternal complications attended,TOTAL,7.0,24.0,35.0,22.0,30.0,46.0,50.0,24.0,17.0,22.0,11.0,15.0,303.0
Korba,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,4.0,4.0,10.0
Korba,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,4.0,4.0,10.0
Korba,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Korba,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,21.0,34.0,22.0,24.0,22.0,62.0,23.0,38.0,23.0,13.0,15.0,12.0,309.0
Korba,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,32.0,41.0,32.0,27.0,25.0,49.0,33.0,39.0,30.0,22.0,25.0,16.0,371.0
Korba,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,53.0,75.0,54.0,51.0,47.0,111.0,56.0,77.0,53.0,35.0,40.0,28.0,680.0
Korba,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Korba,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,9.0,2.0,6.0,7.0,1.0,3.0,10.0,7.0,15.0,60.0
Korba,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,0.0,8.0
Korba,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,17.0,3.0,7.0,7.0,2.0,4.0,10.0,9.0,15.0,74.0
Korba,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Korba,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,146.0,32.0,163.0,210.0,367.0,593.0,281.0,248.0,61.0,2101.0
Korba,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,295.0,0.0,516.0,366.0,747.0,1006.0,665.0,446.0,509.0,4550.0
Korba,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,441.0,32.0,679.0,576.0,1114.0,1599.0,946.0,694.0,570.0,6651.0
Korba,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Korba,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,41.0,1.0,0.0,8.0,0.0,0.0,0.0,0.0,6.0,56.0
Korba,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6.0,0.0,12.0,53.0,20.0,24.0,3.0,90.0,88.0,65.0,57.0,146.0,564.0
Korba,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,10.0,5.0,3.0,9.0,8.0,9.0,12.0,10.0,15.0,12.0,13.0,8.0,114.0
Korba,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,16.0,5.0,15.0,103.0,29.0,33.0,23.0,100.0,103.0,77.0,70.0,160.0,734.0
Korba,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,14.0,18.0,17.0,27.0,28.0,30.0,48.0,31.0,99.0,104.0,90.0,43.0,549.0
Korba,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Korba,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,149.0,275.0,209.0,743.0,497.0,260.0,364.0,290.0,591.0,331.0,196.0,179.0,4084.0
Korba,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,47.0,25.0,19.0,85.0,34.0,14.0,16.0,17.0,26.0,40.0,37.0,31.0,391.0
Korba,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,14.0,10.0,4.0,20.0,18.0,18.0,11.0,21.0,9.0,11.0,15.0,16.0,167.0
Korba,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Korba,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,210.0,310.0,232.0,848.0,549.0,292.0,391.0,328.0,626.0,382.0,248.0,226.0,4642.0
Korba,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Korba,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,19.0,21.0,23.0,10.0,19.0,23.0,29.0,19.0,170.0,94.0,86.0,14.0,527.0
Korba,9.06,Number of IUCD removals,TOTAL,183.0,221.0,200.0,279.0,174.0,226.0,167.0,127.0,169.0,271.0,167.0,279.0,2463.0
Korba,9.07,Number of Oral Pills cycles distributed,TOTAL,4933.0,4775.0,3499.0,4693.0,5144.0,5351.0,4767.0,5632.0,4796.0,4570.0,3950.0,3553.0,55663.0
Korba,9.08,Number of Condom pieces distributed,TOTAL,23076.0,22755.0,17112.0,25734.0,23169.0,23621.0,37237.0,37687.0,33835.0,31309.0,26282.0,26148.0,327965.0
Korba,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,3.0,0.0,2.0,85.0,36.0,16.0,145.0,59.0,210.0,45.0,20.0,13.0,634.0
Korba,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Korba,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,17.0,0.0,22.0,0.0,0.0,0.0,40.0
Korba,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,3.0
Korba,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,9.12,Number of Institutions having NSV trained doctors,TOTAL,2.0,1.0,2.0,3.0,2.0,2.0,2.0,2.0,5.0,2.0,7.0,6.0,-1.0
Korba,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1862.0,1806.0,1940.0,2090.0,1942.0,3706.0,2493.0,2224.0,2439.0,1862.0,1574.0,1937.0,25875.0
Korba,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1952.0,1797.0,1854.0,1969.0,1974.0,3327.0,2492.0,2088.0,2252.0,2079.0,1695.0,2270.0,25749.0
Korba,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2053.0,1849.0,1828.0,1966.0,1994.0,3138.0,2314.0,2192.0,2094.0,2294.0,1706.0,2176.0,25604.0
Korba,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1960.0,1860.0,1870.0,1938.0,1903.0,2999.0,2326.0,2103.0,2372.0,2104.0,1871.0,2274.0,25580.0
Korba,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Korba,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Korba,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Korba,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1219.0,1100.0,1243.0,1370.0,1401.0,2950.0,1545.0,1479.0,1439.0,1221.0,1159.0,1347.0,17473.0
Korba,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1962.0,1787.0,1848.0,1978.0,1988.0,3455.0,2486.0,2091.0,2261.0,2078.0,1706.0,2254.0,25894.0
Korba,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2049.0,1846.0,1802.0,1956.0,1998.0,3154.0,2330.0,2191.0,2087.0,2292.0,1702.0,2166.0,25573.0
Korba,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1957.0,1844.0,1858.0,1935.0,1903.0,2996.0,2336.0,2106.0,2380.0,2101.0,1870.0,2302.0,25588.0
Korba,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,2.0,3.0,0.0,0.0,0.0,67.0,56.0,70.0,90.0,78.0,85.0,451.0
Korba,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,12.0,4.0,0.0,11.0,25.0,93.0,982.0,1477.0,1982.0,1805.0,1547.0,2151.0,10089.0
Korba,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1.0,2.0,0.0,4.0,21.0,89.0,84.0,813.0,1467.0,1809.0,1578.0,2045.0,7913.0
Korba,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,3.0,0.0,0.0,24.0,78.0,51.0,155.0,1032.0,1516.0,1622.0,2127.0,6608.0
Korba,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1870.0,1708.0,1802.0,1847.0,1936.0,2932.0,2153.0,1837.0,2477.0,1985.0,1513.0,2239.0,24299.0
Korba,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,38.0,29.0,68.0,92.0,70.0,78.0,169.0,16.0,6.0,0.0,2.0,0.0,568.0
Korba,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Korba,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,956.0,949.0,940.0,983.0,1024.0,1097.0,1008.0,846.0,1286.0,1051.0,802.0,1217.0,12159.0
Korba,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,912.0,859.0,882.0,945.0,973.0,1030.0,943.0,787.0,1218.0,998.0,739.0,1076.0,11362.0
Korba,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1868.0,1808.0,1822.0,1928.0,1997.0,2127.0,1951.0,1633.0,2504.0,2049.0,1541.0,2293.0,23521.0
Korba,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1608.0,1553.0,1650.0,1559.0,1460.0,1679.0,1833.0,1571.0,2826.0,1792.0,1225.0,2021.0,20777.0
Korba,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1586.0,1531.0,1627.0,1547.0,1449.0,1679.0,1828.0,1556.0,2835.0,1797.0,1145.0,2012.0,20592.0
Korba,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,336.0,261.0,255.0,227.0,148.0,146.0,127.0,198.0,238.0,84.0,95.0,94.0,2209.0
Korba,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,297.0,243.0,241.0,182.0,140.0,121.0,111.0,166.0,202.0,79.0,94.0,88.0,1964.0
Korba,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,633.0,504.0,496.0,409.0,288.0,267.0,238.0,364.0,440.0,163.0,189.0,182.0,4173.0
Korba,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,258.0,256.0,250.0,393.0,831.0,3693.0,3368.0,1899.0,3702.0,2035.0,1637.0,1425.0,19747.0
Korba,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,646.0,640.0,680.0,715.0,2357.0,7365.0,3485.0,2327.0,3030.0,2386.0,1746.0,1083.0,26460.0
Korba,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,603.0,507.0,988.0,763.0,1354.0,6401.0,2970.0,2483.0,2936.0,2156.0,1584.0,1182.0,23927.0
Korba,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26.0,49.0,21.0,27.0,32.0,28.0,48.0,40.0,47.0,43.0,52.0,42.0,455.0
Korba,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,43.0,45.0,65.0,49.0,27.0,37.0,42.0,49.0,51.0,97.0,36.0,32.0,573.0
Korba,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,887.0,861.0,914.0,944.0,972.0,988.0,962.0,919.0,1043.0,987.0,946.0,988.0,11411.0
Korba,10.4.2,Number of Immunisation sessions held during the month,TOTAL,804.0,775.0,836.0,875.0,890.0,914.0,894.0,840.0,982.0,937.0,819.0,893.0,10459.0
Korba,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,641.0,635.0,685.0,711.0,737.0,767.0,790.0,699.0,863.0,841.0,709.0,767.0,8845.0
Korba,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1691.0,1555.0,1684.0,1833.0,1821.0,2078.0,1849.0,1544.0,2676.0,2020.0,1443.0,2139.0,22333.0
Korba,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,289.0,250.0,438.0,417.0,517.0,622.0,495.0,364.0,7410.0,4982.0,357.0,404.0,16545.0
Korba,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,237.0,175.0,137.0,228.0,225.0,1302.0,529.0,286.0,9080.0,6534.0,331.0,498.0,19562.0
Korba,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,18.0,4.0,12.0,0.0,3.0,0.0,0.0,0.0,1.0,38.0
Korba,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,581.0,499.0,627.0,745.0,749.0,765.0,576.0,444.0,504.0,462.0,523.0,616.0,7091.0
Korba,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,241.0,185.0,250.0,190.0,245.0,392.0,483.0,348.0,186.0,178.0,240.0,261.0,3199.0
Korba,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,111.0,120.0,45.0,50.0,25.0,106.0,37.0,31.0,18.0,17.0,106.0,47.0,713.0
Korba,13.1,Number of Patients operated for cataract,TOTAL,14.0,30.0,61.0,46.0,59.0,272.0,65.0,389.0,175.0,152.0,216.0,26.0,1505.0
Korba,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,21.0,26.0,21.0,40.0,272.0,65.0,285.0,167.0,124.0,193.0,6.0,1220.0
Korba,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,23.0,141.0,0.0,6.0,5.0,5.0,82.0,5.0,267.0
Korba,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,40.0,19.0,0.0,0.0,1.0,0.0,8.0,0.0,68.0
Korba,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,4.0,3.0,4.0,4.0,4.0,5.0,5.0,4.0,4.0,-1.0
Korba,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,3.0,3.0,5.0,6.0,4.0,7.0,8.0,5.0,3.0,6.0,6.0,-1.0
Korba,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,694.0,825.0,814.0,996.0,952.0,931.0,979.0,906.0,1156.0,938.0,973.0,975.0,-1.0
Korba,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,3.0,-1.0
Korba,14.05,Number of RKS meetings held during the month,TOTAL,17.0,15.0,17.0,20.0,22.0,17.0,17.0,20.0,14.0,14.0,18.0,21.0,212.0
Korba,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,6.0,5.0,5.0,6.0,5.0,5.0,5.0,8.0,7.0,13.0,10.0,-1.0
Korba,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,88.0,91.0,102.0,90.0,105.0,123.0,123.0,119.0,136.0,150.0,162.0,152.0,1441.0
Korba,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2.0,3.0,3.0,3.0,3.0,3.0,4.0,4.0,3.0,2.0,2.0,1.0,-1.0
Korba,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-1.0
Korba,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,132.0,172.0,134.0,204.0,236.0,216.0,231.0,150.0,101.0,169.0,163.0,184.0,2092.0
Korba,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,555.0,535.0,510.0,557.0,543.0,666.0,507.0,641.0,557.0,451.0,472.0,545.0,6539.0
Korba,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,115.0,185.0,128.0,165.0,187.0,156.0,137.0,155.0,85.0,165.0,132.0,123.0,1733.0
Korba,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,722.0,749.0,1052.0,1201.0,1205.0,1215.0,1155.0,1160.0,1198.0,1138.0,1186.0,1258.0,13239.0
Korba,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,247.0,357.0,262.0,369.0,423.0,372.0,368.0,305.0,186.0,334.0,295.0,307.0,3825.0
Korba,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1277.0,1284.0,1562.0,1758.0,1748.0,1881.0,1662.0,1801.0,1755.0,1589.0,1658.0,1803.0,19778.0
Korba,14.10.2.a,Number of death cases of Inpatient males,TOTAL,13.0,16.0,16.0,20.0,14.0,12.0,15.0,25.0,19.0,14.0,18.0,12.0,194.0
Korba,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,10.0,10.0,12.0,13.0,16.0,21.0,17.0,12.0,8.0,7.0,10.0,147.0
Korba,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24.0,26.0,26.0,32.0,27.0,28.0,36.0,42.0,31.0,22.0,25.0,22.0,341.0
Korba,14.11,In-Patient Head Count at midnight,TOTAL,112.0,614.0,503.0,556.0,498.0,533.0,520.0,495.0,595.0,506.0,576.0,580.0,6088.0
Korba,14.12.1,OPD attendance (All),TOTAL,23510.0,24917.0,25349.0,33464.0,35536.0,36931.0,31971.0,31123.0,31917.0,27736.0,31888.0,32536.0,366878.0
Korba,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,52.0,52.0,30.0,56.0,46.0,184.0,39.0,36.0,383.0,262.0,225.0,51.0,1416.0
Korba,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Korba,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,469.0,434.0,372.0,564.0,313.0,820.0,587.0,658.0,551.0,594.0,516.0,545.0,6423.0
Korba,14.14.a,Number of patients given AYUSH treatment,TOTAL,767.0,976.0,789.0,1386.0,1009.0,1397.0,1585.0,1148.0,1632.0,1397.0,1427.0,2016.0,15529.0
Korba,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,0.0,0.0,3.0,0.0,10.0
Korba,14.14.c,Number of Adolescents counselled,TOTAL,57.0,44.0,40.0,21.0,41.0,67.0,39.0,36.0,31.0,20.0,51.0,43.0,490.0
Korba,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1056.0,1113.0,1582.0,2091.0,1838.0,1976.0,2369.0,2024.0,2223.0,1982.0,2284.0,2061.0,22599.0
Korba,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,113.0,105.0,156.0,181.0,215.0,189.0,228.0,122.0,212.0,151.0,172.0,142.0,1986.0
Korba,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,115.0,213.0,160.0,211.0,222.0,333.0,393.0,270.0,279.0,309.0,288.0,439.0,3232.0
Korba,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,4.0,2.0,3.0,2.0,4.0,1.0,2.0,3.0,4.0,0.0,2.0,29.0
Korba,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,66.0,104.0,110.0,205.0,148.0,207.0,143.0,103.0,300.0,203.0,166.0,134.0,1889.0
Korba,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,4.0,3.0,3.0,23.0,1.0,4.0,39.0
Korba,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,204.0,354.0,355.0,269.0,274.0,318.0,280.0,208.0,291.0,319.0,336.0,325.0,3533.0
Korba,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,3.0,0.0,2.0,0.0,11.0,1.0,1.0,0.0,0.0,1.0,19.0
Korba,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,385.0,671.0,625.0,685.0,644.0,858.0,816.0,581.0,870.0,831.0,790.0,898.0,8654.0
Korba,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,4.0,5.0,3.0,4.0,5.0,16.0,6.0,7.0,27.0,1.0,7.0,87.0
Korba,15.2,Number of Widal tests conducted,Number tested,259.0,264.0,233.0,302.0,308.0,325.0,306.0,256.0,279.0,292.0,306.0,302.0,3432.0
Korba,15.3.a,Number of VDRL tests conducted on males,Number tested,42.0,73.0,92.0,118.0,109.0,158.0,226.0,237.0,291.0,306.0,312.0,296.0,2260.0
Korba,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,34.0,45.0,57.0,108.0,89.0,121.0,166.0,49.0,67.0,142.0,89.0,80.0,1047.0
Korba,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,70.0,72.0,92.0,112.0,90.0,265.0,119.0,125.0,165.0,133.0,146.0,156.0,1545.0
Korba,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,146.0,190.0,241.0,338.0,288.0,544.0,511.0,411.0,523.0,581.0,547.0,532.0,4852.0
Korba,15.4.1,Number of blood smears examined for Malaria,TOTAL,6400.0,6307.0,8839.0,7318.0,9761.0,10787.0,9751.0,13343.0,9827.0,6114.0,6923.0,9110.0,104480.0
Korba,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,317.0,414.0,469.0,669.0,676.0,785.0,532.0,899.0,658.0,244.0,355.0,313.0,6331.0
Korba,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,128.0,132.0,157.0,195.0,310.0,365.0,584.0,919.0,743.0,323.0,182.0,276.0,4314.0
Korba,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4000.0,18000.0,8000.0,8000.0,9000.0,11000.0,10000.0,8000.0,14000.0,7500.0,10500.0,10500.0,118500.0
Korba,16.1.1,Stock position of DPT vaccines,2. Stocks Received,36000.0,0.0,0.0,10000.0,20000.0,20000.0,0.0,24000.0,0.0,20000.0,0.0,10000.0,140000.0
Korba,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Korba,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,22000.0,0.0,3000.0,9000.0,18000.0,11000.0,2000.0,17500.0,6500.0,17500.0,0.0,12500.0,119000.0
Korba,16.1.1,Stock position of DPT vaccines,5. Total Stock,18000.0,18000.0,5000.0,9000.0,11000.0,20000.0,8000.0,14500.0,7500.0,10000.0,10500.0,8000.0,139500.0
Korba,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Korba,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Korba,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Korba,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Korba,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,16000.0,18000.0,9000.0,9000.0,8000.0,16000.0,2000.0,1000.0,2000.0,5500.0,8000.0,8000.0,102500.0
Korba,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,0.0,0.0,10000.0,30000.0,10000.0,0.0,30000.0,10000.0,20000.0,213000.0,213000.0,556000.0
Korba,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Korba,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,18000.0,0.0,4000.0,11000.0,22000.0,24000.0,1000.0,27000.0,6500.0,17500.0,213000.0,220000.0,564000.0
Korba,16.1.2,Stock position of OPV vaccines,5. Total Stock,18000.0,18000.0,5000.0,8000.0,16000.0,2000.0,1000.0,4000.0,5500.0,8000.0,8000.0,1000.0,94500.0
Korba,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2500.0,14500.0,4000.0,4000.0,8000.0,2500.0,8500.0,5500.0,16000.0,9000.0,25000.0,25000.0,124500.0
Korba,16.1.3,Stock position of TT vaccines,2. Stocks Received,30000.0,0.0,0.0,10000.0,2500.0,40000.0,0.0,24000.0,0.0,30000.0,0.0,10000.0,146500.0
Korba,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Korba,16.1.3,Stock position of TT vaccines,4. Stock Distributed,18000.0,0.0,2000.0,6000.0,8000.0,31500.0,3000.0,13500.0,7000.0,14000.0,0.0,15000.0,118000.0
Korba,16.1.3,Stock position of TT vaccines,5. Total Stock,14500.0,14500.0,2000.0,8000.0,2500.0,11000.0,5500.0,16000.0,9000.0,25000.0,25000.0,20000.0,153000.0
Korba,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6000.0,7000.0,2000.0,2000.0,8500.0,1500.0,500.0,0.0,3000.0,5500.0,4500.0,2500.0,43000.0
Korba,16.1.5,Stock position of BCG vaccines,2. Stocks Received,20000.0,0.0,0.0,10000.0,0.0,10000.0,0.0,15000.0,10000.0,7000.0,0.0,10000.0,82000.0
Korba,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,19000.0,0.0,1500.0,3500.0,7000.0,11000.0,500.0,12000.0,7500.0,8000.0,2000.0,11500.0,83500.0
Korba,16.1.5,Stock position of BCG vaccines,5. Total Stock,7000.0,7000.0,500.0,8500.0,1500.0,500.0,0.0,3000.0,5500.0,4500.0,2500.0,1000.0,41500.0
Korba,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4250.0,6750.0,3000.0,3000.0,4500.0,3500.0,6250.0,6250.0,14000.0,12000.0,7000.0,7000.0,77500.0
Korba,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,0.0,5000.0,0.0,10000.0,0.0,10000.0,14000.0,5000.0,0.0,5000.0,54000.0
Korba,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2500.0,0.0,1500.0,3500.0,1000.0,7250.0,0.0,4250.0,2000.0,10000.0,0.0,2000.0,34000.0
Korba,16.1.6,Stock position of Measles vaccines,5. Total Stock,6750.0,6750.0,1500.0,4500.0,3500.0,6250.0,6250.0,12000.0,26000.0,7000.0,7000.0,10000.0,97500.0
Korba,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,5700.0,10700.0,10400.0,17500.0,17500.0,73800.0
Korba,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,25000.0,0.0,24000.0,0.0,20000.0,0.0,0.0,69000.0
Korba,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,13000.0,6300.0,18900.0,300.0,12900.0,0.0,3600.0,55000.0
Korba,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,12000.0,5700.0,10800.0,10400.0,17500.0,17500.0,13900.0,87800.0
Korba,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,108000.0,0.0,0.0,1264.0,0.0,0.0,55440.0,0.0,0.0,0.0,0.0,0.0,164704.0
Korba,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,7889.0,0.0,0.0,55440.0,0.0,0.0,0.0,0.0,0.0,0.0,63329.0
Korba,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,42000.0,0.0,6565.0,0.0,0.0,0.0,32760.0,0.0,0.0,0.0,0.0,0.0,81325.0
Korba,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,66000.0,0.0,1324.0,1264.0,0.0,55440.0,22680.0,0.0,0.0,0.0,0.0,0.0,146708.0
Korba,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,66000.0,42000.0,48000.0,5000.0,0.0,0.0,22680.0,0.0,0.0,0.0,0.0,183680.0
Korba,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,36000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36000.0
Korba,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,24000.0,30000.0,43000.0,5000.0,0.0,0.0,22680.0,0.0,0.0,0.0,0.0,124680.0
Korba,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,42000.0,48000.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,95000.0
Korba,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Korba,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Korba,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,8000.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Korba,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Korba,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,3215.0,3215.0,2715.0,2715.0,2715.0,2715.0,2215.0,1115.0,1115.0,1115.0,1115.0,23965.0
Korba,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,3215.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3215.0
Korba,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,500.0,0.0,0.0,0.0,500.0,1100.0,1115.0,0.0,0.0,800.0,4015.0
Korba,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3215.0,3215.0,2715.0,2715.0,2715.0,2715.0,2215.0,1115.0,0.0,1115.0,1115.0,315.0,23165.0
Korba,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,3000.0,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31000.0
Korba,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0
Korba,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,3000.0,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31000.0
Korba,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,28000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28000.0
Korba,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,59250.0,6750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,296000.0,362000.0
Korba,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,195000.0,120000.0,0.0,296000.0,370000.0,981000.0
Korba,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,52500.0,6750.0,0.0,0.0,0.0,0.0,0.0,195000.0,120000.0,0.0,0.0,249000.0,623250.0
Korba,16.3.07,Stock Position of IFA Tablets,5. Total Stock,6750.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,296000.0,417000.0,719750.0
Korba,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,41800.0,32250.0,29100.0,25600.0,14400.0,11400.0,5700.0,1700.0,6300.0,4700.0,2950.0,950.0,176850.0
Korba,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6300.0,2500.0,0.0,0.0,8500.0,17300.0
Korba,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,9550.0,3150.0,3500.0,11200.0,3000.0,0.0,4000.0,1700.0,4100.0,1750.0,2000.0,7500.0,51450.0
Korba,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,32250.0,29100.0,25600.0,14400.0,11400.0,11400.0,1700.0,6300.0,4700.0,2950.0,950.0,1950.0,142700.0
Korba,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,545.0,545.0,545.0,545.0,184.0,184.0,184.0,2417.0,417.0,417.0,417.0,3817.0,10217.0
Korba,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,3817.0,0.0,0.0,0.0,3700.0,0.0,7517.0
Korba,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,361.0,0.0,0.0,4001.0,2000.0,417.0,0.0,300.0,2000.0,9079.0
Korba,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,545.0,545.0,545.0,184.0,184.0,184.0,0.0,417.0,0.0,417.0,3817.0,1817.0,8655.0
Korba,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0,3200.0
Korba,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3200.0,3200.0
Korba,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,17500.0
Korba,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,9000.0
Korba,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,9000.0
Korba,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8500.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,17500.0
Korba,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,332400.0,388400.0,424400.0,402400.0,442800.0,404000.0,404000.0,28900.0,28900.0,28900.0,28900.0,28900.0,2942900.0
Korba,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,648800.0,36000.0,0.0,62400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,747200.0
Korba,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,92000.0,,22000.0,22000.0,38800.0,0.0,375100.0,0.0,0.0,0.0,0.0,0.0,549900.0
Korba,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,889200.0,424400.0,402400.0,442800.0,404000.0,404000.0,28900.0,28900.0,28900.0,28900.0,28900.0,28900.0,3140200.0
Korba,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,9000.0
Korba,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Korba,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,0.0,12000.0
Korba,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Korba,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,,1.0,5.0,5.0,1.0,3.0,4.0,2.0,2.0,,,25.0
Korba,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Korba,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,1.0,,,1.0,3.0
Korba,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,1.0,,,1.0,3.0
Korba,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,1.0,,,,,,,,,2.0
Korba,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Korba,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,1.0,,,,,1.0,,,,3.0
Korba,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,,1.0,3.0,,1.0,3.0,2.0,1.0,,13.0
Korba,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,,,,,,1.0,1.0,4.0
Korba,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,1.0,,2.0,3.0,,1.0,3.0,2.0,2.0,1.0,17.0
Korba,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,,2.0,,,3.0,,,2.0,2.0,,2.0,14.0
Korba,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,3.0,,2.0,2.0,2.0,,,11.0
Korba,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,,2.0,1.0,,6.0,,2.0,4.0,4.0,,2.0,25.0
Korba,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,4.0,,,1.0,,,6.0
Korba,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,1.0,2.0,,,3.0
Korba,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,,4.0,,1.0,3.0,,,9.0
Korba,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Korba,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Korba,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Korba,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,,,,,,,,,,,2.0
Korba,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,,,1.0,2.0,,,,,4.0
Korba,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,1.0,,,,,1.0,2.0,,,,,6.0
Korba,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Korba,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Korba,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Korba,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,5.0,,,2.0,4.0,,,,2.0,14.0
Korba,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,1.0,1.0,,3.0,1.0,2.0,1.0,2.0,2.0,14.0
Korba,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,2.0,6.0,1.0,,5.0,5.0,2.0,1.0,2.0,4.0,28.0
Korba,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Korba,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Korba,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,,1.0,,2.0
Korba,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Korba,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,3.0,3.0,,3.0,2.0,5.0,1.0,2.0,,1.0,1.0,21.0
Korba,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,,1.0,,,,,2.0,,1.0,,7.0
Korba,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,4.0,3.0,1.0,3.0,2.0,5.0,2.0,4.0,,2.0,1.0,29.0
Korba,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Korba,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,1.0,,,,1.0,1.0,,,,,3.0
Korba,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,2.0,,,,2.0,1.0,,,,,5.0
Korba,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,,1.0,,,,,,2.0
Korba,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Korba,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,1.0,,1.0,,,,,,3.0
Korba,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,1.0,,,1.0,,,,,,,3.0
Korba,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,6.0,2.0,3.0,8.0,,8.0,5.0,11.0,2.0,1.0,1.0,48.0
Korba,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,3.0,2.0,1.0,,1.0,,1.0,3.0,,,,11.0
Korba,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,10.0,5.0,4.0,8.0,2.0,8.0,6.0,14.0,2.0,1.0,1.0,62.0
Korba,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Korba,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Korba,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Korba,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,2.0,2.0,4.0,2.0,3.0,1.0,2.0,6.0,9.0,4.0,4.0,3.0,42.0
Korba,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,1.0,3.0,2.0,5.0,3.0,1.0,2.0,3.0,,,20.0
Korba,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,2.0,2.0,5.0,5.0,5.0,6.0,5.0,7.0,11.0,7.0,4.0,3.0,62.0
Korba,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Korba,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,2.0,1.0,,4.0,,,8.0
Korba,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Korba,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,1.0,1.0,,1.0,2.0,1.0,,4.0,,1.0,11.0
Korba,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Korba,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Korba,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,1.0,,1.0
Korba,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Korba,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,1.0,,,,,1.0
Korba,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,1.0,,,,,2.0
Korba,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Korba,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,1.0,,,,,,,,,,1.0
Korba,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,,,,,,,1.0,2.0
Korba,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,1.0,,1.0,1.0,,,,1.0,5.0
Korba,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Korba,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,1.0,,1.0,1.0,,,,1.0,5.0
Korba,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,2.0,,,1.0,,,4.0
Korba,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Korba,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,2.0,,,1.0,,,4.0
Korba,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Korba,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,3.0,,1.0,1.0,,1.0,1.0,3.0,,12.0
Korba,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,2.0,,,,2.0,1.0,,5.0
Korba,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,3.0,,3.0,1.0,,1.0,3.0,4.0,,17.0
Korba,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,,1.0,,1.0,,2.0,,,,,6.0
Korba,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,10.0,14.0,13.0,7.0,10.0,10.0,6.0,7.0,10.0,5.0,9.0,107.0
Korba,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,2.0,2.0,1.0,,,,1.0,1.0,,1.0,9.0
Korba,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,7.0,12.0,16.0,16.0,8.0,11.0,10.0,8.0,8.0,11.0,5.0,10.0,122.0
Korba,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Korba,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,5.0,4.0,7.0,7.0,8.0,10.0,6.0,7.0,3.0,2.0,1.0,69.0
Korba,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,,,,,,,1.0,,2.0
Korba,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,10.0,5.0,4.0,7.0,7.0,9.0,10.0,6.0,7.0,3.0,3.0,1.0,72.0
Korba,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,,1.0,,,,1.0,,,,3.0
Korba,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,4.0,,7.0,2.0,5.0,3.0,3.0,1.0,1.0,1.0,1.0,29.0
Korba,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,1.0,1.0,1.0,,,,1.0,1.0,,,,7.0
Korba,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,3.0,5.0,2.0,8.0,3.0,5.0,3.0,4.0,3.0,1.0,1.0,1.0,39.0
Korba,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,1.0,,,,,1.0,,2.0
Korba,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,3.0,4.0,7.0,4.0,4.0,7.0,2.0,12.0,6.0,6.0,2.0,59.0
Korba,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,1.0,2.0,4.0,6.0,7.0,2.0,1.0,2.0,3.0,1.0,1.0,31.0
Korba,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,3.0,4.0,6.0,11.0,10.0,12.0,9.0,3.0,14.0,9.0,8.0,3.0,92.0
Korba,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,,2.0,2.0,,,,,,5.0
Korba,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,4.0,7.0,9.0,9.0,7.0,10.0,11.0,8.0,4.0,6.0,5.0,82.0
Korba,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,11.0,7.0,13.0,7.0,11.0,7.0,19.0,7.0,7.0,4.0,,9.0,102.0
Korba,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,14.0,11.0,20.0,16.0,20.0,16.0,31.0,18.0,15.0,8.0,6.0,14.0,189.0
Korba,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,6.0,3.0,2.0,3.0,1.0,6.0,,,1.0,,25.0
Korba,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,13.0,15.0,32.0,28.0,13.0,27.0,30.0,20.0,28.0,25.0,12.0,6.0,249.0
Korba,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,21.0,26.0,37.0,34.0,15.0,26.0,58.0,33.0,18.0,16.0,18.0,15.0,317.0
Korba,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,36.0,42.0,75.0,65.0,30.0,56.0,89.0,59.0,46.0,41.0,31.0,21.0,591.0
Koriya,1.1,Total number of pregnant women Registered for ANC,TOTAL,1725.0,1789.0,1702.0,2342.0,1865.0,2123.0,1896.0,1504.0,2146.0,2154.0,2089.0,2391.0,23726.0
Koriya,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,433.0,381.0,457.0,568.0,471.0,447.0,411.0,367.0,508.0,602.0,560.0,603.0,5808.0
Koriya,1.2,Number of Pregnant women registered under JSY,TOTAL,1544.0,1593.0,1499.0,2186.0,1716.0,1936.0,1736.0,1334.0,2011.0,1936.0,1773.0,2230.0,21494.0
Koriya,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1329.0,1524.0,1595.0,1544.0,1603.0,1813.0,1543.0,1279.0,1497.0,1436.0,1370.0,1744.0,18277.0
Koriya,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1003.0,994.0,964.0,1179.0,791.0,895.0,825.0,880.0,1142.0,1045.0,986.0,1165.0,11869.0
Koriya,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1121.0,1114.0,999.0,1057.0,1235.0,955.0,940.0,858.0,960.0,1111.0,968.0,1161.0,12479.0
Koriya,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,950.0,954.0,1064.0,996.0,717.0,1104.0,701.0,704.0,893.0,797.0,777.0,855.0,10512.0
Koriya,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,43.0,70.0,41.0,47.0,18.0,7.0,10.0,4.0,38.0,18.0,18.0,27.0,341.0
Koriya,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,3.0,16.0,1.0,0.0,9.0,1.0,1.0,1.0,3.0,1.0,1.0,38.0
Koriya,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,234.0,441.0,433.0,469.0,336.0,425.0,380.0,360.0,437.0,358.0,311.0,361.0,4545.0
Koriya,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8.0,40.0,26.0,27.0,35.0,34.0,27.0,18.0,8.0,16.0,10.0,12.0,261.0
Koriya,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Koriya,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,96.0,111.0,138.0,189.0,156.0,127.0,123.0,95.0,106.0,93.0,47.0,75.0,1356.0
Koriya,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,193.0,220.0,254.0,350.0,330.0,386.0,289.0,303.0,256.0,219.0,189.0,279.0,3268.0
Koriya,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,289.0,331.0,392.0,539.0,486.0,513.0,412.0,398.0,362.0,312.0,236.0,354.0,4624.0
Koriya,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,166.0,217.0,272.0,341.0,309.0,340.0,248.0,233.0,213.0,190.0,149.0,263.0,2941.0
Koriya,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,113.0,111.0,111.0,182.0,172.0,186.0,137.0,97.0,110.0,98.0,75.0,88.0,1480.0
Koriya,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,395.0,534.0,638.0,859.0,716.0,589.0,626.0,539.0,530.0,477.0,448.0,558.0,6909.0
Koriya,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,357.0,426.0,535.0,630.0,639.0,483.0,575.0,458.0,472.0,454.0,348.0,515.0,5892.0
Koriya,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,410.0,474.0,640.0,799.0,712.0,579.0,572.0,534.0,496.0,490.0,435.0,552.0,6693.0
Koriya,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,293.0,307.0,421.0,348.0,495.0,410.0,395.0,356.0,349.0,407.0,344.0,425.0,4550.0
Koriya,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,5.0,3.0,4.0,1.0,10.0,5.0,2.0,5.0,4.0,0.0,3.0,42.0
Koriya,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Koriya,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Koriya,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Koriya,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Koriya,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,4.0,2.0,2.0,2.0,1.0,0.0,2.0,1.0,0.0,0.0,14.0
Koriya,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,8.0,15.0,12.0,23.0,6.0,10.0,9.0,12.0,12.0,6.0,3.0,23.0,139.0
Koriya,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8.0,15.0,16.0,25.0,8.0,12.0,10.0,12.0,14.0,7.0,3.0,23.0,153.0
Koriya,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,4.1.1.a,Number of male live births,TOTAL,340.0,424.0,469.0,696.0,584.0,542.0,491.0,440.0,427.0,405.0,335.0,487.0,5640.0
Koriya,4.1.1.b,Number of female live births,TOTAL,331.0,435.0,519.0,669.0,583.0,530.0,500.0,417.0,454.0,387.0,326.0,420.0,5571.0
Koriya,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,671.0,859.0,988.0,1365.0,1167.0,1072.0,991.0,857.0,881.0,792.0,661.0,907.0,11211.0
Koriya,4.1.2,Number of still births,TOTAL,21.0,21.0,32.0,39.0,26.0,27.0,129.0,19.0,27.0,19.0,19.0,25.0,404.0
Koriya,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,18.0,18.0,23.0,40.0,31.0,20.0,30.0,16.0,30.0,28.0,15.0,47.0,316.0
Koriya,4.2.1,Number of Newborns weighed at birth,TOTAL,600.0,676.0,926.0,1070.0,1061.0,904.0,721.0,723.0,808.0,684.0,611.0,815.0,9599.0
Koriya,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,71.0,72.0,121.0,130.0,127.0,87.0,99.0,106.0,91.0,47.0,88.0,81.0,1120.0
Koriya,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,628.0,754.0,935.0,1178.0,1073.0,1047.0,923.0,881.0,829.0,642.0,567.0,850.0,10307.0
Koriya,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,7.0,8.0,3.0,5.0,4.0,6.0,3.0,13.0,2.0,3.0,6.0,60.0
Koriya,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,2.0,2.0,0.0,1.0,1.0,4.0,13.0,0.0,3.0,9.0,5.0,40.0
Koriya,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,77.0,71.0,10.0,187.0,10.0,8.0,8.0,11.0,7.0,7.0,105.0,8.0,509.0
Koriya,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,77.0,80.0,20.0,190.0,16.0,13.0,18.0,27.0,20.0,12.0,117.0,19.0,609.0
Koriya,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,77.0,75.0,18.0,190.0,177.0,193.0,20.0,14.0,214.0,69.0,115.0,21.0,1183.0
Koriya,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,2.0,10.0,4.0,1.0,3.0,3.0,3.0,18.0,1.0,105.0,8.0,159.0
Koriya,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,77.0,74.0,17.0,183.0,177.0,193.0,20.0,148.0,181.0,69.0,100.0,13.0,1252.0
Koriya,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4.0,7.0,10.0,25.0,21.0,41.0,9.0,9.0,58.0,7.0,25.0,9.0,225.0
Koriya,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,450.0,547.0,591.0,888.0,848.0,710.0,724.0,660.0,684.0,349.0,379.0,630.0,7460.0
Koriya,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,257.0,276.0,208.0,515.0,447.0,545.0,525.0,449.0,256.0,280.0,172.0,306.0,4236.0
Koriya,6.3,PNC maternal complications attended,TOTAL,3.0,1.0,1.0,20.0,9.0,13.0,19.0,10.0,10.0,30.0,5.0,1.0,122.0
Koriya,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Koriya,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Koriya,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,7.0
Koriya,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Koriya,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,33.0,36.0,24.0,14.0,17.0,10.0,12.0,5.0,17.0,12.0,13.0,9.0,202.0
Koriya,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,172.0,158.0,39.0,27.0,29.0,35.0,32.0,16.0,38.0,35.0,29.0,29.0,639.0
Koriya,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,205.0,194.0,63.0,41.0,46.0,45.0,44.0,21.0,55.0,47.0,42.0,38.0,841.0
Koriya,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,9.0,0.0,0.0,0.0,0.0,25.0,40.0
Koriya,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,6.0
Koriya,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Koriya,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,2.0,1.0,0.0,1.0,0.0,7.0
Koriya,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,5.0,0.0,7.0,81.0,103.0,165.0,0.0,20.0,0.0,381.0
Koriya,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,137.0,137.0,185.0,532.0,132.0,126.0,26.0,1276.0
Koriya,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,5.0,1.0,144.0,218.0,288.0,697.0,132.0,146.0,26.0,1657.0
Koriya,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,62.0,0.0,0.0,62.0
Koriya,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Koriya,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,62.0,0.0,0.0,63.0
Koriya,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,80.0,86.0,79.0,132.0,222.0,97.0,96.0,90.0,57.0,90.0,98.0,55.0,1182.0
Koriya,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,0.0,15.0,3.0,2.0,0.0,0.0,0.0,4.0,9.0,0.0,7.0,1.0,41.0
Koriya,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koriya,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,80.0,101.0,82.0,134.0,222.0,97.0,96.0,94.0,66.0,90.0,105.0,56.0,1223.0
Koriya,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Koriya,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Koriya,9.06,Number of IUCD removals,TOTAL,194.0,90.0,49.0,93.0,116.0,89.0,94.0,131.0,187.0,140.0,131.0,193.0,1507.0
Koriya,9.07,Number of Oral Pills cycles distributed,TOTAL,1065.0,1322.0,1974.0,2175.0,1700.0,1513.0,1159.0,1044.0,1131.0,1408.0,1171.0,1220.0,16882.0
Koriya,9.08,Number of Condom pieces distributed,TOTAL,10270.0,12448.0,17770.0,22696.0,18399.0,16717.0,13332.0,14594.0,11253.0,12395.0,10857.0,11438.0,172169.0
Koriya,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,12.0,3.0,89.0,70.0,85.0,4.0,3.0,197.0,20.0,220.0,34.0,737.0
Koriya,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,31.0,15.0,6.0,26.0,1.0,44.0,15.0,1.0,8.0,10.0,0.0,0.0,157.0
Koriya,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,3.0,1.0,9.0,10.0,0.0,0.0,25.0
Koriya,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,3.0,1.0,7.0,27.0,19.0,94.0,35.0,26.0,0.0,213.0
Koriya,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,4.0,0.0,1.0,2.0,1.0,0.0,3.0,0.0,0.0,0.0,13.0
Koriya,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,3.0,2.0,1.0,2.0,3.0,2.0,4.0,3.0,6.0,6.0,-1.0
Koriya,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,604.0,681.0,686.0,983.0,948.0,889.0,987.0,1026.0,1065.0,826.0,641.0,931.0,10267.0
Koriya,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,707.0,912.0,973.0,1214.0,1134.0,1199.0,1138.0,1167.0,1486.0,1368.0,983.0,1079.0,13360.0
Koriya,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,866.0,848.0,893.0,1039.0,1090.0,1145.0,1205.0,1143.0,1440.0,1323.0,1287.0,1171.0,13450.0
Koriya,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,888.0,961.0,878.0,974.0,962.0,1097.0,1126.0,1193.0,1481.0,1217.0,1247.0,1461.0,13485.0
Koriya,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Koriya,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Koriya,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Koriya,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,353.0,486.0,479.0,757.0,721.0,620.0,635.0,673.0,652.0,612.0,467.0,514.0,6969.0
Koriya,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,713.0,906.0,968.0,1190.0,1109.0,1199.0,1127.0,1143.0,1480.0,1335.0,995.0,1048.0,13213.0
Koriya,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,865.0,850.0,886.0,1042.0,1054.0,1139.0,1195.0,1121.0,1438.0,1288.0,1271.0,1153.0,13302.0
Koriya,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,878.0,964.0,878.0,969.0,932.0,1086.0,1098.0,1161.0,1458.0,1195.0,1219.0,1447.0,13285.0
Koriya,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,35.0,31.0,77.0,34.0,103.0,33.0,313.0
Koriya,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,114.0,80.0,59.0,100.0,54.0,73.0,417.0,635.0,731.0,847.0,606.0,819.0,4535.0
Koriya,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,71.0,63.0,16.0,13.0,6.0,12.0,325.0,425.0,824.0,1226.0,1216.0,1050.0,5247.0
Koriya,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,92.0,26.0,11.0,14.0,5.0,16.0,258.0,381.0,516.0,747.0,1134.0,1427.0,4627.0
Koriya,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,912.0,891.0,954.0,1364.0,1124.0,1027.0,1122.0,916.0,1805.0,1375.0,1195.0,1647.0,14332.0
Koriya,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,19.0,55.0,9.0,14.0,68.0,24.0,165.0,354.0
Koriya,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Koriya,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,485.0,611.0,476.0,696.0,671.0,642.0,580.0,560.0,997.0,697.0,603.0,794.0,7812.0
Koriya,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,456.0,470.0,436.0,667.0,601.0,539.0,545.0,496.0,927.0,634.0,565.0,732.0,7068.0
Koriya,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,941.0,1081.0,912.0,1363.0,1272.0,1181.0,1125.0,1056.0,1924.0,1331.0,1168.0,1526.0,14880.0
Koriya,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,737.0,733.0,702.0,861.0,848.0,854.0,726.0,703.0,1975.0,1269.0,818.0,1222.0,11448.0
Koriya,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,736.0,723.0,694.0,853.0,803.0,862.0,716.0,694.0,1951.0,1257.0,781.0,1195.0,11265.0
Koriya,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,20.0,61.0,42.0,66.0,20.0,23.0,94.0,48.0,21.0,11.0,0.0,21.0,427.0
Koriya,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,250.0,377.0,298.0,327.0,271.0,291.0,291.0,389.0,606.0,349.0,307.0,428.0,4184.0
Koriya,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,248.0,382.0,285.0,294.0,276.0,288.0,308.0,354.0,576.0,324.0,270.0,361.0,3966.0
Koriya,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,498.0,759.0,583.0,621.0,547.0,579.0,599.0,743.0,1182.0,673.0,577.0,789.0,8150.0
Koriya,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,315.0,314.0,350.0,531.0,952.0,859.0,633.0,582.0,1738.0,1073.0,647.0,1042.0,9036.0
Koriya,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,483.0,567.0,503.0,903.0,2049.0,2168.0,850.0,812.0,1629.0,1427.0,919.0,1386.0,13696.0
Koriya,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,633.0,642.0,602.0,723.0,1314.0,1893.0,634.0,775.0,1184.0,1307.0,744.0,1407.0,11858.0
Koriya,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,18.0,17.0,3.0,10.0,3.0,17.0,8.0,0.0,22.0,8.0,7.0,9.0,122.0
Koriya,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Koriya,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,740.0,892.0,773.0,787.0,784.0,804.0,802.0,767.0,975.0,891.0,800.0,789.0,9804.0
Koriya,10.4.2,Number of Immunisation sessions held during the month,TOTAL,691.0,763.0,717.0,749.0,742.0,768.0,759.0,725.0,922.0,858.0,722.0,764.0,9180.0
Koriya,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,544.0,562.0,567.0,575.0,581.0,589.0,984.0,520.0,663.0,639.0,476.0,587.0,7287.0
Koriya,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,713.0,714.0,762.0,1110.0,1173.0,986.0,936.0,847.0,1984.0,1249.0,783.0,1495.0,12752.0
Koriya,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,249.0,247.0,164.0,540.0,2459.0,452.0,405.0,270.0,4175.0,1696.0,329.0,518.0,11504.0
Koriya,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,243.0,98.0,164.0,361.0,2092.0,527.0,318.0,199.0,3883.0,1947.0,209.0,322.0,10363.0
Koriya,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24.0,10.0,23.0,16.0,35.0,20.0,36.0,11.0,8.0,9.0,13.0,24.0,229.0
Koriya,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,241.0,403.0,416.0,286.0,330.0,273.0,134.0,155.0,177.0,201.0,238.0,187.0,3041.0
Koriya,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,233.0,228.0,196.0,323.0,380.0,303.0,263.0,125.0,157.0,112.0,209.0,135.0,2664.0
Koriya,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,14.0,1.0,2.0,6.0,9.0,13.0,16.0,26.0,7.0,14.0,40.0,9.0,157.0
Koriya,13.1,Number of Patients operated for cataract,TOTAL,20.0,17.0,7.0,11.0,11.0,69.0,228.0,344.0,245.0,67.0,241.0,57.0,1317.0
Koriya,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,20.0,17.0,7.0,11.0,11.0,69.0,228.0,344.0,245.0,67.0,239.0,47.0,1305.0
Koriya,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,24.0,124.0,692.0,531.0,223.0,351.0,86.0,423.0,654.0,3108.0
Koriya,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,55.0,145.0,533.0,8.0,271.0,76.0,10.0,207.0,1305.0
Koriya,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,0.0,34.0
Koriya,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34.0,0.0,34.0
Koriya,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2.0,4.0,3.0,3.0,2.0,3.0,3.0,3.0,4.0,4.0,3.0,3.0,-1.0
Koriya,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,1.0,3.0,1.0,1.0,5.0,3.0,2.0,2.0,8.0,5.0,3.0,-1.0
Koriya,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,528.0,570.0,638.0,676.0,586.0,623.0,637.0,565.0,725.0,662.0,615.0,648.0,-1.0
Koriya,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,4.0,5.0,4.0,5.0,3.0,5.0,4.0,4.0,4.0,4.0,2.0,2.0,-1.0
Koriya,14.05,Number of RKS meetings held during the month,TOTAL,5.0,7.0,7.0,8.0,7.0,7.0,5.0,7.0,7.0,6.0,11.0,9.0,86.0
Koriya,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,5.0,9.0,9.0,9.0,7.0,9.0,10.0,10.0,12.0,12.0,10.0,14.0,-1.0
Koriya,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,54.0,71.0,76.0,92.0,95.0,109.0,111.0,262.0,81.0,91.0,155.0,217.0,1414.0
Koriya,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,2.0,2.0,2.0,2.0,1.0,1.0,2.0,3.0,2.0,2.0,-1.0
Koriya,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,2.0,1.0,1.0,1.0,2.0,2.0,0.0,1.0,1.0,1.0,1.0,-1.0
Koriya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,84.0,150.0,204.0,196.0,119.0,437.0,429.0,399.0,188.0,183.0,134.0,187.0,2710.0
Koriya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,373.0,1272.0,630.0,727.0,556.0,675.0,499.0,411.0,639.0,535.0,383.0,475.0,7175.0
Koriya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,148.0,193.0,276.0,201.0,186.0,793.0,690.0,280.0,295.0,210.0,269.0,223.0,3764.0
Koriya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,827.0,2633.0,1287.0,1371.0,1113.0,866.0,866.0,733.0,1033.0,889.0,748.0,927.0,13293.0
Koriya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,232.0,343.0,480.0,397.0,305.0,1230.0,1119.0,679.0,483.0,393.0,403.0,410.0,6474.0
Koriya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1200.0,3905.0,1917.0,2098.0,1669.0,1541.0,1365.0,1144.0,1672.0,1424.0,1131.0,1402.0,20468.0
Koriya,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8.0,17.0,16.0,18.0,7.0,20.0,28.0,26.0,26.0,28.0,9.0,10.0,213.0
Koriya,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,15.0,13.0,15.0,11.0,19.0,25.0,19.0,27.0,19.0,12.0,8.0,190.0
Koriya,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,15.0,32.0,29.0,33.0,18.0,39.0,53.0,45.0,53.0,47.0,21.0,18.0,403.0
Koriya,14.11,In-Patient Head Count at midnight,TOTAL,462.0,914.0,929.0,899.0,908.0,1145.0,1046.0,1130.0,1240.0,718.0,600.0,620.0,10611.0
Koriya,14.12.1,OPD attendance (All),TOTAL,17434.0,21980.0,25313.0,29707.0,24372.0,38562.0,31554.0,25771.0,23686.0,22539.0,24774.0,20481.0,306173.0
Koriya,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,38.0,48.0,49.0,46.0,11.0,44.0,45.0,30.0,36.0,83.0,115.0,80.0,625.0
Koriya,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Koriya,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,125.0,127.0,108.0,119.0,128.0,143.0,136.0,122.0,111.0,94.0,118.0,39.0,1370.0
Koriya,14.14.a,Number of patients given AYUSH treatment,TOTAL,1308.0,1756.0,1257.0,962.0,623.0,1416.0,1532.0,1282.0,2013.0,2592.0,2131.0,1824.0,18696.0
Koriya,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8.0,3.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,12.0
Koriya,14.14.c,Number of Adolescents counselled,TOTAL,22.0,13.0,17.0,5.0,0.0,26.0,12.0,12.0,44.0,0.0,34.0,0.0,185.0
Koriya,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,778.0,1253.0,1294.0,1494.0,502.0,1761.0,1426.0,1249.0,1163.0,1044.0,975.0,1163.0,14102.0
Koriya,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,62.0,97.0,105.0,70.0,36.0,134.0,860.0,93.0,111.0,71.0,111.0,63.0,1813.0
Koriya,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,53.0,140.0,187.0,120.0,94.0,155.0,97.0,129.0,122.0,67.0,65.0,88.0,1317.0
Koriya,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,3.0,1.0,0.0,1.0,0.0,0.0,3.0,2.0,0.0,0.0,0.0,10.0
Koriya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,70.0,125.0,176.0,142.0,132.0,146.0,122.0,126.0,130.0,16.0,140.0,115.0,1440.0
Koriya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,5.0,0.0,22.0,9.0,14.0,0.0,1.0,0.0,0.0,0.0,51.0
Koriya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,147.0,294.0,312.0,513.0,221.0,285.0,276.0,205.0,276.0,197.0,273.0,271.0,3270.0
Koriya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,7.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Koriya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,270.0,559.0,675.0,775.0,447.0,586.0,495.0,460.0,528.0,280.0,478.0,474.0,6027.0
Koriya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,5.0,13.0,1.0,23.0,9.0,14.0,3.0,3.0,0.0,0.0,0.0,71.0
Koriya,15.2,Number of Widal tests conducted,Number tested,343.0,390.0,537.0,618.0,494.0,1085.0,1003.0,685.0,340.0,416.0,429.0,361.0,6701.0
Koriya,15.3.a,Number of VDRL tests conducted on males,Number tested,47.0,73.0,36.0,46.0,45.0,95.0,48.0,60.0,88.0,73.0,46.0,71.0,728.0
Koriya,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,87.0,95.0,69.0,38.0,71.0,103.0,69.0,90.0,73.0,40.0,121.0,91.0,947.0
Koriya,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,173.0,263.0,99.0,197.0,53.0,303.0,181.0,121.0,206.0,207.0,214.0,297.0,2314.0
Koriya,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,307.0,431.0,204.0,281.0,169.0,501.0,298.0,271.0,367.0,320.0,381.0,459.0,3989.0
Koriya,15.4.1,Number of blood smears examined for Malaria,TOTAL,2395.0,2398.0,1960.0,3269.0,2480.0,7480.0,5693.0,5294.0,2983.0,6997.0,2791.0,3820.0,47560.0
Koriya,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,87.0,63.0,70.0,106.0,75.0,116.0,120.0,95.0,120.0,55.0,53.0,106.0,1066.0
Koriya,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,153.0,180.0,174.0,397.0,449.0,784.0,510.0,578.0,232.0,192.0,169.0,263.0,4081.0
Koriya,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7020.0,6870.0,9240.0,8950.0,10530.0,9250.0,11580.0,8720.0,8230.0,8760.0,4440.0,4440.0,98030.0
Koriya,16.1.1,Stock position of DPT vaccines,2. Stocks Received,3500.0,6000.0,4000.0,5500.0,3500.0,4500.0,7500.0,3500.0,4500.0,6500.0,6500.0,6500.0,62000.0
Koriya,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,2510.0,2910.0,3000.0,0.0,3530.0,3530.0,4240.0,1650.0,1810.0,6010.0,6010.0,6010.0,41210.0
Koriya,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3710.0,3060.0,4290.0,6120.0,4590.0,4380.0,8360.0,3990.0,5090.0,4170.0,2300.0,2300.0,52360.0
Koriya,16.1.1,Stock position of DPT vaccines,5. Total Stock,4300.0,6900.0,5950.0,8330.0,5910.0,5840.0,6480.0,6580.0,5830.0,5080.0,2630.0,2630.0,66460.0
Koriya,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Koriya,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Koriya,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Koriya,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Koriya,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2952.0,2600.0,3100.0,3800.0,2852.0,1392.0,1992.0,3262.0,6772.0,3192.0,1372.0,1372.0,34658.0
Koriya,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3500.0,6500.0,7000.0,7500.0,6000.0,7000.0,11500.0,9200.0,8100.0,2600.0,1100.0,1100.0,71100.0
Koriya,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,800.0,820.0,0.0,0.0,1300.0,1300.0,2570.0,2720.0,900.0,0.0,0.0,0.0,10410.0
Koriya,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4340.0,5160.0,5940.0,7200.0,6700.0,5980.0,9230.0,5690.0,10280.0,5270.0,2000.0,2000.0,69790.0
Koriya,16.1.2,Stock position of OPV vaccines,5. Total Stock,1312.0,3120.0,4160.0,4100.0,852.0,1112.0,1692.0,4052.0,3692.0,522.0,472.0,472.0,25558.0
Koriya,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8539.0,8200.0,11040.0,7050.0,5459.0,6169.0,7849.0,10339.0,8999.0,10219.0,4099.0,4099.0,92061.0
Koriya,16.1.3,Stock position of TT vaccines,2. Stocks Received,2500.0,5000.0,1000.0,5000.0,7000.0,7000.0,9000.0,4000.0,5000.0,4000.0,4000.0,4000.0,57500.0
Koriya,16.1.3,Stock position of TT vaccines,3. Unusable Stock,590.0,1470.0,480.0,0.0,1700.0,1700.0,3300.0,1850.0,1230.0,4700.0,4700.0,4700.0,26420.0
Koriya,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4740.0,3910.0,4990.0,7150.0,6300.0,5300.0,5510.0,5290.0,5560.0,3870.0,1790.0,1790.0,56200.0
Koriya,16.1.3,Stock position of TT vaccines,5. Total Stock,5709.0,7820.0,6570.0,4900.0,4459.0,6169.0,8039.0,7199.0,7209.0,5649.0,1609.0,1609.0,66941.0
Koriya,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,2150.0,0.0,0.0,0.0,1950.0,1750.0,1550.0,1350.0,1150.0,1150.0,1150.0,1150.0,13350.0
Koriya,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,200.0,200.0,600.0
Koriya,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.4,Stock position of DT vaccines,4. Stock Distributed,200.0,0.0,0.0,0.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,200.0,1800.0
Koriya,16.1.4,Stock position of DT vaccines,5. Total Stock,1950.0,0.0,0.0,0.0,1750.0,1550.0,1350.0,1150.0,950.0,1150.0,1150.0,1150.0,12150.0
Koriya,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3283.0,4950.0,3730.0,5640.0,4233.0,5193.0,5173.0,4023.0,6133.0,5223.0,1733.0,1733.0,51047.0
Koriya,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500.0,3000.0,4500.0,5500.0,4500.0,2500.0,3000.0,5050.0,5000.0,3000.0,3000.0,3000.0,43550.0
Koriya,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,1010.0,1500.0,1610.0,0.0,1250.0,1250.0,3300.0,1665.0,1230.0,2930.0,2930.0,2930.0,21605.0
Koriya,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1650.0,3520.0,2590.0,5710.0,3340.0,3230.0,3950.0,1470.0,5100.0,2160.0,1370.0,1370.0,35460.0
Koriya,16.1.5,Stock position of BCG vaccines,5. Total Stock,2123.0,2930.0,4030.0,5430.0,4143.0,3213.0,923.0,5938.0,4803.0,3133.0,433.0,433.0,37532.0
Koriya,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3447.0,3925.0,4690.0,4160.0,4337.0,6062.0,6762.0,5307.0,5937.0,6072.0,3062.0,3062.0,56823.0
Koriya,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,2000.0,1000.0,1750.0,2500.0,1000.0,1500.0,2200.0,4000.0,500.0,500.0,500.0,18450.0
Koriya,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,1265.0,525.0,1340.0,0.0,1340.0,1340.0,2005.0,1665.0,2090.0,2105.0,2105.0,2105.0,17885.0
Koriya,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1080.0,1200.0,1530.0,2370.0,1175.0,1045.0,2405.0,1470.0,3270.0,1115.0,535.0,535.0,17730.0
Koriya,16.1.6,Stock position of Measles vaccines,5. Total Stock,2102.0,4200.0,2820.0,3540.0,4322.0,4677.0,3852.0,4372.0,4577.0,3352.0,922.0,922.0,39658.0
Koriya,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,2100.0,2280.0,3630.0,2610.0,200.0,200.0,11020.0
Koriya,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,2500.0,4200.0,3900.0,2400.0,2400.0,17200.0
Koriya,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,2700.0,1800.0,1800.0,1800.0,8600.0
Koriya,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,1600.0,1150.0,1400.0,2860.0,800.0,800.0,8610.0
Koriya,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,2300.0,3130.0,3730.0,1850.0,0.0,0.0,11010.0
Koriya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1450.0,1335.0,1600.0,2535.0,1200.0,1000.0,950.0,1200.0,800.0,300.0,0.0,0.0,12370.0
Koriya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,150.0,0.0,0.0,1950.0,450.0,450.0,50.0,50.0,50.0,50.0,50.0,50.0,3300.0
Koriya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,50.0,46.0,134.0,0.0,400.0,400.0,0.0,0.0,0.0,0.0,0.0,0.0,1030.0
Koriya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,150.0,139.0,316.0,1678.0,300.0,100.0,100.0,150.0,50.0,50.0,50.0,50.0,3133.0
Koriya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1400.0,1150.0,1150.0,2807.0,950.0,950.0,900.0,1100.0,800.0,300.0,0.0,0.0,11507.0
Koriya,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,105000.0,69000.0,77000.0,112000.0,72000.0,52000.0,35000.0,22000.0,15000.0,7500.0,5500.0,5500.0,577500.0
Koriya,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,2000.0,0.0,0.0,68000.0,2000.0,2000.0,2000.0,2000.0,2000.0,8000.0,2000.0,2000.0,92000.0
Koriya,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,18000.0,30000.0,8000.0,0.0,0.0,0.0,0.0,0.0,0.0,3500.0,3500.0,3500.0,66500.0
Koriya,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,62000.0,25000.0,9000.0,66000.0,34000.0,19000.0,17000.0,7000.0,2000.0,4000.0,4000.0,4000.0,253000.0
Koriya,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,27000.0,14000.0,60000.0,114000.0,40000.0,35000.0,20000.0,17000.0,15000.0,8000.0,0.0,0.0,350000.0
Koriya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,0.0,0.0,150.0,200.0,0.0,550.0,400.0,400.0,2700.0
Koriya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,100.0,0.0,0.0,6000.0,100.0,100.0,100.0,100.0,100.0,600.0,100.0,100.0,7400.0
Koriya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,150.0,0.0,0.0,300.0,300.0,300.0,1050.0
Koriya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,100.0,0.0,0.0,2500.0,100.0,100.0,100.0,100.0,100.0,200.0,200.0,200.0,3700.0
Koriya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,200.0,0.0,650.0,0.0,0.0,5350.0
Koriya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,180.0,0.0,170.0,0.0,0.0,0.0,0.0,1000.0,0.0,800.0,0.0,0.0,2150.0
Koriya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,1000.0,0.0,0.0,2000.0
Koriya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,40.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,0.0,640.0
Koriya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,10.0,0.0,130.0,0.0,0.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,540.0
Koriya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,170.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,1800.0,0.0,0.0,2970.0
Koriya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1450.0,1650.0,1400.0,1400.0,1400.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,8700.0
Koriya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,1600.0,1600.0,1600.0,5800.0
Koriya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,1400.0,1400.0,1390.0,0.0,1400.0,1400.0,0.0,600.0,0.0,1600.0,1600.0,1600.0,12390.0
Koriya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,50.0,250.0,10.0,100.0,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,810.0
Koriya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1300.0
Koriya,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,200.0,300.0,0.0,200.0,0.0,0.0,0.0,300.0,0.0,250.0,0.0,0.0,1250.0
Koriya,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,0.0,200.0,0.0,0.0,250.0
Koriya,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Koriya,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,200.0,0.0,0.0,100.0,0.0,0.0,0.0,200.0,0.0,100.0,0.0,0.0,600.0
Koriya,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,250.0,0.0,100.0,0.0,0.0,0.0,150.0,0.0,350.0,0.0,0.0,850.0
Koriya,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,10.0,650.0,250.0,100.0,100.0,50.0,0.0,300.0,0.0,200.0,0.0,0.0,1660.0
Koriya,16.3.02,Stock Position of Gloves,2. Stocks Received,300.0,0.0,100.0,700.0,0.0,0.0,0.0,2000.0,0.0,500.0,0.0,0.0,3600.0
Koriya,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,100.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Koriya,16.3.02,Stock Position of Gloves,4. Stock Distributed,10.0,0.0,200.0,200.0,0.0,0.0,0.0,2100.0,0.0,200.0,0.0,0.0,2710.0
Koriya,16.3.02,Stock Position of Gloves,5. Total Stock,300.0,550.0,100.0,600.0,100.0,50.0,0.0,200.0,0.0,500.0,0.0,0.0,2400.0
Koriya,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Koriya,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,100.0
Koriya,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,25.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,0.0,0.0,0.0,125.0
Koriya,16.3.03,Stock Position of MVA Syringes,5. Total Stock,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,75.0
Koriya,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,2200.0,2600.0,3300.0,3000.0,1700.0,1500.0,1400.0,0.0,0.0,0.0,0.0,0.0,15700.0
Koriya,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0
Koriya,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,1000.0,1400.0,1600.0,1400.0,200.0,200.0,200.0,0.0,0.0,0.0,0.0,0.0,6000.0
Koriya,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,250.0,1200.0,1000.0,1100.0,200.0,200.0,200.0,0.0,0.0,0.0,0.0,0.0,4150.0
Koriya,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,950.0,0.0,700.0,1500.0,1300.0,1100.0,1000.0,0.0,0.0,0.0,0.0,0.0,6550.0
Koriya,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Koriya,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,5.0
Koriya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,5.0,5.0,15.0,5000.0,5.0,5.0,5.0,0.0,5.0,0.0,0.0,0.0,5045.0
Koriya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koriya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Koriya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Koriya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,5.0,5.0,5.0,5000.0,5.0,5.0,5.0,0.0,5.0,0.0,0.0,0.0,5035.0
Koriya,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,233405.0,62500.0,20000.0,20000.0,82405.0,79405.0,56405.0,53405.0,50405.0,57405.0,57405.0,57405.0,830145.0
Koriya,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,50000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,60000.0
Koriya,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,62000.0,60000.0,10000.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,142000.0
Koriya,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,158500.0,0.0,10000.0,10000.0,23000.0,23000.0,3000.0,3000.0,3000.0,14000.0,13000.0,13000.0,273500.0
Koriya,16.3.07,Stock Position of IFA Tablets,5. Total Stock,62905.0,2500.0,0.0,0.0,59405.0,56405.0,53405.0,50405.0,47405.0,53405.0,44405.0,44405.0,474645.0
Koriya,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,1200.0,1600.0,1500.0,500.0,500.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,5800.0
Koriya,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,1500.0
Koriya,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,500.0,500.0,600.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2100.0
Koriya,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,700.0,0.0,900.0,100.0,500.0,500.0,0.0,0.0,0.0,300.0,0.0,0.0,3000.0
Koriya,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,1100.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,700.0,0.0,0.0,2200.0
Koriya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,6000.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Koriya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,20000.0
Koriya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0
Koriya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,3000.0,0.0,1000.0,3000.0,0.0,0.0,0.0,0.0,0.0,1000.0,0.0,0.0,8000.0
Koriya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,3000.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,0.0,9000.0,0.0,0.0,19000.0
Koriya,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,188.0,353.0,272.0,252.0,180.0,46.0,34.0,34.0,331.0,240.0,240.0,240.0,2410.0
Koriya,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,90.0,0.0,0.0,35.0,0.0,0.0,0.0,750.0,450.0,0.0,0.0,0.0,1325.0
Koriya,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,40.0,0.0,28.0,28.0,0.0,0.0,0.0,0.0,240.0,29.0,29.0,29.0,423.0
Koriya,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,50.0,15.0,87.0,49.0,134.0,12.0,0.0,3.0,210.0,181.0,181.0,181.0,1103.0
Koriya,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,188.0,338.0,157.0,210.0,46.0,34.0,34.0,781.0,331.0,30.0,30.0,30.0,2209.0
Koriya,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,6747.0,2300.0,950.0,500.0,5622.0,5422.0,4440.0,4258.0,8358.0,8858.0,8558.0,8558.0,64571.0
Koriya,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,2000.0,1000.0,0.0,2500.0,0.0,0.0,1000.0,6000.0,800.0,500.0,0.0,0.0,13800.0
Koriya,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,900.0,500.0,300.0,0.0,0.0,0.0,1000.0,200.0,200.0,0.0,0.0,0.0,3100.0
Koriya,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2125.0,725.0,450.0,1400.0,1600.0,1282.0,682.0,1300.0,1000.0,1100.0,1000.0,1000.0,13664.0
Koriya,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,5722.0,2075.0,200.0,1600.0,4022.0,4140.0,3758.0,8758.0,7958.0,8258.0,7558.0,7558.0,61607.0
Koriya,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,890.0,6067.0,1642.0,2567.0,2937.0,2717.0,2637.0,1407.0,1362.0,555.0,96.0,96.0,22973.0
Koriya,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,1400.0,1000.0,1000.0,1600.0,1500.0,1000.0,300.0,1000.0,800.0,0.0,0.0,0.0,9600.0
Koriya,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,800.0,3500.0,100.0,0.0,0.0,0.0,800.0,600.0,775.0,25.0,25.0,25.0,6650.0
Koriya,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1127.0,125.0,475.0,1230.0,1220.0,580.0,730.0,445.0,382.0,171.0,71.0,71.0,6627.0
Koriya,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,363.0,3442.0,2067.0,2937.0,3217.0,3137.0,1407.0,1362.0,1005.0,359.0,0.0,0.0,19296.0
Koriya,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,13850.0,24853.0,8863.0,22853.0,29503.0,36418.0,33698.0,29498.0,31418.0,21360.0,12300.0,12300.0,276914.0
Koriya,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,500.0,14400.0,12000.0,12000.0,2000.0,8000.0,4800.0,4000.0,0.0,0.0,0.0,57700.0
Koriya,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,4900.0,8000.0,0.0,0.0,0.0,0.0,8000.0,2600.0,6800.0,400.0,400.0,400.0,31500.0
Koriya,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2525.0,490.0,3510.0,5150.0,8285.0,4720.0,7200.0,3480.0,2458.0,1700.0,1200.0,1200.0,41918.0
Koriya,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6425.0,16863.0,19753.0,29703.0,33218.0,33698.0,26498.0,28218.0,26160.0,19260.0,10700.0,10700.0,261196.0
Koriya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,25.0,0.0,0.0,400.0,825.0,675.0,615.0,975.0,900.0,334.0,280.0,280.0,5309.0
Koriya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,400.0,500.0,800.0,800.0,1000.0,1000.0,2000.0,0.0,0.0,0.0,6500.0
Koriya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,500.0,1000.0,2000.0,0.0,0.0,0.0,3500.0
Koriya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,25.0,0.0,0.0,75.0,950.0,860.0,140.0,75.0,321.0,105.0,60.0,60.0,2671.0
Koriya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,400.0,825.0,675.0,615.0,975.0,900.0,579.0,229.0,220.0,220.0,5638.0
Koriya,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,2.0,,,1.0,,1.0,1.0,1.0,1.0,,10.0
Koriya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,2.0,,,,,,,3.0
Koriya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Koriya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,1.0,,,,2.0,,,,,,,4.0
Koriya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Koriya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Koriya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Koriya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,2.0,,,5.0,1.0,1.0,1.0,2.0,1.0,3.0,3.0,19.0
Koriya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Koriya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,3.0,,,5.0,1.0,1.0,1.0,2.0,1.0,3.0,3.0,20.0
Koriya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,4.0,3.0,,,1.0,,1.0,2.0,6.0,2.0,4.0,23.0
Koriya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Koriya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,5.0,3.0,,,1.0,,1.0,2.0,6.0,2.0,4.0,24.0
Koriya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,,,1.0,,2.0,1.0,5.0
Koriya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,1.0,1.0,,,,,,,,,2.0
Koriya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,2.0,,,,,1.0,,2.0,1.0,7.0
Koriya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Koriya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,2.0,,,,,,2.0
Koriya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,2.0,,,,,,2.0
Koriya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,3.0,,,,1.0,,,1.0,,,5.0
Koriya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,1.0,2.0
Koriya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,3.0,,,,1.0,,,2.0,,1.0,7.0
Koriya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Koriya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Koriya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Koriya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,1.0,2.0,1.0,,2.0,5.0,1.0,1.0,2.0,15.0
Koriya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,,1.0,1.0,2.0,2.0,1.0,2.0,10.0
Koriya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,2.0,1.0,1.0,3.0,7.0,3.0,2.0,4.0,25.0
Koriya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,1.0,,,,1.0,,,,,,3.0
Koriya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Koriya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,1.0,,,,1.0,1.0,,,,,4.0
Koriya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,4.0,,2.0,,1.0,,,,,7.0
Koriya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Koriya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,4.0,,2.0,,1.0,,,,,7.0
Koriya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,,,,,,,1.0,1.0,,,3.0
Koriya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Koriya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,2.0,,,,,,,,1.0,1.0,,,4.0
Koriya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Koriya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Koriya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Koriya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Koriya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,2.0,,,,,,,1.0,,3.0
Koriya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,2.0,4.0,1.0,,1.0,,,1.0,9.0
Koriya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,,2.0,1.0,,,2.0,,6.0
Koriya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,2.0,2.0,4.0,3.0,1.0,1.0,,3.0,1.0,18.0
Koriya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Koriya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Koriya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Koriya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,1.0,,,2.0,1.0,,1.0,1.0,6.0
Koriya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,,,,1.0,,1.0,2.0,,,,,5.0
Koriya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1.0,,,,2.0,,1.0,4.0,1.0,,1.0,1.0,11.0
Koriya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,,,,2.0,2.0,,,5.0
Koriya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Koriya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,1.0,,,,,2.0,2.0,,,5.0
Koriya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Koriya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Koriya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Koriya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,1.0,,1.0,1.0,,,,,1.0,,5.0
Koriya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,1.0,,,,,,,1.0
Koriya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,1.0,,1.0,2.0,,,,,1.0,,6.0
Koriya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Koriya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Koriya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,,,1.0
Koriya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Koriya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Koriya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Koriya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,1.0,1.0,,,1.0,,,,,,4.0
Koriya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,1.0,,2.0,,,,,,,,1.0,,4.0
Koriya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,1.0,1.0,3.0,1.0,,,1.0,,,,1.0,,8.0
Koriya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,1.0,1.0,2.0,2.0,,2.0,,1.0,2.0,13.0
Koriya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,1.0,,,,,,,,1.0,,2.0
Koriya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,1.0,1.0,1.0,2.0,2.0,,2.0,,2.0,2.0,15.0
Koriya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,1.0,,1.0,1.0,,,,,,4.0
Koriya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,,3.0,1.0,1.0,1.0,4.0,4.0,6.0,3.0,,4.0,28.0
Koriya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,1.0,1.0,,,,1.0,,3.0
Koriya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,2.0,,3.0,2.0,1.0,3.0,6.0,4.0,6.0,3.0,1.0,4.0,35.0
Koriya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,3.0,1.0,,1.0,1.0,6.0,2.0,3.0,2.0,3.0,13.0,37.0
Koriya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Koriya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,3.0,1.0,,2.0,1.0,6.0,2.0,3.0,2.0,3.0,14.0,39.0
Koriya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,,5.0,1.0,,3.0,1.0,1.0,2.0,,2.0,17.0
Koriya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,1.0,,2.0,2.0,,,,,6.0
Koriya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,,6.0,2.0,,5.0,3.0,1.0,2.0,,2.0,23.0
Koriya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Koriya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,3.0,,2.0,,1.0,,1.0,2.0,,2.0,1.0,12.0
Koriya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,2.0,3.0,1.0,2.0,2.0,2.0,3.0,1.0,,1.0,3.0,21.0
Koriya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,1.0,5.0,3.0,3.0,2.0,3.0,2.0,4.0,3.0,,3.0,4.0,33.0
Koriya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,1.0,,,,,,2.0
Koriya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,2.0,1.0,2.0,2.0,2.0,5.0,2.0,9.0,6.0,4.0,5.0,40.0
Koriya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,2.0,1.0,2.0,4.0,10.0,2.0,6.0,,3.0,2.0,3.0,36.0
Koriya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,1.0,4.0,2.0,4.0,6.0,13.0,8.0,8.0,9.0,9.0,6.0,8.0,78.0
Koriya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,2.0,,3.0,1.0,,,,,,7.0
Koriya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,1.0,2.0,2.0,1.0,1.0,3.0,4.0,3.0,6.0,5.0,5.0,16.0,49.0
Koriya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,4.0,6.0,7.0,1.0,6.0,9.0,14.0,10.0,2.0,4.0,10.0,21.0,94.0
Koriya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,5.0,8.0,10.0,4.0,7.0,15.0,19.0,13.0,8.0,9.0,15.0,37.0,150.0
Mahasamund,1.1,Total number of pregnant women Registered for ANC,TOTAL,2043.0,1906.0,2832.0,2732.0,2339.0,2472.0,2369.0,2201.0,2336.0,1985.0,2103.0,1911.0,27229.0
Mahasamund,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1072.0,1000.0,1426.0,1403.0,1418.0,1445.0,1346.0,1256.0,1397.0,1117.0,1090.0,1078.0,15048.0
Mahasamund,1.2,Number of Pregnant women registered under JSY,TOTAL,2006.0,1912.0,2796.0,2662.0,2322.0,2464.0,2356.0,2156.0,2355.0,1983.0,2083.0,1882.0,26977.0
Mahasamund,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1707.0,1763.0,2114.0,2057.0,2276.0,2257.0,2132.0,2048.0,2005.0,1939.0,2023.0,1917.0,24238.0
Mahasamund,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1608.0,1492.0,2357.0,2179.0,1806.0,2030.0,1911.0,1733.0,1876.0,1507.0,1554.0,1656.0,21709.0
Mahasamund,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1506.0,1584.0,2034.0,2144.0,1905.0,1879.0,1831.0,2194.0,1692.0,1903.0,1513.0,1581.0,21766.0
Mahasamund,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1254.0,980.0,1631.0,1632.0,1449.0,1466.0,1400.0,1203.0,1899.0,1448.0,1276.0,1357.0,16995.0
Mahasamund,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,71.0,42.0,49.0,75.0,185.0,134.0,46.0,38.0,47.0,59.0,83.0,81.0,910.0
Mahasamund,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,3.0,2.0,0.0,6.0,1.0,1.0,0.0,3.0,2.0,2.0,0.0,22.0
Mahasamund,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,486.0,305.0,858.0,956.0,456.0,437.0,341.0,1048.0,1106.0,434.0,734.0,585.0,7746.0
Mahasamund,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,25.0,30.0,13.0,18.0,13.0,23.0,17.0,24.0,27.0,23.0,24.0,35.0,272.0
Mahasamund,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Mahasamund,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,291.0,253.0,358.0,363.0,318.0,313.0,285.0,240.0,271.0,290.0,268.0,201.0,3451.0
Mahasamund,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,180.0,214.0,325.0,242.0,195.0,281.0,209.0,239.0,311.0,215.0,223.0,249.0,2883.0
Mahasamund,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,471.0,467.0,683.0,605.0,513.0,594.0,494.0,479.0,582.0,505.0,491.0,450.0,6334.0
Mahasamund,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,379.0,391.0,549.0,504.0,408.0,474.0,399.0,378.0,459.0,392.0,355.0,345.0,5033.0
Mahasamund,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,79.0,94.0,115.0,94.0,92.0,96.0,61.0,53.0,85.0,54.0,43.0,58.0,924.0
Mahasamund,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1036.0,1093.0,1241.0,1238.0,1231.0,1124.0,1019.0,1259.0,1305.0,1173.0,1200.0,994.0,13913.0
Mahasamund,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,790.0,858.0,985.0,968.0,975.0,941.0,858.0,1067.0,894.0,930.0,958.0,969.0,11193.0
Mahasamund,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,934.0,975.0,1118.0,1178.0,1093.0,1110.0,998.0,1242.0,1164.0,1025.0,1008.0,1030.0,12875.0
Mahasamund,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,720.0,739.0,885.0,890.0,878.0,905.0,752.0,969.0,948.0,780.0,802.0,768.0,10036.0
Mahasamund,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,54.0,30.0,1.0,4.0,29.0,46.0,91.0,33.0,25.0,23.0,12.0,22.0,370.0
Mahasamund,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Mahasamund,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Mahasamund,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Mahasamund,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1.0,0.0,0.0,0.0,0.0,4.0,3.0,2.0,1.0,4.0,3.0,8.0,26.0
Mahasamund,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1.0,0.0,4.0,0.0,0.0,4.0,3.0,2.0,1.0,4.0,3.0,8.0,30.0
Mahasamund,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,4.1.1.a,Number of male live births,TOTAL,794.0,776.0,979.0,934.0,835.0,882.0,777.0,917.0,941.0,798.0,868.0,806.0,10307.0
Mahasamund,4.1.1.b,Number of female live births,TOTAL,658.0,679.0,875.0,878.0,826.0,807.0,765.0,860.0,790.0,748.0,764.0,682.0,9332.0
Mahasamund,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1452.0,1455.0,1854.0,1812.0,1661.0,1689.0,1542.0,1777.0,1731.0,1546.0,1632.0,1488.0,19639.0
Mahasamund,4.1.2,Number of still births,TOTAL,52.0,53.0,53.0,53.0,42.0,44.0,46.0,54.0,44.0,31.0,38.0,57.0,567.0
Mahasamund,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,28.0,32.0,45.0,39.0,42.0,43.0,41.0,45.0,34.0,37.0,48.0,31.0,465.0
Mahasamund,4.2.1,Number of Newborns weighed at birth,TOTAL,1377.0,1434.0,1815.0,1752.0,1635.0,1653.0,1470.0,1702.0,1688.0,1517.0,1619.0,1474.0,19136.0
Mahasamund,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,160.0,185.0,261.0,266.0,226.0,265.0,268.0,307.0,240.0,258.0,192.0,161.0,2789.0
Mahasamund,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1242.0,1305.0,1713.0,1643.0,1528.0,1521.0,1364.0,1607.0,1573.0,1358.0,1469.0,1449.0,17772.0
Mahasamund,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,10.0,14.0,9.0,35.0,3.0,8.0,12.0,2.0,10.0,5.0,5.0,115.0
Mahasamund,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,23.0,8.0,5.0,5.0,45.0,1.0,14.0,13.0,10.0,20.0,35.0,185.0
Mahasamund,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,2.0,,4.0,4.0,17.0
Mahasamund,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,8.0,33.0,22.0,14.0,47.0,48.0,9.0,26.0,17.0,20.0,29.0,44.0,317.0
Mahasamund,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,8.0,78.0,86.0,2.0,109.0,125.0,2.0,18.0,0.0,10.0,7.0,10.0,455.0
Mahasamund,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,6.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,2.0,12.0
Mahasamund,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2.0,22.0,10.0,0.0,34.0,45.0,6.0,52.0,10.0,32.0,21.0,34.0,268.0
Mahasamund,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mahasamund,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1191.0,1271.0,1696.0,1559.0,1442.0,1465.0,1356.0,1594.0,1561.0,1293.0,1348.0,1405.0,17181.0
Mahasamund,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,919.0,953.0,1287.0,1319.0,1102.0,1188.0,1130.0,1216.0,1244.0,1023.0,1172.0,1065.0,13618.0
Mahasamund,6.3,PNC maternal complications attended,TOTAL,5.0,3.0,13.0,19.0,14.0,11.0,8.0,5.0,6.0,5.0,23.0,24.0,136.0
Mahasamund,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,0.0,4.0,6.0,4.0,6.0,0.0,4.0,0.0,2.0,2.0,1.0,33.0
Mahasamund,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,6.0,5.0,0.0,1.0,0.0,0.0,0.0,0.0,13.0
Mahasamund,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,0.0,4.0,7.0,10.0,11.0,0.0,5.0,0.0,2.0,2.0,1.0,46.0
Mahasamund,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,4.0,6.0,8.0,7.0,21.0,18.0,6.0,12.0,19.0,46.0,20.0,31.0,198.0
Mahasamund,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,21.0,10.0,16.0,24.0,24.0,24.0,16.0,22.0,16.0,61.0,53.0,47.0,334.0
Mahasamund,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,25.0,16.0,24.0,31.0,45.0,42.0,22.0,34.0,35.0,107.0,73.0,78.0,532.0
Mahasamund,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,37.0,0.0,9.0,46.0
Mahasamund,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,27.0,17.0,15.0,10.0,3.0,6.0,7.0,3.0,4.0,92.0
Mahasamund,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,33.0,0.0,0.0,0.0,21.0,0.0,42.0,0.0,26.0,122.0
Mahasamund,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,60.0,17.0,15.0,10.0,24.0,6.0,49.0,3.0,30.0,214.0
Mahasamund,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0,40.0,0.0,0.0,0.0,76.0
Mahasamund,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,27.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27.0
Mahasamund,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0
Mahasamund,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,27.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0,40.0,0.0,0.0,0.0,103.0
Mahasamund,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,19.0,111.0,117.0,88.0,191.0,197.0,71.0,794.0
Mahasamund,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7.0,0.0,7.0,347.0,407.0,320.0,394.0,289.0,580.0,129.0,281.0,281.0,3042.0
Mahasamund,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,30.0,0.0,31.0,175.0,50.0,134.0,83.0,109.0,328.0,439.0,,90.0,1469.0
Mahasamund,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,37.0,0.0,38.0,522.0,457.0,473.0,588.0,515.0,996.0,759.0,478.0,442.0,5305.0
Mahasamund,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,92.0,0.0,0.0,0.0,0.0,0.0,54.0,0.0,17.0,163.0
Mahasamund,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,3.0,2.0,0.0,0.0,2.0,264.0,144.0,0.0,415.0
Mahasamund,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,7.0
Mahasamund,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,1.0,92.0,4.0,2.0,0.0,0.0,3.0,318.0,146.0,19.0,585.0
Mahasamund,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,122.0,181.0,166.0,298.0,144.0,198.0,200.0,136.0,116.0,133.0,147.0,113.0,1954.0
Mahasamund,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,5.0,6.0,13.0,11.0,11.0,8.0,5.0,4.0,2.0,7.0,6.0,5.0,83.0
Mahasamund,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,4.0,7.0,9.0,1.0,8.0,7.0,2.0,8.0,3.0,2.0,5.0,56.0
Mahasamund,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,0.0,3.0,1.0,0.0,1.0,0.0,3.0,1.0,2.0,2.0,4.0,17.0
Mahasamund,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mahasamund,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,127.0,191.0,189.0,319.0,156.0,215.0,212.0,145.0,127.0,145.0,157.0,127.0,2110.0
Mahasamund,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Mahasamund,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mahasamund,9.06,Number of IUCD removals,TOTAL,247.0,599.0,289.0,303.0,150.0,153.0,204.0,163.0,202.0,190.0,312.0,277.0,3089.0
Mahasamund,9.07,Number of Oral Pills cycles distributed,TOTAL,6510.0,6192.0,6707.0,7190.0,7495.0,6271.0,6144.0,5488.0,5626.0,4868.0,6346.0,5346.0,74183.0
Mahasamund,9.08,Number of Condom pieces distributed,TOTAL,33411.0,35751.0,44850.0,46619.0,40169.0,37336.0,36665.0,32777.0,45989.0,41048.0,36376.0,32057.0,463048.0
Mahasamund,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,4.0,100.0,4.0,4.0,0.0,0.0,114.0
Mahasamund,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,54.0,60.0,7.0,11.0,16.0,57.0,352.0,12.0,25.0,2.0,5.0,611.0
Mahasamund,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,9.0,0.0,1.0,1.0,1.0,1.0,0.0,0.0,15.0,5.0,3.0,36.0
Mahasamund,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,9.0,1.0,40.0,12.0,10.0,3.0,23.0,8.0,97.0,68.0,13.0,285.0
Mahasamund,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Mahasamund,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,7.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,9.0
Mahasamund,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,9.12,Number of Institutions having NSV trained doctors,TOTAL,3.0,9.0,8.0,8.0,11.0,10.0,6.0,8.0,16.0,22.0,20.0,18.0,-1.0
Mahasamund,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1274.0,1412.0,1837.0,1781.0,1742.0,1610.0,1448.0,1653.0,1778.0,1609.0,1922.0,1988.0,20054.0
Mahasamund,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1416.0,1404.0,1816.0,1887.0,1817.0,1638.0,1748.0,1594.0,1624.0,1601.0,1654.0,2066.0,20265.0
Mahasamund,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1529.0,1446.0,1624.0,1766.0,1788.0,1661.0,1666.0,1774.0,1587.0,1561.0,1667.0,1824.0,19893.0
Mahasamund,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1537.0,1494.0,1637.0,1616.0,1704.0,1649.0,1604.0,1688.0,1663.0,1573.0,1599.0,1874.0,19638.0
Mahasamund,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Mahasamund,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Mahasamund,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Mahasamund,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,909.0,1029.0,1368.0,1313.0,1247.0,1185.0,1035.0,1256.0,1416.0,1316.0,1503.0,1503.0,15080.0
Mahasamund,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1414.0,1402.0,1820.0,1884.0,1812.0,1628.0,1750.0,1582.0,1624.0,1599.0,1654.0,2066.0,20235.0
Mahasamund,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1511.0,1440.0,1616.0,1762.0,1784.0,1638.0,1664.0,1764.0,1582.0,1559.0,1667.0,1825.0,19812.0
Mahasamund,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1540.0,1488.0,1636.0,1598.0,1711.0,1629.0,1605.0,1683.0,1676.0,1569.0,1599.0,1872.0,19606.0
Mahasamund,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,26.0,17.0,6.0,17.0,1.0,222.0,241.0,756.0,586.0,512.0,453.0,2837.0
Mahasamund,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,34.0,83.0,20.0,11.0,17.0,54.0,877.0,1500.0,1512.0,1542.0,1310.0,1382.0,8342.0
Mahasamund,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,33.0,75.0,5.0,9.0,5.0,36.0,149.0,1005.0,1201.0,1286.0,1174.0,1154.0,6132.0
Mahasamund,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,29.0,103.0,11.0,24.0,11.0,35.0,204.0,290.0,1095.0,1188.0,1045.0,1158.0,5193.0
Mahasamund,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1254.0,1285.0,1746.0,1689.0,1621.0,1755.0,1621.0,1383.0,1868.0,1353.0,1653.0,1887.0,19115.0
Mahasamund,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,3.0,11.0,0.0,49.0,98.0,85.0,109.0,27.0,36.0,84.0,502.0
Mahasamund,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Mahasamund,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,661.0,698.0,904.0,880.0,806.0,944.0,811.0,734.0,976.0,705.0,841.0,997.0,9957.0
Mahasamund,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,542.0,594.0,849.0,819.0,778.0,818.0,837.0,657.0,923.0,634.0,787.0,914.0,9152.0
Mahasamund,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1203.0,1292.0,1753.0,1699.0,1584.0,1762.0,1648.0,1391.0,1899.0,1339.0,1628.0,1911.0,19109.0
Mahasamund,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1021.0,1060.0,1469.0,1451.0,1368.0,1469.0,1380.0,1307.0,1951.0,1238.0,1367.0,1637.0,16718.0
Mahasamund,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1020.0,1060.0,1452.0,1451.0,1365.0,1461.0,1380.0,1309.0,1944.0,1240.0,1352.0,1623.0,16657.0
Mahasamund,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,4.0,0.0,0.0,5.0,5.0,19.0
Mahasamund,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,400.0,403.0,474.0,475.0,479.0,605.0,453.0,457.0,619.0,362.0,471.0,454.0,5652.0
Mahasamund,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,394.0,382.0,400.0,439.0,492.0,619.0,467.0,457.0,544.0,336.0,522.0,459.0,5511.0
Mahasamund,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,794.0,785.0,874.0,914.0,971.0,1224.0,920.0,914.0,1163.0,698.0,993.0,913.0,11163.0
Mahasamund,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,186.0,219.0,482.0,1669.0,2049.0,3021.0,1594.0,1270.0,1950.0,923.0,1003.0,868.0,15234.0
Mahasamund,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,246.0,382.0,722.0,2136.0,3121.0,6020.0,2564.0,2462.0,1347.0,782.0,702.0,502.0,20986.0
Mahasamund,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,306.0,386.0,10631.0,1751.0,2517.0,4475.0,2444.0,1896.0,1516.0,1341.0,1607.0,917.0,29787.0
Mahasamund,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,20.0,13.0,10.0,18.0,13.0,16.0,15.0,12.0,9.0,11.0,5.0,11.0,153.0
Mahasamund,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,1.0,2.0,2.0,2.0,11.0
Mahasamund,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,983.0,956.0,1010.0,1005.0,992.0,940.0,994.0,946.0,1236.0,1009.0,995.0,998.0,12064.0
Mahasamund,10.4.2,Number of Immunisation sessions held during the month,TOTAL,959.0,929.0,995.0,997.0,987.0,924.0,987.0,928.0,1193.0,1004.0,984.0,997.0,11884.0
Mahasamund,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,913.0,883.0,923.0,941.0,937.0,869.0,898.0,891.0,1158.0,960.0,932.0,944.0,11249.0
Mahasamund,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,10.0,0.0,11.0,0.0,0.0,0.0,26.0
Mahasamund,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1214.0,1269.0,1713.0,1656.0,1570.0,1871.0,1617.0,1362.0,1894.0,1340.0,1639.0,1873.0,19018.0
Mahasamund,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,200.0,97.0,108.0,159.0,86.0,3096.0,853.0,298.0,5273.0,611.0,169.0,211.0,11161.0
Mahasamund,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,180.0,36.0,24.0,84.0,50.0,2945.0,758.0,149.0,6319.0,619.0,158.0,119.0,11441.0
Mahasamund,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20.0,3.0,6.0,0.0,22.0,28.0,2.0,2.0,9.0,1.0,0.0,6.0,99.0
Mahasamund,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,233.0,201.0,297.0,347.0,503.0,389.0,240.0,176.0,239.0,278.0,234.0,266.0,3403.0
Mahasamund,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,57.0,11.0,81.0,142.0,107.0,54.0,177.0,82.0,13.0,8.0,7.0,19.0,758.0
Mahasamund,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8.0,9.0,75.0,61.0,23.0,20.0,24.0,36.0,13.0,26.0,24.0,42.0,361.0
Mahasamund,13.1,Number of Patients operated for cataract,TOTAL,9.0,19.0,18.0,4.0,7.0,149.0,14.0,74.0,108.0,217.0,54.0,19.0,692.0
Mahasamund,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,9.0,19.0,18.0,4.0,7.0,149.0,14.0,74.0,108.0,226.0,65.0,26.0,719.0
Mahasamund,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,3.0,10.0,50.0,217.0,206.0,4.0,0.0,21.0,106.0,17.0,634.0
Mahasamund,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,10.0,15.0,25.0,12.0,0.0,0.0,18.0,12.0,17.0,109.0
Mahasamund,13.5,Number of eyes collected through eye donation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mahasamund,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,1.0,-1.0
Mahasamund,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,4.0,9.0,5.0,6.0,3.0,1.0,2.0,9.0,14.0,11.0,10.0,-1.0
Mahasamund,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,974.0,994.0,990.0,1074.0,994.0,966.0,1028.0,959.0,1068.0,1038.0,1056.0,1151.0,-1.0
Mahasamund,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,4.0,-1.0
Mahasamund,14.05,Number of RKS meetings held during the month,TOTAL,3.0,4.0,4.0,4.0,3.0,2.0,2.0,2.0,3.0,2.0,4.0,3.0,36.0
Mahasamund,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,7.0,12.0,15.0,12.0,12.0,9.0,8.0,8.0,13.0,18.0,16.0,13.0,-1.0
Mahasamund,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,60.0,52.0,47.0,40.0,45.0,74.0,123.0,71.0,65.0,77.0,146.0,138.0,938.0
Mahasamund,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,2.0,-1.0
Mahasamund,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,6.0,2.0,2.0,2.0,0.0,2.0,2.0,2.0,2.0,2.0,-1.0
Mahasamund,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,115.0,96.0,78.0,177.0,126.0,136.0,100.0,124.0,125.0,81.0,77.0,96.0,1331.0
Mahasamund,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,265.0,321.0,288.0,542.0,486.0,563.0,304.0,372.0,247.0,167.0,227.0,451.0,4233.0
Mahasamund,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,69.0,72.0,84.0,116.0,118.0,59.0,99.0,177.0,98.0,48.0,89.0,169.0,1198.0
Mahasamund,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,546.0,703.0,808.0,1244.0,948.0,1007.0,942.0,887.0,969.0,1159.0,1286.0,1073.0,11572.0
Mahasamund,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,184.0,168.0,162.0,293.0,244.0,195.0,199.0,301.0,223.0,129.0,166.0,265.0,2529.0
Mahasamund,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,811.0,1024.0,1096.0,1786.0,1434.0,1570.0,1246.0,1259.0,1216.0,1326.0,1513.0,1524.0,15805.0
Mahasamund,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,11.0,3.0,7.0,12.0,9.0,7.0,3.0,0.0,139.0,6.0,6.0,210.0
Mahasamund,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3.0,1.0,2.0,7.0,23.0,5.0,5.0,2.0,0.0,685.0,6.0,5.0,744.0
Mahasamund,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10.0,12.0,5.0,14.0,35.0,14.0,12.0,5.0,0.0,824.0,12.0,11.0,954.0
Mahasamund,14.11,In-Patient Head Count at midnight,TOTAL,25.0,25.0,572.0,783.0,511.0,2061.0,1030.0,1001.0,1804.0,1873.0,1423.0,2224.0,13332.0
Mahasamund,14.12.1,OPD attendance (All),TOTAL,25387.0,25668.0,30737.0,33947.0,35380.0,37948.0,30142.0,31383.0,30210.0,27831.0,32070.0,34800.0,375503.0
Mahasamund,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1.0,285.0,0.0,184.0,5.0,148.0,4.0,902.0,43.0,486.0,264.0,163.0,2485.0
Mahasamund,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Mahasamund,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,357.0,299.0,149.0,647.0,295.0,267.0,480.0,349.0,369.0,233.0,303.0,265.0,4013.0
Mahasamund,14.14.a,Number of patients given AYUSH treatment,TOTAL,290.0,282.0,285.0,423.0,421.0,649.0,670.0,992.0,1306.0,1474.0,1207.0,1220.0,9219.0
Mahasamund,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3.0,5.0,3.0,3.0,0.0,0.0,2.0,3.0,3.0,2.0,2.0,1.0,27.0
Mahasamund,14.14.c,Number of Adolescents counselled,TOTAL,12.0,12.0,12.0,7.0,18.0,11.0,15.0,12.0,12.0,24.0,15.0,12.0,162.0
Mahasamund,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1667.0,1769.0,2343.0,2954.0,2201.0,2725.0,2249.0,2956.0,2921.0,2776.0,2782.0,3102.0,30445.0
Mahasamund,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,48.0,58.0,79.0,63.0,66.0,45.0,62.0,62.0,90.0,124.0,100.0,185.0,982.0
Mahasamund,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,88.0,111.0,141.0,149.0,123.0,127.0,222.0,263.0,386.0,121.0,330.0,354.0,2415.0
Mahasamund,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5.0,5.0,8.0,1.0,5.0,3.0,2.0,1.0,5.0,2.0,2.0,5.0,44.0
Mahasamund,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,265.0,283.0,338.0,414.0,179.0,210.0,345.0,339.0,351.0,300.0,450.0,421.0,3895.0
Mahasamund,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,1.0,43.0,22.0,27.0,99.0
Mahasamund,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,102.0,123.0,102.0,120.0,87.0,98.0,7.0,99.0,121.0,176.0,142.0,138.0,1315.0
Mahasamund,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,30.0,0.0,33.0
Mahasamund,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,455.0,517.0,581.0,683.0,389.0,435.0,574.0,701.0,858.0,597.0,922.0,913.0,7625.0
Mahasamund,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,6.0,10.0,1.0,7.0,3.0,2.0,1.0,6.0,47.0,54.0,32.0,176.0
Mahasamund,15.2,Number of Widal tests conducted,Number tested,170.0,202.0,270.0,374.0,362.0,435.0,226.0,239.0,230.0,213.0,281.0,289.0,3291.0
Mahasamund,15.3.a,Number of VDRL tests conducted on males,Number tested,10.0,19.0,57.0,12.0,8.0,5.0,1.0,37.0,37.0,4.0,0.0,1.0,191.0
Mahasamund,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,63.0,56.0,47.0,20.0,32.0,43.0,15.0,11.0,18.0,17.0,89.0,0.0,411.0
Mahasamund,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,71.0,29.0,38.0,3.0,7.0,7.0,0.0,8.0,7.0,0.0,30.0,0.0,200.0
Mahasamund,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,144.0,104.0,142.0,35.0,47.0,55.0,16.0,56.0,62.0,21.0,119.0,1.0,802.0
Mahasamund,15.4.1,Number of blood smears examined for Malaria,TOTAL,3386.0,4456.0,4507.0,5688.0,5115.0,6247.0,4226.0,4567.0,3689.0,1158.0,3077.0,3723.0,49839.0
Mahasamund,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,4.0,16.0,89.0,73.0,715.0,352.0,19.0,16.0,39.0,7.0,37.0,1370.0
Mahasamund,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,7.0,7.0,15.0,19.0,41.0,28.0,16.0,12.0,13.0,6.0,5.0,6.0,175.0
Mahasamund,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Mahasamund,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Mahasamund,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Mahasamund,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Mahasamund,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mahasamund,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,5.0,3.0,,2.0,3.0,1.0,3.0,,1.0,1.0,1.0,21.0
Mahasamund,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,3.0,1.0,,1.0,1.0,,,,,1.0,1.0,8.0
Mahasamund,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,1.0,1.0,,,,,4.0
Mahasamund,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,4.0,2.0,,1.0,1.0,1.0,1.0,,,1.0,1.0,12.0
Mahasamund,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,2.0,,,,2.0,2.0,1.0,8.0
Mahasamund,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Mahasamund,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,2.0,,,2.0,,,,2.0,2.0,1.0,9.0
Mahasamund,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,3.0,2.0,2.0,3.0,1.0,5.0,5.0,7.0,7.0,9.0,3.0,48.0
Mahasamund,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,,,,3.0,1.0,2.0,,2.0,,,,10.0
Mahasamund,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,3.0,2.0,2.0,6.0,2.0,7.0,5.0,9.0,7.0,9.0,3.0,58.0
Mahasamund,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,2.0,2.0,,3.0,1.0,3.0,4.0,7.0,2.0,5.0,7.0,40.0
Mahasamund,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,2.0,1.0,,,,1.0,1.0,,2.0,,1.0,9.0
Mahasamund,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,4.0,3.0,,3.0,1.0,4.0,5.0,7.0,4.0,5.0,8.0,49.0
Mahasamund,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,,2.0,,,,1.0,1.0,5.0
Mahasamund,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,1.0,1.0,,1.0,1.0,1.0,2.0,,8.0
Mahasamund,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,1.0,,1.0,1.0,2.0,1.0,1.0,1.0,3.0,1.0,13.0
Mahasamund,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahasamund,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,1.0,,,,,1.0,2.0,1.0,,5.0
Mahasamund,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,1.0,,,,,1.0,2.0,1.0,,5.0
Mahasamund,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,1.0,,,,,,,,1.0
Mahasamund,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Mahasamund,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,,1.0,,,2.0
Mahasamund,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mahasamund,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mahasamund,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mahasamund,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,3.0,,2.0,1.0,2.0,2.0,2.0,1.0,,3.0,18.0
Mahasamund,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,3.0,2.0,1.0,1.0,1.0,1.0,6.0,10.0,6.0,2.0,1.0,35.0
Mahasamund,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,4.0,5.0,1.0,3.0,2.0,3.0,8.0,12.0,7.0,2.0,4.0,53.0
Mahasamund,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,1.0,1.0,,1.0,,,,,1.0,5.0
Mahasamund,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Mahasamund,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,1.0,2.0,1.0,1.0,,,,,1.0,7.0
Mahasamund,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Mahasamund,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,2.0,,1.0,,3.0,2.0,1.0,1.0,,2.0,13.0
Mahasamund,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,,,,,1.0,,,,,2.0
Mahasamund,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,1.0,3.0,,1.0,1.0,3.0,3.0,1.0,1.0,,2.0,16.0
Mahasamund,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,1.0,1.0,2.0,,,,,,,4.0
Mahasamund,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,1.0,1.0,3.0,,,,,,5.0
Mahasamund,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,1.0,2.0,3.0,3.0,,,,,,9.0
Mahasamund,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Mahasamund,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mahasamund,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Mahasamund,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,,,1.0,,,,,,,2.0
Mahasamund,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Mahasamund,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,1.0,1.0,1.0,1.0,1.0,,2.0,,8.0
Mahasamund,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,1.0,,,,,,1.0
Mahasamund,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,1.0,1.0,2.0,2.0,1.0,,2.0,,10.0
Mahasamund,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Mahasamund,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Mahasamund,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,3.0,,,,,,,,3.0
Mahasamund,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,3.0,,1.0,,1.0,,,,5.0
Mahasamund,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Mahasamund,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,3.0,2.0,5.0,3.0,6.0,8.0,1.0,3.0,2.0,4.0,2.0,5.0,44.0
Mahasamund,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,3.0,2.0,3.0,,,3.0,3.0,2.0,1.0,1.0,,1.0,19.0
Mahasamund,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,4.0,9.0,3.0,7.0,11.0,4.0,5.0,3.0,5.0,2.0,6.0,65.0
Mahasamund,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Mahasamund,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,,1.0,,1.0,4.0,,1.0,,1.0,2.0,1.0,13.0
Mahasamund,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,,1.0,2.0,,,,1.0,,5.0
Mahasamund,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,2.0,1.0,1.0,,1.0,6.0,2.0,1.0,,1.0,3.0,1.0,19.0
Mahasamund,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mahasamund,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mahasamund,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mahasamund,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mahasamund,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,,2.0,3.0
Mahasamund,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,1.0,,,,,,,,,,,,1.0
Mahasamund,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,1.0,,,,,,,2.0,4.0
Mahasamund,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,1.0,1.0,,,2.0,,1.0,6.0
Mahasamund,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mahasamund,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,1.0,1.0,,,2.0,,1.0,6.0
Mahasamund,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,1.0,,,,,2.0
Mahasamund,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mahasamund,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,1.0,,,,,2.0
Mahasamund,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mahasamund,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,2.0,2.0,3.0,3.0,,4.0,2.0,2.0,4.0,2.0,27.0
Mahasamund,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,1.0,,4.0,,1.0,,,,,,,7.0
Mahasamund,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,4.0,2.0,6.0,3.0,4.0,,4.0,2.0,2.0,4.0,2.0,34.0
Mahasamund,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,5.0,1.0,,,,2.0,,,,,10.0
Mahasamund,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,13.0,22.0,5.0,10.0,13.0,13.0,8.0,10.0,15.0,6.0,8.0,135.0
Mahasamund,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,1.0,1.0,2.0,,2.0,2.0,,,,,1.0,11.0
Mahasamund,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,16.0,14.0,28.0,8.0,10.0,15.0,15.0,10.0,10.0,15.0,6.0,9.0,156.0
Mahasamund,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Mahasamund,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,8.0,11.0,12.0,18.0,16.0,18.0,15.0,15.0,13.0,11.0,9.0,153.0
Mahasamund,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,1.0,,1.0,1.0,,2.0,2.0,,,2.0,1.0,12.0
Mahasamund,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,9.0,9.0,11.0,13.0,19.0,16.0,20.0,17.0,15.0,13.0,14.0,10.0,166.0
Mahasamund,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,2.0,,,1.0,2.0,,,,,,,,5.0
Mahasamund,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,4.0,8.0,8.0,11.0,7.0,6.0,1.0,3.0,2.0,2.0,4.0,58.0
Mahasamund,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,2.0,2.0,3.0,4.0,2.0,1.0,,1.0,,2.0,18.0
Mahasamund,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,5.0,10.0,11.0,16.0,11.0,8.0,2.0,3.0,3.0,2.0,6.0,81.0
Mahasamund,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,2.0,,,,1.0,1.0,1.0,,,,5.0
Mahasamund,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,8.0,15.0,6.0,15.0,16.0,11.0,17.0,16.0,4.0,12.0,2.0,125.0
Mahasamund,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,6.0,13.0,6.0,11.0,10.0,15.0,10.0,3.0,1.0,,,81.0
Mahasamund,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,9.0,14.0,30.0,12.0,26.0,26.0,27.0,28.0,20.0,5.0,12.0,2.0,211.0
Mahasamund,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,3.0,,1.0,2.0,4.0,2.0,1.0,,,,,13.0
Mahasamund,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,15.0,12.0,19.0,18.0,25.0,23.0,22.0,20.0,14.0,14.0,16.0,18.0,216.0
Mahasamund,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,15.0,18.0,35.0,24.0,26.0,42.0,39.0,38.0,3.0,3.0,2.0,10.0,255.0
Mahasamund,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,30.0,33.0,54.0,43.0,53.0,69.0,63.0,59.0,17.0,17.0,18.0,28.0,484.0
Mahasamund,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,4.0,7.0,2.0,4.0,,1.0,,,,,21.0
Mahasamund,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,31.0,20.0,30.0,35.0,49.0,36.0,30.0,31.0,30.0,16.0,29.0,31.0,368.0
Mahasamund,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,55.0,30.0,62.0,78.0,64.0,97.0,79.0,66.0,18.0,5.0,6.0,6.0,566.0
Mahasamund,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,88.0,51.0,96.0,120.0,115.0,137.0,109.0,98.0,48.0,21.0,35.0,37.0,955.0
Mungeli,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Mungeli,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Mungeli,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Mungeli,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Mungeli,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Mungeli,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Mungeli,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Mungeli,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Mungeli,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Mungeli,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Mungeli,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Mungeli,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Mungeli,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Mungeli,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Mungeli,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Mungeli,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Mungeli,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Mungeli,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Mungeli,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Mungeli,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Mungeli,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Mungeli,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Mungeli,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Mungeli,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mungeli,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Mungeli,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Mungeli,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Mungeli,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Mungeli,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Mungeli,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Mungeli,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Mungeli,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Mungeli,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Mungeli,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Mungeli,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Mungeli,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Mungeli,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Mungeli,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Mungeli,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Mungeli,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Mungeli,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Mungeli,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Mungeli,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Mungeli,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Mungeli,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Mungeli,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Mungeli,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Mungeli,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Mungeli,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Mungeli,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Mungeli,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Mungeli,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Mungeli,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Mungeli,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Mungeli,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Mungeli,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Mungeli,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Mungeli,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Mungeli,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Mungeli,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Mungeli,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Mungeli,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Mungeli,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Mungeli,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Mungeli,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Mungeli,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Mungeli,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Mungeli,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Mungeli,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Mungeli,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Mungeli,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Mungeli,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Mungeli,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Mungeli,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Mungeli,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Mungeli,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Mungeli,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Mungeli,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Mungeli,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Mungeli,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Mungeli,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Mungeli,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Mungeli,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Mungeli,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Mungeli,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Mungeli,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Mungeli,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Mungeli,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Mungeli,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Mungeli,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Mungeli,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Mungeli,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Mungeli,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Mungeli,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Mungeli,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Mungeli,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Mungeli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Mungeli,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Mungeli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Mungeli,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Mungeli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Mungeli,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Mungeli,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Mungeli,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Mungeli,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Mungeli,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Mungeli,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Mungeli,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Mungeli,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Mungeli,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Mungeli,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Mungeli,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Mungeli,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Mungeli,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Mungeli,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Mungeli,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Mungeli,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Mungeli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Mungeli,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Mungeli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Mungeli,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Mungeli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Mungeli,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Mungeli,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Mungeli,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Mungeli,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Mungeli,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Mungeli,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Mungeli,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Mungeli,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Mungeli,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Mungeli,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Mungeli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Mungeli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Mungeli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Mungeli,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mungeli,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Mungeli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mungeli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mungeli,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Mungeli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mungeli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mungeli,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Mungeli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mungeli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mungeli,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Mungeli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Mungeli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mungeli,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Mungeli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mungeli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mungeli,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Mungeli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mungeli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mungeli,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mungeli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mungeli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mungeli,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Mungeli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mungeli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mungeli,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mungeli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Mungeli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Mungeli,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Mungeli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Mungeli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Mungeli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Mungeli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Mungeli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Mungeli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Mungeli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Mungeli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mungeli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Mungeli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mungeli,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Mungeli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Mungeli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Mungeli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Mungeli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Mungeli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Mungeli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Mungeli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Mungeli,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Narayanpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,287.0,216.0,220.0,345.0,311.0,310.0,311.0,270.0,446.0,297.0,289.0,244.0,3546.0
Narayanpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,87.0,44.0,51.0,84.0,82.0,68.0,85.0,69.0,109.0,80.0,83.0,70.0,912.0
Narayanpur,1.2,Number of Pregnant women registered under JSY,TOTAL,211.0,167.0,175.0,274.0,250.0,224.0,244.0,208.0,310.0,252.0,203.0,214.0,2732.0
Narayanpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,137.0,152.0,177.0,212.0,258.0,228.0,221.0,215.0,260.0,252.0,292.0,263.0,2667.0
Narayanpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,155.0,140.0,126.0,196.0,178.0,157.0,192.0,155.0,281.0,207.0,154.0,125.0,2066.0
Narayanpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,175.0,201.0,206.0,255.0,273.0,245.0,247.0,242.0,316.0,317.0,248.0,289.0,3014.0
Narayanpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,266.0,139.0,206.0,192.0,207.0,202.0,160.0,158.0,226.0,135.0,195.0,218.0,2304.0
Narayanpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,24.0,6.0,11.0,17.0,16.0,14.0,18.0,21.0,25.0,9.0,15.0,18.0,194.0
Narayanpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,14.0
Narayanpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,18.0,10.0,7.0,10.0,9.0,12.0,7.0,13.0,18.0,13.0,13.0,22.0,152.0
Narayanpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,5.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0,8.0,,3.0,22.0
Narayanpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Narayanpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,80.0,38.0,37.0,29.0,9.0,43.0,25.0,36.0,34.0,47.0,57.0,41.0,476.0
Narayanpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,49.0,78.0,81.0,151.0,164.0,112.0,136.0,91.0,180.0,116.0,95.0,157.0,1410.0
Narayanpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,129.0,116.0,118.0,180.0,173.0,155.0,161.0,127.0,214.0,163.0,152.0,198.0,1886.0
Narayanpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,77.0,62.0,70.0,84.0,124.0,91.0,99.0,90.0,128.0,124.0,98.0,105.0,1152.0
Narayanpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,22.0,20.0,12.0,35.0,25.0,29.0,41.0,37.0,31.0,28.0,16.0,20.0,316.0
Narayanpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,119.0,128.0,115.0,144.0,135.0,137.0,93.0,127.0,112.0,169.0,181.0,101.0,1561.0
Narayanpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,119.0,129.0,115.0,144.0,135.0,137.0,93.0,126.0,118.0,169.0,147.0,88.0,1520.0
Narayanpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,150.0,137.0,95.0,148.0,158.0,130.0,94.0,130.0,120.0,184.0,177.0,102.0,1625.0
Narayanpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,126.0,107.0,43.0,113.0,112.0,112.0,76.0,112.0,81.0,117.0,168.0,97.0,1264.0
Narayanpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,17.0,4.0,3.0,17.0,20.0,18.0,4.0,20.0,28.0,8.0,23.0,24.0,186.0
Narayanpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Narayanpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Narayanpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Narayanpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Narayanpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,4.1.1.a,Number of male live births,TOTAL,138.0,151.0,142.0,152.0,167.0,158.0,133.0,144.0,174.0,157.0,183.0,152.0,1851.0
Narayanpur,4.1.1.b,Number of female live births,TOTAL,105.0,88.0,83.0,161.0,137.0,132.0,118.0,105.0,146.0,170.0,146.0,138.0,1529.0
Narayanpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,243.0,239.0,225.0,313.0,304.0,290.0,251.0,249.0,320.0,327.0,329.0,290.0,3380.0
Narayanpur,4.1.2,Number of still births,TOTAL,5.0,5.0,6.0,11.0,4.0,3.0,3.0,5.0,6.0,6.0,4.0,9.0,67.0
Narayanpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,4.0,3.0,26.0,11.0,9.0,14.0,7.0,7.0,10.0,20.0,17.0,7.0,135.0
Narayanpur,4.2.1,Number of Newborns weighed at birth,TOTAL,220.0,220.0,207.0,242.0,273.0,250.0,217.0,234.0,307.0,322.0,328.0,278.0,3098.0
Narayanpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,23.0,19.0,22.0,31.0,26.0,28.0,18.0,14.0,24.0,31.0,16.0,24.0,276.0
Narayanpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,227.0,232.0,214.0,288.0,269.0,252.0,213.0,232.0,305.0,323.0,328.0,278.0,3161.0
Narayanpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,,,,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Narayanpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Narayanpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,3.0
Narayanpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Narayanpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Narayanpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,168.0,170.0,115.0,126.0,124.0,123.0,134.0,181.0,181.0,176.0,188.0,185.0,1871.0
Narayanpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,158.0,99.0,91.0,155.0,176.0,144.0,102.0,57.0,131.0,124.0,113.0,102.0,1452.0
Narayanpur,6.3,PNC maternal complications attended,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Narayanpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,2.0
Narayanpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,36.0,24.0,84.0,98.0,87.0,105.0,18.0,11.0,33.0,17.0,15.0,16.0,544.0
Narayanpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,88.0,22.0,124.0,157.0,123.0,139.0,15.0,20.0,15.0,45.0,26.0,22.0,796.0
Narayanpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,124.0,46.0,208.0,255.0,210.0,244.0,33.0,31.0,48.0,62.0,41.0,38.0,1340.0
Narayanpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,88.0,22.0,0.0,0.0,0.0,0.0,33.0,0.0,0.0,0.0,0.0,0.0,143.0
Narayanpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Narayanpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,,0.0,23.0,10.0,30.0,34.0,6.0,0.0,15.0,11.0,3.0,132.0
Narayanpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,,0.0,23.0,10.0,30.0,34.0,6.0,0.0,15.0,11.0,3.0,132.0
Narayanpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Narayanpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,,0.0,66.0,0.0,17.0,21.0,32.0,0.0,87.0,38.0,11.0,272.0
Narayanpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,,0.0,66.0,0.0,17.0,21.0,32.0,0.0,87.0,38.0,11.0,272.0
Narayanpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Narayanpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Narayanpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Narayanpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Narayanpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,3.0,3.0,6.0,12.0,5.0,7.0,12.0,8.0,4.0,8.0,10.0,7.0,85.0
Narayanpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Narayanpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0
Narayanpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,0.0,,0.0,88.0,56.0,36.0,0.0,0.0,0.0,0.0,0.0,0.0,180.0
Narayanpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Narayanpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,3.0,3.0,6.0,100.0,61.0,43.0,12.0,8.0,4.0,8.0,10.0,8.0,266.0
Narayanpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,0.0,,,0.0
Narayanpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Narayanpur,9.06,Number of IUCD removals,TOTAL,49.0,54.0,40.0,63.0,73.0,67.0,29.0,29.0,22.0,33.0,37.0,48.0,544.0
Narayanpur,9.07,Number of Oral Pills cycles distributed,TOTAL,876.0,471.0,1577.0,2446.0,3278.0,2399.0,1013.0,1158.0,900.0,1000.0,948.0,1198.0,17264.0
Narayanpur,9.08,Number of Condom pieces distributed,TOTAL,24996.0,10921.0,32602.0,36002.0,39430.0,37536.0,13947.0,14117.0,14217.0,13068.0,13691.0,11755.0,262282.0
Narayanpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,50.0,5.0,50.0,0.0,100.0,61.0,26.0,0.0,10.0,10.0,15.0,0.0,327.0
Narayanpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,67.0,53.0,125.0,240.0,916.0,756.0,53.0,156.0,105.0,20.0,110.0,31.0,2632.0
Narayanpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,5.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Narayanpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0,3.0,0.0,0.0,0.0,9.0
Narayanpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Narayanpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1.0,,1.0,,,1.0,,1.0,1.0,1.0,,,-1.0
Narayanpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,150.0,171.0,183.0,223.0,240.0,242.0,194.0,190.0,293.0,290.0,234.0,342.0,2752.0
Narayanpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,180.0,196.0,225.0,227.0,181.0,244.0,211.0,199.0,294.0,215.0,199.0,268.0,2639.0
Narayanpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,192.0,190.0,204.0,223.0,207.0,193.0,261.0,212.0,235.0,233.0,213.0,258.0,2621.0
Narayanpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,176.0,202.0,175.0,199.0,200.0,204.0,199.0,244.0,240.0,244.0,234.0,286.0,2603.0
Narayanpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,0.0,,,0.0
Narayanpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,0.0,,,0.0
Narayanpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,0.0,,,0.0
Narayanpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,75.0,68.0,76.0,73.0,90.0,91.0,63.0,98.0,192.0,265.0,235.0,158.0,1484.0
Narayanpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,171.0,197.0,219.0,248.0,183.0,249.0,199.0,200.0,297.0,215.0,198.0,268.0,2644.0
Narayanpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,186.0,186.0,204.0,228.0,202.0,188.0,247.0,213.0,237.0,234.0,213.0,258.0,2596.0
Narayanpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,168.0,191.0,179.0,195.0,200.0,210.0,198.0,226.0,238.0,243.0,234.0,286.0,2568.0
Narayanpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,,,0.0,0.0,0.0,34.0,34.0,57.0,55.0,69.0,66.0,315.0
Narayanpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,6.0,19.0,4.0,0.0,0.0,80.0,137.0,248.0,215.0,198.0,256.0,1163.0
Narayanpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,108.0,146.0,221.0,213.0,242.0,930.0
Narayanpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,10.0,0.0,0.0,7.0,0.0,0.0,39.0,151.0,234.0,234.0,264.0,939.0
Narayanpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,147.0,211.0,214.0,198.0,205.0,225.0,195.0,137.0,432.0,207.0,232.0,319.0,2722.0
Narayanpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,,0.0,0.0,,9.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Narayanpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,0.0,,,0.0
Narayanpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,82.0,100.0,111.0,114.0,117.0,120.0,98.0,83.0,226.0,105.0,125.0,162.0,1443.0
Narayanpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,57.0,110.0,103.0,81.0,88.0,105.0,97.0,54.0,206.0,102.0,107.0,157.0,1267.0
Narayanpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,139.0,210.0,214.0,195.0,205.0,225.0,195.0,137.0,432.0,207.0,232.0,319.0,2710.0
Narayanpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,103.0,116.0,122.0,206.0,185.0,287.0,184.0,203.0,284.0,285.0,284.0,325.0,2584.0
Narayanpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,108.0,116.0,120.0,209.0,185.0,291.0,179.0,197.0,282.0,280.0,283.0,324.0,2574.0
Narayanpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Narayanpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,50.0,46.0,40.0,55.0,75.0,106.0,40.0,48.0,177.0,50.0,40.0,33.0,760.0
Narayanpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,38.0,55.0,35.0,47.0,65.0,92.0,46.0,45.0,136.0,48.0,28.0,35.0,670.0
Narayanpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,88.0,101.0,75.0,102.0,140.0,198.0,86.0,93.0,313.0,98.0,68.0,68.0,1430.0
Narayanpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,24.0,28.0,31.0,55.0,191.0,349.0,226.0,305.0,177.0,211.0,292.0,493.0,2382.0
Narayanpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,53.0,87.0,136.0,193.0,420.0,391.0,266.0,641.0,416.0,310.0,318.0,384.0,3615.0
Narayanpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,63.0,99.0,102.0,138.0,241.0,230.0,192.0,339.0,457.0,287.0,327.0,480.0,2955.0
Narayanpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,65.0,57.0,43.0,45.0,68.0,88.0,76.0,82.0,113.0,101.0,120.0,107.0,965.0
Narayanpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,14.0,66.0,13.0,37.0,86.0,10.0,12.0,21.0,11.0,7.0,18.0,301.0
Narayanpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,240.0,296.0,314.0,293.0,300.0,316.0,319.0,284.0,324.0,299.0,319.0,342.0,3646.0
Narayanpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,210.0,263.0,267.0,270.0,280.0,276.0,297.0,260.0,336.0,298.0,319.0,315.0,3391.0
Narayanpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,174.0,200.0,221.0,231.0,245.0,225.0,248.0,211.0,315.0,274.0,319.0,282.0,2945.0
Narayanpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,123.0,195.0,254.0,157.0,147.0,196.0,138.0,113.0,442.0,181.0,195.0,282.0,2423.0
Narayanpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,6.0,8.0,18.0,33.0,126.0,673.0,173.0,118.0,1160.0,23.0,499.0,48.0,2885.0
Narayanpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,8.0,159.0,730.0,0.0,0.0,742.0,13.0,505.0,26.0,2183.0
Narayanpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Narayanpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,,0.0,0.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Narayanpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,11.0,8.0,11.0,11.0,8.0,5.0,7.0,20.0,5.0,4.0,56.0,155.0
Narayanpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,120.0,167.0,751.0,208.0,890.0,409.0,456.0,226.0,295.0,238.0,275.0,178.0,4213.0
Narayanpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,410.0,204.0,422.0,654.0,304.0,557.0,401.0,268.0,416.0,259.0,332.0,287.0,4514.0
Narayanpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,0.0,0.0,0.0,147.0,157.0,60.0,64.0,70.0,26.0,46.0,40.0,610.0
Narayanpur,13.1,Number of Patients operated for cataract,TOTAL,0.0,0.0,0.0,48.0,20.0,32.0,0.0,10.0,0.0,52.0,16.0,32.0,210.0
Narayanpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0.0,0.0,0.0,0.0,20.0,32.0,0.0,10.0,0.0,52.0,16.0,29.0,159.0
Narayanpur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,84.0,274.0,10.0,369.0
Narayanpur,13.4,Number of children provided free glasses,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0,320.0,10.0,368.0
Narayanpur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Narayanpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Narayanpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1.0,,,1.0,1.0,1.0,2.0,1.0,1.0,,1.0,,-1.0
Narayanpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,3.0,2.0,1.0,,,,1.0,1.0,-1.0
Narayanpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,175.0,202.0,181.0,217.0,213.0,406.0,259.0,212.0,222.0,187.0,150.0,186.0,-1.0
Narayanpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1.0,,,1.0,2.0,1.0,2.0,1.0,1.0,,1.0,1.0,-1.0
Narayanpur,14.05,Number of RKS meetings held during the month,TOTAL,4.0,4.0,4.0,4.0,2.0,10.0,11.0,8.0,4.0,4.0,4.0,4.0,63.0
Narayanpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2.0,,,1.0,4.0,2.0,5.0,2.0,3.0,2.0,1.0,3.0,-1.0
Narayanpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,0.0,0.0,19.0,22.0,28.0,25.0,22.0,23.0,28.0,27.0,29.0,28.0,251.0
Narayanpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,1.0,,,,,1.0,1.0,,,,-1.0
Narayanpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,-1.0
Narayanpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,66.0,17.0,78.0,87.0,86.0,123.0,88.0,109.0,96.0,89.0,112.0,122.0,1073.0
Narayanpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,168.0,103.0,208.0,222.0,138.0,212.0,130.0,188.0,149.0,137.0,176.0,173.0,2004.0
Narayanpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,83.0,13.0,62.0,114.0,79.0,109.0,115.0,106.0,111.0,155.0,137.0,150.0,1234.0
Narayanpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,156.0,92.0,182.0,240.0,137.0,202.0,162.0,154.0,163.0,205.0,163.0,183.0,2039.0
Narayanpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,149.0,30.0,140.0,201.0,165.0,232.0,203.0,215.0,207.0,244.0,249.0,272.0,2307.0
Narayanpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,324.0,195.0,390.0,462.0,275.0,414.0,292.0,342.0,312.0,342.0,339.0,356.0,4043.0
Narayanpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6.0,0.0,5.0,3.0,3.0,2.0,4.0,4.0,9.0,6.0,6.0,9.0,57.0
Narayanpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,0.0,2.0,5.0,2.0,2.0,2.0,3.0,2.0,8.0,3.0,6.0,37.0
Narayanpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8.0,0.0,7.0,8.0,5.0,4.0,6.0,7.0,11.0,14.0,9.0,15.0,94.0
Narayanpur,14.11,In-Patient Head Count at midnight,TOTAL,0.0,0.0,7.0,8.0,0.0,0.0,0.0,0.0,11.0,14.0,0.0,0.0,40.0
Narayanpur,14.12.1,OPD attendance (All),TOTAL,13633.0,4475.0,8215.0,10770.0,13146.0,16934.0,10816.0,10308.0,11386.0,10538.0,11728.0,11755.0,133704.0
Narayanpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Narayanpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,164.0,18.0,149.0,196.0,191.0,128.0,177.0,162.0,196.0,232.0,237.0,272.0,2122.0
Narayanpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,3.0,3.0,3.0,3.0,1.0,1.0,1.0,1.0,2.0,2.0,2.0,1.0,23.0
Narayanpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,14.14.c,Number of Adolescents counselled,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,481.0,30.0,350.0,602.0,775.0,546.0,970.0,436.0,482.0,346.0,421.0,402.0,5841.0
Narayanpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,44.0,3.0,23.0,3.0,45.0,42.0,71.0,25.0,49.0,30.0,38.0,35.0,408.0
Narayanpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,31.0,,9.0,20.0,18.0,22.0,16.0,15.0,31.0,17.0,38.0,20.0,237.0
Narayanpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0.0,,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,1.0,3.0,6.0
Narayanpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2.0,,1.0,1.0,1.0,1.0,2.0,1.0,2.0,4.0,19.0,11.0,45.0
Narayanpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Narayanpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3.0,,4.0,3.0,4.0,2.0,3.0,1.0,3.0,5.0,37.0,9.0,74.0
Narayanpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,3.0
Narayanpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,36.0,,14.0,24.0,23.0,25.0,21.0,17.0,36.0,26.0,94.0,40.0,356.0
Narayanpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0.0,,0.0,0.0,0.0,1.0,2.0,1.0,0.0,0.0,2.0,5.0,11.0
Narayanpur,15.2,Number of Widal tests conducted,Number tested,56.0,0.0,50.0,104.0,135.0,222.0,11.0,83.0,56.0,37.0,44.0,60.0,858.0
Narayanpur,15.3.a,Number of VDRL tests conducted on males,Number tested,33.0,0.0,11.0,17.0,16.0,26.0,1.0,11.0,33.0,17.0,15.0,0.0,180.0
Narayanpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,5.0,0.0,15.0,20.0,19.0,15.0,1.0,13.0,5.0,8.0,10.0,1.0,112.0
Narayanpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,10.0,0.0,6.0,5.0,3.0,5.0,0.0,13.0,10.0,18.0,16.0,0.0,86.0
Narayanpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,48.0,0.0,32.0,42.0,38.0,46.0,2.0,37.0,48.0,43.0,41.0,1.0,378.0
Narayanpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,1337.0,619.0,2223.0,3234.0,2015.0,4946.0,1634.0,1616.0,1542.0,1125.0,1115.0,2177.0,23583.0
Narayanpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8.0,5.0,0.0,39.0,73.0,97.0,39.0,198.0,59.0,15.0,51.0,66.0,650.0
Narayanpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,169.0,96.0,103.0,498.0,546.0,822.0,102.0,421.0,355.0,134.0,232.0,317.0,3795.0
Narayanpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,2680.0,,,,,2680.0
Narayanpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,4000.0,,,,,4000.0
Narayanpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,2060.0,,,,,2060.0
Narayanpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4620.0,0.0,0.0,0.0,0.0,4620.0
Narayanpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,1600.0,,,,,1600.0
Narayanpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,7000.0,,,,,7000.0
Narayanpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,3240.0,,,,,3240.0
Narayanpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5360.0,0.0,0.0,0.0,0.0,5360.0
Narayanpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,3510.0,,,,,3510.0
Narayanpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,7000.0,,,,,7000.0
Narayanpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,2750.0,,,,,2750.0
Narayanpur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7760.0,0.0,0.0,0.0,0.0,7760.0
Narayanpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,1630.0,,,,,1630.0
Narayanpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,5000.0,,,,,5000.0
Narayanpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,710.0,,,,,710.0
Narayanpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5920.0,0.0,0.0,0.0,0.0,5920.0
Narayanpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,1865.0,,,,,1865.0
Narayanpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,21500.0,,,,,21500.0
Narayanpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,9935.0,,,,,9935.0
Narayanpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13430.0,0.0,0.0,0.0,0.0,13430.0
Narayanpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,325.0,,,,,325.0
Narayanpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,2300.0,,,,,2300.0
Narayanpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,1550.0,,,,,1550.0
Narayanpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1075.0,0.0,0.0,0.0,0.0,1075.0
Narayanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,15000.0,,,,,15000.0
Narayanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,4000.0,,,,,4000.0
Narayanpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,0.0,0.0,0.0,0.0,11000.0
Narayanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,3500.0,,,,,3500.0
Narayanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,2000.0,,,,,2000.0
Narayanpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,1500.0
Narayanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,277.0,,,,,277.0
Narayanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,6.0,,,,,6.0
Narayanpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,271.0,0.0,0.0,0.0,0.0,271.0
Narayanpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,556.0,,,,,556.0
Narayanpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,50.0,,,,,50.0
Narayanpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,506.0,0.0,0.0,0.0,0.0,506.0
Narayanpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,500.0,,,,,500.0
Narayanpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,3000.0,,,,,3000.0
Narayanpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,500.0,,,,,500.0
Narayanpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,3000.0
Narayanpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,3.0,,,,,3.0
Narayanpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,1.0,,,,,1.0
Narayanpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0
Narayanpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,14000.0,,,,,14000.0
Narayanpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,7000.0,,,,,7000.0
Narayanpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7000.0,0.0,0.0,0.0,0.0,7000.0
Narayanpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,269.0,,,,,269.0
Narayanpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,269.0,,,,,269.0
Narayanpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Narayanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Narayanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Narayanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Narayanpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Narayanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,8500.0,,,,,8500.0
Narayanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,10000.0,,,,,10000.0
Narayanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,0.0,,,,,0.0
Narayanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,5000.0,,,,,5000.0
Narayanpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13500.0,0.0,0.0,0.0,0.0,13500.0
Narayanpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,2.0,,,,1.0,1.0,,1.0,,5.0
Narayanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,2.0,3.0
Narayanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narayanpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,,2.0,3.0
Narayanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Narayanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Narayanpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Narayanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,3.0,,,2.0,6.0,2.0,1.0,15.0
Narayanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,3.0,,,,,,,3.0,,,6.0
Narayanpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,4.0,,,3.0,,,2.0,9.0,2.0,1.0,21.0
Narayanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,1.0,1.0,,,,4.0,2.0,,8.0
Narayanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Narayanpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,1.0,1.0,1.0,,,4.0,2.0,,9.0
Narayanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,2.0,1.0,2.0,,3.0,,,1.0,,9.0
Narayanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,,1.0,1.0,3.0,1.0,,7.0
Narayanpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,2.0,2.0,2.0,,4.0,1.0,3.0,2.0,,16.0
Narayanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narayanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Narayanpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Narayanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narayanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,1.0,,,,,1.0,,3.0,6.0
Narayanpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,,,,,1.0,,3.0,6.0
Narayanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Narayanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Narayanpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Narayanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,3.0,3.0,,,1.0,,,1.0,,,8.0
Narayanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,1.0,1.0,2.0,1.0,1.0,1.0,2.0,9.0
Narayanpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,3.0,3.0,,1.0,2.0,2.0,1.0,2.0,1.0,2.0,17.0
Narayanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Narayanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,1.0,1.0
Narayanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,2.0,,1.0,,,,,1.0,,,4.0
Narayanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,1.0,1.0,,,,,,,,2.0
Narayanpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,2.0,1.0,2.0,,,,,1.0,,,6.0
Narayanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,1.0,1.0,2.0,1.0,1.0,6.0
Narayanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Narayanpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,1.0,1.0,2.0,2.0,1.0,7.0
Narayanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Narayanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,1.0,,1.0
Narayanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Narayanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,2.0,,1.0,1.0,,2.0,2.0,,1.0,10.0
Narayanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,3.0,,2.0,,1.0,,,,,6.0
Narayanpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,6.0,1.0,3.0,1.0,1.0,2.0,2.0,,1.0,18.0
Narayanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Narayanpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,1.0,,,,,,,1.0
Narayanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Narayanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,1.0,1.0,,,,,1.0,,1.0,,4.0
Narayanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,1.0,,,,1.0,,,,,2.0
Narayanpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,1.0,2.0,1.0,,,1.0,1.0,,1.0,,7.0
Narayanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Narayanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,1.0,,1.0,,,,3.0,,6.0,11.0
Narayanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Narayanpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,3.0,,1.0,,,,3.0,,6.0,13.0
Narayanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Narayanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,2.0,,,,,,,3.0
Narayanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,2.0,,,,,,,3.0
Narayanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Narayanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Narayanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Narayanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,1.0,,,,,1.0
Narayanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Narayanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Narayanpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,1.0,1.0
Narayanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Narayanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,1.0,3.0,3.0,1.0,,2.0,,1.0,12.0
Narayanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,1.0,,,,,,,1.0
Narayanpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,1.0,4.0,3.0,1.0,,2.0,,1.0,13.0
Narayanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,2.0,1.0,1.0,,,,,,,,4.0
Narayanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,5.0,4.0,7.0,4.0,3.0,4.0,3.0,8.0,6.0,3.0,47.0
Narayanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,1.0,1.0,,,,,,,2.0
Narayanpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,7.0,5.0,9.0,5.0,3.0,4.0,3.0,8.0,6.0,3.0,53.0
Narayanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Narayanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,1.0,2.0,1.0,1.0,,2.0,,1.0,1.0,1.0,10.0
Narayanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,1.0,,,,,,,1.0
Narayanpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,1.0,2.0,1.0,3.0,,2.0,,1.0,1.0,1.0,12.0
Narayanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,1.0,1.0,,,1.0,,,,,,3.0
Narayanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,5.0,3.0,2.0,,1.0,2.0,2.0,3.0,,4.0,22.0
Narayanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,2.0,1.0,1.0,2.0,2.0,,,,,,8.0
Narayanpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,8.0,5.0,3.0,2.0,4.0,2.0,2.0,3.0,,4.0,33.0
Narayanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,2.0,,,,,3.0
Narayanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,2.0,2.0,4.0,4.0,1.0,18.0,11.0,7.0,7.0,2.0,58.0
Narayanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,4.0,5.0,5.0,6.0,4.0,11.0,,,,,35.0
Narayanpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,6.0,8.0,9.0,10.0,5.0,31.0,11.0,7.0,7.0,2.0,96.0
Narayanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,,1.0,,,,,,,,2.0
Narayanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,5.0,3.0,6.0,7.0,4.0,6.0,6.0,7.0,6.0,8.0,58.0
Narayanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,5.0,1.0,7.0,4.0,2.0,,,,1.0,,20.0
Narayanpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,11.0,4.0,14.0,11.0,6.0,6.0,6.0,7.0,7.0,8.0,80.0
Narayanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,2.0,1.0,,1.0,,,,,,,4.0
Narayanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,1.0,2.0,3.0,2.0,3.0,,2.0,4.0,1.0,3.0,21.0
Narayanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,1.0,5.0,1.0,2.0,,2.0,,,,,11.0
Narayanpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,4.0,8.0,4.0,5.0,3.0,2.0,2.0,4.0,1.0,3.0,36.0
Raigarh,1.1,Total number of pregnant women Registered for ANC,TOTAL,2648.0,2711.0,2804.0,3027.0,2830.0,2767.0,3100.0,2738.0,3054.0,2688.0,2293.0,3050.0,33710.0
Raigarh,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1482.0,1487.0,1579.0,1729.0,1628.0,1426.0,1780.0,1490.0,1634.0,1467.0,1177.0,1541.0,18420.0
Raigarh,1.2,Number of Pregnant women registered under JSY,TOTAL,2648.0,2711.0,2802.0,3027.0,2830.0,2767.0,3100.0,2738.0,3054.0,2688.0,2293.0,2982.0,33640.0
Raigarh,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2229.0,2264.0,2322.0,2362.0,2470.0,2327.0,2480.0,2212.0,2366.0,2267.0,2183.0,2538.0,28020.0
Raigarh,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2590.0,2652.0,2791.0,2958.0,2819.0,2683.0,3001.0,2713.0,2963.0,2594.0,2192.0,2979.0,32935.0
Raigarh,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2115.0,2601.0,2483.0,2707.0,2940.0,2756.0,2663.0,2835.0,2685.0,2834.0,2484.0,2494.0,31597.0
Raigarh,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2036.0,1839.0,1921.0,2057.0,2012.0,1755.0,1702.0,1390.0,2142.0,1738.0,1433.0,1446.0,21471.0
Raigarh,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,78.0,112.0,79.0,92.0,105.0,108.0,142.0,112.0,29.0,34.0,35.0,36.0,962.0
Raigarh,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,7.0,4.0,3.0,3.0,7.0,6.0,9.0,19.0,8.0,8.0,0.0,78.0
Raigarh,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,437.0,541.0,629.0,656.0,667.0,642.0,634.0,564.0,628.0,757.0,657.0,759.0,7571.0
Raigarh,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,79.0,84.0,95.0,119.0,88.0,102.0,78.0,21.0,21.0,58.0,37.0,60.0,842.0
Raigarh,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Raigarh,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,353.0,450.0,525.0,577.0,557.0,494.0,534.0,436.0,423.0,414.0,344.0,422.0,5529.0
Raigarh,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,430.0,385.0,386.0,379.0,444.0,464.0,374.0,352.0,438.0,457.0,466.0,479.0,5054.0
Raigarh,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,783.0,835.0,911.0,956.0,1001.0,958.0,908.0,788.0,861.0,871.0,810.0,901.0,10583.0
Raigarh,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,649.0,755.0,684.0,819.0,890.0,799.0,778.0,716.0,764.0,709.0,695.0,765.0,9023.0
Raigarh,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,143.0,87.0,78.0,97.0,98.0,87.0,69.0,50.0,71.0,44.0,77.0,73.0,974.0
Raigarh,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1200.0,1300.0,1317.0,1303.0,1417.0,1352.0,1372.0,1500.0,1378.0,1314.0,1308.0,1661.0,16422.0
Raigarh,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,23.0,57.0,49.0,59.0,45.0,48.0,41.0,56.0,57.0,100.0,195.0,168.0,898.0
Raigarh,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1200.0,1300.0,1317.0,1303.0,1417.0,1352.0,1372.0,1500.0,1378.0,1314.0,1310.0,1661.0,16424.0
Raigarh,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,750.0,857.0,920.0,932.0,921.0,912.0,901.0,1100.0,887.0,919.0,934.0,1155.0,11188.0
Raigarh,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,52.0,35.0,56.0,47.0,68.0,75.0,73.0,113.0,62.0,131.0,115.0,105.0,932.0
Raigarh,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,285.0,324.0,306.0,343.0,368.0,341.0,330.0,341.0,305.0,280.0,291.0,385.0,3899.0
Raigarh,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,261.0,306.0,289.0,306.0,348.0,324.0,330.0,341.0,305.0,280.0,291.0,385.0,3766.0
Raigarh,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,2.0,3.0,4.0,7.0,3.0,1.0,9.0,5.0,4.0,7.0,4.0,7.0,56.0
Raigarh,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,6.0,2.0,1.0,0.0,4.0,3.0,17.0
Raigarh,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,14.0,14.0,12.0,7.0,11.0,7.0,0.0,9.0,5.0,4.0,4.0,0.0,87.0
Raigarh,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,91.0,105.0,97.0,98.0,115.0,95.0,94.0,85.0,87.0,78.0,80.0,52.0,1077.0
Raigarh,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,105.0,119.0,109.0,105.0,126.0,102.0,94.0,94.0,92.0,82.0,84.0,52.0,1164.0
Raigarh,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,104.0,113.0,124.0,118.0,119.0,119.0,103.0,134.0,95.0,78.0,120.0,161.0,1388.0
Raigarh,4.1.1.a,Number of male live births,TOTAL,1157.0,1222.0,1288.0,1303.0,1432.0,1315.0,1291.0,1339.0,1281.0,1221.0,1234.0,1471.0,15554.0
Raigarh,4.1.1.b,Number of female live births,TOTAL,1075.0,1169.0,1167.0,1219.0,1284.0,1274.0,1262.0,1240.0,1210.0,1182.0,1129.0,1399.0,14610.0
Raigarh,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2232.0,2391.0,2455.0,2522.0,2716.0,2589.0,2553.0,2579.0,2491.0,2403.0,2363.0,2870.0,30164.0
Raigarh,4.1.2,Number of still births,TOTAL,43.0,73.0,79.0,90.0,75.0,77.0,67.0,60.0,68.0,67.0,54.0,86.0,839.0
Raigarh,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,71.0,95.0,99.0,96.0,107.0,110.0,68.0,86.0,245.0,95.0,91.0,55.0,1218.0
Raigarh,4.2.1,Number of Newborns weighed at birth,TOTAL,2232.0,2389.0,2450.0,2522.0,2716.0,2588.0,2551.0,2579.0,2491.0,2403.0,2363.0,2870.0,30154.0
Raigarh,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,323.0,316.0,363.0,510.0,379.0,431.0,482.0,415.0,396.0,363.0,396.0,370.0,4744.0
Raigarh,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2198.0,2338.0,2428.0,2498.0,2686.0,2574.0,2529.0,2564.0,2477.0,2370.0,2349.0,2851.0,29862.0
Raigarh,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,16.0,12.0,22.0,26.0,23.0,10.0,23.0,18.0,15.0,5.0,7.0,10.0,187.0
Raigarh,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,19.0,44.0,11.0,35.0,53.0,33.0,36.0,21.0,6.0,6.0,14.0,35.0,313.0
Raigarh,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,91.0,107.0,97.0,98.0,115.0,95.0,92.0,85.0,87.0,58.0,78.0,71.0,1074.0
Raigarh,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,126.0,163.0,130.0,159.0,191.0,138.0,151.0,124.0,108.0,69.0,99.0,116.0,1574.0
Raigarh,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,104.0,113.0,124.0,118.0,119.0,119.0,103.0,134.0,95.0,78.0,120.0,161.0,1388.0
Raigarh,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,230.0,276.0,254.0,277.0,310.0,257.0,254.0,239.0,203.0,147.0,219.0,277.0,2943.0
Raigarh,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,54.0,68.0,44.0,36.0,59.0,64.0,84.0,72.0,17.0,58.0,63.0,75.0,694.0
Raigarh,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,26.0,28.0,31.0,53.0,60.0,61.0,46.0,91.0,84.0,53.0,68.0,71.0,672.0
Raigarh,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,66.0,63.0,66.0,54.0,80.0,56.0,58.0,58.0,58.0,56.0,56.0,56.0,727.0
Raigarh,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1960.0,2189.0,2216.0,2263.0,2442.0,2322.0,2307.0,2398.0,2376.0,2274.0,2004.0,2717.0,27468.0
Raigarh,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,277.0,258.0,291.0,319.0,337.0,332.0,298.0,229.0,162.0,186.0,210.0,279.0,3178.0
Raigarh,6.3,PNC maternal complications attended,TOTAL,30.0,65.0,18.0,6.0,11.0,13.0,59.0,71.0,73.0,57.0,64.0,31.0,498.0
Raigarh,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,17.0,19.0,23.0,15.0,20.0,48.0,28.0,20.0,23.0,24.0,16.0,15.0,268.0
Raigarh,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,8.0,1.0,7.0,2.0,17.0,4.0,15.0,3.0,5.0,2.0,4.0,68.0
Raigarh,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,17.0,27.0,24.0,22.0,22.0,65.0,32.0,35.0,26.0,29.0,18.0,19.0,336.0
Raigarh,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,17.0,13.0,12.0,66.0,30.0,29.0,43.0,53.0,33.0,32.0,41.0,22.0,391.0
Raigarh,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,24.0,32.0,37.0,51.0,27.0,86.0,83.0,98.0,75.0,95.0,111.0,126.0,845.0
Raigarh,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,41.0,45.0,49.0,117.0,57.0,115.0,126.0,151.0,108.0,127.0,152.0,148.0,1236.0
Raigarh,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Raigarh,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,1.0,10.0,3.0,4.0,6.0,3.0,7.0,2.0,8.0,45.0
Raigarh,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,21.0,0.0,0.0,1.0,0.0,23.0
Raigarh,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,2.0,1.0,10.0,3.0,4.0,27.0,3.0,7.0,3.0,8.0,68.0
Raigarh,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,55.0,0.0,7.0,212.0,221.0,164.0,848.0,1331.0,866.0,1892.0,948.0,386.0,6930.0
Raigarh,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,1.0,14.0,10.0,70.0,3.0,3.0,0.0,37.0,36.0,24.0,83.0,40.0,321.0
Raigarh,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,56.0,14.0,17.0,282.0,224.0,167.0,848.0,1368.0,902.0,1916.0,1031.0,426.0,7251.0
Raigarh,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,1.0,2.0,6.0,60.0,1.0,53.0,0.0,5.0,2.0,1.0,1.0,7.0,139.0
Raigarh,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,25.0,12.0,10.0,25.0,41.0,47.0,37.0,57.0,69.0,49.0,84.0,27.0,483.0
Raigarh,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,26.0,14.0,16.0,85.0,42.0,100.0,37.0,62.0,71.0,50.0,85.0,34.0,622.0
Raigarh,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,16.0,10.0,12.0,21.0,20.0,24.0,20.0,23.0,20.0,27.0,28.0,52.0,273.0
Raigarh,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,4.0,0.0,0.0,9.0
Raigarh,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,2.0,4.0,0.0,0.0,9.0
Raigarh,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,474.0,284.0,326.0,1209.0,1109.0,765.0,845.0,1005.0,690.0,825.0,762.0,947.0,9241.0
Raigarh,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,7.0,1.0,2.0,0.0,6.0,1.0,0.0,2.0,5.0,4.0,1.0,3.0,32.0
Raigarh,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,8.0,0.0,0.0,0.0,6.0,4.0,8.0,9.0,5.0,23.0,63.0
Raigarh,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,13.0,11.0,15.0,20.0,26.0,24.0,14.0,21.0,5.0,16.0,20.0,23.0,208.0
Raigarh,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raigarh,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,494.0,296.0,351.0,1229.0,1141.0,790.0,865.0,1032.0,708.0,854.0,788.0,996.0,9544.0
Raigarh,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Raigarh,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.06,Number of IUCD removals,TOTAL,828.0,736.0,699.0,845.0,572.0,511.0,470.0,549.0,419.0,451.0,476.0,650.0,7206.0
Raigarh,9.07,Number of Oral Pills cycles distributed,TOTAL,2477.0,1935.0,1799.0,5043.0,6138.0,5055.0,4102.0,5796.0,4448.0,7317.0,4718.0,7607.0,56435.0
Raigarh,9.08,Number of Condom pieces distributed,TOTAL,11074.0,8650.0,9975.0,25895.0,26548.0,23620.0,18446.0,30759.0,23526.0,30925.0,19768.0,29235.0,258421.0
Raigarh,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,5.0,1.0,30.0,8.0,21.0,8.0,5.0,5.0,0.0,83.0
Raigarh,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,9.12,Number of Institutions having NSV trained doctors,TOTAL,19.0,19.0,19.0,32.0,29.0,27.0,33.0,28.0,34.0,35.0,29.0,29.0,-1.0
Raigarh,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2080.0,2306.0,2510.0,2477.0,2609.0,2694.0,2495.0,2555.0,2611.0,2376.0,2422.0,2809.0,29944.0
Raigarh,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1921.0,2102.0,2453.0,2477.0,2512.0,2617.0,2639.0,2425.0,2539.0,2681.0,2488.0,2766.0,29620.0
Raigarh,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2044.0,2144.0,2186.0,2455.0,2528.0,2460.0,2596.0,2457.0,2471.0,2509.0,2642.0,2822.0,29314.0
Raigarh,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2151.0,2246.0,2236.0,2164.0,2526.0,2537.0,2430.0,2565.0,2434.0,2476.0,2423.0,3060.0,29248.0
Raigarh,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Raigarh,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Raigarh,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Raigarh,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1864.0,2212.0,2232.0,2177.0,2381.0,2632.0,2438.0,2531.0,2561.0,2285.0,2366.0,2758.0,28437.0
Raigarh,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1921.0,2381.0,2455.0,2482.0,2512.0,2617.0,2639.0,2425.0,2539.0,2681.0,2488.0,2766.0,29906.0
Raigarh,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2044.0,2148.0,2186.0,2450.0,2529.0,2460.0,2595.0,2457.0,2474.0,2507.0,2542.0,2822.0,29214.0
Raigarh,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2151.0,2257.0,2236.0,2164.0,2526.0,2534.0,2430.0,2565.0,2434.0,2476.0,2423.0,3060.0,29256.0
Raigarh,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,289.0,446.0,506.0,604.0,665.0,716.0,3226.0
Raigarh,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1276.0,2191.0,2358.0,2599.0,2302.0,2608.0,13334.0
Raigarh,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1186.0,2145.0,2368.0,2359.0,2704.0,10762.0
Raigarh,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,1625.0,2307.0,2206.0,2870.0,9018.0
Raigarh,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2015.0,2358.0,2386.0,2559.0,2792.0,2628.0,2391.0,2112.0,2380.0,2751.0,2452.0,3158.0,29982.0
Raigarh,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Raigarh,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1020.0,1233.0,1212.0,1338.0,1438.0,1324.0,1218.0,1081.0,1232.0,1326.0,1224.0,1533.0,15179.0
Raigarh,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,995.0,1125.0,1173.0,1221.0,1354.0,1298.0,1173.0,978.0,1070.0,1162.0,1190.0,1433.0,14172.0
Raigarh,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2015.0,2358.0,2385.0,2559.0,2792.0,2622.0,2391.0,2059.0,2302.0,2488.0,2414.0,2966.0,29351.0
Raigarh,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1717.0,1901.0,2262.0,2239.0,2767.0,2161.0,2202.0,2138.0,3643.0,2455.0,2073.0,2684.0,28242.0
Raigarh,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1717.0,1906.0,2262.0,2239.0,2767.0,2161.0,2198.0,2138.0,3643.0,2455.0,2075.0,2684.0,28245.0
Raigarh,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,0.0,0.0,8.0,10.0,0.0,0.0,0.0,40.0,5.0,0.0,0.0,76.0
Raigarh,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,14.0,0.0,0.0,10.0,13.0,0.0,0.0,0.0,30.0,2.0,0.0,0.0,69.0
Raigarh,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,27.0,0.0,0.0,18.0,23.0,0.0,0.0,0.0,70.0,7.0,0.0,0.0,145.0
Raigarh,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,888.0,1303.0,1242.0,1650.0,3976.0,2755.0,1974.0,1547.0,5303.0,2987.0,1904.0,2872.0,28401.0
Raigarh,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1442.0,1737.0,1914.0,2267.0,3498.0,3705.0,2558.0,2225.0,3150.0,2716.0,2105.0,2786.0,30103.0
Raigarh,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1262.0,1751.0,2056.0,2186.0,3289.0,2950.0,2421.0,2218.0,2805.0,2523.0,2348.0,2739.0,28548.0
Raigarh,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,189.0,260.0,265.0,279.0,279.0,243.0,249.0,231.0,186.0,225.0,244.0,260.0,2910.0
Raigarh,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,286.0,640.0,615.0,687.0,570.0,706.0,686.0,667.0,901.0,831.0,815.0,874.0,8278.0
Raigarh,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1624.0,1699.0,1729.0,1760.0,1746.0,1712.0,1715.0,1723.0,1769.0,1788.0,1768.0,1779.0,20812.0
Raigarh,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1511.0,1634.0,1691.0,1709.0,1717.0,1677.0,1680.0,1700.0,1740.0,1733.0,1649.0,1744.0,20185.0
Raigarh,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1357.0,1479.0,1531.0,1541.0,1544.0,1539.0,1597.0,1635.0,1697.0,1690.0,1602.0,1601.0,18813.0
Raigarh,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2007.0,2369.0,2467.0,2559.0,2767.0,2628.0,2391.0,2112.0,2065.0,2347.0,2452.0,3148.0,29312.0
Raigarh,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,30.0,43.0,14.0,153.0,5654.0,671.0,254.0,249.0,7829.0,5508.0,353.0,589.0,21347.0
Raigarh,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,9.0,0.0,9.0,109.0,6133.0,749.0,247.0,126.0,8099.0,5762.0,318.0,412.0,21973.0
Raigarh,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,4.0,5.0,0.0,1.0,0.0,0.0,5.0,24.0,2.0,0.0,0.0,41.0
Raigarh,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,683.0,789.0,823.0,984.0,1095.0,813.0,654.0,548.0,608.0,824.0,876.0,981.0,9678.0
Raigarh,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,88.0,57.0,66.0,33.0,145.0,265.0,25.0,115.0,221.0,85.0,40.0,30.0,1170.0
Raigarh,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,99.0,43.0,63.0,63.0,74.0,223.0,150.0,79.0,53.0,148.0,139.0,116.0,1250.0
Raigarh,13.1,Number of Patients operated for cataract,TOTAL,166.0,90.0,69.0,129.0,98.0,378.0,459.0,740.0,1112.0,815.0,716.0,412.0,5184.0
Raigarh,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,163.0,90.0,69.0,129.0,97.0,376.0,459.0,738.0,1112.0,815.0,716.0,412.0,5176.0
Raigarh,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,7.0,45.0,15.0,1188.0,606.0,10.0,59.0,111.0,111.0,2152.0
Raigarh,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,47.0,117.0,28.0,77.0,0.0,0.0,269.0
Raigarh,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,5.0,7.0,6.0,6.0,6.0,7.0,7.0,6.0,6.0,6.0,-1.0
Raigarh,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,20.0,20.0,18.0,23.0,28.0,23.0,19.0,20.0,19.0,15.0,19.0,13.0,-1.0
Raigarh,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1504.0,1660.0,1684.0,1679.0,1731.0,1594.0,1633.0,1582.0,1601.0,1563.0,1547.0,1697.0,-1.0
Raigarh,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,12.0,10.0,12.0,12.0,12.0,11.0,12.0,11.0,11.0,10.0,11.0,-1.0
Raigarh,14.05,Number of RKS meetings held during the month,TOTAL,16.0,9.0,10.0,3.0,13.0,11.0,13.0,5.0,4.0,3.0,9.0,21.0,117.0
Raigarh,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,33.0,35.0,28.0,36.0,37.0,32.0,31.0,28.0,31.0,34.0,27.0,29.0,-1.0
Raigarh,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,152.0,177.0,176.0,154.0,209.0,258.0,260.0,259.0,229.0,220.0,335.0,320.0,2749.0
Raigarh,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,6.0,5.0,6.0,6.0,4.0,6.0,5.0,5.0,5.0,5.0,5.0,-1.0
Raigarh,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,3.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,-1.0
Raigarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,574.0,445.0,740.0,856.0,855.0,881.0,723.0,526.0,591.0,564.0,692.0,679.0,8126.0
Raigarh,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,903.0,1096.0,987.0,1154.0,1233.0,1207.0,1243.0,882.0,1022.0,969.0,912.0,1425.0,13033.0
Raigarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,589.0,442.0,668.0,690.0,745.0,744.0,677.0,571.0,602.0,572.0,741.0,659.0,7700.0
Raigarh,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1678.0,2093.0,1930.0,1986.0,2092.0,2170.0,2352.0,1947.0,1865.0,2069.0,1851.0,2841.0,24874.0
Raigarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1163.0,887.0,1408.0,1546.0,1600.0,1625.0,1400.0,1097.0,1193.0,1136.0,1433.0,1338.0,15826.0
Raigarh,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2581.0,3189.0,2917.0,3140.0,3325.0,3377.0,3595.0,2829.0,2887.0,3038.0,2763.0,4266.0,37907.0
Raigarh,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,16.0,22.0,16.0,26.0,18.0,16.0,17.0,12.0,17.0,23.0,19.0,217.0
Raigarh,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6.0,10.0,10.0,17.0,14.0,10.0,11.0,16.0,11.0,12.0,4.0,14.0,135.0
Raigarh,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,21.0,26.0,32.0,33.0,40.0,28.0,27.0,33.0,23.0,29.0,27.0,33.0,352.0
Raigarh,14.11,In-Patient Head Count at midnight,TOTAL,603.0,695.0,425.0,458.0,495.0,556.0,280.0,888.0,372.0,500.0,465.0,1126.0,6863.0
Raigarh,14.12.1,OPD attendance (All),TOTAL,37398.0,44196.0,44849.0,54575.0,58111.0,69149.0,56792.0,49478.0,52671.0,49065.0,54094.0,60993.0,631371.0
Raigarh,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,212.0,216.0,181.0,182.0,109.0,115.0,65.0,93.0,82.0,92.0,311.0,292.0,1950.0
Raigarh,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Raigarh,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,591.0,522.0,458.0,459.0,548.0,527.0,438.0,427.0,507.0,599.0,520.0,552.0,6148.0
Raigarh,14.14.a,Number of patients given AYUSH treatment,TOTAL,102.0,671.0,596.0,816.0,534.0,1407.0,691.0,1393.0,392.0,1213.0,2680.0,3809.0,14304.0
Raigarh,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4.0,7.0,11.0,13.0,51.0,47.0,41.0,53.0,42.0,61.0,58.0,66.0,454.0
Raigarh,14.14.c,Number of Adolescents counselled,TOTAL,3.0,1.0,0.0,2.0,1.0,12.0,0.0,0.0,0.0,5.0,0.0,7.0,31.0
Raigarh,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2493.0,2676.0,3021.0,3224.0,3391.0,2975.0,3736.0,3172.0,3450.0,3891.0,3527.0,3885.0,39441.0
Raigarh,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,153.0,131.0,277.0,301.0,244.0,178.0,238.0,167.0,189.0,216.0,240.0,139.0,2473.0
Raigarh,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,572.0,526.0,638.0,683.0,468.0,446.0,470.0,387.0,309.0,664.0,414.0,506.0,6083.0
Raigarh,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,0.0,2.0,1.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,8.0
Raigarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,189.0,263.0,202.0,160.0,476.0,249.0,458.0,397.0,371.0,304.0,367.0,551.0,3987.0
Raigarh,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Raigarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,301.0,318.0,120.0,167.0,247.0,344.0,265.0,257.0,322.0,377.0,388.0,613.0,3719.0
Raigarh,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1062.0,1107.0,960.0,1010.0,1191.0,1039.0,1193.0,1041.0,1002.0,1345.0,1169.0,1670.0,13789.0
Raigarh,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2.0,0.0,2.0,1.0,1.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,10.0
Raigarh,15.2,Number of Widal tests conducted,Number tested,346.0,364.0,302.0,370.0,691.0,850.0,851.0,584.0,506.0,400.0,383.0,577.0,6224.0
Raigarh,15.3.a,Number of VDRL tests conducted on males,Number tested,129.0,151.0,65.0,107.0,175.0,171.0,132.0,140.0,73.0,136.0,189.0,177.0,1645.0
Raigarh,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,114.0,85.0,142.0,147.0,135.0,110.0,131.0,88.0,111.0,87.0,150.0,292.0,1592.0
Raigarh,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,256.0,260.0,64.0,52.0,165.0,213.0,179.0,174.0,122.0,179.0,198.0,201.0,2063.0
Raigarh,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,499.0,496.0,271.0,306.0,475.0,494.0,442.0,402.0,306.0,402.0,537.0,670.0,5300.0
Raigarh,15.4.1,Number of blood smears examined for Malaria,TOTAL,8607.0,6903.0,9569.0,16526.0,20158.0,22233.0,17226.0,13156.0,9057.0,4313.0,7038.0,10385.0,145171.0
Raigarh,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,108.0,77.0,201.0,309.0,310.0,355.0,292.0,171.0,199.0,164.0,119.0,161.0,2466.0
Raigarh,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,146.0,115.0,220.0,576.0,1176.0,832.0,514.0,646.0,417.0,298.0,118.0,163.0,5221.0
Raigarh,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,34500.0,16500.0,34500.0,38000.0,33000.0,29500.0,17500.0,14000.0,11500.0,20500.0,37000.0,25500.0,312000.0
Raigarh,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,30000.0,20000.0,10000.0,15000.0,15000.0,10000.0,20000.0,20000.0,30000.0,0.0,25000.0,195000.0
Raigarh,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,18000.0,12000.0,16500.0,15000.0,18500.0,27000.0,13500.0,22500.0,11000.0,13500.0,11500.0,18500.0,197500.0
Raigarh,16.1.1,Stock position of DPT vaccines,5. Total Stock,16500.0,34500.0,38000.0,33000.0,29500.0,17500.0,14000.0,11500.0,20500.0,37000.0,25500.0,32000.0,309500.0
Raigarh,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Raigarh,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Raigarh,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Raigarh,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Raigarh,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,23000.0,500.0,13500.0,13100.0,800.0,20500.0,10400.0,10000.0,18000.0,7000.0,4000.0,19000.0,139800.0
Raigarh,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,40000.0,15000.0,8000.0,50000.0,20000.0,30000.0,50000.0,3000.0,20000.0,255000.0,56400.0,547400.0
Raigarh,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,22500.0,27000.0,15400.0,20300.0,30300.0,30100.0,30400.0,42000.0,14000.0,23000.0,240000.0,19000.0,514000.0
Raigarh,16.1.2,Stock position of OPV vaccines,5. Total Stock,500.0,13500.0,13100.0,800.0,20500.0,10400.0,10000.0,18000.0,7000.0,4000.0,19000.0,56400.0,173200.0
Raigarh,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,40500.0,25500.0,34000.0,40500.0,37500.0,27000.0,28000.0,33500.0,29000.0,23500.0,40000.0,29000.0,388000.0
Raigarh,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,20000.0,20000.0,10000.0,10000.0,25000.0,20000.0,20000.0,5000.0,30000.0,0.0,30000.0,190000.0
Raigarh,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.3,Stock position of TT vaccines,4. Stock Distributed,15000.0,11500.0,13500.0,13000.0,20500.0,24000.0,14500.0,24500.0,10500.0,13500.0,11000.0,15500.0,187000.0
Raigarh,16.1.3,Stock position of TT vaccines,5. Total Stock,25500.0,34000.0,40500.0,37500.0,27000.0,28000.0,33500.0,29000.0,23500.0,40000.0,29000.0,43500.0,391000.0
Raigarh,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,29500.0,18500.0,26500.0,24500.0,21500.0,20500.0,10000.0,11000.0,9000.0,5000.0,7500.0,2000.0,185500.0
Raigarh,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,15000.0,8000.0,5000.0,15000.0,0.0,10000.0,15000.0,2000.0,10000.0,0.0,15000.0,95000.0
Raigarh,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11000.0,7000.0,10000.0,8000.0,16000.0,10500.0,9000.0,17000.0,6000.0,7500.0,5500.0,10500.0,118000.0
Raigarh,16.1.5,Stock position of BCG vaccines,5. Total Stock,18500.0,26500.0,24500.0,21500.0,20500.0,10000.0,11000.0,9000.0,5000.0,7500.0,2000.0,6500.0,162500.0
Raigarh,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10000.0,3750.0,9250.0,10250.0,10250.0,7250.0,10750.0,17750.0,26250.0,26250.0,24250.0,22250.0,178250.0
Raigarh,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,10000.0,7000.0,5000.0,5000.0,10000.0,14500.0,10000.0,0.0,0.0,0.0,0.0,61500.0
Raigarh,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,6250.0,4500.0,6000.0,5000.0,8000.0,6500.0,7500.0,1500.0,0.0,2000.0,2000.0,4750.0,54000.0
Raigarh,16.1.6,Stock position of Measles vaccines,5. Total Stock,3750.0,9250.0,10250.0,10250.0,7250.0,10750.0,17750.0,26250.0,26250.0,24250.0,22250.0,17500.0,185750.0
Raigarh,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,25000.0,13900.0,26500.0,21100.0,12100.0,4000.0,102600.0
Raigarh,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,29800.0,0.0,25000.0,0.0,0.0,0.0,18000.0,72800.0
Raigarh,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,4800.0,11100.0,12400.0,5400.0,9000.0,8100.0,14100.0,64900.0
Raigarh,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,25000.0,13900.0,26500.0,21100.0,12100.0,4000.0,7900.0,110500.0
Raigarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,16700.0,2100.0,2100.0,2100.0,1500.0,1500.0,1500.0,1500.0,900.0,29900.0
Raigarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,19800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19800.0
Raigarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,0.0,3100.0,14600.0,0.0,0.0,600.0,0.0,0.0,0.0,600.0,0.0,18900.0
Raigarh,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,16700.0,2100.0,2100.0,2100.0,1500.0,1500.0,1500.0,1500.0,900.0,900.0,30800.0
Raigarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,78000.0,12000.0,12000.0,75000.0,73040.0,60440.0,60440.0,22640.0,10040.0,403600.0
Raigarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,96000.0,0.0,0.0,63000.0,68040.0,0.0,0.0,0.0,0.0,0.0,227040.0
Raigarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,0.0,18000.0,66000.0,0.0,0.0,70000.0,12600.0,0.0,37800.0,12600.0,2500.0,219500.0
Raigarh,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,78000.0,12000.0,12000.0,75000.0,73040.0,60440.0,60440.0,22640.0,10040.0,7540.0,411140.0
Raigarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,19000.0,1000.0,1000.0,10600.0,3600.0,2400.0,2400.0,0.0,0.0,40000.0
Raigarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,25000.0,0.0,0.0,9600.0,0.0,0.0,0.0,0.0,0.0,0.0,34600.0
Raigarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,6000.0,18000.0,0.0,0.0,7000.0,1200.0,0.0,2400.0,0.0,0.0,34600.0
Raigarh,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,19000.0,1000.0,1000.0,10600.0,3600.0,2400.0,2400.0,0.0,0.0,0.0,40000.0
Raigarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,5600.0,200.0,0.0,200.0,0.0,5100.0,5100.0,3700.0,3200.0,23100.0
Raigarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,7000.0,0.0,0.0,7000.0,0.0,5400.0,0.0,0.0,0.0,0.0,19400.0
Raigarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,1400.0,5400.0,200.0,6800.0,200.0,300.0,0.0,1400.0,500.0,0.0,16200.0
Raigarh,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,5600.0,200.0,0.0,200.0,0.0,5100.0,5100.0,3700.0,3200.0,3200.0,26300.0
Raigarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4000.0,4000.0,4000.0,4000.0,4000.0,4000.0,3000.0,1300.0,6900.0,5900.0,600.0,5000.0,46700.0
Raigarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6900.0,0.0,0.0,5000.0,0.0,11900.0
Raigarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,1000.0,1700.0,1300.0,1000.0,5300.0,600.0,0.0,10900.0
Raigarh,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4000.0,4000.0,4000.0,4000.0,4000.0,3000.0,1300.0,6900.0,5900.0,600.0,5000.0,5000.0,47700.0
Raigarh,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1000.0,1000.0,1000.0,600.0,7800.0,2900.0,900.0,400.0,4550.0,3050.0,2200.0,400.0,25800.0
Raigarh,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,3000.0,18000.0
Raigarh,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,400.0,2800.0,4900.0,2000.0,500.0,850.0,1500.0,850.0,1800.0,400.0,16000.0
Raigarh,16.3.02,Stock Position of Gloves,5. Total Stock,1000.0,1000.0,600.0,7800.0,2900.0,900.0,400.0,4550.0,3050.0,2200.0,400.0,3000.0,27800.0
Raigarh,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,57000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,130000.0,60000.0,25000.0,272000.0
Raigarh,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,220000.0,140000.0,0.0,0.0,0.0,360000.0
Raigarh,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,57000.0,0.0,0.0,0.0,0.0,0.0,0.0,220000.0,10000.0,70000.0,35000.0,10000.0,402000.0
Raigarh,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,130000.0,60000.0,25000.0,15000.0,230000.0
Raigarh,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14500.0,8400.0,37274.0,60174.0
Raigarh,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21700.0,0.0,49200.0,0.0,70900.0
Raigarh,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7200.0,6100.0,20326.0,30874.0,64500.0
Raigarh,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14500.0,8400.0,37274.0,6400.0,66574.0
Raigarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,1054.0,1054.0,1054.0,1026.0,326.0,25.0,25.0,4564.0
Raigarh,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,1234.0,0.0,0.0,3432.0,0.0,0.0,0.0,3500.0,8166.0
Raigarh,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,180.0,0.0,0.0,3460.0,700.0,301.0,0.0,0.0,4641.0
Raigarh,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,1054.0,1054.0,1054.0,1026.0,326.0,25.0,25.0,3525.0,8089.0
Raigarh,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,17725.0,715.0,715.0,690.0,2000.0,13050.0,4325.0,19325.0,18125.0,17000.0,14900.0,13900.0,122470.0
Raigarh,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,4000.0,45500.0,0.0,25000.0,0.0,0.0,0.0,0.0,8000.0,82500.0
Raigarh,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,17010.0,0.0,25.0,2690.0,34450.0,8725.0,10000.0,1200.0,1125.0,2100.0,1000.0,5100.0,83425.0
Raigarh,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,715.0,715.0,690.0,2000.0,13050.0,4325.0,19325.0,18125.0,17000.0,14900.0,13900.0,16800.0,121545.0
Raigarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3000.0,1100.0,11000.0,7000.0,4800.0,2800.0,4700.0,4700.0,500.0,0.0,0.0,6800.0,46400.0
Raigarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,15000.0,,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,9000.0,0.0,30000.0
Raigarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1900.0,5100.0,4000.0,2200.0,2000.0,4100.0,0.0,4200.0,500.0,0.0,2200.0,2400.0,28600.0
Raigarh,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1100.0,11000.0,7000.0,4800.0,2800.0,4700.0,4700.0,500.0,0.0,0.0,6800.0,4400.0,47800.0
Raigarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,87900.0,141900.0,61900.0,49900.0,47800.0,123000.0,87600.0,87600.0,44400.0,42000.0,42000.0,42000.0,858000.0
Raigarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,120000.0,0.0,,0.0,117600.0,3000.0,0.0,326400.0,0.0,0.0,0.0,0.0,567000.0
Raigarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,66000.0,80000.0,12000.0,2100.0,42400.0,38400.0,0.0,369600.0,2400.0,0.0,0.0,14100.0,627000.0
Raigarh,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,141900.0,61900.0,49900.0,47800.0,123000.0,87600.0,87600.0,44400.0,42000.0,42000.0,42000.0,27900.0,798000.0
Raigarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,600.0,100.0,2700.0,2200.0,1700.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,8500.0
Raigarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4800.0,,0.0,0.0,0.0,0.0,65000.0,0.0,0.0,0.0,0.0,69800.0
Raigarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raigarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,2200.0,500.0,500.0,500.0,1200.0,0.0,65000.0,0.0,0.0,0.0,0.0,70400.0
Raigarh,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,2700.0,2200.0,1700.0,1200.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7900.0
Raigarh,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,7.0,5.0,4.0,6.0,2.0,3.0,3.0,2.0,6.0,3.0,1.0,44.0
Raigarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,3.0,,2.0,,1.0,,,,,,,1.0,7.0
Raigarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,1.0,,,,2.0
Raigarh,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,,2.0,1.0,1.0,,,,1.0,,,1.0,9.0
Raigarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,3.0,16.0,10.0,14.0,9.0,3.0,1.0,,1.0,,1.0,59.0
Raigarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,2.0,1.0,,1.0,,,,,1.0,,5.0
Raigarh,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,3.0,18.0,11.0,14.0,10.0,3.0,1.0,,1.0,1.0,1.0,64.0
Raigarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,11.0,3.0,8.0,6.0,5.0,20.0,9.0,2.0,3.0,2.0,6.0,9.0,84.0
Raigarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,3.0,4.0,1.0,2.0,1.0,5.0,6.0,5.0,1.0,,2.0,,30.0
Raigarh,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,14.0,7.0,9.0,8.0,6.0,25.0,15.0,7.0,4.0,2.0,8.0,9.0,114.0
Raigarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,,6.0,7.0,3.0,1.0,2.0,1.0,8.0,3.0,12.0,45.0
Raigarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,2.0,1.0,3.0,2.0,5.0,3.0,5.0,1.0,4.0,3.0,,31.0
Raigarh,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,3.0,1.0,9.0,9.0,8.0,4.0,7.0,2.0,12.0,6.0,12.0,76.0
Raigarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,,2.0,,1.0,,2.0,2.0,2.0,1.0,4.0,16.0
Raigarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,1.0,2.0,,,2.0,,,1.0,7.0
Raigarh,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,2.0,,2.0,1.0,3.0,,2.0,4.0,2.0,1.0,5.0,23.0
Raigarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,,1.0,1.0,2.0,,5.0
Raigarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,1.0,,,,,,,,1.0,,2.0
Raigarh,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,1.0,,,1.0,,,1.0,1.0,3.0,,7.0
Raigarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,2.0,,1.0,1.0,,5.0
Raigarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,,,3.0,1.0,2.0,2.0,1.0,,,10.0
Raigarh,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,,,3.0,1.0,4.0,2.0,2.0,1.0,,15.0
Raigarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raigarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raigarh,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Raigarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,2.0,6.0,7.0,12.0,11.0,4.0,11.0,7.0,3.0,11.0,11.0,88.0
Raigarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,3.0,,7.0,10.0,7.0,7.0,6.0,5.0,1.0,2.0,5.0,1.0,54.0
Raigarh,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,2.0,13.0,17.0,19.0,18.0,10.0,16.0,8.0,5.0,16.0,12.0,142.0
Raigarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,2.0,2.0,,,,,,5.0
Raigarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Raigarh,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,1.0,2.0,2.0,,,,,,6.0
Raigarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,,3.0,2.0,6.0,3.0,2.0,2.0,1.0,3.0,1.0,1.0,28.0
Raigarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,1.0,,,1.0,,,,1.0,,,6.0
Raigarh,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,1.0,4.0,2.0,6.0,4.0,2.0,2.0,1.0,4.0,1.0,1.0,34.0
Raigarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,1.0,,1.0,,,,1.0,,,4.0
Raigarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,1.0,2.0,1.0,,,,1.0,1.0,7.0
Raigarh,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,1.0,1.0,1.0,1.0,3.0,1.0,,,1.0,1.0,1.0,11.0
Raigarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,1.0,1.0,2.0,,,2.0,,,,,6.0
Raigarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,1.0,,,2.0
Raigarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Raigarh,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,1.0,3.0,,,2.0,,1.0,,,8.0
Raigarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,3.0,1.0,1.0,2.0,1.0,,,,9.0
Raigarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,3.0,3.0,7.0,3.0,1.0,5.0,2.0,2.0,6.0,2.0,35.0
Raigarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,1.0,2.0,1.0,2.0,1.0,,1.0,1.0,2.0,,12.0
Raigarh,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,4.0,6.0,11.0,6.0,3.0,7.0,4.0,3.0,8.0,2.0,56.0
Raigarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Raigarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Raigarh,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Raigarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,3.0,4.0,5.0,5.0,3.0,3.0,2.0,1.0,2.0,,2.0,31.0
Raigarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,4.0,2.0,7.0,7.0,2.0,3.0,2.0,5.0,2.0,3.0,,,37.0
Raigarh,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,5.0,11.0,12.0,7.0,6.0,5.0,7.0,3.0,5.0,,2.0,68.0
Raigarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,1.0,1.0,1.0,,,2.0,1.0,2.0,,,1.0,9.0
Raigarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Raigarh,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,1.0,1.0,1.0,,,2.0,1.0,2.0,,,1.0,9.0
Raigarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Raigarh,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Raigarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,1.0,,,,,,,,,,2.0
Raigarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Raigarh,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,1.0,,,,,,,,,,2.0
Raigarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,2.0,,,,,,,,,,,2.0
Raigarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Raigarh,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,2.0,,,,,,,,,,,2.0
Raigarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,2.0,,1.0,1.0,3.0,,2.0,4.0,14.0
Raigarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Raigarh,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,2.0,,1.0,1.0,3.0,,2.0,4.0,14.0
Raigarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,2.0,1.0,,,,1.0,,,,,4.0
Raigarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Raigarh,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,2.0,1.0,,,,1.0,,,,,4.0
Raigarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Raigarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3.0,3.0,,4.0,3.0,3.0,2.0,,3.0,3.0,2.0,1.0,27.0
Raigarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,4.0,2.0,2.0,,,,,1.0,,,9.0
Raigarh,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,3.0,4.0,6.0,5.0,3.0,2.0,,3.0,4.0,2.0,1.0,36.0
Raigarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,3.0,1.0,1.0,1.0,,,,,1.0,1.0,9.0
Raigarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,3.0,16.0,8.0,10.0,15.0,8.0,10.0,8.0,4.0,14.0,11.0,114.0
Raigarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,1.0,2.0,2.0,4.0,7.0,2.0,3.0,,1.0,1.0,,26.0
Raigarh,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,4.0,21.0,11.0,15.0,23.0,10.0,13.0,8.0,5.0,16.0,12.0,149.0
Raigarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,1.0,,,,,,,1.0,3.0
Raigarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,10.0,11.0,16.0,8.0,8.0,1.0,9.0,7.0,7.0,8.0,8.0,101.0
Raigarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,2.0,3.0,2.0,1.0,,1.0,,,,1.0,12.0
Raigarh,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,9.0,12.0,13.0,19.0,11.0,9.0,1.0,10.0,7.0,7.0,8.0,10.0,116.0
Raigarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,2.0,,,,,1.0,,,,3.0
Raigarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,3.0,3.0,6.0,2.0,11.0,4.0,1.0,2.0,,2.0,2.0,2.0,38.0
Raigarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,2.0,2.0,3.0,5.0,2.0,2.0,1.0,1.0,,,,19.0
Raigarh,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,5.0,8.0,7.0,16.0,6.0,3.0,3.0,2.0,2.0,2.0,2.0,60.0
Raigarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,2.0,2.0,3.0,2.0,,1.0,1.0,,12.0
Raigarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,3.0,13.0,4.0,16.0,9.0,9.0,12.0,10.0,10.0,10.0,8.0,109.0
Raigarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,14.0,7.0,15.0,8.0,10.0,15.0,7.0,21.0,4.0,,17.0,8.0,126.0
Raigarh,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,19.0,10.0,29.0,12.0,28.0,26.0,19.0,35.0,14.0,11.0,28.0,16.0,247.0
Raigarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,2.0,3.0,4.0,4.0,1.0,2.0,1.0,2.0,,,20.0
Raigarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,3.0,27.0,21.0,33.0,33.0,21.0,29.0,22.0,21.0,19.0,25.0,265.0
Raigarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,35.0,21.0,35.0,46.0,54.0,56.0,50.0,69.0,48.0,40.0,37.0,38.0,529.0
Raigarh,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,47.0,24.0,64.0,70.0,91.0,93.0,72.0,100.0,71.0,63.0,56.0,63.0,814.0
Raigarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,4.0,3.0,2.0,7.0,2.0,3.0,8.0,3.0,3.0,5.0,3.0,44.0
Raigarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,24.0,26.0,52.0,34.0,45.0,52.0,41.0,40.0,48.0,37.0,45.0,33.0,477.0
Raigarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,61.0,57.0,88.0,79.0,122.0,151.0,108.0,170.0,86.0,118.0,82.0,60.0,1182.0
Raigarh,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,86.0,87.0,143.0,115.0,174.0,205.0,152.0,218.0,137.0,158.0,132.0,96.0,1703.0
Raipur,1.1,Total number of pregnant women Registered for ANC,TOTAL,6275.0,6698.0,7637.0,8432.0,7159.0,6922.0,7456.0,7128.0,7080.0,7171.0,6463.0,7410.0,85831.0
Raipur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3282.0,3406.0,3956.0,4164.0,3461.0,3387.0,3814.0,3448.0,3411.0,3470.0,3111.0,3619.0,42529.0
Raipur,1.2,Number of Pregnant women registered under JSY,TOTAL,4159.0,4649.0,5449.0,5977.0,5193.0,4850.0,5455.0,5107.0,5067.0,5083.0,4641.0,5612.0,61242.0
Raipur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4516.0,4665.0,5077.0,5605.0,5498.0,5621.0,5418.0,5579.0,5683.0,5733.0,5165.0,5657.0,64217.0
Raipur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4605.0,4752.0,5525.0,5940.0,5211.0,4976.0,5457.0,5024.0,5106.0,5036.0,4516.0,5026.0,61174.0
Raipur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4470.0,5127.0,5969.0,6364.0,6018.0,5550.0,5504.0,5785.0,5552.0,5695.0,5250.0,5646.0,66930.0
Raipur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4847.0,5502.0,4790.0,5220.0,3865.0,3622.0,3526.0,3394.0,5479.0,5121.0,3821.0,3995.0,53182.0
Raipur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,245.0,239.0,269.0,389.0,236.0,231.0,277.0,309.0,236.0,252.0,201.0,215.0,3099.0
Raipur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,5.0,2.0,0.0,19.0,3.0,4.0,3.0,24.0,1.0,0.0,0.0,66.0
Raipur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1065.0,1162.0,1569.0,1533.0,1359.0,1291.0,1306.0,1290.0,1210.0,1164.0,1170.0,1329.0,15448.0
Raipur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,54.0,5.0,15.0,48.0,37.0,27.0,19.0,38.0,29.0,24.0,8.0,6.0,310.0
Raipur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Raipur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,977.0,1313.0,1354.0,1459.0,1514.0,1492.0,1554.0,1669.0,1623.0,1560.0,995.0,1248.0,16758.0
Raipur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1296.0,1658.0,2012.0,2113.0,1794.0,1807.0,1859.0,1928.0,1877.0,1851.0,1846.0,1922.0,21963.0
Raipur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2273.0,2971.0,3366.0,3572.0,3308.0,3299.0,3413.0,3597.0,3500.0,3411.0,2841.0,3170.0,38721.0
Raipur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1801.0,2198.0,2691.0,2857.0,2557.0,2452.0,2660.0,2900.0,2727.0,2631.0,2297.0,2413.0,30184.0
Raipur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,166.0,222.0,208.0,185.0,220.0,180.0,182.0,208.0,179.0,198.0,119.0,160.0,2227.0
Raipur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1400.0,1651.0,1549.0,1924.0,2104.0,1953.0,2316.0,2315.0,2366.0,1985.0,1707.0,2109.0,23379.0
Raipur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1292.0,1573.0,1510.0,1913.0,2009.0,1935.0,2315.0,2408.0,2404.0,2046.0,1815.0,2159.0,23379.0
Raipur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1365.0,1969.0,1673.0,2120.0,2137.0,2088.0,2212.0,2523.0,2452.0,2146.0,2088.0,2521.0,25294.0
Raipur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1125.0,1462.0,1354.0,1699.0,1679.0,1546.0,1722.0,1910.0,1912.0,1649.0,1597.0,1967.0,19622.0
Raipur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,97.0,103.0,90.0,135.0,109.0,160.0,126.0,103.0,162.0,101.0,88.0,75.0,1349.0
Raipur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1673.0,1741.0,1851.0,2114.0,1926.0,2189.0,2427.0,2293.0,2468.0,2058.0,2979.0,2699.0,26418.0
Raipur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,1673.0,1741.0,1851.0,2114.0,1926.0,2189.0,2427.0,2293.0,2468.0,2058.0,2979.0,2699.0,26418.0
Raipur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,102.0,118.0,205.0,223.0,178.0,196.0,211.0,201.0,246.0,222.0,269.0,320.0,2491.0
Raipur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,8.0,6.0,15.0,21.0,3.0,12.0,11.0,14.0,13.0,33.0,20.0,33.0,189.0
Raipur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,2.0,0.0,4.0,1.0,2.0,2.0,3.0,5.0,2.0,5.0,12.0,38.0
Raipur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,10.0,12.0,6.0,4.0,2.0,4.0,9.0,9.0,1.0,10.0,8.0,7.0,82.0
Raipur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10.0,14.0,6.0,8.0,3.0,6.0,11.0,12.0,6.0,12.0,13.0,19.0,120.0
Raipur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,961.0,1064.0,1113.0,1215.0,1112.0,1223.0,1413.0,1330.0,1448.0,1185.0,1745.0,1525.0,15334.0
Raipur,4.1.1.a,Number of male live births,TOTAL,1972.0,2578.0,2794.0,2976.0,2862.0,2919.0,2930.0,3166.0,3157.0,2937.0,2559.0,3047.0,33897.0
Raipur,4.1.1.b,Number of female live births,TOTAL,1832.0,2405.0,2472.0,2780.0,2684.0,2580.0,2661.0,2954.0,2965.0,2630.0,2400.0,2789.0,31152.0
Raipur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3804.0,4983.0,5266.0,5756.0,5546.0,5499.0,5591.0,6120.0,6122.0,5567.0,4959.0,5836.0,65049.0
Raipur,4.1.2,Number of still births,TOTAL,92.0,108.0,154.0,113.0,109.0,96.0,112.0,128.0,121.0,103.0,71.0,114.0,1321.0
Raipur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,71.0,78.0,66.0,78.0,102.0,89.0,91.0,72.0,96.0,92.0,70.0,62.0,967.0
Raipur,4.2.1,Number of Newborns weighed at birth,TOTAL,3430.0,4546.0,4949.0,5424.0,5131.0,5022.0,5090.0,5672.0,5677.0,5224.0,4675.0,5305.0,60145.0
Raipur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,299.0,326.0,374.0,406.0,487.0,427.0,442.0,529.0,469.0,351.0,342.0,364.0,4816.0
Raipur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3447.0,4584.0,4857.0,5362.0,5245.0,5148.0,5198.0,5710.0,5734.0,5297.0,4694.0,5628.0,60904.0
Raipur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,1.0,1.0,3.0,16.0,3.0,5.0,16.0,29.0,9.0,6.0,18.0,112.0
Raipur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,6.0,0.0,2.0,2.0,0.0,10.0,6.0,12.0,8.0,10.0,0.0,3.0,59.0
Raipur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,2.0,4.0,2.0,2.0,4.0,3.0,6.0,6.0,5.0,6.0,1.0,2.0,43.0
Raipur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,13.0,5.0,5.0,7.0,20.0,16.0,17.0,34.0,42.0,25.0,7.0,23.0,214.0
Raipur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,2.0,4.0,2.0,4.0,4.0,12.0,12.0,18.0,13.0,9.0,1.0,8.0,89.0
Raipur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,1.0,12.0
Raipur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,5.0,0.0,4.0,0.0,6.0,0.0,8.0,8.0,7.0,19.0,3.0,9.0,69.0
Raipur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2995.0,3723.0,3795.0,4260.0,4085.0,4088.0,4151.0,4380.0,4603.0,4291.0,3919.0,4427.0,48717.0
Raipur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2566.0,3285.0,3253.0,3677.0,3379.0,3394.0,3567.0,3831.0,3847.0,3558.0,3109.0,3562.0,41028.0
Raipur,6.3,PNC maternal complications attended,TOTAL,16.0,44.0,41.0,36.0,15.0,53.0,27.0,11.0,58.0,58.0,63.0,13.0,435.0
Raipur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,3.0,4.0,5.0,5.0,1.0,8.0,8.0,11.0,41.0,7.0,9.0,106.0
Raipur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,19.0,0.0,0.0,20.0
Raipur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,3.0,4.0,6.0,5.0,1.0,8.0,8.0,11.0,60.0,7.0,9.0,126.0
Raipur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,3.0,15.0,19.0,21.0,16.0,15.0,10.0,12.0,10.0,14.0,13.0,15.0,163.0
Raipur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,61.0,70.0,50.0,71.0,64.0,60.0,60.0,75.0,76.0,64.0,49.0,50.0,750.0
Raipur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,64.0,85.0,69.0,92.0,80.0,75.0,70.0,87.0,86.0,78.0,62.0,65.0,913.0
Raipur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,4.0,16.0,4.0,46.0,0.0,0.0,0.0,0.0,0.0,15.0,0.0,0.0,85.0
Raipur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,29.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0
Raipur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,9.0,5.0,6.0,53.0,41.0,40.0,33.0,621.0,18.0,35.0,42.0,22.0,925.0
Raipur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,0.0,1.0,3.0,3.0,3.0,0.0,13.0,8.0,2.0,0.0,1.0,37.0
Raipur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,12.0,5.0,7.0,56.0,73.0,43.0,33.0,634.0,26.0,37.0,42.0,23.0,991.0
Raipur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,15.0,0.0,1.0,0.0,0.0,0.0,17.0,15.0,15.0,63.0
Raipur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,317.0,25.0,189.0,309.0,184.0,204.0,620.0,238.0,201.0,2287.0
Raipur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,17.0,18.0
Raipur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0.0,0.0,0.0,332.0,25.0,191.0,309.0,184.0,204.0,637.0,253.0,233.0,2368.0
Raipur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,2.0,2.0,0.0,0.0,15.0,5.0,6.0,12.0,9.0,1.0,0.0,0.0,52.0
Raipur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,190.0,54.0,71.0,764.0,277.0,297.0,496.0,618.0,1111.0,1605.0,1506.0,1304.0,8293.0
Raipur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14.0,15.0,39.0,40.0,20.0,19.0,26.0,23.0,69.0,59.0,71.0,15.0,410.0
Raipur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,206.0,71.0,110.0,804.0,312.0,321.0,528.0,653.0,1189.0,1665.0,1577.0,1319.0,8755.0
Raipur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,13.0
Raipur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,0.0,0.0,1.0,2.0,2.0,0.0,3.0,0.0,140.0,0.0,1.0,151.0
Raipur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,1.0,0.0,1.0,2.0,2.0,0.0,3.0,0.0,152.0,0.0,1.0,164.0
Raipur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,222.0,291.0,512.0,532.0,379.0,421.0,429.0,373.0,368.0,411.0,394.0,283.0,4615.0
Raipur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,25.0,22.0,25.0,59.0,37.0,37.0,23.0,27.0,28.0,28.0,21.0,26.0,358.0
Raipur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,86.0,29.0,29.0,98.0,184.0,23.0,36.0,64.0,34.0,99.0,37.0,35.0,754.0
Raipur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,8.0,2.0,3.0,9.0,6.0,1.0,1.0,2.0,8.0,5.0,6.0,5.0,56.0
Raipur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raipur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,341.0,344.0,569.0,698.0,606.0,482.0,489.0,466.0,438.0,543.0,458.0,349.0,5783.0
Raipur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Raipur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Raipur,9.06,Number of IUCD removals,TOTAL,852.0,898.0,1057.0,850.0,995.0,689.0,663.0,609.0,563.0,756.0,653.0,689.0,9274.0
Raipur,9.07,Number of Oral Pills cycles distributed,TOTAL,20815.0,20930.0,21914.0,22766.0,21169.0,23212.0,19413.0,18111.0,21096.0,18933.0,19396.0,17188.0,244943.0
Raipur,9.08,Number of Condom pieces distributed,TOTAL,107929.0,105639.0,118834.0,139237.0,116457.0,111588.0,93579.0,91931.0,100138.0,114141.0,113837.0,97349.0,1310659.0
Raipur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,207.0,436.0,346.0,1040.0,194.0,420.0,322.0,495.0,507.0,587.0,153.0,298.0,5005.0
Raipur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,10.0,6.0,0.0,28.0,17.0,3.0,32.0,10.0,7.0,5.0,6.0,10.0,134.0
Raipur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,43.0,11.0,25.0,231.0,126.0,93.0,250.0,117.0,252.0,341.0,228.0,150.0,1867.0
Raipur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,1.0,0.0,4.0,1.0,0.0,0.0,2.0,1.0,0.0,0.0,9.0
Raipur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,3.0,6.0,6.0,9.0,8.0,10.0,11.0,26.0,54.0,12.0,145.0
Raipur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Raipur,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,22.0,22.0,30.0,36.0,29.0,41.0,37.0,31.0,44.0,34.0,38.0,-1.0
Raipur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3950.0,4872.0,5351.0,5851.0,5952.0,5750.0,5916.0,6275.0,6285.0,6338.0,5404.0,6156.0,68100.0
Raipur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4265.0,5003.0,5570.0,5664.0,5485.0,5791.0,5906.0,7823.0,6082.0,6640.0,5686.0,6747.0,70662.0
Raipur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4414.0,4848.0,5201.0,5829.0,5581.0,5445.0,5768.0,5875.0,5854.0,6480.0,5753.0,6835.0,67883.0
Raipur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4669.0,5040.0,4919.0,5418.0,5756.0,5484.0,5457.0,5718.0,5685.0,6219.0,5688.0,7047.0,67100.0
Raipur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Raipur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Raipur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Raipur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3050.0,3692.0,3970.0,4403.0,4017.0,4205.0,3723.0,4367.0,4499.0,4557.0,3881.0,4523.0,48887.0
Raipur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4233.0,5028.0,5559.0,5609.0,5240.0,5776.0,5545.0,6047.0,6036.0,6587.0,5591.0,6307.0,67558.0
Raipur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4423.0,4854.0,5223.0,5752.0,5262.0,5400.0,5246.0,5832.0,5765.0,6483.0,5674.0,6432.0,66346.0
Raipur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4669.0,5025.0,4900.0,5360.0,5436.0,5423.0,5006.0,5733.0,5642.0,6165.0,5650.0,6650.0,65659.0
Raipur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,37.0,78.0,36.0,47.0,36.0,48.0,2544.0,3435.0,3829.0,4519.0,4683.0,6037.0,25329.0
Raipur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,27.0,47.0,5.0,25.0,12.0,15.0,131.0,1798.0,3203.0,4209.0,4378.0,5860.0,19710.0
Raipur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,46.0,50.0,9.0,23.0,9.0,25.0,114.0,183.0,1813.0,3652.0,3947.0,5595.0,15466.0
Raipur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3797.0,4565.0,5081.0,5636.0,5730.0,5631.0,5659.0,4956.0,11516.0,7354.0,4791.0,6299.0,71015.0
Raipur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6.0,22.0,0.0,0.0,0.0,72.0,90.0,275.0,7264.0,2300.0,186.0,143.0,10358.0
Raipur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Raipur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2207.0,2523.0,2790.0,2986.0,3078.0,3059.0,2961.0,2709.0,4407.0,3448.0,2897.0,3391.0,36456.0
Raipur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2017.0,2292.0,2668.0,2814.0,2869.0,2796.0,2844.0,2556.0,4309.0,3243.0,2688.0,3171.0,34267.0
Raipur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4224.0,4815.0,5458.0,5800.0,5947.0,5855.0,5805.0,5265.0,8716.0,6691.0,5585.0,6562.0,70723.0
Raipur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3677.0,4255.0,4643.0,5107.0,4820.0,4658.0,4707.0,4563.0,6057.0,5314.0,4308.0,6025.0,58134.0
Raipur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3657.0,4235.0,4583.0,5062.0,4599.0,4584.0,4423.0,4545.0,5948.0,5233.0,4220.0,5651.0,56740.0
Raipur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1982.0,2278.0,2370.0,2744.0,2675.0,2637.0,2519.0,2616.0,3316.0,3108.0,3187.0,2696.0,32128.0
Raipur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1891.0,2219.0,2405.0,2508.0,2498.0,2553.0,2420.0,2595.0,2781.0,2921.0,2914.0,2497.0,30202.0
Raipur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3873.0,4497.0,4775.0,5252.0,5173.0,5190.0,4939.0,5211.0,6097.0,6029.0,6101.0,5193.0,62330.0
Raipur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,822.0,1155.0,1379.0,2450.0,6869.0,6515.0,4502.0,3557.0,3578.0,3557.0,2531.0,2394.0,39309.0
Raipur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1092.0,1291.0,1975.0,3592.0,12399.0,18657.0,13919.0,7067.0,4242.0,3655.0,4209.0,3038.0,75136.0
Raipur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1175.0,1517.0,2304.0,2977.0,7165.0,12399.0,10932.0,6288.0,4489.0,3851.0,5758.0,3608.0,62463.0
Raipur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,105.0,122.0,101.0,211.0,144.0,168.0,156.0,231.0,173.0,159.0,171.0,144.0,1885.0
Raipur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,52.0,28.0,56.0,132.0,81.0,63.0,93.0,59.0,137.0,128.0,91.0,61.0,981.0
Raipur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2627.0,2756.0,2888.0,2929.0,2909.0,3001.0,2852.0,2894.0,2957.0,2927.0,3023.0,3040.0,34803.0
Raipur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2345.0,2661.0,2728.0,2839.0,2852.0,2907.0,2794.0,2814.0,2839.0,2880.0,2908.0,3029.0,33596.0
Raipur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2147.0,2599.0,2566.0,2592.0,2594.0,2720.0,2449.0,2487.0,2574.0,2618.0,2702.0,2700.0,30748.0
Raipur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3722.0,4462.0,5011.0,5461.0,4931.0,5055.0,4791.0,4066.0,8539.0,8531.0,4424.0,6256.0,65249.0
Raipur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1626.0,1911.0,1810.0,2269.0,1931.0,1556.0,1395.0,1490.0,23089.0,15884.0,2048.0,2814.0,57823.0
Raipur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1114.0,1209.0,1363.0,1321.0,1594.0,963.0,582.0,812.0,24567.0,16948.0,1900.0,3572.0,55945.0
Raipur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,124.0,105.0,183.0,73.0,228.0,69.0,21.0,71.0,641.0,43.0,17.0,63.0,1638.0
Raipur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,694.0,806.0,947.0,1108.0,1409.0,1371.0,1129.0,790.0,815.0,768.0,741.0,713.0,11291.0
Raipur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,628.0,387.0,649.0,621.0,980.0,773.0,633.0,427.0,505.0,334.0,210.0,305.0,6452.0
Raipur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,50.0,58.0,50.0,102.0,26.0,86.0,61.0,99.0,78.0,80.0,180.0,154.0,1024.0
Raipur,13.1,Number of Patients operated for cataract,TOTAL,55.0,30.0,96.0,162.0,238.0,474.0,458.0,176.0,66.0,130.0,330.0,256.0,2471.0
Raipur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,50.0,67.0,95.0,162.0,238.0,427.0,211.0,177.0,64.0,130.0,294.0,256.0,2171.0
Raipur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,3.0,4.0,43.0,90.0,111.0,62.0,422.0,105.0,111.0,356.0,198.0,1505.0
Raipur,13.4,Number of children provided free glasses,TOTAL,3.0,3.0,4.0,34.0,64.0,39.0,27.0,62.0,70.0,148.0,259.0,106.0,819.0
Raipur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,80.0,0.0,0.0,80.0,0.0,0.0,0.0,160.0
Raipur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,80.0,0.0,0.0,80.0,0.0,0.0,0.0,160.0
Raipur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,5.0,-1.0
Raipur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,5.0,7.0,9.0,15.0,19.0,15.0,18.0,20.0,11.0,14.0,13.0,13.0,-1.0
Raipur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1901.0,2121.0,2173.0,2382.0,2284.0,2248.0,2231.0,2213.0,2058.0,2259.0,2322.0,2317.0,-1.0
Raipur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,18.0,17.0,17.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,18.0,-1.0
Raipur,14.05,Number of RKS meetings held during the month,TOTAL,3.0,5.0,4.0,6.0,8.0,5.0,9.0,8.0,4.0,6.0,5.0,6.0,69.0
Raipur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,27.0,22.0,32.0,35.0,29.0,35.0,34.0,36.0,44.0,36.0,40.0,-1.0
Raipur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,54.0,39.0,45.0,108.0,70.0,106.0,83.0,84.0,86.0,114.0,128.0,44.0,961.0
Raipur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,,,,,,,1.0,,,,1.0,-1.0
Raipur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,2.0,1.0,3.0,3.0,1.0,2.0,1.0,1.0,2.0,1.0,-1.0
Raipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,68.0,98.0,115.0,120.0,150.0,165.0,112.0,102.0,125.0,517.0,129.0,181.0,1882.0
Raipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,572.0,809.0,681.0,893.0,780.0,981.0,860.0,625.0,543.0,1128.0,501.0,716.0,9089.0
Raipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,86.0,163.0,84.0,169.0,166.0,250.0,203.0,147.0,251.0,106.0,162.0,188.0,1975.0
Raipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1138.0,1438.0,1423.0,2349.0,1861.0,2313.0,2461.0,2021.0,2101.0,2430.0,3020.0,3122.0,25677.0
Raipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,154.0,261.0,199.0,289.0,316.0,415.0,315.0,249.0,376.0,623.0,291.0,369.0,3857.0
Raipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1710.0,2247.0,2104.0,3242.0,2641.0,3294.0,3321.0,2646.0,2644.0,3558.0,3521.0,3838.0,34766.0
Raipur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5.0,18.0,7.0,7.0,5.0,28.0,6.0,2.0,6.0,7.0,5.0,11.0,107.0
Raipur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2.0,7.0,3.0,8.0,6.0,6.0,7.0,8.0,1.0,3.0,1.0,7.0,59.0
Raipur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7.0,25.0,10.0,15.0,11.0,34.0,13.0,10.0,7.0,10.0,6.0,18.0,166.0
Raipur,14.11,In-Patient Head Count at midnight,TOTAL,318.0,255.0,267.0,697.0,809.0,498.0,437.0,539.0,735.0,839.0,1169.0,1091.0,7654.0
Raipur,14.12.1,OPD attendance (All),TOTAL,36593.0,42659.0,49285.0,59649.0,59994.0,63785.0,60174.0,49330.0,52529.0,51400.0,55105.0,60764.0,641267.0
Raipur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,104.0,41.0,1326.0,615.0,314.0,335.0,270.0,474.0,221.0,430.0,439.0,738.0,5307.0
Raipur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Raipur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,338.0,238.0,334.0,782.0,414.0,513.0,501.0,507.0,849.0,1315.0,1130.0,793.0,7714.0
Raipur,14.14.a,Number of patients given AYUSH treatment,TOTAL,142.0,216.0,270.0,264.0,428.0,693.0,615.0,637.0,694.0,723.0,696.0,946.0,6324.0
Raipur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,86.0,113.0,161.0,69.0,66.0,60.0,62.0,45.0,49.0,62.0,84.0,36.0,893.0
Raipur,14.14.c,Number of Adolescents counselled,TOTAL,8.0,10.0,210.0,63.0,150.0,50.0,56.0,54.0,27.0,70.0,46.0,55.0,799.0
Raipur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2381.0,3145.0,3974.0,5229.0,4461.0,4416.0,4771.0,4197.0,4576.0,5689.0,5871.0,5878.0,54588.0
Raipur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,89.0,100.0,130.0,181.0,134.0,151.0,161.0,93.0,144.0,137.0,120.0,158.0,1598.0
Raipur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,142.0,109.0,142.0,193.0,183.0,215.0,174.0,189.0,371.0,166.0,397.0,262.0,2543.0
Raipur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,6.0,6.0,7.0,7.0,13.0,16.0,6.0,5.0,5.0,3.0,10.0,7.0,91.0
Raipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,129.0,167.0,279.0,372.0,222.0,292.0,209.0,317.0,427.0,565.0,498.0,445.0,3922.0
Raipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,3.0,738.0,7.0,10.0,5.0,2.0,6.0,1.0,2.0,1.0,7.0,787.0
Raipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,209.0,362.0,384.0,435.0,334.0,367.0,318.0,313.0,550.0,435.0,387.0,526.0,4620.0
Raipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,2.0,69.0,1.0,0.0,2.0,0.0,0.0,1.0,0.0,1.0,64.0,140.0
Raipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,480.0,638.0,805.0,1000.0,739.0,874.0,701.0,819.0,1348.0,1166.0,1282.0,1233.0,11085.0
Raipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11.0,11.0,814.0,15.0,23.0,23.0,8.0,11.0,7.0,5.0,12.0,78.0,1018.0
Raipur,15.2,Number of Widal tests conducted,Number tested,82.0,96.0,93.0,131.0,167.0,155.0,250.0,204.0,144.0,67.0,158.0,237.0,1784.0
Raipur,15.3.a,Number of VDRL tests conducted on males,Number tested,53.0,33.0,48.0,73.0,98.0,62.0,45.0,88.0,118.0,111.0,44.0,64.0,837.0
Raipur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,111.0,93.0,203.0,108.0,127.0,104.0,41.0,146.0,112.0,100.0,111.0,101.0,1357.0
Raipur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,90.0,209.0,268.0,246.0,207.0,205.0,233.0,184.0,327.0,317.0,270.0,370.0,2926.0
Raipur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,254.0,335.0,519.0,427.0,432.0,371.0,319.0,418.0,557.0,528.0,425.0,535.0,5120.0
Raipur,15.4.1,Number of blood smears examined for Malaria,TOTAL,4394.0,5172.0,6869.0,8996.0,7676.0,12752.0,10485.0,9016.0,9398.0,3074.0,5779.0,5764.0,89375.0
Raipur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,32.0,42.0,27.0,17.0,325.0,38.0,177.0,76.0,386.0,45.0,45.0,64.0,1274.0
Raipur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,39.0,14.0,26.0,34.0,76.0,99.0,135.0,137.0,79.0,26.0,10.0,21.0,696.0
Raipur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Raipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Raipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Raipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Raipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raipur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,2.0,4.0,,2.0,,4.0,1.0,2.0,1.0,,17.0
Raipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,,,,1.0,,,,,,2.0
Raipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Raipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,,,,,1.0,,,,,,3.0
Raipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,,,,,,,,,1.0,,2.0
Raipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,,,,,,,,1.0
Raipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,,1.0,,,,,,,1.0,,3.0
Raipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,1.0,,,4.0,,4.0,1.0,4.0,,18.0
Raipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,1.0,1.0,2.0,1.0,1.0,,,,,,,7.0
Raipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,3.0,2.0,3.0,1.0,1.0,4.0,,4.0,1.0,4.0,,25.0
Raipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,4.0,,,1.0,,,,,,,,5.0
Raipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,2.0,,,,,3.0
Raipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,5.0,,,1.0,,,2.0,,,,,8.0
Raipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,2.0,2.0,1.0,3.0,5.0,4.0,1.0,4.0,2.0,5.0,29.0
Raipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,1.0,1.0,1.0,,1.0,,,4.0
Raipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,2.0,2.0,1.0,4.0,6.0,5.0,1.0,5.0,2.0,5.0,33.0
Raipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,1.0,,,,,,1.0,,2.0
Raipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Raipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,1.0,,,,1.0,,1.0,,3.0
Raipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Raipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Raipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,4.0,5.0,3.0,,,3.0,4.0,1.0,6.0,7.0,2.0,37.0
Raipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,1.0,1.0,,1.0,2.0,,1.0,3.0,1.0,11.0
Raipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,4.0,5.0,4.0,1.0,,4.0,6.0,1.0,7.0,10.0,3.0,48.0
Raipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Raipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Raipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,1.0,,2.0
Raipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Raipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,6.0,3.0,2.0,2.0,,2.0,,2.0,2.0,2.0,22.0
Raipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,,,,,,,1.0,2.0,1.0,2.0,7.0
Raipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,2.0,6.0,3.0,2.0,2.0,,2.0,1.0,4.0,3.0,5.0,30.0
Raipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,,,,,,1.0,,,,,3.0
Raipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,,,1.0,,1.0,1.0,,2.0,,1.0,7.0
Raipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1.0,2.0,,,1.0,,1.0,2.0,,2.0,,1.0,10.0
Raipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Raipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Raipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,1.0,,,,,,2.0
Raipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,1.0,,,,1.0,1.0,,,1.0,5.0
Raipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,4.0,2.0,1.0,5.0,2.0,2.0,3.0,1.0,1.0,2.0,,23.0
Raipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,2.0,,,,1.0,,,3.0
Raipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,5.0,2.0,2.0,5.0,4.0,2.0,4.0,2.0,2.0,2.0,1.0,31.0
Raipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,,,,,,1.0,,,2.0
Raipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Raipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,1.0,,,,,,1.0,,,2.0
Raipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Raipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,4.0,5.0,5.0,8.0,3.0,7.0,6.0,11.0,12.0,6.0,8.0,7.0,82.0
Raipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1.0,10.0,4.0,4.0,2.0,9.0,12.0,14.0,4.0,10.0,11.0,8.0,89.0
Raipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,5.0,15.0,10.0,12.0,5.0,16.0,18.0,25.0,16.0,16.0,19.0,15.0,172.0
Raipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,1.0,,,,,,2.0
Raipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,3.0,2.0,,,,2.0,2.0,,1.0,1.0,2.0,13.0
Raipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,1.0,,,2.0,1.0,,4.0,,8.0
Raipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,4.0,2.0,,1.0,,3.0,4.0,1.0,1.0,5.0,2.0,23.0
Raipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Raipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Raipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Raipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,1.0,,1.0,,,,,,2.0
Raipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Raipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,1.0,,1.0,,,,,,2.0
Raipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,1.0,,,,,,,,2.0
Raipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,1.0,,,,,,1.0,,,2.0
Raipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,1.0,1.0,,,,,1.0,,,4.0
Raipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,1.0,,,1.0,,,3.0,1.0,7.0
Raipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Raipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,1.0,,,1.0,,,3.0,1.0,7.0
Raipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Raipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Raipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
Raipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Raipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,2.0,,1.0,1.0,,2.0,3.0,1.0,,,1.0,13.0
Raipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,1.0,7.0,1.0,,1.0,,,,1.0,,2.0,14.0
Raipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,3.0,7.0,2.0,1.0,1.0,2.0,3.0,1.0,1.0,,3.0,27.0
Raipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,,3.0,2.0,2.0,,6.0,,1.0,1.0,1.0,,18.0
Raipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,16.0,12.0,14.0,18.0,10.0,13.0,8.0,14.0,7.0,11.0,12.0,12.0,147.0
Raipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,,,4.0,,2.0,3.0,1.0,1.0,2.0,,3.0,17.0
Raipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,19.0,12.0,17.0,24.0,12.0,15.0,17.0,15.0,9.0,14.0,13.0,15.0,182.0
Raipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,1.0,,,1.0,,3.0
Raipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,1.0,19.0,16.0,18.0,10.0,10.0,12.0,7.0,5.0,8.0,14.0,5.0,125.0
Raipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,4.0,,,,1.0,,1.0,,,1.0,8.0
Raipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,1.0,20.0,20.0,18.0,10.0,11.0,13.0,8.0,6.0,8.0,15.0,6.0,136.0
Raipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,2.0,2.0,,1.0,,,,,,,6.0
Raipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,2.0,2.0,7.0,3.0,2.0,3.0,2.0,1.0,1.0,2.0,4.0,29.0
Raipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,4.0,,,,3.0,4.0,4.0,,,2.0,2.0,20.0
Raipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,7.0,4.0,9.0,3.0,6.0,7.0,6.0,1.0,1.0,4.0,6.0,55.0
Raipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,2.0,,,1.0,1.0,1.0,1.0,,,2.0,10.0
Raipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,8.0,9.0,4.0,11.0,4.0,12.0,17.0,4.0,11.0,12.0,8.0,104.0
Raipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,1.0,12.0,8.0,11.0,9.0,12.0,7.0,16.0,11.0,13.0,12.0,12.0,124.0
Raipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,6.0,21.0,19.0,15.0,20.0,17.0,20.0,34.0,16.0,24.0,24.0,22.0,238.0
Raipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,2.0,2.0,1.0,,1.0,,7.0
Raipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1.0,17.0,17.0,12.0,10.0,11.0,13.0,9.0,8.0,7.0,10.0,12.0,127.0
Raipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,4.0,30.0,19.0,26.0,31.0,20.0,42.0,33.0,32.0,49.0,36.0,29.0,351.0
Raipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,48.0,36.0,38.0,41.0,31.0,57.0,44.0,41.0,56.0,47.0,41.0,485.0
Raipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,4.0,1.0,2.0,2.0,1.0,3.0,3.0,1.0,1.0,,1.0,21.0
Raipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,5.0,20.0,24.0,17.0,20.0,19.0,24.0,26.0,22.0,23.0,18.0,11.0,229.0
Raipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,25.0,60.0,68.0,60.0,61.0,53.0,61.0,58.0,67.0,79.0,67.0,53.0,712.0
Raipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,32.0,84.0,93.0,79.0,83.0,73.0,88.0,87.0,90.0,103.0,85.0,65.0,962.0
Rajnandgaon,1.1,Total number of pregnant women Registered for ANC,TOTAL,2836.0,3371.0,3425.0,3399.0,2968.0,2538.0,3607.0,3424.0,3450.0,2848.0,3080.0,3273.0,38219.0
Rajnandgaon,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1376.0,1484.0,1647.0,1668.0,1391.0,1367.0,1613.0,1494.0,1464.0,1342.0,1405.0,1409.0,17660.0
Rajnandgaon,1.2,Number of Pregnant women registered under JSY,TOTAL,2338.0,2876.0,2955.0,2641.0,2346.0,2589.0,3063.0,2558.0,2655.0,2471.0,2493.0,2612.0,31597.0
Rajnandgaon,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1868.0,2157.0,2271.0,2493.0,2241.0,2426.0,2408.0,2469.0,2384.0,2086.0,2401.0,2144.0,27348.0
Rajnandgaon,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1998.0,2455.0,2501.0,2545.0,2045.0,2104.0,2642.0,2477.0,2498.0,2015.0,2122.0,2245.0,27647.0
Rajnandgaon,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2305.0,2241.0,2754.0,2690.0,2431.0,2161.0,2268.0,2696.0,2676.0,2386.0,2418.0,2157.0,29183.0
Rajnandgaon,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1255.0,1211.0,1183.0,1498.0,1055.0,1121.0,733.0,568.0,1530.0,776.0,509.0,590.0,12029.0
Rajnandgaon,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,179.0,154.0,137.0,527.0,120.0,448.0,176.0,170.0,81.0,125.0,113.0,145.0,2375.0
Rajnandgaon,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1.0,0.0,1.0,4.0,3.0,4.0,7.0,5.0,1.0,1.0,0.0,4.0,31.0
Rajnandgaon,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,593.0,720.0,1019.0,814.0,751.0,753.0,972.0,895.0,880.0,930.0,737.0,958.0,10022.0
Rajnandgaon,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15.0,97.0,17.0,21.0,11.0,14.0,36.0,5.0,8.0,13.0,6.0,0.0,243.0
Rajnandgaon,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Rajnandgaon,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,23.0,19.0,8.0,6.0,6.0,4.0,5.0,8.0,12.0,15.0,13.0,123.0
Rajnandgaon,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,702.0,913.0,1027.0,1097.0,1199.0,1176.0,1079.0,1262.0,1209.0,1080.0,973.0,1097.0,12814.0
Rajnandgaon,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,706.0,936.0,1046.0,1105.0,1205.0,1182.0,1083.0,1267.0,1217.0,1092.0,988.0,1110.0,12937.0
Rajnandgaon,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,492.0,649.0,700.0,755.0,832.0,791.0,802.0,921.0,839.0,700.0,645.0,755.0,8881.0
Rajnandgaon,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,36.0,42.0,60.0,57.0,47.0,71.0,71.0,41.0,51.0,22.0,36.0,59.0,593.0
Rajnandgaon,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,780.0,1096.0,1071.0,1285.0,1295.0,1127.0,1219.0,1194.0,1325.0,1263.0,1260.0,1637.0,14552.0
Rajnandgaon,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,448.0,701.0,685.0,790.0,846.0,734.0,858.0,877.0,650.0,759.0,461.0,921.0,8730.0
Rajnandgaon,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,974.0,1044.0,1020.0,982.0,915.0,837.0,856.0,969.0,935.0,806.0,980.0,1275.0,11593.0
Rajnandgaon,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,660.0,913.0,697.0,917.0,859.0,785.0,777.0,861.0,870.0,761.0,918.0,1147.0,10165.0
Rajnandgaon,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,21.0,10.0,11.0,7.0,26.0,22.0,18.0,22.0,20.0,12.0,16.0,21.0,206.0
Rajnandgaon,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,158.0,164.0,111.0,160.0,171.0,191.0,182.0,188.0,155.0,160.0,157.0,165.0,1962.0
Rajnandgaon,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,139.0,157.0,103.0,185.0,125.0,218.0,217.0,199.0,155.0,143.0,132.0,142.0,1915.0
Rajnandgaon,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,28.0,24.0,24.0,24.0,25.0,25.0,40.0,76.0,24.0,28.0,21.0,33.0,372.0
Rajnandgaon,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,78.0,64.0,47.0,52.0,52.0,50.0,56.0,59.0,66.0,61.0,54.0,74.0,713.0
Rajnandgaon,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,78.0,64.0,47.0,52.0,52.0,50.0,56.0,59.0,66.0,61.0,54.0,74.0,713.0
Rajnandgaon,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,101.0,87.0,65.0,107.0,87.0,97.0,91.0,126.0,88.0,84.0,107.0,89.0,1129.0
Rajnandgaon,4.1.1.a,Number of male live births,TOTAL,875.0,1039.0,1071.0,1193.0,1217.0,1145.0,1091.0,1273.0,1225.0,1173.0,1146.0,1361.0,13809.0
Rajnandgaon,4.1.1.b,Number of female live births,TOTAL,855.0,962.0,1039.0,1144.0,1252.0,1128.0,1177.0,1133.0,1263.0,1137.0,1066.0,1331.0,13487.0
Rajnandgaon,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1730.0,2001.0,2110.0,2337.0,2469.0,2273.0,2268.0,2406.0,2488.0,2310.0,2212.0,2692.0,27296.0
Rajnandgaon,4.1.2,Number of still births,TOTAL,53.0,61.0,52.0,84.0,58.0,76.0,72.0,61.0,78.0,65.0,91.0,86.0,837.0
Rajnandgaon,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,37.0,46.0,72.0,59.0,42.0,53.0,55.0,53.0,52.0,59.0,61.0,62.0,651.0
Rajnandgaon,4.2.1,Number of Newborns weighed at birth,TOTAL,1739.0,1998.0,2068.0,2328.0,2460.0,2275.0,2240.0,2416.0,2110.0,2332.0,1830.0,2634.0,26430.0
Rajnandgaon,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,147.0,176.0,173.0,218.0,308.0,207.0,226.0,292.0,316.0,231.0,197.0,249.0,2740.0
Rajnandgaon,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1727.0,1964.0,2077.0,2332.0,2439.0,2246.0,2238.0,2422.0,2456.0,2301.0,1827.0,2604.0,26633.0
Rajnandgaon,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,3.0,3.0,2.0,4.0,0.0,0.0,4.0,0.0,17.0
Rajnandgaon,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Rajnandgaon,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,78.0,64.0,53.0,60.0,123.0,154.0,56.0,56.0,0.0,111.0,134.0,136.0,1025.0
Rajnandgaon,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,78.0,64.0,54.0,60.0,126.0,159.0,58.0,60.0,0.0,111.0,138.0,136.0,1044.0
Rajnandgaon,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,8.0,5.0,3.0,6.0,4.0,4.0,2.0,4.0,6.0,0.0,,5.0,47.0
Rajnandgaon,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,280.0,244.0,53.0,294.0,328.0,277.0,348.0,211.0,357.0,342.0,326.0,360.0,3420.0
Rajnandgaon,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,100.0,60.0,53.0,100.0,100.0,100.0,100.0,52.0,45.0,50.0,50.0,136.0,946.0
Rajnandgaon,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,280.0,244.0,276.0,294.0,328.0,277.0,348.0,211.0,357.0,342.0,326.0,360.0,3643.0
Rajnandgaon,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14.0,10.0,53.0,15.0,50.0,20.0,28.0,24.0,42.0,32.0,0.0,21.0,309.0
Rajnandgaon,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1358.0,1569.0,1539.0,1803.0,1779.0,1620.0,1667.0,1784.0,1875.0,1847.0,1711.0,2064.0,20616.0
Rajnandgaon,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1205.0,1301.0,1360.0,1523.0,1612.0,1379.0,1512.0,1555.0,1617.0,1563.0,1400.0,1764.0,17791.0
Rajnandgaon,6.3,PNC maternal complications attended,TOTAL,35.0,2.0,3.0,1.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,46.0
Rajnandgaon,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,21.0,13.0,13.0,18.0,19.0,10.0,13.0,17.0,7.0,17.0,23.0,21.0,192.0
Rajnandgaon,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,10.0,10.0,11.0,2.0,3.0,0.0,5.0,11.0,8.0,4.0,1.0,5.0,70.0
Rajnandgaon,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,31.0,23.0,24.0,20.0,22.0,10.0,18.0,28.0,15.0,21.0,24.0,26.0,262.0
Rajnandgaon,7.2,Number of MTPs conducted at Private Facilities,TOTAL,20.0,18.0,19.0,22.0,19.0,7.0,0.0,0.0,0.0,12.0,2.0,21.0,140.0
Rajnandgaon,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,15.0,33.0,33.0,118.0,35.0,41.0,90.0,221.0,65.0,45.0,44.0,40.0,780.0
Rajnandgaon,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,127.0,112.0,113.0,118.0,82.0,96.0,155.0,339.0,145.0,58.0,217.0,197.0,1759.0
Rajnandgaon,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,142.0,145.0,146.0,236.0,117.0,137.0,245.0,560.0,210.0,103.0,261.0,237.0,2539.0
Rajnandgaon,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,4.0
Rajnandgaon,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,7.0,7.0,12.0,73.0,11.0,46.0,23.0,3.0,8.0,55.0,11.0,1.0,257.0
Rajnandgaon,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,1.0,0.0,5.0,1.0,6.0,0.0,0.0,0.0,0.0,0.0,15.0
Rajnandgaon,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,7.0,9.0,13.0,73.0,16.0,47.0,29.0,3.0,8.0,55.0,11.0,1.0,272.0
Rajnandgaon,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Rajnandgaon,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,1.0,1.0,1.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,7.0
Rajnandgaon,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,55.0,87.0,233.0,535.0,57.0,473.0,240.0,164.0,77.0,296.0,276.0,425.0,2918.0
Rajnandgaon,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,22.0,43.0,35.0,38.0,125.0,30.0,91.0,85.0,469.0
Rajnandgaon,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,55.0,88.0,234.0,536.0,81.0,516.0,275.0,202.0,204.0,326.0,367.0,510.0,3394.0
Rajnandgaon,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,24.0,22.0,16.0,21.0,32.0,30.0,32.0,22.0,22.0,18.0,23.0,26.0,288.0
Rajnandgaon,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,112.0,50.0,79.0,95.0,11.0,78.0,30.0,91.0,321.0,20.0,54.0,83.0,1024.0
Rajnandgaon,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,46.0,32.0,47.0,50.0,37.0,66.0,44.0,75.0,110.0,216.0,83.0,105.0,911.0
Rajnandgaon,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,158.0,82.0,126.0,145.0,48.0,144.0,74.0,166.0,431.0,236.0,137.0,188.0,1935.0
Rajnandgaon,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,5.0,0.0,,,,5.0
Rajnandgaon,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,0.0,0.0,0.0,,,,0.0
Rajnandgaon,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,180.0,213.0,389.0,700.0,395.0,334.0,254.0,262.0,205.0,332.0,283.0,225.0,3772.0
Rajnandgaon,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,16.0,10.0,16.0,4.0,10.0,4.0,6.0,6.0,4.0,1.0,9.0,6.0,92.0
Rajnandgaon,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,15.0,21.0,108.0,83.0,50.0,50.0,50.0,42.0,79.0,82.0,61.0,652.0
Rajnandgaon,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3.0,0.0,5.0,2.0,12.0,5.0,3.0,6.0,4.0,4.0,4.0,4.0,52.0
Rajnandgaon,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,210.0,238.0,431.0,814.0,500.0,393.0,313.0,324.0,255.0,416.0,378.0,296.0,4568.0
Rajnandgaon,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Rajnandgaon,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,1.0,7.0,3.0,6.0,5.0,4.0,4.0,4.0,6.0,6.0,7.0,5.0,58.0
Rajnandgaon,9.06,Number of IUCD removals,TOTAL,531.0,328.0,284.0,584.0,504.0,286.0,298.0,235.0,251.0,259.0,326.0,268.0,4154.0
Rajnandgaon,9.07,Number of Oral Pills cycles distributed,TOTAL,3407.0,3600.0,3927.0,6693.0,5493.0,5621.0,5507.0,5544.0,5519.0,6464.0,4908.0,4064.0,60747.0
Rajnandgaon,9.08,Number of Condom pieces distributed,TOTAL,7756.0,7284.0,9748.0,23621.0,25097.0,24624.0,17094.0,14624.0,14651.0,13722.0,11518.0,12612.0,182351.0
Rajnandgaon,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,53.0,38.0,96.0,40.0,18.0,80.0,17.0,20.0,24.0,13.0,9.0,408.0
Rajnandgaon,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,6.0
Rajnandgaon,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,4.0,4.0,18.0,6.0,7.0,5.0,0.0,0.0,0.0,0.0,0.0,44.0
Rajnandgaon,9.11.2.a,Number of failures following male sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Rajnandgaon,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Rajnandgaon,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,9.12,Number of Institutions having NSV trained doctors,TOTAL,7.0,3.0,9.0,10.0,9.0,8.0,9.0,7.0,14.0,13.0,12.0,14.0,-1.0
Rajnandgaon,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1846.0,2213.0,2423.0,2456.0,2687.0,2510.0,2448.0,2915.0,2775.0,2638.0,2755.0,3060.0,30726.0
Rajnandgaon,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1770.0,2233.0,2554.0,2406.0,2568.0,2530.0,2550.0,2785.0,2701.0,2711.0,3017.0,2736.0,30561.0
Rajnandgaon,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2033.0,2089.0,2357.0,2600.0,2556.0,2446.0,2593.0,2929.0,2504.0,2669.0,3087.0,2794.0,30657.0
Rajnandgaon,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2005.0,2370.0,2315.0,2403.0,2680.0,2461.0,2321.0,2869.0,2628.0,2545.0,2978.0,2863.0,30438.0
Rajnandgaon,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Rajnandgaon,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Rajnandgaon,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Rajnandgaon,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1339.0,1522.0,1623.0,1764.0,1932.0,1710.0,1666.0,2145.0,1916.0,1840.0,1972.0,2086.0,21515.0
Rajnandgaon,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1725.0,2213.0,2540.0,2388.0,2559.0,2519.0,2525.0,2742.0,2620.0,2636.0,2573.0,2619.0,29659.0
Rajnandgaon,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1997.0,2083.0,2363.0,2590.0,2571.0,2458.0,2562.0,2882.0,2460.0,2612.0,2672.0,2662.0,29912.0
Rajnandgaon,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1961.0,2385.0,2271.0,2394.0,2700.0,2426.0,2291.0,2807.0,2583.0,2439.0,2547.0,2722.0,29526.0
Rajnandgaon,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,3.0,0.0,0.0,0.0,3.0,98.0,415.0,408.0,492.0,501.0,661.0,2581.0
Rajnandgaon,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,183.0,158.0,208.0,100.0,112.0,140.0,338.0,1056.0,1320.0,1841.0,2364.0,1923.0,9743.0
Rajnandgaon,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,154.0,108.0,140.0,110.0,58.0,102.0,129.0,515.0,830.0,1556.0,2333.0,1838.0,7873.0
Rajnandgaon,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,188.0,146.0,112.0,93.0,63.0,93.0,137.0,417.0,501.0,1019.0,1945.0,1801.0,6515.0
Rajnandgaon,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1530.0,2176.0,2608.0,2634.0,2722.0,2443.0,2528.0,2413.0,2505.0,2377.0,2467.0,2661.0,29064.0
Rajnandgaon,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Rajnandgaon,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,816.0,1151.0,1427.0,1345.0,1412.0,1117.0,1342.0,1267.0,1294.0,1156.0,1298.0,1390.0,15015.0
Rajnandgaon,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,776.0,1060.0,1391.0,1332.0,1415.0,1081.0,1306.0,1201.0,1249.0,1089.0,1206.0,1344.0,14450.0
Rajnandgaon,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1592.0,2211.0,2818.0,2677.0,2827.0,2198.0,2648.0,2468.0,2543.0,2245.0,2504.0,2734.0,29465.0
Rajnandgaon,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1220.0,1693.0,1972.0,2069.0,2868.0,1928.0,2044.0,2201.0,2499.0,2260.0,1864.0,2239.0,24857.0
Rajnandgaon,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1188.0,1671.0,2006.0,2088.0,2847.0,1920.0,2006.0,2174.0,2466.0,2247.0,1743.0,2125.0,24481.0
Rajnandgaon,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,281.0,427.0,505.0,528.0,652.0,454.0,510.0,595.0,545.0,504.0,595.0,607.0,6203.0
Rajnandgaon,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,264.0,412.0,515.0,488.0,648.0,434.0,491.0,592.0,509.0,454.0,582.0,605.0,5994.0
Rajnandgaon,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,545.0,839.0,1020.0,1016.0,1300.0,888.0,1001.0,1187.0,1054.0,958.0,1177.0,1212.0,12197.0
Rajnandgaon,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,538.0,629.0,932.0,1744.0,5283.0,4181.0,2121.0,1727.0,2808.0,1139.0,1203.0,2660.0,24965.0
Rajnandgaon,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,805.0,951.0,1210.0,2425.0,10466.0,7972.0,3333.0,2239.0,1665.0,1372.0,1606.0,5695.0,39739.0
Rajnandgaon,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,636.0,848.0,1260.0,1881.0,5719.0,6078.0,3285.0,2455.0,2160.0,1537.0,1868.0,3922.0,31649.0
Rajnandgaon,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,21.0,25.0,110.0,103.0,109.0,151.0,174.0,78.0,123.0,41.0,60.0,18.0,1013.0
Rajnandgaon,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,41.0,132.0,122.0,237.0,225.0,280.0,210.0,225.0,193.0,208.0,125.0,113.0,2111.0
Rajnandgaon,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1540.0,1637.0,1685.0,1687.0,1701.0,1700.0,1675.0,1686.0,1712.0,1708.0,1699.0,1696.0,20126.0
Rajnandgaon,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1434.0,1554.0,1620.0,1646.0,1683.0,1611.0,1623.0,1640.0,1683.0,1636.0,1639.0,1707.0,19476.0
Rajnandgaon,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1273.0,1401.0,1472.0,1521.0,1556.0,1554.0,1497.0,1508.0,1534.0,1556.0,1545.0,1613.0,18030.0
Rajnandgaon,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1518.0,2068.0,2347.0,2231.0,2919.0,2448.0,2497.0,2297.0,2474.0,2283.0,1947.0,2624.0,27653.0
Rajnandgaon,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,185.0,317.0,185.0,308.0,8506.0,2096.0,589.0,341.0,6188.0,4406.0,620.0,1777.0,25518.0
Rajnandgaon,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,178.0,128.0,159.0,382.0,8469.0,2252.0,327.0,244.0,7092.0,4744.0,561.0,974.0,25510.0
Rajnandgaon,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,6.0,23.0,28.0,18.0,22.0,10.0,28.0,7.0,20.0,5.0,11.0,28.0,206.0
Rajnandgaon,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,394.0,617.0,514.0,699.0,894.0,772.0,491.0,402.0,748.0,846.0,637.0,642.0,7656.0
Rajnandgaon,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,156.0,41.0,42.0,139.0,291.0,148.0,87.0,155.0,98.0,98.0,52.0,157.0,1464.0
Rajnandgaon,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,5.0,34.0,37.0,47.0,77.0,89.0,98.0,2.0,62.0,83.0,152.0,75.0,761.0
Rajnandgaon,13.1,Number of Patients operated for cataract,TOTAL,13.0,63.0,148.0,242.0,79.0,35.0,104.0,30.0,27.0,49.0,0.0,0.0,790.0
Rajnandgaon,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,13.0,62.0,147.0,241.0,79.0,35.0,104.0,30.0,27.0,49.0,0.0,0.0,787.0
Rajnandgaon,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,17.0,33.0,54.0,7.0,49.0,20.0,4.0,240.0,23.0,447.0
Rajnandgaon,13.4,Number of children provided free glasses,TOTAL,0.0,1.0,0.0,0.0,0.0,12.0,0.0,0.0,3.0,49.0,32.0,28.0,125.0
Rajnandgaon,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,5.0,6.0,7.0,7.0,6.0,5.0,7.0,6.0,5.0,6.0,7.0,6.0,-1.0
Rajnandgaon,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,3.0,4.0,7.0,7.0,4.0,4.0,6.0,4.0,13.0,13.0,8.0,9.0,-1.0
Rajnandgaon,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1126.0,1309.0,1369.0,1408.0,1370.0,1463.0,1455.0,1487.0,1893.0,1528.0,1780.0,1525.0,-1.0
Rajnandgaon,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,9.0,9.0,7.0,7.0,8.0,9.0,8.0,8.0,9.0,9.0,9.0,-1.0
Rajnandgaon,14.05,Number of RKS meetings held during the month,TOTAL,9.0,11.0,6.0,15.0,13.0,9.0,12.0,21.0,10.0,12.0,11.0,9.0,138.0
Rajnandgaon,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,17.0,19.0,17.0,18.0,18.0,18.0,20.0,24.0,27.0,23.0,22.0,-1.0
Rajnandgaon,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,212.0,166.0,208.0,240.0,223.0,239.0,303.0,271.0,289.0,268.0,264.0,314.0,2997.0
Rajnandgaon,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,1.0,3.0,2.0,4.0,2.0,3.0,3.0,3.0,2.0,4.0,4.0,-1.0
Rajnandgaon,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,2.0,1.0,1.0,1.0,2.0,1.0,1.0,2.0,2.0,1.0,1.0,-1.0
Rajnandgaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,589.0,663.0,757.0,650.0,728.0,710.0,760.0,674.0,830.0,599.0,689.0,652.0,8301.0
Rajnandgaon,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1047.0,981.0,1018.0,963.0,1103.0,1521.0,1124.0,931.0,1082.0,979.0,864.0,1029.0,12642.0
Rajnandgaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,581.0,847.0,581.0,685.0,681.0,621.0,677.0,651.0,538.0,675.0,556.0,592.0,7685.0
Rajnandgaon,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1589.0,1558.0,1540.0,2028.0,1687.0,2122.0,1710.0,1578.0,1775.0,1726.0,1497.0,2125.0,20935.0
Rajnandgaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1170.0,1510.0,1338.0,1335.0,1409.0,1331.0,1437.0,1325.0,1368.0,1274.0,1245.0,1244.0,15986.0
Rajnandgaon,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2636.0,2539.0,2558.0,2991.0,2790.0,3643.0,2834.0,2509.0,2857.0,2705.0,2361.0,3154.0,33577.0
Rajnandgaon,14.10.2.a,Number of death cases of Inpatient males,TOTAL,29.0,18.0,29.0,24.0,37.0,45.0,51.0,24.0,22.0,4.0,30.0,29.0,342.0
Rajnandgaon,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,19.0,21.0,19.0,21.0,23.0,13.0,58.0,17.0,2.0,19.0,17.0,239.0
Rajnandgaon,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,39.0,37.0,50.0,43.0,58.0,68.0,64.0,82.0,39.0,6.0,49.0,46.0,581.0
Rajnandgaon,14.11,In-Patient Head Count at midnight,TOTAL,233.0,119.0,235.0,398.0,7960.0,274.0,730.0,191.0,249.0,248.0,277.0,283.0,11197.0
Rajnandgaon,14.12.1,OPD attendance (All),TOTAL,31239.0,36714.0,38033.0,48376.0,49098.0,53781.0,51114.0,41666.0,46044.0,42428.0,44602.0,48115.0,531210.0
Rajnandgaon,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,116.0,127.0,216.0,243.0,160.0,270.0,126.0,172.0,213.0,179.0,123.0,851.0,2796.0
Rajnandgaon,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Rajnandgaon,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,243.0,279.0,450.0,751.0,331.0,484.0,415.0,351.0,493.0,562.0,415.0,550.0,5324.0
Rajnandgaon,14.14.a,Number of patients given AYUSH treatment,TOTAL,243.0,495.0,471.0,515.0,599.0,1015.0,628.0,413.0,680.0,687.0,638.0,547.0,6931.0
Rajnandgaon,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,112.0,141.0,124.0,120.0,89.0,128.0,54.0,130.0,155.0,104.0,165.0,168.0,1490.0
Rajnandgaon,14.14.c,Number of Adolescents counselled,TOTAL,20.0,23.0,16.0,15.0,57.0,7.0,11.0,0.0,62.0,22.0,0.0,0.0,233.0
Rajnandgaon,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2711.0,3571.0,3742.0,4463.0,3710.0,3400.0,3933.0,3357.0,3764.0,3662.0,3515.0,4202.0,44030.0
Rajnandgaon,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,101.0,73.0,56.0,98.0,97.0,60.0,79.0,241.0,54.0,88.0,43.0,50.0,1040.0
Rajnandgaon,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,181.0,266.0,211.0,329.0,201.0,185.0,188.0,308.0,404.0,228.0,205.0,314.0,3020.0
Rajnandgaon,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,17.0,6.0,10.0,6.0,9.0,4.0,6.0,12.0,8.0,7.0,8.0,11.0,104.0
Rajnandgaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,187.0,157.0,288.0,334.0,228.0,295.0,190.0,503.0,395.0,203.0,393.0,308.0,3481.0
Rajnandgaon,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,2.0,7.0,7.0,8.0,2.0,2.0,9.0,27.0,3.0,21.0,5.0,96.0
Rajnandgaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,202.0,340.0,407.0,458.0,354.0,369.0,331.0,329.0,395.0,361.0,382.0,399.0,4327.0
Rajnandgaon,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,1.0,0.0,0.0,1.0,1.0,4.0,0.0,1.0,1.0,11.0
Rajnandgaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,570.0,763.0,906.0,1121.0,783.0,849.0,709.0,1140.0,1194.0,792.0,980.0,1021.0,10828.0
Rajnandgaon,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,20.0,8.0,19.0,14.0,17.0,6.0,9.0,22.0,39.0,10.0,30.0,17.0,211.0
Rajnandgaon,15.2,Number of Widal tests conducted,Number tested,123.0,10.0,111.0,335.0,285.0,175.0,238.0,269.0,157.0,0.0,168.0,192.0,2063.0
Rajnandgaon,15.3.a,Number of VDRL tests conducted on males,Number tested,4.0,2.0,8.0,15.0,7.0,14.0,7.0,76.0,20.0,14.0,12.0,10.0,189.0
Rajnandgaon,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,13.0,11.0,26.0,38.0,28.0,100.0,53.0,227.0,99.0,26.0,123.0,46.0,790.0
Rajnandgaon,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,7.0,8.0,14.0,52.0,63.0,59.0,42.0,69.0,55.0,68.0,34.0,17.0,488.0
Rajnandgaon,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,24.0,21.0,48.0,105.0,98.0,173.0,102.0,372.0,174.0,108.0,169.0,73.0,1467.0
Rajnandgaon,15.4.1,Number of blood smears examined for Malaria,TOTAL,1772.0,2388.0,2686.0,5883.0,9482.0,8727.0,7673.0,5398.0,6826.0,5473.0,5355.0,3923.0,65586.0
Rajnandgaon,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,26.0,41.0,56.0,91.0,190.0,224.0,137.0,86.0,155.0,86.0,65.0,76.0,1233.0
Rajnandgaon,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3.0,7.0,8.0,21.0,30.0,66.0,24.0,104.0,120.0,65.0,18.0,31.0,497.0
Rajnandgaon,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1500.0,8000.0,9500.0,10500.0,15000.0,4000.0,9500.0,14500.0,500.0,14000.0,0.0,11000.0,98000.0
Rajnandgaon,16.1.1,Stock position of DPT vaccines,2. Stocks Received,20000.0,20000.0,20000.0,20000.0,10000.0,40000.0,10000.0,0.0,22000.0,0.0,20000.0,0.0,182000.0
Rajnandgaon,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,13500.0,18500.0,19000.0,15500.0,21000.0,34500.0,5000.0,14000.0,8500.0,14000.0,9000.0,10000.0,182500.0
Rajnandgaon,16.1.1,Stock position of DPT vaccines,5. Total Stock,8000.0,9500.0,10500.0,15000.0,4000.0,9500.0,14500.0,500.0,14000.0,0.0,11000.0,1000.0,97500.0
Rajnandgaon,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Rajnandgaon,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Rajnandgaon,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Rajnandgaon,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0.0,11000.0,8000.0,3000.0,3500.0,5000.0,5000.0,22500.0,0.0,8500.0,500.0,3000.0,70000.0
Rajnandgaon,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,20000.0,20000.0,10000.0,25000.0,20000.0,40000.0,0.0,20000.0,0.0,5000.0,0.0,185000.0
Rajnandgaon,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14000.0,23000.0,25000.0,9500.0,23500.0,20000.0,22500.0,22500.0,11500.0,8000.0,2500.0,3000.0,185000.0
Rajnandgaon,16.1.2,Stock position of OPV vaccines,5. Total Stock,11000.0,8000.0,3000.0,3500.0,5000.0,5000.0,22500.0,0.0,8500.0,500.0,3000.0,0.0,70000.0
Rajnandgaon,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,9000.0,16000.0,20500.0,20000.0,17500.0,18000.0,21000.0,27000.0,10000.0,27000.0,11000.0,23000.0,220000.0
Rajnandgaon,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,20000.0,20000.0,10000.0,30000.0,65000.0,10000.0,0.0,22000.0,0.0,20000.0,0.0,217000.0
Rajnandgaon,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13000.0,15500.0,20500.0,12500.0,29500.0,62000.0,4000.0,17000.0,5000.0,16000.0,8000.0,5000.0,208000.0
Rajnandgaon,16.1.3,Stock position of TT vaccines,5. Total Stock,16000.0,20500.0,20000.0,17500.0,18000.0,21000.0,27000.0,10000.0,27000.0,11000.0,23000.0,18000.0,229000.0
Rajnandgaon,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,5500.0,6500.0,4500.0,3000.0,4000.0,9500.0,0.0,17000.0,1500.0,14500.0,3500.0,1000.0,70500.0
Rajnandgaon,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,10000.0,10000.0,10000.0,20000.0,10000.0,20000.0,0.0,23000.0,0.0,500.0,0.0,113500.0
Rajnandgaon,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9000.0,12000.0,11500.0,9000.0,14500.0,19500.0,3000.0,15500.0,10000.0,11000.0,3000.0,1000.0,119000.0
Rajnandgaon,16.1.5,Stock position of BCG vaccines,5. Total Stock,6500.0,4500.0,3000.0,4000.0,9500.0,0.0,17000.0,1500.0,14500.0,3500.0,1000.0,0.0,65000.0
Rajnandgaon,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,750.0,2750.0,1000.0,0.0,5750.0,1500.0,12000.0,10000.0,5500.0,5500.0,18250.0,18250.0,81250.0
Rajnandgaon,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,500.0,5000.0,10000.0,5000.0,24000.0,0.0,0.0,0.0,12750.0,0.0,0.0,62250.0
Rajnandgaon,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3000.0,2250.0,6000.0,4250.0,9250.0,13500.0,2000.0,4500.0,0.0,0.0,0.0,3000.0,47750.0
Rajnandgaon,16.1.6,Stock position of Measles vaccines,5. Total Stock,2750.0,1000.0,0.0,5750.0,1500.0,12000.0,10000.0,5500.0,5500.0,18250.0,18250.0,15250.0,95750.0
Rajnandgaon,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,9000.0,27000.0,4200.0,3600.0,600.0,600.0,45000.0
Rajnandgaon,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,30000.0,30000.0,0.0,0.0,0.0,0.0,0.0,60000.0
Rajnandgaon,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,21000.0,12000.0,22800.0,600.0,3000.0,0.0,600.0,60000.0
Rajnandgaon,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,9000.0,27000.0,4200.0,3600.0,600.0,600.0,0.0,45000.0
Rajnandgaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1043.0,880.0,880.0,280.0,3680.0,0.0,0.0,0.0,0.0,3600.0,3000.0,3000.0,16363.0
Rajnandgaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,4800.0,0.0,0.0,0.0,10800.0
Rajnandgaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,163.0,0.0,600.0,2600.0,3680.0,0.0,0.0,0.0,1200.0,600.0,0.0,0.0,8843.0
Rajnandgaon,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,880.0,880.0,280.0,3680.0,0.0,0.0,0.0,0.0,3600.0,3000.0,3000.0,3000.0,18320.0
Rajnandgaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,84000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,84000.0
Rajnandgaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,96000.0,120000.0,30000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,246000.0
Rajnandgaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,96000.0,36000.0,114000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,246000.0
Rajnandgaon,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,84000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,84000.0
Rajnandgaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,14000.0,4000.0,0.0,0.0,0.0,2000.0,0.0,0.0,21000.0
Rajnandgaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,10000.0,20000.0,10000.0,6000.0,0.0,0.0,15000.0,0.0,0.0,0.0,61000.0
Rajnandgaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,9000.0,7000.0,20000.0,10000.0,0.0,0.0,13000.0,2000.0,0.0,0.0,61000.0
Rajnandgaon,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,1000.0,14000.0,4000.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,21000.0
Rajnandgaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5690.0,5690.0,5690.0,10690.0,9500.0,8500.0,7500.0,7500.0,6500.0,6500.0,5000.0,5000.0,83760.0
Rajnandgaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8400.0,13400.0
Rajnandgaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1190.0,1000.0,1000.0,0.0,1000.0,0.0,1500.0,0.0,500.0,6190.0
Rajnandgaon,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,5690.0,5690.0,10690.0,9500.0,8500.0,7500.0,7500.0,6500.0,6500.0,5000.0,5000.0,12900.0,90970.0
Rajnandgaon,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1000.0,850.0,141.0,141.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0,3132.0
Rajnandgaon,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,0.0,0.0,4000.0
Rajnandgaon,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.02,Stock Position of Gloves,4. Stock Distributed,150.0,709.0,0.0,141.0,0.0,0.0,0.0,0.0,0.0,3500.0,0.0,500.0,5000.0
Rajnandgaon,16.3.02,Stock Position of Gloves,5. Total Stock,850.0,141.0,141.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0,500.0,0.0,2132.0
Rajnandgaon,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72000.0,62000.0,40000.0,0.0,174000.0
Rajnandgaon,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,240000.0,0.0,0.0,0.0,80000.0,320000.0
Rajnandgaon,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,168000.0,10000.0,22000.0,40000.0,47000.0,287000.0
Rajnandgaon,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72000.0,62000.0,40000.0,0.0,33000.0,207000.0
Rajnandgaon,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,16100.0,15600.0,15300.0,15300.0,11300.0,9300.0,6800.0,6800.0,0.0,14100.0,14100.0,19100.0,143800.0
Rajnandgaon,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15700.0,0.0,8000.0,0.0,23700.0
Rajnandgaon,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,500.0,300.0,0.0,4000.0,2000.0,2500.0,0.0,6800.0,1600.0,0.0,3000.0,2900.0,23600.0
Rajnandgaon,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,15600.0,15300.0,15300.0,11300.0,9300.0,6800.0,6800.0,0.0,14100.0,14100.0,19100.0,16200.0,143900.0
Rajnandgaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Rajnandgaon,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,86.0,86.0,86.0,0.0,807.0,0.0,0.0,1824.0,0.0,0.0,0.0,0.0,2889.0
Rajnandgaon,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,1107.0,0.0,0.0,1824.0,3324.0,0.0,0.0,0.0,0.0,6255.0
Rajnandgaon,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,86.0,300.0,807.0,0.0,0.0,5148.0,0.0,0.0,0.0,0.0,6341.0
Rajnandgaon,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,86.0,86.0,0.0,807.0,0.0,0.0,1824.0,0.0,0.0,0.0,0.0,0.0,2803.0
Rajnandgaon,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,33000.0,20000.0,14050.0,4800.0,3000.0,800.0,75.0,2675.0,200.0,19000.0,28160.0,16000.0,141760.0
Rajnandgaon,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,3150.0,1000.0,0.0,0.0,0.0,3200.0,0.0,19200.0,22000.0,0.0,4000.0,52550.0
Rajnandgaon,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,13000.0,9100.0,10250.0,1800.0,2200.0,725.0,600.0,2475.0,400.0,12840.0,12160.0,15000.0,80550.0
Rajnandgaon,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,20000.0,14050.0,4800.0,3000.0,800.0,75.0,2675.0,200.0,19000.0,28160.0,16000.0,5000.0,113760.0
Rajnandgaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2800.0,200.0,12800.0,3200.0,1200.0,9000.0,1000.0,1000.0,600.0,1400.0,400.0,400.0,34000.0
Rajnandgaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,15000.0,0.0,0.0,10000.0,6000.0,0.0,0.0,9000.0,0.0,0.0,0.0,40000.0
Rajnandgaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2600.0,2400.0,9600.0,2000.0,2200.0,14000.0,0.0,400.0,8200.0,1000.0,0.0,400.0,42800.0
Rajnandgaon,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200.0,12800.0,3200.0,1200.0,9000.0,1000.0,1000.0,600.0,1400.0,400.0,400.0,0.0,31200.0
Rajnandgaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,244600.0,228600.0,304600.0,210200.0,210200.0,199400.0,0.0,120000.0,21600.0,16800.0,14400.0,14400.0,1584800.0
Rajnandgaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,218400.0,0.0,0.0,0.0,2400.0,120000.0,218400.0,0.0,0.0,0.0,0.0,559200.0
Rajnandgaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,16000.0,142400.0,94400.0,0.0,10800.0,201800.0,0.0,316800.0,4800.0,2400.0,0.0,0.0,789400.0
Rajnandgaon,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,228600.0,304600.0,210200.0,210200.0,199400.0,0.0,120000.0,21600.0,16800.0,14400.0,14400.0,14400.0,1354600.0
Rajnandgaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,3600.0,1500.0,500.0,12600.0,2300.0,2300.0,17300.0,4600.0,4600.0,4600.0,53900.0
Rajnandgaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4000.0,0.0,0.0,14600.0,3400.0,0.0,67600.0,0.0,0.0,1500.0,0.0,91100.0
Rajnandgaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Rajnandgaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,400.0,2100.0,1000.0,2500.0,13700.0,0.0,52600.0,12700.0,0.0,1500.0,3000.0,89500.0
Rajnandgaon,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,3600.0,1500.0,500.0,12600.0,2300.0,2300.0,17300.0,4600.0,4600.0,4600.0,1600.0,55500.0
Rajnandgaon,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,2.0,6.0,6.0,4.0,7.0,9.0,4.0,4.0,,1.0,3.0,48.0
Rajnandgaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,3.0,2.0,,,1.0,2.0,,,,8.0
Rajnandgaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,3.0,2.0,,,,,,,5.0
Rajnandgaon,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,3.0,5.0,2.0,,1.0,2.0,,,,13.0
Rajnandgaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,1.0,2.0,,4.0
Rajnandgaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Rajnandgaon,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,,,,,1.0,2.0,,4.0
Rajnandgaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,4.0,4.0,1.0,7.0,5.0,1.0,4.0,13.0,7.0,4.0,3.0,54.0
Rajnandgaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,3.0,,,2.0,6.0,2.0,1.0,,,1.0,16.0
Rajnandgaon,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,4.0,7.0,1.0,7.0,7.0,7.0,6.0,14.0,7.0,4.0,4.0,70.0
Rajnandgaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,1.0,4.0,2.0,5.0,2.0,,4.0,2.0,3.0,5.0,30.0
Rajnandgaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,3.0,,2.0,4.0,,,3.0,4.0,2.0,2.0,1.0,22.0
Rajnandgaon,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,4.0,1.0,6.0,6.0,5.0,2.0,3.0,8.0,4.0,5.0,6.0,52.0
Rajnandgaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,4.0,2.0,2.0,3.0,6.0,2.0,1.0,2.0,8.0,9.0,3.0,43.0
Rajnandgaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,2.0,,,,1.0,,2.0,2.0,,7.0
Rajnandgaon,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,4.0,2.0,4.0,3.0,6.0,2.0,2.0,2.0,10.0,11.0,3.0,50.0
Rajnandgaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Rajnandgaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,1.0,,,1.0,,,,2.0
Rajnandgaon,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,,1.0,,,1.0,3.0
Rajnandgaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,1.0,,,,2.0,,,,4.0
Rajnandgaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,1.0,1.0,,1.0,,4.0,1.0,,,,8.0
Rajnandgaon,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,2.0,1.0,1.0,1.0,,4.0,3.0,,,,12.0
Rajnandgaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Rajnandgaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Rajnandgaon,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,1.0,,,,,,,,1.0
Rajnandgaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,5.0,10.0,3.0,5.0,4.0,2.0,4.0,1.0,5.0,6.0,12.0,63.0
Rajnandgaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,,2.0,1.0,2.0,6.0,3.0,5.0,2.0,4.0,2.0,6.0,35.0
Rajnandgaon,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,5.0,12.0,4.0,7.0,10.0,5.0,9.0,3.0,9.0,8.0,18.0,98.0
Rajnandgaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Rajnandgaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Rajnandgaon,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,1.0,,,,,2.0
Rajnandgaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,3.0,3.0,5.0,3.0,1.0,8.0,4.0,1.0,5.0,,4.0,42.0
Rajnandgaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,,1.0,1.0,2.0,4.0,2.0,5.0,6.0,1.0,2.0,26.0
Rajnandgaon,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,4.0,3.0,6.0,4.0,3.0,12.0,6.0,6.0,11.0,1.0,6.0,68.0
Rajnandgaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,1.0,,,1.0,3.0,,2.0,2.0,1.0,,,10.0
Rajnandgaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,1.0,1.0,,1.0,4.0,2.0,1.0,1.0,1.0,,2.0,14.0
Rajnandgaon,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,2.0,1.0,,2.0,7.0,2.0,3.0,3.0,2.0,,2.0,24.0
Rajnandgaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,1.0,,1.0,,,,,1.0,,3.0
Rajnandgaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,,1.0,,,,2.0,1.0,,,5.0
Rajnandgaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Rajnandgaon,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,2.0,,,1.0,1.0,1.0,,,2.0,1.0,1.0,,9.0
Rajnandgaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,1.0,2.0,1.0,,,5.0
Rajnandgaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,1.0,1.0,1.0,3.0,3.0,2.0,3.0,2.0,2.0,,2.0,22.0
Rajnandgaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,3.0,2.0,,,,1.0,,5.0,,1.0,,2.0,14.0
Rajnandgaon,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,3.0,1.0,1.0,4.0,4.0,2.0,9.0,4.0,4.0,,4.0,41.0
Rajnandgaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,1.0,1.0,,1.0,1.0,1.0,1.0,,,,,6.0
Rajnandgaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Rajnandgaon,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,,7.0
Rajnandgaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,,,1.0,1.0,,,3.0
Rajnandgaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,21.0,15.0,13.0,12.0,11.0,9.0,13.0,7.0,16.0,4.0,11.0,14.0,146.0
Rajnandgaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,12.0,11.0,5.0,7.0,13.0,14.0,6.0,6.0,7.0,8.0,14.0,13.0,116.0
Rajnandgaon,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,33.0,26.0,19.0,19.0,24.0,23.0,19.0,13.0,24.0,13.0,25.0,27.0,265.0
Rajnandgaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Rajnandgaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,1.0,1.0,,2.0,1.0,,1.0,,1.0,2.0,11.0
Rajnandgaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,2.0,,1.0,1.0,1.0,2.0,2.0,1.0,,1.0,3.0,14.0
Rajnandgaon,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,4.0,1.0,2.0,1.0,3.0,3.0,3.0,2.0,,2.0,5.0,26.0
Rajnandgaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Rajnandgaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,1.0,,,,,1.0
Rajnandgaon,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,2.0,,,,,2.0
Rajnandgaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Rajnandgaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Rajnandgaon,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Rajnandgaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,1.0,,,,,,,2.0
Rajnandgaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,2.0,,,,,,,1.0,,,,,3.0
Rajnandgaon,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,2.0,,,1.0,,1.0,,1.0,,,,,5.0
Rajnandgaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,1.0,1.0,,,,,,3.0
Rajnandgaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Rajnandgaon,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,1.0,1.0,,,,,,3.0
Rajnandgaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,,,,,1.0,,,2.0
Rajnandgaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Rajnandgaon,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,,,,,1.0,,,2.0
Rajnandgaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Rajnandgaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,3.0,,1.0,3.0,1.0,,1.0,3.0,2.0,1.0,5.0,20.0
Rajnandgaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,2.0,1.0,1.0,,,,,,1.0,,4.0,10.0
Rajnandgaon,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,5.0,1.0,2.0,3.0,1.0,,1.0,3.0,3.0,1.0,9.0,30.0
Rajnandgaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,4.0,,2.0,,,,1.0,,2.0,1.0,,10.0
Rajnandgaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,13.0,13.0,20.0,10.0,14.0,10.0,16.0,14.0,13.0,14.0,22.0,171.0
Rajnandgaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,2.0,2.0,1.0,1.0,1.0,4.0,4.0,2.0,3.0,2.0,3.0,27.0
Rajnandgaon,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,14.0,19.0,15.0,23.0,11.0,15.0,14.0,21.0,16.0,18.0,17.0,25.0,208.0
Rajnandgaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,1.0,,,,,,,2.0
Rajnandgaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,16.0,17.0,11.0,6.0,5.0,3.0,7.0,2.0,6.0,12.0,14.0,104.0
Rajnandgaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,1.0,1.0,4.0,1.0,1.0,,,,1.0,11.0
Rajnandgaon,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,16.0,19.0,12.0,7.0,10.0,4.0,8.0,2.0,6.0,12.0,15.0,117.0
Rajnandgaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,5.0,3.0,4.0,,1.0,2.0,,16.0
Rajnandgaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,4.0,6.0,4.0,7.0,3.0,7.0,2.0,6.0,4.0,2.0,,46.0
Rajnandgaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,2.0,5.0,4.0,2.0,4.0,6.0,2.0,1.0,,1.0,27.0
Rajnandgaon,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,4.0,8.0,9.0,11.0,10.0,14.0,12.0,8.0,6.0,4.0,1.0,89.0
Rajnandgaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,2.0,1.0,5.0,1.0,,,,,,,9.0
Rajnandgaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,5.0,11.0,10.0,14.0,15.0,10.0,12.0,14.0,10.0,3.0,18.0,126.0
Rajnandgaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,11.0,12.0,9.0,17.0,24.0,18.0,19.0,15.0,19.0,9.0,17.0,178.0
Rajnandgaon,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,12.0,16.0,25.0,20.0,36.0,40.0,28.0,31.0,29.0,29.0,12.0,35.0,313.0
Rajnandgaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,1.0,,2.0,3.0,,2.0,2.0,2.0,1.0,1.0,2.0,18.0
Rajnandgaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,11.0,20.0,14.0,29.0,20.0,20.0,24.0,14.0,20.0,24.0,18.0,224.0
Rajnandgaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,15.0,22.0,29.0,42.0,54.0,65.0,49.0,43.0,45.0,56.0,50.0,43.0,513.0
Rajnandgaon,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,34.0,49.0,58.0,86.0,85.0,71.0,69.0,61.0,77.0,75.0,63.0,755.0
Rajnandgaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,4.0,2.0,,2.0,3.0,1.0,2.0,1.0,2.0,3.0,1.0,23.0
Rajnandgaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,13.0,23.0,29.0,32.0,29.0,30.0,30.0,41.0,31.0,27.0,28.0,16.0,329.0
Rajnandgaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,43.0,70.0,89.0,83.0,114.0,119.0,103.0,84.0,107.0,115.0,91.0,74.0,1092.0
Rajnandgaon,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,58.0,97.0,120.0,115.0,145.0,152.0,134.0,127.0,139.0,144.0,122.0,91.0,1444.0
Sukma,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Sukma,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Sukma,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Sukma,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Sukma,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Sukma,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Sukma,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Sukma,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Sukma,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Sukma,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Sukma,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Sukma,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Sukma,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Sukma,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Sukma,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Sukma,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Sukma,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Sukma,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Sukma,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Sukma,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Sukma,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Sukma,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sukma,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Sukma,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sukma,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Sukma,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Sukma,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Sukma,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Sukma,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Sukma,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Sukma,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Sukma,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Sukma,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Sukma,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Sukma,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Sukma,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Sukma,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Sukma,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Sukma,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Sukma,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Sukma,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Sukma,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Sukma,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Sukma,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Sukma,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Sukma,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Sukma,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Sukma,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Sukma,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Sukma,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Sukma,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Sukma,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Sukma,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Sukma,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Sukma,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Sukma,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Sukma,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Sukma,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Sukma,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Sukma,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Sukma,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Sukma,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Sukma,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Sukma,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Sukma,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Sukma,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Sukma,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Sukma,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Sukma,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Sukma,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Sukma,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Sukma,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Sukma,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Sukma,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Sukma,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Sukma,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Sukma,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Sukma,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Sukma,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Sukma,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Sukma,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Sukma,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Sukma,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Sukma,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Sukma,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Sukma,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Sukma,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Sukma,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Sukma,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Sukma,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Sukma,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Sukma,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Sukma,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Sukma,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Sukma,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Sukma,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Sukma,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Sukma,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Sukma,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Sukma,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Sukma,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Sukma,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Sukma,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Sukma,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Sukma,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Sukma,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Sukma,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Sukma,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Sukma,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Sukma,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Sukma,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Sukma,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Sukma,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Sukma,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Sukma,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Sukma,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Sukma,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Sukma,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Sukma,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Sukma,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Sukma,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Sukma,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Sukma,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Sukma,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Sukma,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Sukma,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Sukma,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Sukma,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Sukma,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Sukma,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Sukma,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Sukma,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Sukma,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Sukma,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Sukma,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Sukma,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Sukma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Sukma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Sukma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Sukma,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Sukma,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Sukma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sukma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sukma,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Sukma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sukma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sukma,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Sukma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sukma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sukma,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Sukma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Sukma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Sukma,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Sukma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sukma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sukma,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Sukma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sukma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sukma,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Sukma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sukma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sukma,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Sukma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Sukma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Sukma,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Sukma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Sukma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Sukma,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Sukma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Sukma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Sukma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Sukma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Sukma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Sukma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Sukma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Sukma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Sukma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Sukma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Sukma,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Sukma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Sukma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Sukma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Sukma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Sukma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Sukma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Sukma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Sukma,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Surajpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,,,,,,,,,,,,,
Surajpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,,,,,,,,,,,,,
Surajpur,1.2,Number of Pregnant women registered under JSY,TOTAL,,,,,,,,,,,,,
Surajpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,,,,,,,,,,,,,
Surajpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,,,,,,,,,,,,,
Surajpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,,,,,,,,,,,,,
Surajpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,,,,,,,,,,,,,
Surajpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,,,,,,,,,,,,,
Surajpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,,,,,,,,,,,,,
Surajpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,,,,,,,,,,,,,
Surajpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,,,,,,,,,,,,,
Surajpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,,,,,,,,,,,,,
Surajpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,,,,,,,,,,,,,
Surajpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,,,,,,,,,,,,,
Surajpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,,,,,,,,,,,,,
Surajpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Surajpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,,,,,,,,,,,,,
Surajpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Surajpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,,,,,,,,,,,,,
Surajpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Surajpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,,,,,,,,,,,,,
Surajpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Surajpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Surajpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Surajpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Surajpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Surajpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,,,,,,,,,,,,,
Surajpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Surajpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,,,,,,,,,,,,,
Surajpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,,,,,,,,,,,,,
Surajpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,4.1.1.a,Number of male live births,TOTAL,,,,,,,,,,,,,
Surajpur,4.1.1.b,Number of female live births,TOTAL,,,,,,,,,,,,,
Surajpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,,,,,,,,,,,,,
Surajpur,4.1.2,Number of still births,TOTAL,,,,,,,,,,,,,
Surajpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,,,,,,,,,,,,,
Surajpur,4.2.1,Number of Newborns weighed at birth,TOTAL,,,,,,,,,,,,,
Surajpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,,,,,,,,,,,,,
Surajpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,,,,,,,,,,,,,
Surajpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,,,,,,,,,,,,,
Surajpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,,,,,,,,,,,,,
Surajpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,,,,,,,,,,,,,
Surajpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,,,,,,,,,,,,,
Surajpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,,,,,,,,,,,,,
Surajpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,,,,,,,,,,,,,
Surajpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,,,,,,,,,,,,,
Surajpur,6.3,PNC maternal complications attended,TOTAL,,,,,,,,,,,,,
Surajpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Surajpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,,,,,,,,,,,,,
Surajpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,,,,,,,,,,,,,
Surajpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,,,,,,,,,,,,,
Surajpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Surajpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,,,,,,,,,,,,,
Surajpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,,,,,,,,,,,,,
Surajpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,,,,,,,,,,,,,
Surajpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,,,,,,,,,,,,,
Surajpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,,,,,,,,,,,,,
Surajpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,,,,,,,,,,,,,
Surajpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,,,,,,,,,,,,,
Surajpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,,,,,,,,,,,,,
Surajpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Surajpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surajpur,9.06,Number of IUCD removals,TOTAL,,,,,,,,,,,,,
Surajpur,9.07,Number of Oral Pills cycles distributed,TOTAL,,,,,,,,,,,,,
Surajpur,9.08,Number of Condom pieces distributed,TOTAL,,,,,,,,,,,,,
Surajpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,,,,,,,,,,,,,
Surajpur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.2.a,Number of failures following male sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.2.b,Number of failures following female sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,,,,,,,,,,,,,
Surajpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,,,,,,,,,,,,,-1.0
Surajpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,,,,,,,,,,,,,
Surajpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,,,,,,,,,,,,,
Surajpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,,,,,,,,,,,,,
Surajpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,,,,,,,,,,,,,
Surajpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,,,,,,,,,,,,,
Surajpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,,,,,,,,,,,,,
Surajpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,,,,,,,,,,,,,
Surajpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,,,,,,,,,,,,,
Surajpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,,,,,,,,,,,,,
Surajpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Surajpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Surajpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,,,,,,,,,,,,,
Surajpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,,,,,,,,,,,,,
Surajpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,,,,,,,,,,,,,
Surajpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,,,,,,,,,,,,,
Surajpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,,,,,,,,,,,,,
Surajpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,,,,,,,,,,,,,
Surajpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,,,,,,,,,,,,,
Surajpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,,,,,,,,,,,,,
Surajpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,,,,,,,,,,,,,
Surajpur,13.1,Number of Patients operated for cataract,TOTAL,,,,,,,,,,,,,
Surajpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,,,,,,,,,,,,,
Surajpur,13.3,Number of School children detected with Refractive errors,TOTAL,,,,,,,,,,,,,
Surajpur,13.4,Number of children provided free glasses,TOTAL,,,,,,,,,,,,,
Surajpur,13.5,Number of eyes collected through eye donation,TOTAL,,,,,,,,,,,,,
Surajpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,,,,,,,,,,,,,
Surajpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.05,Number of RKS meetings held during the month,TOTAL,,,,,,,,,,,,,
Surajpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,,,,,,,,,,,,,
Surajpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,,,,,,,,,,,,,-1.0
Surajpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,,,,,,,,,,,,,
Surajpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,,,,,,,,,,,,,
Surajpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,,,,,,,,,,,,,
Surajpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,,,,,,,,,,,,,
Surajpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,,,,,,,,,,,,,
Surajpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,,,,,,,,,,,,,
Surajpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,,,,,,,,,,,,,
Surajpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,,,,,,,,,,,,,
Surajpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,,,,,,,,,,,,,
Surajpur,14.11,In-Patient Head Count at midnight,TOTAL,,,,,,,,,,,,,
Surajpur,14.12.1,OPD attendance (All),TOTAL,,,,,,,,,,,,,
Surajpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,,,,,,,,,,,,,
Surajpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Surajpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,,,,,,,,,,,,,
Surajpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,,,,,,,,,,,,,
Surajpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,,,,,,,,,,,,,
Surajpur,14.14.c,Number of Adolescents counselled,TOTAL,,,,,,,,,,,,,
Surajpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,,,,,,,,,,,,,
Surajpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,,,,,,,,,,,,,
Surajpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,,,,,,,,,,,,,
Surajpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,,,,,,,,,,,,,
Surajpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,,,,,,,,,,,,,
Surajpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,,,,,,,,,,,,,
Surajpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,,,,,,,,,,,,,
Surajpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,,,,,,,,,,,,,
Surajpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,,,,,,,,,,,,,
Surajpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,,,,,,,,,,,,,
Surajpur,15.2,Number of Widal tests conducted,Number tested,,,,,,,,,,,,,
Surajpur,15.3.a,Number of VDRL tests conducted on males,Number tested,,,,,,,,,,,,,
Surajpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,,,,,,,,,,,,,
Surajpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,,,,,,,,,,,,,
Surajpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,,,,,,,,,,,,,
Surajpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,,,,,,,,,,,,,
Surajpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,,,,,,,,,,,,,
Surajpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,,,,,,,,,,,,,
Surajpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Surajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Surajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Surajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Surajpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surajpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Surajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Surajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surajpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Surajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Surajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surajpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,,,,,,,,
Surajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Surajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surajpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,,
Surajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Surajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Surajpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,,,,,,,,
Surajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surajpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Surajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surajpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Surajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surajpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Surajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surajpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Surajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,,,,,,,
Surajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Surajpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,,,,,,,,,,
Surajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Surajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,,,,,,,,,,,,,
Surajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,,,,,,,,,,,
Surajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Surajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,,,,,,,
Surajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,,,,,,,,,,
Surajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,,,,,,,,,,,,,
Surajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Surajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,,,,,,
Surajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Surajpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,,,,,,
Surajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,,,,,,,,,,,,,
Surajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,,,,,,,,,,,,,
Surajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,,,,,,,,,
Surajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,,,,,,,,,,,,,
Surajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,,,,,,,,,,,,,
Surajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,,,,,,,,
Surajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,,,,,,,,,,,,,
Surajpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,,,,,,,,,,,,,
Surguja,1.1,Total number of pregnant women Registered for ANC,TOTAL,6248.0,8236.0,9200.0,9009.0,7596.0,7938.0,7353.0,5178.0,6118.0,5461.0,5705.0,6746.0,84788.0
Surguja,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3013.0,4559.0,4570.0,4556.0,3631.0,4019.0,3844.0,2576.0,3052.0,2735.0,2802.0,3242.0,42599.0
Surguja,1.2,Number of Pregnant women registered under JSY,TOTAL,5482.0,5853.0,6234.0,6743.0,5157.0,5348.0,5202.0,4940.0,5812.0,5065.0,5022.0,6178.0,67036.0
Surguja,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3933.0,6010.0,6021.0,6552.0,6186.0,6143.0,5458.0,4071.0,4091.0,3867.0,4116.0,4649.0,61097.0
Surguja,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4530.0,5276.0,5318.0,5307.0,4611.0,4648.0,4886.0,4012.0,4886.0,4059.0,3969.0,4634.0,56136.0
Surguja,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3890.0,5914.0,5609.0,6117.0,5550.0,4882.0,10858.0,3987.0,4083.0,4058.0,4003.0,4571.0,63522.0
Surguja,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4683.0,6009.0,6110.0,5942.0,5734.0,5220.0,5543.0,3616.0,4180.0,3722.0,3597.0,4016.0,58372.0
Surguja,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,215.0,851.0,393.0,337.0,283.0,468.0,312.0,108.0,177.0,122.0,154.0,89.0,3509.0
Surguja,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,17.0,34.0,24.0,73.0,29.0,38.0,13.0,9.0,5.0,6.0,7.0,265.0
Surguja,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1001.0,1244.0,1302.0,1823.0,1388.0,1434.0,1128.0,972.0,1081.0,958.0,1073.0,1181.0,14585.0
Surguja,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,84.0,95.0,62.0,91.0,124.0,76.0,48.0,49.0,74.0,38.0,52.0,84.0,877.0
Surguja,1.8,Number of pregnancy test kits used at SC level,TOTAL,,0.0,,,,,,,,,,,0.0
Surguja,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,824.0,1206.0,1498.0,1393.0,1462.0,1490.0,1349.0,914.0,965.0,833.0,693.0,781.0,13408.0
Surguja,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,770.0,789.0,948.0,917.0,947.0,1006.0,950.0,971.0,927.0,708.0,778.0,783.0,10494.0
Surguja,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1594.0,1995.0,2446.0,2310.0,2409.0,2496.0,2299.0,1885.0,1892.0,1541.0,1471.0,1564.0,23902.0
Surguja,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1355.0,1402.0,1666.0,1680.0,1767.0,1839.0,1660.0,1621.0,1572.0,1312.0,1338.0,1371.0,18583.0
Surguja,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,361.0,440.0,435.0,546.0,411.0,420.0,427.0,317.0,313.0,325.0,310.0,215.0,4520.0
Surguja,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2265.0,3061.0,3366.0,3584.0,3653.0,2826.0,2711.0,2369.0,2171.0,2046.0,2003.0,2232.0,32287.0
Surguja,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1948.0,2185.0,2303.0,2568.0,3758.0,3279.0,2967.0,2055.0,1897.0,1739.0,1670.0,1652.0,28021.0
Surguja,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2274.0,3436.0,3769.0,3837.0,3836.0,3561.0,2777.0,2342.0,2295.0,1978.0,1978.0,2031.0,34114.0
Surguja,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2111.0,3038.0,3352.0,3320.0,3332.0,3198.0,2452.0,2125.0,1842.0,1521.0,1525.0,1532.0,29348.0
Surguja,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,20.0,192.0,126.0,204.0,87.0,293.0,192.0,37.0,14.0,14.0,11.0,71.0,1261.0
Surguja,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,,,,,,,,,,,,,
Surguja,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Surguja,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,,,,,,,,,,,,,
Surguja,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,,,,,,,,,,,,,
Surguja,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1.0,0.0,48.0,8.0,4.0,43.0,37.0,0.0,0.0,0.0,0.0,0.0,141.0
Surguja,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,2.0,3.0,1.0,3.0,106.0,4.0,3.0,2.0,0.0,0.0,1.0,3.0,128.0
Surguja,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,79.0,98.0,77.0,112.0,87.0,98.0,81.0,82.0,71.0,60.0,90.0,99.0,1034.0
Surguja,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,82.0,101.0,126.0,123.0,197.0,145.0,121.0,84.0,71.0,60.0,91.0,102.0,1303.0
Surguja,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,4.1.1.a,Number of male live births,TOTAL,2046.0,2994.0,3429.0,3561.0,3655.0,3437.0,3190.0,2299.0,2155.0,1919.0,1811.0,2046.0,32542.0
Surguja,4.1.1.b,Number of female live births,TOTAL,1820.0,2776.0,3158.0,3241.0,3250.0,3179.0,2997.0,1934.0,1875.0,1655.0,1574.0,1767.0,29226.0
Surguja,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3866.0,5770.0,6587.0,6802.0,6905.0,6616.0,6187.0,4233.0,4030.0,3574.0,3385.0,3813.0,61768.0
Surguja,4.1.2,Number of still births,TOTAL,55.0,128.0,195.0,236.0,263.0,277.0,228.0,87.0,79.0,56.0,70.0,73.0,1747.0
Surguja,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,94.0,159.0,263.0,254.0,376.0,236.0,168.0,176.0,147.0,120.0,113.0,205.0,2311.0
Surguja,4.2.1,Number of Newborns weighed at birth,TOTAL,3588.0,5004.0,5833.0,6352.0,5749.0,5582.0,5208.0,4084.0,3780.0,3402.0,3331.0,3663.0,55576.0
Surguja,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,271.0,615.0,592.0,604.0,575.0,493.0,577.0,207.0,182.0,185.0,181.0,260.0,4742.0
Surguja,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3661.0,5130.0,5956.0,6178.0,5979.0,5696.0,5426.0,4105.0,3832.0,3400.0,3309.0,3605.0,56277.0
Surguja,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,17.0,2.0,3.0,7.0,6.0,32.0,4.0,18.0,12.0,16.0,58.0,175.0
Surguja,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,15.0,119.0,15.0,71.0,187.0,38.0,72.0,25.0,24.0,5.0,36.0,21.0,628.0
Surguja,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,150.0,110.0,98.0,124.0,87.0,98.0,81.0,82.0,71.0,60.0,90.0,99.0,1150.0
Surguja,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,165.0,246.0,115.0,198.0,281.0,142.0,185.0,111.0,113.0,77.0,142.0,178.0,1953.0
Surguja,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,94.0,309.0,219.0,275.0,462.0,323.0,112.0,107.0,109.0,120.0,131.0,177.0,2438.0
Surguja,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,10.0,23.0,3.0,47.0,52.0,25.0,8.0,11.0,6.0,5.0,5.0,7.0,202.0
Surguja,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,152.0,679488.0,513.0,611.0,189.0,202.0,104.0,29.0,35.0,53.0,41.0,67.0,681484.0
Surguja,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,66.0,72.0,52.0,71.0,143.0,55.0,43.0,36.0,28.0,31.0,37.0,75.0,709.0
Surguja,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2866.0,3918.0,4588.0,4512.0,4345.0,4007.0,3959.0,3241.0,3110.0,2686.0,2681.0,2765.0,42678.0
Surguja,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2097.0,3499.0,3550.0,3559.0,3555.0,3370.0,3188.0,2683.0,2417.0,2243.0,1991.0,2239.0,34391.0
Surguja,6.3,PNC maternal complications attended,TOTAL,9.0,14.0,42.0,62.0,28.0,46.0,155.0,22.0,32.0,18.0,27.0,24.0,479.0
Surguja,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,42.0,34.0,12.0,36.0,29.0,34.0,7.0,32.0,18.0,20.0,26.0,49.0,339.0
Surguja,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,20.0,41.0,11.0,12.0,8.0,3.0,7.0,1.0,2.0,6.0,6.0,122.0
Surguja,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,47.0,54.0,53.0,47.0,41.0,42.0,10.0,39.0,19.0,22.0,32.0,55.0,461.0
Surguja,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,3.0
Surguja,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,31.0,134.0,90.0,113.0,303.0,149.0,180.0,87.0,61.0,50.0,42.0,25.0,1265.0
Surguja,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,96.0,217.0,139.0,122.0,228.0,178.0,167.0,106.0,87.0,62.0,93.0,41.0,1536.0
Surguja,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,127.0,351.0,229.0,235.0,531.0,327.0,347.0,193.0,148.0,112.0,135.0,66.0,2801.0
Surguja,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,59.0,136.0,63.0,107.0,183.0,24.0,38.0,71.0,32.0,46.0,50.0,13.0,822.0
Surguja,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,19.0,3.0,21.0,3.0,0.0,0.0,0.0,0.0,0.0,46.0
Surguja,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,4.0,2.0,6.0,108.0,18.0,35.0,42.0,69.0,18.0,15.0,10.0,3.0,330.0
Surguja,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,8.0,10.0
Surguja,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,3.0,6.0,127.0,21.0,56.0,45.0,70.0,18.0,15.0,10.0,11.0,386.0
Surguja,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,6.0,55.0,12.0,81.0,56.0,299.0,276.0,382.0,375.0,278.0,135.0,58.0,2013.0
Surguja,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,92.0,14.0,73.0,419.0,240.0,937.0,730.0,1214.0,2299.0,1937.0,1309.0,450.0,9714.0
Surguja,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,2.0,2.0,1.0,1.0,5.0,0.0,2.0,0.0,10.0,12.0,5.0,6.0,46.0
Surguja,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,100.0,71.0,86.0,501.0,301.0,1236.0,1008.0,1596.0,2684.0,2227.0,1449.0,514.0,11773.0
Surguja,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,10.0,0.0,9.0,0.0,4.0,2.0,0.0,0.0,70.0,1.0,0.0,96.0
Surguja,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,2.0,3.0,7.0,2.0,45.0,7.0,0.0,0.0,0.0,0.0,0.0,66.0
Surguja,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,109.0,0.0,0.0,3.0,6.0,6.0,8.0,8.0,62.0,203.0
Surguja,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1.0,12.0,3.0,125.0,2.0,49.0,12.0,6.0,6.0,78.0,9.0,62.0,365.0
Surguja,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,21.0,2.0,0.0,24.0,1.0,0.0,0.0,0.0,6.0,0.0,54.0
Surguja,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,2.0,3.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0,44.0
Surguja,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,15.0,42.0,40.0,0.0,36.0,71.0,64.0,59.0,40.0,44.0,98.0,20.0,529.0
Surguja,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,15.0,44.0,64.0,2.0,39.0,95.0,65.0,59.0,40.0,44.0,104.0,56.0,627.0
Surguja,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,446.0,908.0,567.0,1430.0,505.0,449.0,542.0,363.0,346.0,319.0,463.0,478.0,6816.0
Surguja,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,166.0,214.0,204.0,287.0,256.0,163.0,158.0,141.0,66.0,67.0,81.0,24.0,1827.0
Surguja,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,75.0,269.0,383.0,722.0,355.0,177.0,149.0,54.0,40.0,41.0,30.0,38.0,2333.0
Surguja,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,19.0,26.0,26.0,18.0,20.0,14.0,6.0,10.0,11.0,33.0,30.0,0.0,213.0
Surguja,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Surguja,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,706.0,1417.0,1180.0,2457.0,1136.0,803.0,855.0,568.0,463.0,460.0,604.0,540.0,11189.0
Surguja,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,,,,,,,,,,,,,
Surguja,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,,,,,,,,,,,,,
Surguja,9.06,Number of IUCD removals,TOTAL,592.0,868.0,573.0,1201.0,842.0,865.0,758.0,428.0,581.0,396.0,450.0,911.0,8465.0
Surguja,9.07,Number of Oral Pills cycles distributed,TOTAL,9696.0,15158.0,14154.0,21255.0,14887.0,14153.0,15783.0,8162.0,8034.0,8207.0,5959.0,8184.0,143632.0
Surguja,9.08,Number of Condom pieces distributed,TOTAL,32970.0,45699.0,50608.0,74458.0,39973.0,57727.0,63953.0,31003.0,30668.0,30050.0,26609.0,23264.0,506982.0
Surguja,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,847.0,959.0,1548.0,1060.0,1865.0,1212.0,189.0,84.0,8.0,0.0,159.0,7933.0
Surguja,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,259.0,308.0,527.0,612.0,886.0,584.0,1161.0,298.0,251.0,151.0,152.0,100.0,5289.0
Surguja,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,33.0,9.0,37.0,17.0,57.0,88.0,0.0,47.0,1.0,0.0,0.0,289.0
Surguja,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,18.0,30.0,23.0,265.0,99.0,281.0,314.0,68.0,77.0,34.0,5.0,3.0,1217.0
Surguja,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,1.0,4.0,8.0,2.0,5.0,34.0,0.0,0.0,0.0,0.0,0.0,54.0
Surguja,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,3.0,14.0,16.0,34.0,23.0,32.0,0.0,1.0,0.0,0.0,0.0,123.0
Surguja,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,2.0,8.0,0.0,0.0,8.0,5.0,0.0,0.0,0.0,0.0,0.0,23.0
Surguja,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,3.0,5.0,9.0,7.0,25.0,4.0,0.0,4.0,0.0,0.0,0.0,57.0
Surguja,9.12,Number of Institutions having NSV trained doctors,TOTAL,48.0,73.0,71.0,68.0,75.0,74.0,71.0,47.0,49.0,41.0,30.0,33.0,-1.0
Surguja,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3320.0,4854.0,5338.0,5682.0,5172.0,5426.0,5409.0,3763.0,3798.0,3313.0,2518.0,3489.0,52082.0
Surguja,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4104.0,5148.0,5351.0,5817.0,5634.0,6009.0,6162.0,4998.0,5722.0,4830.0,4162.0,4607.0,62544.0
Surguja,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4340.0,5348.0,4922.0,5281.0,5608.0,5333.0,6023.0,5270.0,5248.0,5181.0,4800.0,4775.0,62129.0
Surguja,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4702.0,5602.0,5120.0,5017.0,5226.0,5143.0,5439.0,5108.0,5404.0,4943.0,4896.0,5368.0,61968.0
Surguja,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,,,,,,,,,,,,,
Surguja,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,,,,,,,,,,,,,
Surguja,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,,,,,,,,,,,,,
Surguja,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2326.0,2675.0,2633.0,2463.0,2624.0,2947.0,2866.0,2529.0,2687.0,2194.0,1766.0,2024.0,29734.0
Surguja,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4091.0,4932.0,5170.0,5439.0,5109.0,5891.0,5985.0,4963.0,5458.0,4674.0,3984.0,4339.0,60035.0
Surguja,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4324.0,5205.0,4952.0,5016.0,5254.0,5284.0,5912.0,5150.0,5163.0,4821.0,4616.0,4525.0,60222.0
Surguja,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4598.0,5379.0,5093.0,4706.0,4730.0,4993.0,5305.0,4940.0,5287.0,4569.0,4738.0,5007.0,59345.0
Surguja,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,0.0,8.0,2.0,0.0,0.0,0.0,0.0,7.0,94.0,171.0,240.0,243.0,765.0
Surguja,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,47.0,129.0,84.0,50.0,54.0,89.0,280.0,692.0,2957.0,2299.0,1341.0,1831.0,9853.0
Surguja,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,25.0,29.0,35.0,5.0,15.0,20.0,10.0,190.0,707.0,1314.0,1679.0,2153.0,6182.0
Surguja,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,19.0,32.0,30.0,4.0,16.0,29.0,6.0,156.0,496.0,517.0,1350.0,2157.0,4812.0
Surguja,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4150.0,5361.0,5754.0,5849.0,6446.0,5264.0,5358.0,4510.0,6853.0,4393.0,3270.0,4603.0,61811.0
Surguja,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,12.0,7.0,0.0,0.0,0.0,255.0,123.0,0.0,0.0,18.0,64.0,146.0,625.0
Surguja,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,,0.0,,,,,,,,,,,0.0
Surguja,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2132.0,3275.0,4091.0,3499.0,3613.0,3506.0,3100.0,2246.0,3407.0,2247.0,1876.0,2303.0,35295.0
Surguja,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1948.0,2883.0,3716.0,3271.0,3290.0,3187.0,2745.0,2032.0,3124.0,2175.0,1740.0,2115.0,32226.0
Surguja,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4080.0,6158.0,7807.0,6770.0,6903.0,6693.0,5845.0,4278.0,6531.0,4422.0,3616.0,4418.0,67521.0
Surguja,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2717.0,3916.0,4070.0,4055.0,4153.0,3949.0,4074.0,2899.0,6285.0,4060.0,2948.0,4071.0,47197.0
Surguja,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2717.0,3748.0,3959.0,3838.0,3784.0,3850.0,3917.0,2793.0,5957.0,3675.0,2739.0,3817.0,44794.0
Surguja,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,4.0,412.0,429.0,380.0,454.0,403.0,375.0,10.0,40.0,31.0,14.0,59.0,2611.0
Surguja,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1071.0,2096.0,2173.0,2087.0,1910.0,2032.0,2055.0,1073.0,1846.0,1126.0,794.0,990.0,19253.0
Surguja,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,940.0,1977.0,2041.0,2031.0,1911.0,1767.0,1910.0,975.0,1731.0,1066.0,754.0,957.0,18060.0
Surguja,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2011.0,4073.0,4214.0,4118.0,3821.0,3799.0,3965.0,2048.0,3577.0,2192.0,1548.0,1947.0,37313.0
Surguja,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,585.0,1140.0,1271.0,1529.0,2346.0,1895.0,1836.0,1576.0,5232.0,2348.0,1264.0,1789.0,22811.0
Surguja,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1300.0,2415.0,2446.0,2946.0,6092.0,5930.0,4130.0,2853.0,6190.0,4421.0,2314.0,2730.0,43767.0
Surguja,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1093.0,1942.0,2170.0,2344.0,4397.0,3759.0,3011.0,2523.0,4328.0,3375.0,1919.0,2557.0,33418.0
Surguja,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,10.0,24.0,22.0,62.0,34.0,6.0,7.0,0.0,3.0,4.0,5.0,180.0
Surguja,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,15.0,12.0,6.0,7.0,1.0,0.0,0.0,0.0,0.0,0.0,41.0
Surguja,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,0.0,13.0,0.0,11.0,13.0,14.0,0.0,0.0,19.0,6.0,7.0,91.0
Surguja,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2470.0,2738.0,2758.0,2736.0,2784.0,2472.0,2694.0,2253.0,3089.0,2585.0,2393.0,2474.0,31446.0
Surguja,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2402.0,2768.0,2757.0,2688.0,2665.0,2392.0,2475.0,2182.0,2927.0,2503.0,2186.0,2432.0,30377.0
Surguja,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2280.0,2861.0,2749.0,2670.0,2684.0,2239.0,2400.0,2051.0,2777.0,2500.0,2071.0,2339.0,29621.0
Surguja,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Surguja,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3298.0,4587.0,5134.0,5544.0,5134.0,4781.0,4862.0,3425.0,7568.0,4149.0,3050.0,4384.0,55916.0
Surguja,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,710.0,1181.0,856.0,2289.0,2935.0,1558.0,1751.0,803.0,14226.0,6828.0,999.0,1202.0,35338.0
Surguja,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,442.0,627.0,434.0,1310.0,2495.0,955.0,1012.0,522.0,15632.0,6172.0,696.0,961.0,31258.0
Surguja,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,115.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,120.0
Surguja,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,66.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,70.0
Surguja,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,23.0,0.0,0.0,22.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Surguja,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Surguja,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,38.0,143.0,106.0,69.0,125.0,100.0,107.0,24.0,10.0,4.0,6.0,1.0,733.0
Surguja,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,615.0,1230.0,1136.0,1160.0,1215.0,971.0,531.0,275.0,473.0,480.0,482.0,701.0,9269.0
Surguja,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,132.0,1486.0,1804.0,1186.0,1464.0,1182.0,879.0,222.0,84.0,149.0,88.0,57.0,8733.0
Surguja,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,87.0,240.0,165.0,77.0,158.0,209.0,122.0,65.0,44.0,121.0,176.0,176.0,1640.0
Surguja,13.1,Number of Patients operated for cataract,TOTAL,28.0,88.0,152.0,553.0,746.0,300.0,435.0,665.0,421.0,395.0,307.0,129.0,4219.0
Surguja,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,28.0,80.0,159.0,539.0,725.0,295.0,363.0,431.0,424.0,324.0,291.0,128.0,3787.0
Surguja,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,61.0,169.0,329.0,52.0,39.0,33.0,152.0,553.0,199.0,1587.0
Surguja,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,4.0,53.0,34.0,52.0,0.0,13.0,0.0,132.0,173.0,461.0
Surguja,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,14.0,12.0,11.0,13.0,14.0,13.0,7.0,8.0,7.0,8.0,8.0,-1.0
Surguja,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,29.0,52.0,49.0,48.0,48.0,53.0,47.0,28.0,28.0,23.0,21.0,21.0,-1.0
Surguja,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2126.0,2096.0,2122.0,2245.0,2195.0,2103.0,1992.0,1934.0,2257.0,2010.0,1867.0,2042.0,-1.0
Surguja,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,16.0,13.0,12.0,14.0,15.0,15.0,16.0,14.0,13.0,13.0,10.0,-1.0
Surguja,14.05,Number of RKS meetings held during the month,TOTAL,11.0,11.0,14.0,15.0,9.0,12.0,15.0,13.0,11.0,10.0,14.0,19.0,154.0
Surguja,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,40.0,71.0,69.0,59.0,62.0,70.0,62.0,40.0,37.0,35.0,35.0,36.0,-1.0
Surguja,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,97.0,100.0,147.0,264.0,149.0,127.0,198.0,206.0,186.0,155.0,198.0,214.0,2041.0
Surguja,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,12.0,12.0,14.0,10.0,14.0,13.0,13.0,9.0,12.0,10.0,11.0,9.0,-1.0
Surguja,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,1.0,1.0,2.0,1.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,-1.0
Surguja,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,400.0,300.0,421.0,414.0,485.0,389.0,470.0,238.0,266.0,204.0,304.0,1243.0,5134.0
Surguja,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2616.0,2447.0,2578.0,2920.0,3626.0,3178.0,2905.0,2359.0,1939.0,1908.0,1898.0,2647.0,31021.0
Surguja,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,419.0,302.0,348.0,345.0,485.0,315.0,344.0,229.0,240.0,213.0,318.0,1864.0,5422.0
Surguja,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3890.0,3462.0,3668.0,4485.0,4665.0,4558.0,3920.0,3630.0,3161.0,2918.0,3304.0,3903.0,45564.0
Surguja,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,819.0,602.0,769.0,759.0,970.0,704.0,814.0,467.0,506.0,417.0,622.0,3107.0,10556.0
Surguja,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6506.0,5909.0,6246.0,7405.0,8291.0,7736.0,6825.0,5989.0,5100.0,4826.0,5202.0,6550.0,76585.0
Surguja,14.10.2.a,Number of death cases of Inpatient males,TOTAL,45.0,51.0,55.0,59.0,66.0,63.0,60.0,58.0,35.0,45.0,36.0,52.0,625.0
Surguja,14.10.2.b,Number of death cases of Inpatient females,TOTAL,33.0,47.0,38.0,53.0,50.0,59.0,31.0,30.0,23.0,21.0,43.0,42.0,470.0
Surguja,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,78.0,98.0,93.0,112.0,116.0,122.0,91.0,88.0,58.0,66.0,79.0,94.0,1095.0
Surguja,14.11,In-Patient Head Count at midnight,TOTAL,393.0,374.0,367.0,891.0,741.0,333.0,621.0,357.0,256.0,567.0,599.0,833.0,6332.0
Surguja,14.12.1,OPD attendance (All),TOTAL,58025.0,62859.0,68328.0,77206.0,83586.0,85895.0,77197.0,63869.0,64145.0,38436.0,66488.0,71500.0,817534.0
Surguja,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,315.0,401.0,503.0,913.0,593.0,331.0,537.0,172.0,295.0,8922.0,185.0,418.0,13585.0
Surguja,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,,,,,,,,,,,,,
Surguja,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,271.0,282.0,306.0,351.0,310.0,265.0,318.0,349.0,385.0,381.0,571.0,418.0,4207.0
Surguja,14.14.a,Number of patients given AYUSH treatment,TOTAL,2404.0,2428.0,3392.0,3602.0,3746.0,4898.0,4611.0,5146.0,4288.0,3043.0,5437.0,6217.0,49212.0
Surguja,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,339.0,450.0,454.0,488.0,168.0,195.0,373.0,332.0,287.0,493.0,776.0,550.0,4905.0
Surguja,14.14.c,Number of Adolescents counselled,TOTAL,29.0,63.0,74.0,70.0,177.0,157.0,45.0,42.0,9.0,233.0,18.0,23.0,940.0
Surguja,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3347.0,2993.0,4295.0,4716.0,3809.0,13090.0,2879.0,3752.0,3649.0,3339.0,3606.0,4261.0,53736.0
Surguja,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,189.0,275.0,277.0,305.0,312.0,286.0,166.0,272.0,303.0,282.0,251.0,151.0,3069.0
Surguja,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,173.0,153.0,248.0,139.0,185.0,109.0,293.0,360.0,454.0,270.0,416.0,405.0,3205.0
Surguja,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2.0,5.0,0.0,3.0,2.0,4.0,5.0,1.0,2.0,7.0,9.0,5.0,45.0
Surguja,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,135.0,170.0,203.0,276.0,177.0,224.0,166.0,139.0,158.0,228.0,318.0,330.0,2524.0
Surguja,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4.0,42.0,45.0,55.0,62.0,21.0,2.0,0.0,0.0,4.0,1.0,1.0,237.0
Surguja,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,227.0,246.0,174.0,255.0,316.0,155.0,108.0,137.0,129.0,126.0,231.0,283.0,2387.0
Surguja,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,203.0,233.0,241.0,191.0,0.0,9.0,0.0,1.0,1.0,1.0,0.0,881.0
Surguja,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,535.0,569.0,625.0,670.0,678.0,488.0,567.0,636.0,741.0,624.0,965.0,1018.0,8116.0
Surguja,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7.0,250.0,278.0,299.0,255.0,25.0,16.0,1.0,3.0,12.0,11.0,6.0,1163.0
Surguja,15.2,Number of Widal tests conducted,Number tested,180.0,131.0,276.0,349.0,391.0,207.0,305.0,152.0,288.0,97.0,230.0,329.0,2935.0
Surguja,15.3.a,Number of VDRL tests conducted on males,Number tested,75.0,20.0,172.0,27.0,42.0,36.0,70.0,11.0,15.0,16.0,35.0,35.0,554.0
Surguja,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,66.0,91.0,150.0,121.0,91.0,114.0,53.0,19.0,65.0,26.0,79.0,109.0,984.0
Surguja,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,211.0,233.0,341.0,360.0,280.0,55.0,98.0,72.0,83.0,34.0,111.0,104.0,1982.0
Surguja,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,352.0,344.0,663.0,508.0,413.0,205.0,221.0,102.0,163.0,76.0,225.0,248.0,3520.0
Surguja,15.4.1,Number of blood smears examined for Malaria,TOTAL,8774.0,10013.0,15249.0,15829.0,15107.0,17325.0,14873.0,12391.0,11179.0,6965.0,8501.0,8097.0,144303.0
Surguja,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,290.0,138.0,136.0,663.0,610.0,410.0,241.0,288.0,138.0,183.0,109.0,114.0,3320.0
Surguja,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,396.0,322.0,421.0,912.0,727.0,836.0,601.0,669.0,445.0,241.0,234.0,236.0,6040.0
Surguja,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.1,Stock position of DPT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.3,Stock position of TT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.6,Stock position of Measles vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,,,,,,,,,,,,
Surguja,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,,,,,,,
Surguja,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Surguja,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,,,,,,,,,
Surguja,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Surguja,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,10.0,9.0,6.0,4.0,10.0,5.0,9.0,1.0,6.0,4.0,5.0,72.0
Surguja,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,1.0,,,,2.0,,,1.0,,,,5.0
Surguja,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,2.0,,,,,,,4.0
Surguja,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,,,1.0,4.0,,,1.0,,,,9.0
Surguja,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,,3.0,,3.0
Surguja,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,1.0,,2.0
Surguja,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,,,,,,,4.0,,5.0
Surguja,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,4.0,5.0,4.0,9.0,3.0,5.0,4.0,1.0,,7.0,,44.0
Surguja,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,4.0,,2.0,1.0,4.0,1.0,1.0,,,,14.0
Surguja,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,4.0,9.0,4.0,11.0,4.0,9.0,5.0,2.0,,7.0,,58.0
Surguja,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,3.0,2.0,2.0,1.0,2.0,2.0,,2.0,2.0,2.0,1.0,19.0
Surguja,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,1.0,3.0,1.0,4.0,2.0,4.0,,3.0,,2.0,3.0,24.0
Surguja,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,4.0,5.0,3.0,5.0,4.0,6.0,,5.0,2.0,4.0,4.0,43.0
Surguja,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,1.0,2.0,3.0,6.0,4.0,5.0,7.0,6.0,1.0,9.0,6.0,52.0
Surguja,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,3.0,1.0,,1.0,4.0,4.0,3.0,13.0,4.0,1.0,,1.0,35.0
Surguja,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,5.0,2.0,2.0,4.0,10.0,8.0,8.0,20.0,10.0,2.0,9.0,7.0,87.0
Surguja,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,1.0,,,,,,,,,,,2.0,3.0
Surguja,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Surguja,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,1.0,,,,,,,,,,,3.0,4.0
Surguja,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,1.0,,,2.0,4.0,2.0,,,,1.0,11.0
Surguja,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,1.0,,2.0,,3.0,7.0,2.0,,1.0,1.0,18.0
Surguja,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,1.0,2.0,,2.0,2.0,7.0,9.0,2.0,,1.0,2.0,29.0
Surguja,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Surguja,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Surguja,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Surguja,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,3.0,5.0,2.0,7.0,7.0,7.0,9.0,7.0,12.0,11.0,8.0,80.0
Surguja,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,2.0,6.0,11.0,2.0,5.0,8.0,8.0,3.0,1.0,8.0,56.0
Surguja,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,5.0,7.0,8.0,18.0,9.0,12.0,17.0,15.0,15.0,12.0,16.0,136.0
Surguja,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,2.0,4.0,3.0,,,,,,9.0
Surguja,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,2.0,,,,1.0,,,3.0
Surguja,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,2.0,6.0,3.0,,,1.0,,,12.0
Surguja,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,3.0,4.0,5.0,,1.0,1.0,3.0,1.0,,2.0,23.0
Surguja,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,1.0,,,1.0,1.0,,,,,,5.0
Surguja,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,3.0,4.0,4.0,5.0,1.0,2.0,1.0,3.0,1.0,,2.0,28.0
Surguja,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,,,1.0,,2.0,1.0,,1.0,1.0,1.0,1.0,,8.0
Surguja,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,,,,1.0,,,,,,1.0,2.0,,4.0
Surguja,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,,,1.0,1.0,2.0,1.0,,1.0,1.0,2.0,3.0,,12.0
Surguja,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,2.0,1.0,,,,,,,3.0
Surguja,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,4.0,,,2.0,,,,,7.0
Surguja,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,1.0,,,1.0,2.0,5.0,1.0,,,,11.0
Surguja,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,1.0,1.0,6.0,2.0,2.0,7.0,1.0,,,,21.0
Surguja,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,1.0,,3.0,1.0,1.0,4.0,1.0,,1.0,1.0,14.0
Surguja,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,9.0,1.0,4.0,7.0,2.0,3.0,3.0,5.0,2.0,2.0,3.0,44.0
Surguja,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,4.0,1.0,,2.0,3.0,1.0,2.0,3.0,,,5.0,22.0
Surguja,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,14.0,3.0,4.0,12.0,6.0,5.0,9.0,9.0,2.0,3.0,9.0,80.0
Surguja,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Surguja,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,,,,,,,1.0,,2.0
Surguja,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Surguja,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,,,,2.0,,,,,,,1.0,,3.0
Surguja,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,,,,1.0,,1.0,3.0
Surguja,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,1.0,2.0,6.0,4.0,8.0,7.0,4.0,5.0,1.0,4.0,3.0,3.0,48.0
Surguja,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,5.0,11.0,8.0,12.0,5.0,9.0,15.0,8.0,10.0,8.0,7.0,4.0,102.0
Surguja,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,6.0,13.0,14.0,17.0,13.0,16.0,19.0,13.0,11.0,13.0,10.0,8.0,153.0
Surguja,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Surguja,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,2.0,,2.0,2.0,3.0,3.0,2.0,1.0,1.0,,2.0,18.0
Surguja,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,,1.0,,,1.0,,1.0,,1.0,1.0,,1.0,6.0
Surguja,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,,3.0,,2.0,3.0,3.0,4.0,2.0,2.0,2.0,1.0,3.0,25.0
Surguja,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,1.0,,1.0,1.0,,,,,,,,,3.0
Surguja,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Surguja,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,1.0,,1.0,1.0,,,,,,,,,3.0
Surguja,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,1.0,1.0,,1.0,,,,,,4.0
Surguja,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,2.0,,,,,,,,,2.0
Surguja,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,3.0,1.0,,1.0,,,,,,6.0
Surguja,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,2.0,1.0,,1.0,1.0,1.0,,,1.0,,7.0
Surguja,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,1.0,,1.0,,1.0,,1.0,1.0,2.0,2.0,9.0
Surguja,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,3.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,3.0,2.0,16.0
Surguja,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,2.0,,,,,,,3.0
Surguja,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,1.0,,,,1.0
Surguja,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,2.0,,,1.0,,,,4.0
Surguja,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,1.0,,,,,,2.0
Surguja,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,2.0,,,,2.0
Surguja,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,1.0,,2.0,,,,4.0
Surguja,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Surguja,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,2.0,6.0,4.0,8.0,7.0,2.0,5.0,4.0,7.0,2.0,8.0,57.0
Surguja,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,1.0,2.0,4.0,3.0,4.0,5.0,2.0,1.0,,2.0,4.0,1.0,29.0
Surguja,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3.0,4.0,10.0,7.0,12.0,12.0,4.0,6.0,4.0,9.0,6.0,9.0,86.0
Surguja,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,3.0,5.0,5.0,6.0,3.0,3.0,,,,1.0,4.0,30.0
Surguja,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,12.0,16.0,13.0,20.0,12.0,19.0,10.0,19.0,10.0,6.0,18.0,165.0
Surguja,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,6.0,6.0,4.0,6.0,5.0,5.0,2.0,3.0,1.0,5.0,5.0,2.0,50.0
Surguja,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,16.0,21.0,25.0,24.0,31.0,20.0,24.0,13.0,20.0,15.0,12.0,24.0,245.0
Surguja,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,1.0,1.0,1.0,,1.0,,,1.0,6.0
Surguja,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,10.0,10.0,19.0,7.0,12.0,2.0,5.0,11.0,12.0,6.0,20.0,120.0
Surguja,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,2.0,3.0,,1.0,1.0,1.0,,1.0,,1.0,2.0,14.0
Surguja,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,8.0,13.0,13.0,19.0,9.0,14.0,4.0,5.0,13.0,12.0,7.0,23.0,140.0
Surguja,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,4.0,2.0,3.0,,1.0,3.0,,,,1.0,15.0
Surguja,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,9.0,7.0,7.0,14.0,3.0,6.0,4.0,4.0,2.0,1.0,2.0,61.0
Surguja,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,2.0,7.0,1.0,8.0,4.0,2.0,2.0,2.0,1.0,1.0,4.0,34.0
Surguja,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,12.0,18.0,10.0,25.0,7.0,9.0,9.0,6.0,3.0,2.0,7.0,110.0
Surguja,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,3.0,,5.0,5.0,2.0,2.0,7.0,,3.0,1.0,,,28.0
Surguja,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,29.0,25.0,33.0,29.0,31.0,31.0,42.0,30.0,27.0,9.0,27.0,32.0,345.0
Surguja,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,15.0,15.0,32.0,13.0,15.0,16.0,23.0,20.0,16.0,21.0,24.0,20.0,230.0
Surguja,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,47.0,40.0,70.0,47.0,48.0,49.0,72.0,50.0,46.0,31.0,51.0,52.0,603.0
Surguja,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,4.0,2.0,2.0,,1.0,3.0,1.0,2.0,1.0,2.0,19.0
Surguja,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,9.0,8.0,12.0,18.0,22.0,13.0,20.0,22.0,18.0,16.0,15.0,184.0
Surguja,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,21.0,32.0,32.0,34.0,51.0,53.0,48.0,43.0,41.0,46.0,45.0,37.0,483.0
Surguja,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,33.0,41.0,44.0,48.0,71.0,75.0,62.0,66.0,64.0,66.0,62.0,54.0,686.0
Surguja,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,2.0,6.0,8.0,4.0,7.0,7.0,,2.0,4.0,41.0
Surguja,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,22.0,32.0,41.0,41.0,28.0,31.0,40.0,25.0,22.0,27.0,20.0,345.0
Surguja,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,42.0,52.0,50.0,110.0,137.0,139.0,86.0,112.0,93.0,91.0,83.0,61.0,1056.0
Surguja,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,58.0,74.0,83.0,153.0,184.0,175.0,121.0,159.0,125.0,113.0,112.0,85.0,1442.0
